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1.1  Introduction
A large variety of disorders affect the pituitary gland and sur-
rounding region. By far the commonest disorders are pituitary 
adenomas and Rathke’s cleft cysts. Magnetic resonance 
imaging (MRI) is the imaging modality of choice in the inves-
tigation of pituitary pathology. Patients are referred for MR 
imaging of the pituitary most commonly on the basis of clini-
cal and laboratory findings, although given the frequency of 
MR imaging of the brain, it is also not uncommon to discover 
lesions in this region as incidental findings. Computed tomog-
raphy (CT) is used in occasional cases where intra-lesional 
calcifications or bone destruction is suspected.
1.2  Pituitary Adenomas
Despite the many advances in MR imaging over the past 
decade, the imaging work-up of pituitary disease remains 
largely unchanged. T1-weighted images are obtained in the 
sagittal and coronal plane as well as a T2-weighted sequence 
in the coronal (occasionally sagittal). Contrast-enhanced 
sequences are also done in many, but not all, centers on a rou-
tine basis. Many investigators also perform dynamic contrast- 
enhanced T1-weighted imaging, and occasionally delayed 
enhanced images, especially if the patient is a surgical candi-
date and conventional imaging is negative or equivocal.
Pituitary microadenomas commonly exhibit hypointen-
sity to the normal adenohypophysis on T1-weighted images. 
The lesions are round or oval in shape; more commonly than 
not, the pituitary infundibulum is deviated away from the 
side of the lesion. Occasionally, pituitary adenomas may 
exhibit hyperintensity on T1-weighted images, generally 
reflecting internal hemorrhage. Such hemorrhage is more 
common in prolactinomas, oftentimes spontaneous or fol-
lowing pharmacotherapy.
The signal intensity on T2-weighted images of microad-
enomas is variable, although if focal hyperintensity to the 
normal gland is seen, a microadenoma is likely. Hypointensity 
on T2-weighted images is also a helpful feature. In the clini-
cal and laboratory scenario of excess growth hormone, a 
mass of focal T2 hypointensity is highly correlated with a 
diagnosis of a densely granulated GH-secreting adenoma.
In many cases of prolactinoma, unenhanced T1- and 
T2-weighted imaging is normal. If the lesion is not obvi-
ous, contrast enhancement is indicated. As the pituitary is a 
 circumventricular organ and not subject to the blood–brain 
barrier, a half dose of paramagnetic contrast is generally suf-
ficient. Following the administration of contrast, a hypoin-
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Learning Objectives
• Acquire knowledge of the micro-anatomy of the 
parasellar region.
• Learn the basic physiology of the hypothalamic–
pituitary axis.
• Gain an understanding of the diagnostic features of 
the most common lesions arising from each structure 
in this region.
• Become proficient in establishing a concise differ-
ential diagnosis.
Key Point
• Knowledge of the anatomy of the pituitary gland, 
pituitary stalk, cavernous sinuses, suprasellar cis-
tern, optic chiasm, and arteries of the central skull 
base, and their relationship to one another, is essen-
tial for accurate diagnosis.
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tense lesion either surrounded by, or superiorly capped by 
normal avidly enhancing pituitary tissue will reveal a micro-
adenoma or other lesions in the differential diagnosis. As 
well, delayed contrast-enhanced imaging may inadvertently 
obscure microadenomas by virtue of their slower “wash-in” 
curve, relative to normal pituitary. Uncommonly, a small 
tuft of intra-lesional enhancement may be seen within an 
otherwise hypointense (lesser enhancing) microadenoma. 
Dynamic contrast-enhancing imaging may be useful for 
some microadenomas, especially ACTH- secreting tumors.
In contradistinction to the microadenoma, pituitary mac-
roadenomas (defined as tumors greater than 10 mm in size) 
often extend beyond the confines of the sella. Most com-
monly, such tumors extend cephalad toward the optic chiasm 
and hypothalamus or laterally into the cavernous sinus. 
While the delineation of such extension has always been 
important to the surgeon, with the increasing adoption of 
transnasal endoscopic surgical approaches to the sella and 
parasellar regions, the description of such extension has 
become a routine component of the preoperative neurosurgi-
cal checklist.
Macroadenomas that extend cephalad are commonly 
bilobed in shape, constrained at the waist by the diaphragma 
sellae. Unlike their microadenoma counterparts which are 
more commonly of one signal intensity, macroadenomas 
usually are of multiple signal intensities due to the mixed 
solid and cystic nature of these lesions. Solid components 
tend to be slightly hypointense on T2 and T2-weighted 
images and exhibit some contrast enhancement. Cystic and/
or necrotic components exhibit variable signal, but often 
contain proteinaceous debris which may show some hyperin-
tensity on T1-weighted images. On T2-weighted images, 
hyperintensity within the cystic or necrotic components of an 
adenoma is common. Occasionally, an intra-tumoral, intra- 
cystic component may reveal a fluid-fluid level, perhaps 
reflecting intra-lesional hemorrhage.
Usually the posterior lobe hyperintensity on T1-weighted 
images is positioned slightly behind the adenohypophysis, 
often within a cup-shaped depression of the dorsum sellae. 
With a macroadenoma the normal neurohypophysis may be 
compressed, laterally displaced, or completely absent from 
the normal location. In many cases compression of the infun-
dibulum is disruptive enough that the neurohypophyseal 
function is displaced upstream, with a “new” bright spot 
more cephalad along the infundibulum.
Cavernous sinus involvement may be due to compressive 
growth and consequent medial and occasionally lateral dural 
reflection or due to true invasion of the sinus. On imaging, 
invasion is suggested by tumor appearing to encircle the cav-
ernous internal carotid artery. Invasion is excluded if normal 
pituitary tissue is seen between the mass and the sinus.
There is a correlation between prolactin levels and ade-
noma size. However, given two prolactinomas of equal size, 
the hypointense tumor on T2-weighted images usually 
secretes more prolactin than its counterpart. Medical treat-
ment based on bromocriptine decreases adenoma volume 
drastically; occasionally, bromocriptine-induced hemor-
rhage can be seen.
While prolactinomas and growth hormone (GH)-secreting 
adenomas are usually located laterally in the sella turcica, 
ACTH-secreting adenomas in Cushing’s disease, usually 
smaller in size and more difficult to detect, are more often 
located in the midline. Because of the severe prognosis of 
this disease and the surgical possibilities, ACTH-secreting 
lesions require the most detailed and exhaustive imaging.
GH-secreting adenomas have the unique characteristic of 
exhibiting hypointensity on T2-weighted images in two- 
thirds of cases, usually the densely granulated subtype. 
Spontaneous infarction or necrosis of GH-secreting adeno-
mas is far from exceptional. Some cases of acromegaly that 
were detected late in the course of the disease exhibited an 
enlarged, partially empty sella turcica, lined with adenoma-
tous tissue that proved difficult to analyze. Medical treat-
ment based on octreotide analogs (somatostatin) decreases 
the size of the adenoma by an average of 35% and brings the 
level of somatomedin C back to normal in 50% of cases.
Macroadenomas can be nonfunctioning, but they can also 
be prolactin-secreting adenomas, gonadotroph adenomas, and 
growth hormone-secreting adenomas. The greater their size, 
the more heterogeneous they are, as areas of cystic necrosis 
are caused by poor tumoral blood supply. Gonadotroph adeno-
mas are often massive and have a strong tendency to recur.
Hemorrhage occurs in all or parts of 20% of all pituitary 
adenomas, but it is usually occult. Pituitary apoplexy, with 
severe headache, cranial nerve paralysis, and severe hypo-
pituitarism, is generally caused by massive hemorrhage 
within a pituitary macroadenoma. Smaller scale hemor-
rhage occurs much more often and can be seen within pitu-
itary adenomas.
Surgery of the sella and parasellar region is currently usu-
ally undertaken via the transsphenoidal and transnasal endo-
scopic. The transnasal endoscopic approach to the sella has 
been more widely adopted for a number of reasons. Multiple 
instruments can be utilized, including angled endoscopes. A 
transnasal mucosal flap can be created at the time of surgery. 
This flap has been very successful at limiting complication 
of CSF leak. And the exposure can be lateralized to extend to 
parasellar lesions, as well as extended posteriorly through 
the clivus to reach the prepontine cistern, the basilar artery, 
and the anterior brainstem.
Preoperative CT is often routinely performed in some 
centers. CT will reveal bony anatomy including the number 
and location of intra-sphenoidal septae and their insertions, 
the presence of Onodi cells, and the degree of aeration of 
the sphenoid sinus, all of which may influence the surgical 
approach, patient safety and ultimately, the patient outcome.
W. Kucharczyk and C. L. Truwit
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1.3  Postoperative Sella Turcica 
and Pituitary Gland
The surgical cavity immediately after surgery is often filled 
with packing material after transsphenoidal resection of a pitu-
itary adenoma. Surgicel is frequently used and is impregnated 
with blood and secretions. The presence of packing material, 
secretions, and periadenomatous adhesions usually keeps the 
cavity from collapsing in the days and weeks that follow sur-
gery. Blood, secretions, and packing material slowly involute 
over the following 2–3 months. Even after a few months, frag-
ments of blood-impregnated Surgicel can still be found in the 
surgical cavity. If the diaphragm of the sella turcica is torn in 
the course of surgery, fat or muscle implants are inserted by 
the surgeon to prevent the occurrence of a cerebrospinal fluid 
fistula. Their resorption takes much longer. Implanted fat invo-
lutes slowly and may exhibit hyperintensity on the T1-weighted 
image up to 2–3  years after surgery. Postoperative MRI 
2–3 months after surgery is useful to monitor further develop-
ment of a resected adenoma. An earlier MRI examination 
performed 48 hours after surgery checks for potential compli-
cations and may visualize what appears to be residual tumor, 
i.e., a mass of intensity identical to that of the adenoma before 
surgery that commonly occupies a peripheral portion of the 
adenoma. This early investigation is extremely helpful to 
interpret the follow- up MR images. At this stage, the remain-
ing normal pituitary tissue can be characterized: it is usually 
asymmetrical, and a hyperintense area is frequently observed 
at the base of the deviated hypophyseal stalk, due to an ectopic 
collection of neurohypophyseal secretory vesicles. The 
2-month follow- up MRI examination is essential to check for 
residual tumor. Late follow-up MRI, after 1–2 years or more, 
usually demonstrates adenoma recurrence as a rounded or 
convex progressively enlarging mass.
1.4  3T MRI and DWI for Pituitary Imaging
The improved SNR of 3T scanners relative to 1.5T can be 
traded off for thinner image slices and smaller voxels, thereby 
offering improved spatial resolution at comparable SNR. 
Hence, some microadenomas may be detected at 3T that are 
invisible at 1.5T. Also, the cavernous sinus wall can be depicted 
more consistently. These facts favor the performance of pitu-
itary exams on 3T MRI.  DWI and ADC images have been 
applied to pituitary imaging as aid to determining tumor con-
sistency and thereby aiding surgical planning. Early evidence 
suggests that soft adenomas with high cellularity and scant 
fibrous stroma have low ADCs, whereas firm adenomas, with 
low cellularity and abundant fibrous stroma, have high ADCs. 
DWI obtained without echo planar imaging offers improved 
imaging at the skull base. Such TSE-based DWI is increasingly 
supplanting echo planar DWI in pituitary imaging.
1.5  Craniopharyngioma
Craniopharyngiomas are epithelial-derived neoplasms that 
occur exclusively in the region of the sella turcica and supra-
sellar cistern or in the third ventricle. Craniopharyngiomas 
account for approximately 3% of all intracranial tumors and 
show no gender predominance. Craniopharyngiomas are 
hormonally inactive lesions, although compression of the 
stalk may result in diabetes insipidus. They have a bimodal 
age distribution; more than half occur in childhood or ado-
lescence, with a peak incidence between 5 and 10 years of 
age; there is a second smaller peak in adults in the sixth 
decade. The tumors vary greatly in size, from a few millime-
ters to several centimeters in diameter. The center of most is 
in the suprasellar cistern. Infrequently, the lesions are entirely 
within the sella or in the third ventricle.
Most discussions of craniopharyngiomas in the litera-
ture are confined to the most frequent form, the classic 
adamantinomatous type, but a distinct papillary type is 
also recognized. Typically, adamantinomatous craniopha-
ryngiomas are identified during the first two decades of 
life. These children most often present with symptoms 
and signs of increased intracranial pressure: headache, 
nausea, vomiting, and papilledema. Visual disturbances 
due to compression of the optic apparatus are also fre-
quent but difficult to detect in young children. Others 
present with pituitary hypofunction because of compres-
sion of the pituitary gland, pituitary stalk, or hypothala-
mus. Rarely, adamantinomatous craniopharyngiomas are 
found outside the suprasellar cistern, including the poste-
rior fossa, pineal region, third ventricle, and nasal cavity 
(sphenoid sinus).
Adamantinomatous tumors are almost always grossly 
cystic and usually have both solid and cystic components. 
Calcification is seen in the vast majority (~90%) of these 
tumors. Commonly, these calcifications can be identified on 
MR scans as low signal nodular excrescences of the wall of 
the primary lesion. Occasionally, the calcifications are diffi-
cult to discern; in these cases, CT will prove helpful. 
Extensive fibrosis and signs of inflammation are often found 
with these lesions, particularly when they are recurrent, so 
that they adhere to adjacent structures, including the vascula-
ture at the base of the brain. Optic tract edema on T2-weighted 
images is a common associated finding that is not commonly 
seen with other suprasellar masses. Due to the inflammatory 
Key Point
• The most common lesions in the sella turcica are 
pituitary adenomas and Rathke’s cleft cysts. Most 
of these are visible on non-contrast MRI.
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and fibrotic nature of this lesion, recurrence is common, typi-
cally occurring within the first 5 years after surgery.
The most characteristic MRI finding is a suprasellar mass 
that is heterogeneous and contains a cystic component that is 
well defined, internally uniform, and hyperintense on both 
T1- and T2-weighted images. Almost always, an adamanti-
nomatous craniopharyngioma that presents with large cystic 
components in the middle cranial fossa and elsewhere can be 
traced back to the suprasellar region, where a more solid, 
enhancing component of the lesion can be seen. On rare 
occasions, the cyst is absent and the solid component is com-
pletely calcified. These calcified types of tumors can be 
entirely overlooked on MRI unless close scrutiny is paid to 
subtle distortion of the normal suprasellar anatomy. Contrast 
medium administration causes a moderate degree of enhance-
ment of the solid portion of the tumor, which otherwise may 
be difficult to see.
Papillary craniopharyngiomas are typically found in adult 
patients. These lesions are solid, without calcification, and 
may be found within the third ventricle. Although surgery 
remains the definitive mode of therapy for all craniopharyn-
giomas, as papillary variants are encapsulated and are read-
ily separable from nearby structures and adjacent brain, they 
are generally thought to recur much less frequently than the 
adamantinomatous type.
In distinction from their adamantinomatous counterpart, 
MRI typically shows papillary craniopharyngiomas as solid 
lesions. Occasionally, cysts may be seen, although they are 
unlikely to be dominant cysts as in the adamantinomatous 
variety. These lesions demonstrate a non-specific signal 
intensity pattern, without the characteristic hyperintensity on 
T1-weighted images of the cystic component of adamantino-
matous tumors. Like all craniopharyngiomas, papillary 
lesions typically enhance.
1.6  Rathke’s Cleft Cyst
Symptomatic cysts of Rathke’s cleft are less frequent than 
craniopharyngiomas, although asymptomatic Rathke’s cysts 
are a common incidental finding at autopsy. In a recent eval-
uation of 1000 non-selected autopsy specimens, 113 pitu-
itary glands (11.3%) harbored incidental Rathke’s cleft cysts. 
These cysts are predominantly intrasellar in  location. Of 
incidental Rathke’s cysts larger than 2 mm in a large autopsy 
series, 89% were localized to the center of the gland, whereas 
the remaining 11% extended to show predominant lateral 
lesions. In that series, of all incidental pituitary lesions local-
ized to the central part of the gland, 87% were Rathke’s 
cysts. Others may be centered in the suprasellar cistern, usu-
ally midline and anterior to the stalk. Rathke’s cysts are 
found in all age groups. They share a common origin with 
some craniopharyngiomas in that they are thought to origi-
nate from remnants of squamous epithelium from Rathke’s 
cleft. The cyst wall is composed of a single cell layer of 
columnar, cuboidal, or squamous epithelium on a basement 
membrane. The epithelium is often ciliated and may contain 
goblet cells. The cyst contents are typically mucoid, less 
commonly filled with serous fluid or desquamated cellular 
debris. Calcification in the cyst wall is rare.
Most Rathke’s cleft cysts are small and asymptomatic, 
incidentally discovered at autopsy. Symptoms occur if the 
cyst enlarges sufficiently to compress the pituitary gland or 
optic chiasm and rarely, secondary to hemorrhage. The cysts 
with mucoid fluid are hyperintense on T1- and T2-weighted 
images. Those with serous cysts match the signal intensity of 
cerebrospinal fluid (CSF). Those containing cellular debris 
pose the greatest difficulty in differential diagnosis for they 
resemble solid nodules. Rathke’s cleft cysts do not typically 
enhance. However, occasionally there may be thin marginal 
enhancement of the cyst wall. This feature can be used to 
advantage in difficult cases to separate these cysts from 
craniopharyngiomas.
1.7  Meningioma
Approximately 10% of meningiomas occur in the parasellar 
region. These tumors arise from a variety of locations around 
the sella including the tuberculum sellae, clinoid processes, 
medial sphenoid wing, and cavernous sinus. Meningiomas 
are usually slow-growing lesions that present because of 
compression of vital structures. Patients may suffer visual 
loss because of ophthalmoplegia due to cranial nerve involve-
ment, proptosis due to venous congestion at the orbital apex, 
or compression of the optic nerves, chiasm, or optic tracts.
Meningiomas are most frequently isointense—and less 
commonly hypointense—to gray matter on unenhanced 
T1-weighted sequences. Approximately 50% remain isoin-
tense on the T2-weighted sequence, whereas 40% are hyper-
intense. Since there is little image contrast to distinguish 
meningiomas from brain parenchyma, indirect signs such as 
a mass effect, thickening of the dura, buckling of adjacent 
white matter, white matter edema, and hyperostosis are 
important diagnostic features. Other diagnostic signs include 
visualization of a cleft of CSF separating the tumor from the 
brain (thus denoting that the tumor has an extra-axial 
 location) and a clear separation of the tumor from the pitu-
itary gland (thus indicating that the tumor is not of pituitary 
gland origin). The latter sign is particularly well assessed on 
sagittal views of planum sphenoidale meningiomas. A 
peripheral black rim occasionally noted at the edges of these 
meningiomas is thought to be related to surrounding veins. 
Hyperostosis and calcification are features that may be 
apparent on MRI but are better assessed with CT. Vascular 
encasement is not uncommon, particularly with meningio-
W. Kucharczyk and C. L. Truwit
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mas in the cavernous sinus. The pattern of encasement is of 
diagnostic value. Meningiomas commonly constrict the 
lumen of the encased vessel. This is rare with other tumors. 
As on CT, the intravenous administration of contrast medium 
markedly improves the visualization of basal meningiomas. 
They enhance intensely and homogeneously, often with a 
trailing edge of thick surrounding dura (the “dural tail sign”).
1.8  Chiasmatic and Hypothalamic 
Gliomas
The distinction between chiasmatic and hypothalamic glio-
mas often depends on the predominant position of the lesion. 
In many cases, the origin of large gliomas cannot be defini-
tively determined, as the hypothalamus and chiasm are 
inseparable; therefore, hypothalamic and chiasmatic gliomas 
are discussed as a single entity. The vast majority (75%) of 
these tumors occur in the first decade of life, with equal prev-
alence in males and females. There is a definite association 
of optic nerve and chiasmatic gliomas with neurofibromato-
sis, more so for tumors that arise from the beginning of optic 
nerve rather than from the chiasm or hypothalamus.
Tumors of chiasmal origin are also more aggressive than 
those originating from the optic nerves and tend to invade the 
hypothalamus and floor of the third ventricle and cause 
hydrocephalus. Patients suffer from monocular or binocular 
visual disturbances, hydrocephalus, or hypothalamic dys-
function. The appearance of the tumor depends on its posi-
tion and direction of growth. It can be confined to the chiasm 
or the hypothalamus; however, because of its slow growth, 
the tumor usually attains a considerable size by the time of 
presentation, and the site of origin is frequently conjectural. 
Smaller nerve and chiasmal tumors are visually distinct from 
the hypothalamus, and their site of origin is more clear-cut. 
From the point of view of differential diagnosis, these smaller 
tumors can be difficult to distinguish from optic neuritis, 
which can also cause optic nerve enlargement. The clinical 
history is important in these cases (neuritis is painful, tumor 
is not) and, if necessary, interval follow-up of neuritis will 
demonstrate resolution of optic nerve swelling.
On T1-weighted images, the tumors are most often isoin-
tense, while on T2-weighted images they are moderately 
hyperintense. Calcification and hemorrhage are not features 
of these gliomas but cysts are seen, particularly in the larger 
hypothalamic tumors. Contrast enhancement occurs in about 
half of all cases. Because of the tumor’s known propensity to 
invade the brain along the optic radiations, T2-weighted 
images of the entire brain are necessary. This pattern of 
tumor extension is readily evident as hyperintensity on the 
T2-weighted image; however, patients with neurofibromato-
sis (NF) present a problem in differential diagnosis. This 
relates to a high incidence of benign cerebral hamartomas 
and atypical glial cell rests in NF that can exactly mimic 
glioma. These both appear as areas of high signal intensity 
on T2-weighted images within the optic radiations. Lack of 
interval growth and possibly the absence of contrast enhance-
ment are more supportive of a diagnosis of hamartoma, while 
enhancement suggests glioma.
1.9  Metastases
Symptomatic metastases to the pituitary gland are found in 
1–5% of cancer patients. These are primarily patients with 
advanced, disseminated malignancy, particularly breast and 
bronchogenic carcinoma. The vast majority will succumb to 
their underlying disease before becoming symptomatic of 
pituitary disease. Autopsy series have demonstrated a much 
higher incidence, but these by and large are small and asymp-
tomatic lesions. Intrasellar and juxtasellar metastases arise 
via hematogenous seeding to the pituitary gland and stalk, by 
CSF seeding, and by direct extension from head and neck 
neoplasms. There are no distinctive MRI characteristics of 
metastases, although infundibular involvement is common, 
and bone destruction is a prominent feature of lesions that 
involve skull base. Occasionally, leptomeningeal enhance-
ment of posterior fossa sulci may be visualized on the post- 
contrast images which lends credence to the diagnosis in 
those cases of CSF tumor seeding, although this finding also 
invokes the differential diagnosis of sarcoidosis and 
tuberculosis.
1.10  Infections
Infection in the suprasellar cistern and cavernous sinuses is 
usually part of a disseminated process, or occurs by means of 
intracranial extension of an extracranial infection. The basal 
meninges in and around the suprasellar cistern are suscepti-
ble to tuberculous and other forms of granulomatous menin-
gitis. The cistern may also be the site of parasitic cysts, in 
particular (racemose and subarachnoid) neurocysticercosis. 
In infections of the cavernous sinus, many of which are 
accompanied by thrombophlebitis, the imaging findings on 
CT and MRI consist of a convex lateral contour to the 
affected cavernous sinus with evidence of a filling defect 
after contrast administration. The intracavernous portion of 
the internal carotid artery may also be narrowed secondary to 
surrounding inflammatory change.
Infections of the pituitary gland itself are uncommon. 
Direct viral infection of the hypophysis has never been estab-
lished and bacterial infections are unusual. There has been 
speculation that cases of acquired diabetes insipidus may be 
the result of a select viral infection of the hypothalamic 
supra-optic and paraventricular nuclei. Tuberculosis and 
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syphilis, previously encountered in this region because of the 
higher general prevalence of these diseases in the population, 
are now uncommon. Gram-positive cocci are the most fre-
quently identified organisms in pituitary abscesses. Pituitary 
abscesses usually occur in the presence of other sellar masses 
such as pituitary adenomas, Rathke’s cleft cysts, and cranio-
pharyngiomas, indicating that these mass lesions function as 
predisposing factors to infection.
There are a few reports on CT of pituitary abscesses. These 
indicate that the lesion is similar in appearance to an adenoma. 
As a result of the frequent coincidental occurrence of abscesses 
with adenomas, and because of their common clinical presen-
tations, the correct preoperative diagnosis of abscess is difficult 
and rarely made. Non-contrast MRI demonstrates a sellar mass 
indistinguishable from an adenoma. With intravenous adminis-
tration of contrast medium, there is rim enhancement of the 
mass with persistence of low intensity in the center. 
Occasionally, pituitary abscesses are unrelated to primary pitu-
itary lesions. In these cases, erosion of the bony sella from an 
aggressive sphenoid sinusitis may be the route of infection.
1.11  Noninfectious Inflammatory Lesions
Lymphocytic hypophysitis is a rare, noninfectious inflamma-
tory disorder of the pituitary gland. It occurs almost exclu-
sively in women and particularly during late pregnancy or in 
the post-partum period. The diagnosis should be considered 
in a peripartum patient with a pituitary mass, particularly 
when the degree of hypopituitarism is greater than that 
expected from the size of the mass. It is believed that, if 
untreated, the disease results in panhypopituitarism. 
Clinically, the patient complains of headache, visual loss, 
failure to resume menses, inability to lactate, or some combi-
nation thereof. Pituitary hormone levels are depressed. CT 
and MRI demonstrate diffuse enlargement of the anterior 
lobe without evidence of any focal abnormality or change in 
internal characteristics of the gland. The distinction between 
simple pituitary hyperplasia and lymphocytic hypophysitis 
may be difficult on MRI alone.
Sarcoid afflicting the hypothalamic–pituitary axis usually 
manifests itself clinically as diabetes insipidus, or occasion-
ally as a deficiency of one or more anterior lobe hormones. 
Low signal intensity on T2-weighted images is one finding 
that occurs in sarcoid with some frequency, but rarely in 
other diseases, with few exceptions (other granulomatous 
inflammatory diseases, lymphoma, some meningiomas). 
This low signal finding may aid in differential diagnosis. 
Also, the presence of multiple, scattered intra-parenchymal 
brain lesions should raise the possibility of the diagnosis, as 
should diffuse or multifocal lesions of the basal meninges. 
The latter are best defined on coronal contrast-enhanced 
T1-weighted images.
Tolosa–Hunt syndrome (THS) refers to a painful ophthal-
moplegia caused by an inflammatory lesion of the cavernous 
sinus that is responsive to steroid therapy. Pathologically, the 
process is similar to orbital pseudotumor. Imaging in this 
disorder is often normal, or may show subtle findings such as 
asymmetric enlargement of the cavernous sinus, enhance-
ment of the prepontine cistern, or abnormal soft tissue den-
sity in the orbital apex. The lesion resolves promptly with 
steroid therapy. Hypointensity on T2-weighted images may 
be observed; since this observation is uncommon in all but a 
few other diseases (e.g., meningioma, lymphoma, and sar-
coid), it may be helpful in diagnosis. Clinical history allows 
further precision in differential diagnosis: meningioma does 
not respond to steroids, while lymphoma and sarcoid have 
evidence of disease elsewhere in almost all cases.
1.12  Vascular Lesions
Saccular aneurysms in the sella turcica and parasellar area 
arise from either the cavernous sinus portion of the carotid 
artery or its supra-clinoid segment. These are extremely 
important lesions to identify correctly. Confusion with a 
solid tumor can lead to surgical catastrophes. Fortunately, 
their MRI appearance is distinctive and easily appreciated. 
Aneurysms are well defined and lack any internal signal on 
spin echo (SE) images, the so-called signal void created by 
rapidly flowing blood. This blood flow may also cause sub-
stantial artifacts on the image, usually manifest as multiple 
ghosts in the phase-encoding direction, and in itself is a use-
ful diagnostic sign.
Thrombus in the aneurysm lumen fundamentally alters 
these characteristics, the clot usually appearing as multila-
mellated high signal on T1-weighted SE images, partially or 
completely filling the lumen. Hemosiderin from superficial 
siderosis may be visible in the adjacent brain, evident as a 
rim of low signal intensity on T2-weighted SE images, or on 
gradient echo (GE) or susceptibility-weighted images. If 
confusion exists as to the vascular nature of these lesions, 
MR or CT angiography is used to confirm the diagnosis, 
define the neck of the aneurysm, and establish the relation-
ship of the aneurysm to the major vessels.
Carotid cavernous fistulas are abnormal communications 
between the carotid artery and cavernous sinus. Most cases are 
due to trauma; less frequently they are “spontaneous.” These 
spontaneous cases are due to a variety of abnormalities, includ-
ing atherosclerotic degeneration of the arterial wall, congenital 
defects in the media, or rupture of an internal carotid aneurysm 
within the cavernous sinus. Dural arteriovenous malformations 
(AVMs) of the cavernous sinus are another form of abnormal 
arteriovenous (AV) communication in this region.
On MRI, the dilatation of the venous structures, in particular 
the ophthalmic vein and cavernous sinus, is usually clearly vis-
W. Kucharczyk and C. L. Truwit
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ible. The intercavernous venous channels dilate in both direct 
and indirect carotid cavernous fistulae and may also be seen on 
MR images. Furthermore, the internal character of the cavern-
ous sinus is altered; definite flow channels become evident sec-
ondary to the arterial rates of flow within the sinus. The fistulous 
communication itself is most often occult on MRI. The pitu-
itary gland has been noted to be prominent in cases of dural 
arteriovenous fistula without evidence of endocrine dysfunc-
tion. The exact mechanism of pituitary enlargement is not 
known; however, venous congestion is a postulated cause.
Cavernous hemangiomas are acquired lesions and not true 
malformations. However, there have been reports of extra-axial 
cavernous hemangiomas occurring in the suprasellar cistern. Of 
importance is that one of these hemangiomas did not have the 
features usually associated with, and so highly characteristic of, 
cavernous hemangiomas in the brain. The atypical appearance 
of extra-axial cavernous hemangiomas indicates that some cau-
tion must be exercised in the differential diagnosis of parasellar 
masses, because even though cavernous hemangiomas in this 
location are rare, failure of the surgeon to appreciate their vascu-
lar nature can lead to unanticipated hemorrhage. Cavernous 
hemangiomas should at least be considered in the differential 
diagnosis of solid, suprasellar masses that do not have the clas-
sic features of more common lesions, in particular craniopha-
ryngiomas or meningiomas. Furthermore, T2-weighted images 
should be a routine part of the MRI protocol for suprasellar 
masses because visualization of a peripheral dark rim may be 
the only sign of the nature of the lesion.
Other vascular abnormalities of the sella include unilat-
eral tortuous or bilateral “kissing” internal carotid arteries, 
and medial trigeminal artery. While the former are relatively 
straightforward on imaging, the medial trigeminal artery is 
worth remembering. Much like with the intrasellar aneu-
rysm, with the medial trigeminal artery, neurosurgical catas-
trophes can occur if the presence of an intrasellar artery is 
not identified. This artery will arise from the medial aspect of 
the cavernous carotid artery and will course directly posteri-
orly through the gland and through the dorsum sellae to 
reach the basilar artery. Approximately 40% of trigeminal 
arteries arise medially. In addition, patients with trigeminal 
arteries are at increased risk of associated intracranial aneu-
rysm. Finally, congenital absence of the internal carotid 
artery and asymmetric pneumatization of the sphenoid and 
sella can pose confusing images.
1.13  Other Conditions
Many other lesions may involve the sella turcica and parasel-
lar region. These include mass lesions such as germinoma, 
epidermoid, dermoid, teratoma, schwannoma, chordoma, 
ecchordosis, choristoma, arachnoid cyst, hamartoma, IgG4- 
related disease, and Langerhans cell histiocytosis. Also, 
there are several important metabolic conditions that may 
cause pituitary dysfunction or MRI-observable abnormali-
ties in and around the sella. These include diabetes insipidus, 
growth hormone deficiency, hemochromatosis, hypermagne-
semia, and hypothyroidism. Space limitations preclude their 
further discussion in this synopsis.
1.14  Conclusion
There are nine or ten important structures in and around the 
sella turcica. There are only 3–4 types of pathology that arise 
from each of these structures, except in rare circumstances. 
Knowledge of these structures and their relationship to one 
another, and familiarity with these pathologies results in high 
probability of correct diagnosis.
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Take Home Messages
• The vast majority of lesions arising in the sella turcica 
are pituitary adenomas or Rathke’s cleft cysts.
• The most important lesions to not misdiagnose are 
aneurysms and arterial anomalies.
• Anatomic relationships are key to diagnosis.
• Knowledge of basic physiology helps with diagnosis.
Key Point
• Carotid artery aneurysms and anomalies can mimic 
intrasellar and parasellar mass lesions. Arterial 
lesions must be considered in the differential diag-
nosis of lesions in this area. MRA and/or CTA can 
be used to confidently confirm or exclude the pres-
ence of arterial lesions.
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2.1  Introduction
Modern imaging techniques play an essential role for under-
standing of the anatomy of the cerebrospinal fluid (CSF) 
spaces and ventricular system, as well as the hydrodynamics 
of CSF flow. These principles are important to the under-
standing of pathological processes affecting the ventricles 
and CSF spaces, and abnormalities induced by changes in 
the intracranial pressure.
The classical model of CSF hydrodynamics presumes that 
CSF is produced primarily in the choroid plexus epithelium (and 
to a lesser degree in the ependymal cells) at a rate of approxi-
mately 0.2–0.6 mL/min and 400–600/day. However, numerous 
evidences indicate that CSF is also produced throughout the 
entire CSF-interstitial fluid functional unit across the walls of 
central nervous system (CNS) blood capillaries [1].
Since the total volume of CSF in the ventricles and sub-
arachnoidal spaces (SAS) averages approximately 150 mL, a 
threefold turnover of CSF occurs daily, explaining the pres-
ence of a bulk flow of CSF from the sites of origin to the sites 
of absorption. This bulk flow of CSF starts in the lateral ven-
tricles, passes through the third and fourth ventricles and, via 
the foramina of Luschka and the foramen of Magendie into 
the cerebellopontine angle and prepontine cisterns and the 
vallecula of the cisterna magna. From the basilar cisterns, the 
bulk flow of CSF continues cephalad along two major routes: 
a ventral route through the interpeduncular and pre- chiasmatic 
cisterns and a dorsomedial route through the ambient cisterns 
and the cisterna magna. The bulk flow also extends downward 
into the spinal canal dorsal to the cord to the lumbar thecal sac 
and upward in front of the cord to the basilar cistern.
CSF is absorbed not only via the arachnoid villi that are ide-
ally situated to drain CSF from the SAS into the major dural 
sinuses, but also through the lymphatic system, and through 
the glymphatic system in the brain parenchyma, (extracellular 
fluid spaces that are in communication with the brain capillar-
ies). In fact, it is widely accepted that the vast majority of CSF 
is absorbed through the capillary network of the CNS [1, 2].
There is an increasing body of evidence indicating that 
superimposed on the low-velocity bulk flow of CSF, which 
is almost insignificant (4 mL/min), there is a high-velocity 
oscillatory CSF motion (700  mL/min), whose main driv-
ing force is the cardiac-related intracranial arterial expan-
sion. MRI is well suited for demonstrating this oscillatory 
high- velocity craniospinal CSF flow in a noninvasive man-
ner. Cardiac-gated flow-sensitive phase-contrast cine MRI 
(PC-MRI) is probably the method of choice, since it allows 
qualitative and quantitative analysis of oscillatory CSF 
movement in normal and abnormal situations. This MRI 
technique uses a two-dimensional (2D) cine phase-contrast 
sequence that sensitizes the images to velocity changes in 
a specific direction while canceling signals from stationary 
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• To know CSF physiology and the different types of 
hydrocephalus
• To recognize the radiological features of the differ-
ent types of hydrocephalus
• To be able to recognize the imaging features that dis-
tinguish normal pressure hydrocephalus from other 
causes of ventriculomegaly in the adult population
• To recognize imaging findings in disorders of intra-
cranial pressure and how they impact direct subse-
quent management
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In this chapter we will review the clinical and imaging 
features of the different types of hydrocephalus, both in 
adults and in children, and other idiopathic disorders asso-
ciated with an abnormal intracranial pressure, such as idio-
pathic intracranial hypertension and spontaneous intracranial 
hypotension.
2.2  Obstructive Hydrocephalus in Adults
The term obstructive hydrocephalus usually indicates non- 
communicating hydrocephalus, and occurs when the flow of 
CSF is blocked along one or more of the narrow apertures 
connecting the ventricles [5].
Usually CT is the first-line imaging method, especially in the 
emergency setting. Although this technique is able to show signs 
of acute as well as chronic hydrocephalus, MRI is the method 
of choice for detailed assessment of this condition. Contrast-
enhanced T1-weighted imaging is not required for the diagnosis 
unless there is a suspicion of a neoplastic lesion or an inflamma-
tory process. The main purpose of the diagnostic management of 
the patient with obstructive hydrocephalus is to find an obstacle 
impeding the CSF flow within the ventricular system [6].
When conventional MRI sequences are not able to clearly 
find the obstructive lesion, some new MR techniques may 
help for determining the mechanism producing the hydro-
cephalus. These new techniques include PC-MRI and 3D 
heavily T2-weighted steady-state sequences (3DT2WSS) [5]. 
Fig. 2.1 Cine phase-contrast MRI in a normal subject. (a–h) Normal intra-
cranial and upper cervical spine cerebrospinal fluid oscillatory flow pattern: 
Midsagittal phase-contrast flow-sensitive images showing the whole cardiac 
cycle. The flow is sensitized craniocaudally. Caudocranial flow is repre-
sented in black, and craniocaudal in white. Antegrade flow is initiated from 
the lower fourth ventricle and cisterna magna. Caudal flow begins in the 
posterior third ventricle, aqueduct of Sylvius, and upper fourth ventricle. As 
pulsation through the aqueduct continues caudally, pulsation in the cisterna 
magna becomes quiescent, and then reverses to pulse cephalically. All flow 
shows cephalic pulsation. Reproduced from Rovira A.  Communicating 
Hydrocephalus. Normal Pressure Hydrocephalus. In F. Barkhof et al. (eds.), 
Clinical Neuroradiology, © Springer Nature Switzerland AG 2019
Key Points
• The production of CSF mostly takes place within the 
CNS capillaries: filtration of water volume through 
the capillary walls into the surrounding brain tissue. 
The choroid plexuses are a less relevant place for this 
process.
• CSF absorption takes place at different sites, and its 
capacity far exceeds CSF production.
• A high-velocity oscillatory CSF motion driven by 
cardiac- related intracranial arterial expansion can 
be identified and quantified non-invasively with dif-
ferent MRI techniques.
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PC-MRI enables quantitative and qualitative assessment of 
the CSF circulation (Fig.  2.2), while 3DT2WSS sequences 
such as DRIVE (Philips), CISS (Siemens), and FIESTA (GE) 
are useful for accurate anatomic evaluation and are highly rec-
ommended in patients with suspicion of aqueductal pathol-
ogy or intraventricular adhesions. Alternatively, to PC-MRI, 
3D T2-weighted turbo spin-echo sequences with variable 
flip angle (3DT2WTSE) can be used (Siemens: SPACE, GE: 
CUBE, Philips: VISTA) for detecting the high- velocity CSF 
bulk flow, as are strongly susceptible to CSF flow effects. 
This technique is noninvasive, less sensitive to artifacts, and 
enables scanning of the whole skull using isotropic voxels 
with an acceptable acquisition time [5] (Figs. 2.3 and 2.4).
2.2.1  Radiological Features of Hydrocephalus
The typical radiological features of any kind of hydrocepha-
lus are:
• Enlargement of the ventricles (Evans index >0.3) out of 
proportion of the size of SAS (cortical sulci appear dis-
proportionately narrowed), with ballooning of the frontal 
and posterior ventricular horns
• Dilatation of temporal ventricular horns
• Dilatation of the third ventricular recesses
• Reduced mamillopontine distance
• Upward bowing and thinning of the corpus callosum
• Hyperintense on MRI (hypodense on CT) areas in the 
periventricular white matter, suggestive features of acute 
hydrocephalus.
Typical obstacle sites in obstructive hydrocephalus are 
the foramen of Monro, the cerebral aqueduct, the fourth ven-
tricular outlets (Luschka and Magendie foramina), and the 
foramen magnum.
2.2.2  Foramen of Monro Obstruction
Several lesions growing in the region adjacent to Monro 
foramina might produce obstructive hydrocephalus. These 
include intra- and periventricular cysts such as arachnoid, 
colloid, dermoid, epidermoid cysts, tumors (ependymomas, 
Fig. 2.2 Brain MRI in a patient with communicating hydrocephalus 
(a–c) and in a patient with a non-communicating hydrocephalus sec-
ondary to aqueductal stenosis (d–f). Midsagittal T1-weighted and two 
representative frames of the diastolic and systolic phases of a phase- 
contrast flow-sensitive MRI sequence (b, c, e, f). Observe the presence 
of a normal craniocaudal cerebrospinal fluid flow through the aqueduct 
in the patient with a communicating hydrocephalus, and the absence 
of the CSF flow in the patient with aqueductal stenosis. Reproduced 
from Rovira A.  Communicating Hydrocephalus. Normal Pressure 
Hydrocephalus. In F. Barkhof et al. (eds.), Clinical Neuroradiology, © 
Springer Nature Switzerland AG 2019
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subependymomas, central neurocytomas, or glial tumors), as 
well as adhesions. Not infrequently these lesions may lead 
to unilateral ventriculomegaly. Also, unilateral mass lesions 
producing midline shift might eventually obstruct the con-
tralateral foramen of Monro causing contralateral ventricu-
lar dilatation as well as compression of the ipsilateral lateral 
ventricle.
The most common pathology located in this area and 
responsible for hydrocephalus is a colloid cyst, which are 
slow-growing, benign cystic lesions, typically located in 
the anterior part of the third ventricle. These usually oval or 
round lesions are mostly hyperdense on unenhanced CT in 
comparison to the gray matter, although in one-third of cases 
are hypo- or isodense. On MRI, the signal intensity is quite 
variable, depending on their protein content, but approxi-
mately 50% of them are hyperintense on T1-weighted 
sequences and hypointense on T2-weighted sequences.
Subependymal giant cell astrocytomas (SEGAs) are 
the most common brain tumors in tuberosus sclerosis 
complex occurring in about one out of every ten patients. 
These tumors are low-grade (World Health Organization 
[WHO] grade 1), mixed, glioneuronal, and highly vas-
cularized neoplasms predominantly located near the 
foramen of Monro, and frequently with bilateral distribu-
tion. They represent a significant cause of morbidity and 
mortality because of the risk of sudden death from acute 
hydrocephalus, the risk of which is directly proportional 
to their volume. On CT, SEGAs appear as iso/hyperdense 
masses showing frequent calcification. On MRI, they have 
hypo/isointense signal on T1-weighted sequences and 
a b c
d e f
Fig. 2.3 Brain MRI in a patient with communicating hydrocephalus. 
Axial T2-weighted images (a–c) show ventriculomegaly involving the 
supratentorial and infratentorial ventricular cavities. Observe the pres-
ence of flow voids inside the aqueduct and fourth ventricle. Midsagittal 
T1-weighted (d) 3DT2WSS sequence (CISS) (e) and 3DT2WTSE 
(SPACE) (f) images show a morphological normal aqueduct with 
marked flow void, better seen on the SPACE sequence. Reproduced 
from Rovira A.  Communicating Hydrocephalus. Normal Pressure 
Hydrocephalus. In F. Barkhof et al. (eds.), Clinical Neuroradiology, © 
Springer Nature Switzerland AG 2019
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hyperintense signal on T2-weighted sequences, present-
ing intense, but inhomogeneous, contrast enhancement.
2.2.3  Cerebral Aqueduct
Aqueductal stenosis, one of the most common causes of 
obstructive hydrocephalus both in children and adults, can 
be divided into congenital and acquired. The most frequent 
acquired lesion resulting in aqueductal stenosis includes 
pineal region tumors (pineal gland tumors, tectum–tegmen-
tum gliomas, tentorial meningiomas, metastasis), cerebral 
vascular malformations (e.g., vein of Galen aneurysm), 
adjacent intracranial hemorrhage, and infections (meningi-
tis/ventriculitis) (Fig.  2.4). The congenital causes may be 
aqueductal webs or diaphragms. The aqueductal web is a 
membrane formation whose origin may be either congeni-
tal or inflammatory. It has been hypothesized that it might 
be caused by a small glial occlusion of the caudal aqueduct 
with the subsequent development of a sheet of tissue due to 
extended pressure and dilatation of the canal above. On MRI 
sequences, enlargement of the lateral and third ventricles, 
without dilatation of fourth ventricle is a key imaging fea-
ture. The aqueduct may show funneling superiorly.
2.2.4  Trapped Fourth Ventricle
Obstruction of all CSF pathways of the fourth ventricle, includ-
ing foramina of Luschka and Magendie, as well as aqueduct, 
produces and isolated enlargement of this cavity known as the 
trapped fourth ventricle. This is a rare clinical condition most 
often associated with previous ventricular shunting for hydro-
cephalus [7], infection, intraventricular hemorrhage, and post-
inflammatory changes after posterior fossa surgery (Fig.  2.5). 
The clinical symptoms include nausea, vomiting, and cranial 
nerves palsy as a result of cerebellar and brain stem compression. 
Treatment options include placement of a fourth ventriculoperi-
Fig. 2.4 Brain MRI in a 
patient with communicating 
hydrocephalus (a, b) and in a 
patient with a non- 
communicating 
hydrocephalus secondary to 
aqueductal stenosis (c, d). 
Midsagittal 3DT2WSS 
sequence (CISS) (a, c) and 
3DT2WTSE sequence 
(SPACE) (b, d) images. 
Observe the presence of a 
normal morphology of the 
aqueduct and normal 
cerebrospinal fluid flow 
through the aqueduct in the 
patient with a communicating 
hydrocephalus (arrows), and 
the thickened mesencephalic 
tectum (probable tectum 
glioma) and absence of the 
CSF flow in the patient with 
aqueductal stenosis (arrows). 
Note the presence of normal 
CSF flow through the 
Magendie foramen (short 
arrow). Reproduced from 
Rovira A. Communicating 
Hydrocephalus. Normal 
Pressure Hydrocephalus. In 
F. Barkhof et al. (eds.), 
Clinical Neuroradiology, © 
Springer Nature Switzerland 
AG 2019
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toneal shunt, endoscopic aqueductoplasty, as well as interven-
triculostomy or open fenestration via suboccipital craniotomy.
2.2.5  Fourth Ventricular Outlets 
and Foramen Magnum
Obstruction of the fourth ventricle outlets (foramina of 
Luschka and Magendie) and foramen magnum are caused 
by hemorrhage, meningitis, and extrinsically compressing 
lesions including tumors (cerebellar metastases, meningio-
mas, hemangioblastomas, astrocytomas, medulloblastomas) 
and craniocervical developmental malformation involving 
the cranio-cervical junction (osteochondrodysplasia, meta-
bolic diseases, developmental abnormalities, and Chiari 
malformations) [5]. Acute/subacute cerebellar infarcts are 
also a common cause in the adult population [5]. Primary 
obstruction of the foramina of Magendie and Luschka by the 
presence of web-like membranes is an uncommon cause of 
non-communicating hydrocephalus. 3DT2WSS sequences 
are particularly useful in the identification of these thin webs.
Fig. 2.5 Sagittal T1- (a) and 
T2-weighted (b), and coronal 
T2-FLAIR (c) brain MRI in 
an 8-year-old girl with 
congenital hydrocephalus 
secondary to prenatal 
infection treated with 
ventricular shunting. Observe 
the presence of web-like 
membranes (arrows in b) at 
the level of the aqueduct and 
Magendie foramen, producing 
a trapped fourth ventricle. 
(Courtesy of Antoni Rovira. 
Parc Tauli. Sabadell. Spain)
Key Points
• 3DT2WSS sequences are useful for accurate ana-
tomic evaluation of the ventricular system, and are 
highly recommended in patients with suspicion of 
non- communicating hydrocephalus.
• The inclusion in the imaging protocol of CSF-flow 
sensitive sequences, such as PC-MRI and 3D- T2WTSE, 
is highly recommended for detecting the normal high- 
velocity CSF flow through narrower segments of the 
ventricular system.
• Contrast-enhanced T1-weighted imaging should be 
obtained when there is a suspicion of a neoplastic 
lesion or an inflammatory process as the causative 
mechanism of non-communicating hydrocephalus.
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2.3  Hydrocephalus in Children
The etiology and prevalence of pediatric hydrocephalus var-
ies widely throughout the world. In the developing world, 
neonatal infections account for most cases of hydrocephalus, 
while in developed regions the more commonly seen eti-
ologies of hydrocephalus include parenchymal hemorrhage, 
congenital aqueduct stenosis, myelomeningocele, and poste-
rior fossa tumors. The prevalence of hydrocephalus has been 
estimated to be at least 1 in 1000 births [8, 9].
Etiologies for hydrocephalus in the pediatric popula-
tions can also be generally categorized as either congenital 
or acquired entities. Congenital etiologies include aqueduct 
stenosis, neural tube defects, and posterior fossa malforma-
tions (e.g., vein of Galen malformation obstructing flow at 
the aqueduct). Acquired etiologies include: subarachnoid or 
intraventricular hemorrhage or infection, brain tumors, cho-
roid plexus papilloma resulting in overproduction of CSF, 
and extrinsic venous obstruction.
In the infant, hydrocephalus may present with macro-
cephaly, irritability, and bulging of the fontanelles. In the 
older child hydrocephalus typically presents with signs and 
symptoms of elevated intracranial pressure including head-
ache, vomiting, and delay in developmental milestones.
Management of hydrocephalus consists of treatment of 
the underlying primary abnormality such as tumor or hem-
orrhage and CSF diversion procedures with placement of 
ventriculoperitoneal shunting devices. Newer methods of 
endoscopic third ventriculostomy (ETV) and choroid plexus 
cauterization (CPC) have developed since the 1990s and 
represent an alternative treatment for chronic hydrocepha-
lus. A third ventriculostomy involves a small craniotomy 
usually through the right frontal region and placement of 
an endoscope into the right frontal horn, through the fora-
men of Monro toward the floor of the third ventricle where a 
small opening is cut in the floor of the third ventricle allow-
ing direct communication with the prepontine cistern. ETV 
along with CPC via the same endoscopic procedure has 
shown promising results in early trials.
Complications of long-term shunting include periopera-
tive morbidity and mortality, shunt infection (5–9% mostly 
occurring within 3 months of surgery) and shunt malfunction 
(occurring in 40% of children within the first 2  years after 
shunt placement). Interestingly use of valvular apparatus cou-
pled to the silastic catheter has been shown to be ineffective in 
randomized control trials to decrease the rate of shunt failure.
MRI is the current modality of choice for assessing pedi-
atric hydrocephalus and the effects that might produce in 
the developing brain. This includes evaluation for size and 
contour of the ventricles and SAS, presence or absence of 
interstitial periventricular edema, and identification of the 
normal CSF aqueductal flow void. Imaging is obviously also 
indispensable in evaluation for the complications associated 
with surgical management of hydrocephalus. And, following 
ETV, can also demonstrate patency of flow across the surgi-
cal defect, mainly using flow-sensitive MRI sequences, such 
as PC-MRI and 3DT2WTSE [10].
2.4  Communicating Hydrocephalus
Communicating hydrocephalus is defined as a CSF flow 
circulation abnormality outside the ventricular system that 
produces an increase in the ventricular size. Most cases are 
secondary to obstruction of CSF flow between the basal cis-
terns and brain convexity, and include common conditions 
such as subarachnoid hemorrhage, bacterial and aseptic 
meningitis, and leptomeningeal carcinomatosis. This type of 
hydrocephalus could be better classified as communicating 
with obstruction, to differentiate them from idiopathic nor-
mal pressure hydrocephalus (iNPH), in which there is not 
objective obstruction of CSF circulation and absorption [4].
2.4.1  Communicating Hydrocephalus 
with Obstruction
• Subarachnoid hemorrhage: Acute and chronic hydroceph-
alus is one of the major complications after subarachnoid 
hemorrhage, with a reported incidence of 20–30%. The 
hydrocephalus is produced as a consequence of blockage 
of the SAS that produces impairment of CSF circulation 
and absorption. The acute form is more common and usu-
ally develops within few days after the hemorrhage.
• Meningitis: Bacterial meningitis may be complicated 
with communicating hydrocephalus, which is associated 
with poor neurologic outcome. The causative mechanism 
includes the blockage of SAS by exudates and high pro-
tein levels at basal cisterns or convexity that prevent nor-
mal CSF circulation and absorption. Less frequently, 
exudates can block the CSF flow at fourth ventricle exits 
(Magendie and Luschka foramina), resulting in a non- 
communicating type of hydrocephalus. Aseptic meningi-
tis, which could be infective (viral or fungal) or secondary 
to systemic conditions such as autoimmune diseases or 
neurosarcoidosis, might produce a communicating hydro-
cephalus induced by similar mechanisms, but usually 
Key Point
• Neonatal infections account for most cases of hydro-
cephalus in developing regions, while in developed 
regions the most common causes include parenchy-
mal hemorrhage, congenital aqueduct stenosis, 
myelomeningocele, and posterior fossa tumors.
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develops subacutely over a period of weeks to months, 
and is associated with a lower morbi-mortality compared 
to the most common hydrocephalus secondary to bacte-
rial meningitis. CT or MRI is rarely indicated for the 
diagnosis of meningitis, but should be immediately per-
formed in those patients with clinical suspicious of com-
plications (e.g., signs of increased intracranial pressure).
• Leptomeningeal carcinomatosis: Both primary (medul-
loblastoma, ependymoma, glioblastoma, and oligoden-
droglioma) and secondary tumors (lymphoma, lung and 
breast cancers, melanoma) may spread through the SAS 
(leptomeningeal carcinomatosis). In some cases, the 
clinical presentation is secondary to impairment of CSF 
flow with development of communicating hydrocepha-
lus. Contrast-enhanced T1-weighted and T2-FLAIR 
sequences should be added in patients with communicat-
ing hydrocephalus of unknown origin, particularly when 
the clinical symptoms (e.g., headache) developed acutely 
or in patients with a known history of cancer.
• Vestibular schwannomas: Hydrocephalus is relatively 
common in patients with vestibular schwannomas. 
Although obstructive hydrocephalus due to mechanical 
compression of the fourth ventricle or cerebral aqueduct 
by the tumor is demonstrated in some patients, communi-
cating hydrocephalus is more frequent. This latter type of 
hydrocephalus could be explained by a compromise of 
CSF absorption by protein leakage from the tumor.
2.4.2  Normal Pressure Hydrocephalus
Normal pressure hydrocephalus (NPH) is a syndrome initially 
identified in 1957 by Solomon Hakim characterized by the triad 
of gait disturbance, mental deterioration, and urinary inconti-
nence, which are associated with enlargement of the ventricular 
system and normal CSF pressure. It is difficult to establish the 
prevalence of NPH due to the non- specific nature of the symp-
toms, but it has been estimated to be 181.7 per 100,000 people in 
the 70–79 years age group. About 50% of cases with NPH have 
a known cause (secondary or symptomatic NPH [sNPH]), such 
as meningitis, subarachnoid hemorrhage, or cranial trauma, 
while the remaining 50% of cases are idiopathic (iNPH), usu-
ally presenting in the seventh decade of life.
The classical concept that NPH is simply a form of CSF 
circulation disorder, involving an imbalance between CSF 
production, and reabsorption, is probably not valid. In fact, 
unlike other forms of hydrocephalus, the CSF pressure is not 
abnormally raised, which implies that such a simplistic hydro-
dynamic theory would be insufficient to explain the pathophys-
iology of this condition. Other factors might contribute to the 
development of NPH. Chronic hypertension and white matter 
disease (which may naturally occur in the aging brain) may 
lead to periventricular ischemia that increases the compliance 
of the ventricular wall and causes gradual ventricular enlarge-
ment. Alternatively, periventricular ischemia may also lead to 
locally increased venous resistance that may lead to decreased 
CSF absorption and ventricular enlargement. Finally, dimin-
ished vascular (arterial) compliance that frequently occurs in 
the aging brain might produce a redistribution of systolic vas-
cular pulsations, which are then transmitted directly into the 
ventricular system, progressively increasing its size.
iNPH is characterized clinically by gait and balance impair-
ment, cognitive deterioration, and urinary incontinence, and 
radiologically by a communicating ventricular enlargement 
(Evans Index >0.3), in the context of a CSF opening pressure 
of <24 cm of H2O (in recumbent position). However, the com-
plete triad appears only in 50–60% of iNPH patients.
The diagnosis of NPH is a challenging process. Initially the 
diagnosis is suspected on the basis of the history, neurological 
examination, and interpretation of CT and/or MRI scans. MRI 
is particularly useful for establishing that a communicating 
hydrocephalus is present, but may also be effective in identify-
ing patients who will respond to shunting. Exclusion of a non-
communicating hydrocephalus is the first radiological objective 
in the diagnosis of iNPH. Combination of 3DT2WSS such as 
CISS (constructive interference steady state) that offer superb 
anatomical information, and 3DT2WTSE sequences such as 
SPACE (sampling perfection with application optimized con-
trast using different flip angle evolutions), which is highly sensi-
tive to CSF flow, provides an easy evaluation of CSF pathway 
and circulation to establish the patency of CSF flow [11, 12].
A simple way to establish the diagnosis of ventriculomeg-
aly is by means of the Evans index (EI), an indirect linear 
measurement of ventricular size. It has been established that 
in normal adults, the EI is <0.3, and therefore values >0.3 has 
been used for an objective form to diagnose  ventriculomegaly. 
EI is not specific for iNPH, as increases with ventriculomeg-
aly independently of its cause. Other morphological features 
of the ventricular system such as bilateral enlargement of the 
temporal horns not attributable to hippocampal atrophy, and 
a dilated third ventricle, have been described as typical find-
ings in both iNPH and obstructive hydrocephalus, but it is 
not clear the value of these features both for establishing the 
diagnosis of iNPH or to predict shunt response.
Key Points
• The term communicating hydrocephalus, better 
defined as communicating with obstruction, must be 
differentiated from iNPH, in which there is not objec-
tive obstruction of CSF circulation and absorption.
• Common causes of this form of hydrocephalus in the 
adult population include subarachnoid hemorrhage, 
bacterial and aseptic meningitis, and leptomeningeal 
carcinomatosis.
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The callosal angle measured on MRI is determined as the 
angle between the medial superior borders of the left and 
right lateral ventricles, from a coronal image obtained at the 
level of the posterior commissure, perpendicular to a plane 
that intersected the anterior and posterior commissure. The 
CA in patients with iNPH is significantly smaller than those 
with Alzheimer disease or healthy controls, and a value <90–
100° has been used to discriminate between these two groups 
of subjects with a high accuracy. This accuracy is improved 
when combining both the CA and the EI (>0.30–0.32). The 
CA has also been used to predict shunt-responders, as these 
patients have a significantly smaller mean preoperative CA 
compared with non-responders, using 63° as the cut-off 
value to achieve the best prognostic accuracy [13].
Narrow cortical sulci at the high convexity (parietal 
high convexity and medial surface) is a typical finding in 
patients with NPH. This finding, better identified on coro-
nal MRI or CT scans, is frequently associated with wide 
Sylvian fissures. This widening, although not uncommon 
in Alzheimer’s disease, is more pronounced and frequent 
in iNPH. These structural brain changes have been grouped 
under the term “disproportionately enlarged subarachnoid 
space hydrocephalus” (DESH), which refers to the combi-
nation of ventriculomegaly with narrow high convexity 
and medial subarachnoid spaces and enlarged Sylvian fis-
sures (disproportionate distribution of the CSF between 
the inferior and superior subarachnoid spaces), and is pres-
ent in a high proportion of patients with a final diagnosis 
of iNPH (Fig. 2.6).
The DESH pattern is extensively used for iNPH diagnosis 
and predicting shunt response, without the need of a CSF tap 
test or other invasive procedures [14].
Fig. 2.6 Idiopathic normal 
pressure hydrocephalus with 
radiological features of 
disproportionately enlarged 
subarachnoid space 
hydrocephalus (DESH). A 
78-year-old woman with 
one-year history of gait 
disturbances, cognitive 
impairment, and urinary 
incontinence. Observe the 
normal CSF flow across the 
aqueduct on the 3DT2WTSE 
(SPACE) midsagittal image 
(a), the enlarged Sylvian 
fissures associated with 
narrowing of the sulci over 
the high convexity, and low 
callosal angle on the coronal 
T2-FLAIR image (b). 
Ventriculomegaly associated 
with extensive white matter 
and some focal sulcal dilation 
changes is seen on T2 and 
T2-FLAIR images (c, d). 
Reproduced from Rovira 
A. Communicating 
Hydrocephalus. Normal 
Pressure Hydrocephalus. In 
F. Barkhof et al. (eds.), 
Clinical Neuroradiology, © 
Springer Nature Switzerland 
AG 2019
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Focal sulcal dilation also occurs in iNPH and should not 
be mistaken for focal cortical atrophy. These enlarged sulci, 
which have been considered reservoirs of CSF, usually dis-
appear partially or completely after shunting,
White matter abnormalities (leukoaraiosis) on T2-weighted 
images, involving both the periventricular and subcortical 
white matter are a common finding in patients with iNPH, and 
correlated with a higher frequency of vascular risk factors, such 
as hypertension. These signal changes are probably related to 
chronic ischemia as a consequence of cerebral hypoperfusion, 
and can decrease or even disappear after successful shunt sur-
gery, indicating that at least partially correspond to interstitial 
edema, as a consequence of an impairment of the glymphatic 
circulation. The extension of leucoaraiosis in patients with 
iNPH cannot be used to predict shunt responsiveness.
PC-MRI studies, with a slice positioned in the midsagittal 
or axial planes, sensitive to CSF movement in the craniocau-
dal direction (in plane or through plane CSF flow) is a simple 
way to assess the patency of the aqueduct and to assess the 
intensity of the pulsatile movement across it. However, the 
identification and quantification of this CSF movement is not 
completely specific for the diagnosis of iNPH and does not 
predict shunt response.
Diversion of CSF is the standard of surgical care for 
iNPH.  Ventriculoperitoneal (VP) shunts are the most 
popular, while the ventriculoatrial (VA) shunts are rarely 
implanted because of their more frequent long-term compli-
cations. Gait impairment is the symptom that is most respon-
sive to shunting, while cognitive impairment may improve if 
it is not very severe at the time of intervention, while urinary 
incontinence improves in 36–90% of patients.
On CT/MRI studies performed few months after shunt 
surgery, a mild decrease of the ventricular size is usually 
seen, associated with CA increased, partial resolution of 
white matter changes and expansion of sulci over the high 
convexity sulci (resolution of convexity CSF block).
Not every patient with possible or probable iNPH will be 
a candidate for shunt surgery, and the risk to benefit ratio has 
to be assessed on individual bases. Diagnostic test used for 
selecting patients for shunt surgery includes those based on 
surgical invasive procedures (CSF dynamics and intracranial 
pressure monitoring), and those based on morphological or 
functional MRI studies.
2.5  Idiopathic intracranial 
hypertension (IIH)
Idiopathic intracranial hypertension (IIH) also known as pseudo-
tumor cerebri or benign intracranial hypertension is a syndrome 
of elevated intracranial pressure for which there is no identifiable 
underlying cause. It is most commonly  associated with head-
ache and papilledema and more commonly affects females. The 
symptom of tinnitus is also commonly encountered in patients 
with IIH.  The syndrome typically presents in obese females 
of child bearing age but can be seen in just about any male or 
female regardless of body habitus or age. Several medications 
have been implicated as a cause of secondary IIH; these include 
tetracycline, minocycline, vitamin A, and retinoids.
The most recently revised diagnostic criteria for the diag-
nosis of IIH employ a combination of clinical and imaging 
criteria for diagnosis [15]. IIH has traditionally been a diag-
nosis of exclusion where neuroimaging was used to simply 
“rule out” an intracranial mass, hydrocephalus, or dural sinus 
thrombosis as a cause of elevated intracranial pressure. Many 
important signs of IIH on MRI and MR venography are now 
recognized that have dramatically improved our ability to 
identify the disease in patients independent of clinical suspi-
cion for elevated intracranial pressure.
Diagnostic clinical criteria for IIH include papilledema, nor-
mal neurologic examination (except cranial nerve abnormal-
ity), normal imaging of the brain parenchyma and meninges, 
normal CSF composition, and elevated CSF-opening pressure 
(>25 cm H2O). The diagnosis of IIH can be considered prob-
able even if there is no papilledema or CSF opening is not 
elevated provided supportive neuroimaging signs are present.
The neuroimaging signs of elevated intracranial pressure 
(IP) include empty sella, optic globe deformation seen as 
flattening of its posterior aspect, papillary protrusion (appre-
ciable optic nerve head protrusion [± enhancement] into 
the globe correlating with papilledema), tonsillar descent, 
CSF distention of optic nerve sheath, vertical tortuosity of 
the intraorbital optic nerve, and stenosis of the distal trans-
verse sinuses. These signs are highly variable in their sensi-
tivity and specificity for predicting the presence of elevated 
intracranial pressure. Several signs with low sensitivity for 
increased IP such as papillary enhancement (less than 20%) 
have been shown to have very high specificity (99%), while 
another such as empty sella has a relatively high sensitivity 
(80%) but low specificity (less than 80%) since it is com-
Key Points
• NPH is characterized by the triad of gait distur-
bance, mental deterioration, and urinary inconti-
nence, which are associated with enlargement of 
the ventricular system and normal CSF pressure.
• Structural brain changes grouped under the term “dis-
proportionately enlarged subarachnoid space hydro-
cephalus” (DESH), defined as the combination of 
ventriculomegaly with narrow high convexity and 
medial subarachnoid spaces and enlarged Sylvian fis-
sures is a key feature to establish the diagnosis of NPH
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monly seen in normal subjects [16]. Stenosis of the distal 
transverse sinuses remains the most valuable sign for the 
neuroimaging evaluation of IIH since it has consistently and 
reproducibly shown the highest (greater than 93%) sensitiv-
ity and specificity. With the advent of gadolinium-enhanced 
MR venography [17] the transverse sinuses were, for the 
first time, reliably visualized free from flow artifacts com-
monly encountered on time-of-flight and phase-contrast 
MR venographic techniques. Gadolinium-MR venography 
techniques allowed for the visualization and characteriza-
tion of the narrowing of the distal transverse sinuses seen 
in IIH [18]. These most commonly appear as collapse of the 
dural venous sinuses at or proximal to the transverse sigmoid 
junction. Alternatively, the stenosis in this region can occa-
sionally be seen due to an enlarged intraluminal arachnoid 
granulation intrinsically narrowing the lumen.
It must be stressed that the imaging signs described above 
relate to elevated intracranial pressure and are not exclusive 
to IIH, as can be present with all other conditions causing 
elevated IP. The diagnosis of IIH is one of exclusion and all 
other etiologies must be ruled out. A careful drug history and 
CSF analysis is mandatory in the work-up of these patients. 
Moreover, these signs will diminish or resolve following 
treatment of the elevated pressure [19].
Management of IIH is directed primarily at preserving 
vision and diminishing the headaches associated with the dis-
ease. Treatment typically begins with strategies to improve 
body habitus and medication (most commonly acetazolamide) 
and progresses from there as required utilizing surgical proce-
dures of optic nerve fenestration, CSF diversion procedures of 
ventriculoperitoneal or lumbo-peritoneal shunting, and more 
recently transverse venous sinus stenting [20]. Since the cause 
of IIH is not known the treatments can only be directed at the 
phenotypic or characteristic expression of the disease, i.e., drugs 
are given which may decrease CSF production or continually 
remove CSF through extracranial pathways and thus lower IP.
The narrowed transverse sinuses seen in IIH are thought 
to be a combination of secondary effects arising from ele-
vated IP as well as subsequent superimposition of a posi-
tive feedback loop further worsening the IP with venous 
hypertension. In this way the stenoses are thought to exac-
erbate the increased IP.  Stenting of the stenosed segments 
breaks the cycle and normalizes venous pressures providing 
symptomatic relief and protects patients from visual loss. 
Unfortunately, to date, no randomized control trials exist for 
evaluation of the efficacy of the surgical options and, there-
fore, their true efficacy is unknown [21]. Each of the surgical 
and endovascular options has been shown to have success 
in treating headache, papilledema, visual loss, diplopia, and 
tinnitus. Each of these options also carries the risk of compli-
cation or need for revision surgery.
Regardless of the cause, the neuroimaging signs of ele-
vated IP (which may relate to IIH) should not be overlooked 
or overdiagnosed. A diagnosis of IIH cannot be made on 
imaging grounds alone, and clinical correlation is mandatory 
to rule out other causes of elevated IP masquerading as IIH.
2.6  Spontaneous Intracranial 
Hypotension (SIH)
Spontaneous intracranial hypotension (SIH) is commonly 
caused by leakage of CSF from the thecal sac at some point 
along the spinal canal. The leakage of CSF causes variable 
symptoms, the most characteristic of which is a positional 
headache and is commonly associated with typical intra-
cranial MRI features, such as venous distension, pachyme-
ningeal thickening and enhancement, pituitary enlargement, 
effacement of the suprasellar cistern, subdural fluid collection 
hygroma or hemorrhage, and sagging deformity of the brain-
stem with or without tonsillar herniation [22–25] (Fig. 2.7).
In patients being considered for a possible diagnosis of SIH 
imaging of the entire spine with high-resolution T2-weighted 
sagittal sequences is mandatory. While many SIH patients 
present with spinal longitudinal extradural collections 
(SLECs) some do not [26]. These SLECs have a typical 
appearance and are seen exclusively in SIH patients with dural 
mechanical tears along the thecal sac. Conversely, patients 
with more laterally placed CSF leakage beyond the epidural 
compartment either from a CSF-venous fistula (CVF) or from 
a distal root sleeve tear do not display SLECs. The presence 
or absence of a SLEC on MRI is used to proscribe for the 
prone versus lateral decubitus positioning of the subsequent 
dynamic myelography [26, 27]. Digital  subtraction myelogra-
phy (DSM) and ultrafast CT myelography [28] are techniques 
of dynamic myelography which allow for imaging of gravity 
dependent contrast media as it descends within the thecal sac 
from site of injection within the lumbar spine into the cervi-
cal spinal canal. By obtaining images in this manner the site 
at which intrathecal contrast first escapes from the thecal sac 
and enters the epidural space can be identified with certainty.
Imaging and management of patients with suspected SIH 
has been a difficult arena for diagnostic neuroradiology. Until 
Key Points
• IIH has traditionally been a diagnosis of exclusion 
where neuroimaging is used to simply “rule out” an 
intracranial mass, hydrocephalus, or dural sinus 
thrombosis as a cause of elevated IP.
• Stenosis of the distal transverse sinuses remains the 
most valuable sign for the neuroimaging evaluation of 
IIH since it has consistently and reproducibly shown 
the highest sensitivity and specificity for disease.
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recently there has been a paucity of reliable knowledge dis-
seminated about this syndrome. SIH has only recently been 
recognized as a syndrome that requires an organized approach 
by knowledgeable experienced neuroradiologists [26, 29, 30].
In the past, this syndrome has be poorly understood and 
was thought to be a result of several potential causes includ-
ing compliance and laxity problems of the thecal sac, low 
CSF production, and possibly accelerated physiologic loss 
of CSF. It now appears these leaks are predominantly due to 
mechanical tears, leaking root sleeves, and CVF. For practi-
cality and ease of description CSF leaks have been classified 
into four types based on distance from midline [26]. Type 1 is 
caused by degenerative disc disease creating a mechanical tear 
in the ventral dura. Patients with these ventral dural punctures 
are now well recognized as comprising a large population of 
patients with SIH. All of these patients are SLEC-positive on 
MRI with or without intracranial findings and show a typical 
ventral hole in the thecal sac at DSM or dynamic CT. The site 
of CSF leakage is occasionally seen associated with a calcific 
“microspur” at the site of a degenerated disk. Unless imaged 
in a dynamic fashion where the initial flow of contrast is 
imaged as it travels down the spine the site of leakage (which 
is commonly microscopic) will be obscured by mixing of 
contrast in the intradural and extradural compartments above 
Fig. 2.7 Spontaneous 
intracranial hypotension. A 
35-year-old woman with a 
3-month history of positional 
headache. Observe the typical 
intracranial MRI features of 
this condition: sagging 
deformity of the brainstem on 
the sagittal T1-weighted 
image (a), pachymeningeal 
thickening and enhancement 
on axial T2 and contrast- 
enhanced T1-weighted images 
(b, c), and pituitary 
enlargement on coronal 
contrast-enhanced 
T1-weighted images (d)
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and below the hole. A type 2 CSF leak is a less common cause 
of SIH and is due to a posterolateral dural dehiscent lesion 
or tear. Type 2 leaks are also associated with SLECs and are 
not associated with degenerative disk disease. These SLECs 
may tend to be more posteriorly positioned and their site of 
origin is commonly incorrectly visualized as a diverticulum 
adjacent to the root sleeve. In our experience these are more 
commonly seen in females and appear to be more likely suc-
cessfully treated with multiple epidural blood patches (EBPs) 
and bedrest. These are thought to arise from the base of the 
nerve root (within the axilla) possibly relating to a predis-
posed thinned or dehiscent area of the dura [29].
If the tear occurs further along the root sleeve adjacent to an 
arachnoid granulation, where the root sleeve is in close prox-
imity to a venous plexus, then the extravasated fluid is more 
likely to find its way into a venous channel. In this manner an 
embryonic pseudomeningocele drains into the venous system 
and heals aberrantly creating a CVF—a type 3 leak. The type 
4 leak is a rare root sleeve leak that does not fistulize into the 
venous system but rather tracks into and dissipates into the 
adjacent facial planes. Type 3 and type 4 occur more laterally 
along the root sleeve beyond the epidural compartment and 
therefore (1) do not result in a SLEC on spinal MRI and (2) 
do not respond to nondirected EBP. Focal fibrin patching may 
have some slowing effect on these leaks, although in our expe-
rience has not consistently provided durable cure.
MRI of the brain and spine in patients with SIH allows us 
to dichotomize patients into those which may benefit from ini-
tial EBP prior to dynamic myelography, i.e., SLEC- positive 
patients (predicting a type 1 or type 2 leak) from those patients 
in whom nondirected EBP is likely not beneficial, i.e., patients 
with SLEC-negative imaging (who harbor a type 3 or type 4 
leak). SLEC-positive patients (who fail initial EBP) should then 
undergo DSM in the prone position. This will find over 80% of 
the offending type 1 or type 2 tears. If this initial prone DSM is 
negative, then left and right decubitus DSM should be performed 
until a leak is found. Conversely SLEC-negative patients should 
undergo DSM in lateral decubitus position (left then right) to 
find the offending type 3 or type 4 leaks. Using this type of imag-
ing paradigm an overall success rate of definitively locating the 
site of CSF leak can be expected in over 90% of cases.
Dynamic CT myelography (DCTM) is an alternative method 
to DSM for dynamic myelography [25]. Several authors have 
reported success in identifying these types of CSF leaks particu-
larly the type 1 and type 2 [26] leaks. It has also been reported 
on the success of DCTM for type 3 leaks by positioning these 
patients in the decubitus position to search for CVF. Regardless 
of the modality chosen it is the spinal MRI which defines these 
patients as SLEC-positive or SLEC-negative, and proscribes 
the most efficacious positioning for the subsequent dynamic 
myelogram. Once found, management can then be directed 
at the site of CSF leakage. Variable success has been reported 
with targeted epidural fibrin injections for all types of leaks. The 
most definitive curative results for treatment of CSF leaks are 
obtained with surgical repair of the dural tears (types 1 and 2 
and 4) and with surgical clipping of the CVF (type 3).
2.7  Concluding Remarks
Structural and functional MRI plays an essential role for 
understanding the anatomy of the CSF spaces and ventricu-
lar system, as well as the hydrodynamics of CSF flow. These 
principles are important to the comprehension of pathologi-
cal processes affecting the ventricles and CSF spaces, mainly 
the different types of hydrocephalus, and disorders associ-
ated with abnormal intracranial pressure, such as IIH and 
SIH. Combination of 3DT2WSS sequences that offer superb 
anatomical information, and 3DT2WTSE sequences that are 
highly sensitive to CSF flow, provides an easy evaluation 
of CSF pathway and circulation to establish the patency of 
CSF flow and therefore in distinguishing non-communicating 
from communicating hydrocephalus, which is the first radio-
logical objective in patients with ventriculomegaly.
Diagnosis of IIH and SIH cannot be made exclusively on 
imaging features, and clinical correlation is mandatory to rule 
out other causes of elevated or decreased intracranial CSF pres-
sure. In patients being considered for a possible diagnosis of 
SIH, in addition to brain MRI, imaging of the entire spine with 
high-resolution T2-weighted sagittal sequences is mandatory, 
as it provides imaging features that not only support the diagno-
sis but also guide the subsequent dynamic myelography.
Key Points
• SIH is commonly caused by leakage of CSF from 
the thecal sac at some point along the spinal canal.
• In patients being considered for a possible diagnosis 
of SIH imaging of the entire spine with high-resolu-
tion T2-weighted sagittal sequences is mandatory.
• Presence or absence of SLECs on spine MRI is highly 
useful for guiding dynamic myelographic studies, 
which are highly sensitive for detecting dural tears.
Take Home Messages
• MRI is the imaging modality of choice in the diag-
nosis and management of hydrocephalus and other 
CSF-related diseases.
• Conventional MRI sequences associated with 
3DT2WTSE sequences seem to be most efficient MRI 
strategy for evaluation of hydrocephalus.
2 Hydrocephalus and CSF Disorders
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• In complex cases, PC-MRI and 3DT2WSS sequences 
may add relevant diagnostic information.
• Many signs of elevated intracranial pressure on MRI 
may suggest the diagnosis of IIH.  However, this 
diagnosis should only be made after careful clinical 
correlation and exclusion of other etiologies.
• When evaluating patients for a possible diagnosis 
of SIH, a systematic approach, with proper applica-
tion of MRI of the brain and spine allows for subse-
quent efficient work- up and management.
R. Farb and À. Rovira
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3.1  Introduction
Advanced CT and MRI imaging is critical to best practice in 
clinical stroke care, particularly in the era of intravenous 
thrombolysis and intra-arterial thrombectomy treatments for 
appropriately selected candidates. The optimal imaging 
strategy will vary from site to site but needs to harness the 
best modality (CT versus MRI), workflow, communication, 
staff and provider education, expertise, and cost for the right 
patient at the right time. This requires a coordinated system- 
wide approach from regional emergency providers to in- 
hospital care.
The over-arching goal of imaging is to establish the right 
diagnosis, not “just” to help direct critical triage decisions 
for IV thrombolysis or endovascular therapy. The following 
three key areas should be confidently and expeditiously eval-
uated in every acute stroke imaging protocol:
 1. Hemorrhage: Exclude acute intracranial hemorrhage, 
including parenchymal hemorrhage and subarachnoid 
hemorrhage, as this is a critical triage branch point and 
exclusion for revascularization therapy.
 2. Ischemia: When acute ischemic stroke signs are identi-
fied, both the extent of baseline ischemic damage and the 
underlying cause should be determined during the initial 
triage phase if possible.
 3. Mimics: Stroke mimics, including seizures, tumor, infec-
tion, migraine, and other acute neurologic conditions 
should be detected by imaging, or at least suggested in the 
differential diagnosis.
3.2  Evidence Based Guidelines 
for Imaging in Acute Ischemic Stroke
There has been a recent paradigm shift in the treatment of acute 
ischemic stroke. Imaging is a central component in the diagno-
sis, triage, and selection criteria. This is reflected in the updated 
2018 guidelines from American Heart Association (AHA)/
American Stroke Association (ASA) [1] and combined 2019 
European Stroke Organization (ESO) and the European Society 
for Minimally Invasive Neurological Therapy (ESMINT) [2].
Endovascular treatment (EVT) is now established as stan-
dard of care for patients with acute ischemic stroke with large 
vessel occlusion (LVO) involving the anterior circulation. Large 
vessel occlusion is defined as occlusion involving internal 
carotid artery and proximal middle cerebral artery. In 2015, five 
randomized controlled trials (MR CLEAN, ESCAPE, 
REVASCAT, SWIFT-PRIME, and EXTEND-IA) [3–7] dem-
onstrated benefit for patients with LVO within 6 h from symp-
tom onset as compared to medical therapy. These patients had 
moderate to severe stroke deficits (NIHSS score 6) and absence 
of widespread established infarction on brain imaging. In 2018, 
two additional randomized controlled  trials (DAWN and 
DEFUSE 3 [8, 9]) were positive in showing benefit of EVT 
treatment for up to 24 h from the symptom onset. The late onset 
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(6–24  h) trials used automated perfusion imaging including 
volumetric core, penumbra, and mismatch criteria for imaging 
selection. These trials provided level 1a evidence for benefit of 
advanced imaging to predict good outcomes after thrombec-
tomy, by selecting patients with a small estimated core infarct 
(CBF  <  30% of normal) compared to a larger symptomatic 
putative penumbra (clinical deficit or perfusion time prolonged 
>6  s). The DAWN trial used clinical-imaging mismatch as a 
selection criterion between 6 and 24 h from symptom onset. The 
DEFUSE 3 trial used mismatch and core up to 70  mL for 
patients from 6 to 16 h from symptom onset. An example of 
advanced multimodal CT imaging selection for thrombectomy 
is shown in Fig. 3.1.
Recently, two major trials have been published for extending 
the use of intravenous alteplase (IV tissue plasminogen activa-
tor, tPA). The WAKE-UP trial [10] used mismatch between 
diffusion-weighted imaging (DWI) and fluid- attenuated inver-
sion recovery (FLAIR) on MRI and showed benefit of IV tPA 
versus placebo in patients with unknown time of onset and for 
whom mechanical thrombectomy was not performed. The 
EXTEND trial [11] evaluated an extended thrombolytic time 
window from 4.5 to 9 h or patients with a wake-up stroke with 
an uncertain onset and again showed better outcomes for IV tPA 
versus placebo. EXTEND used automated perfusion imaging 
selection (core <70 mL and a mismatch >10 mL). It is expected 
that the guidelines will be updated soon to include the benefit of 
imaging selection for extended times of thrombolytic treatment 
(similar to the current extended EVT times).
3.3  Protocol Strategies: Choice 
of Modality
Investing in acute stroke imaging protocols yields dividends 
for all types of acute neurologic emergency care. With rap-
idly improving hardware and software, automated post- 
Fig. 3.1 A 75-year-old woman with acute right M1 MCA occlusion 
due to cardiac embolism. (a) hyperdense MCA sign (arrow); (b) normal 
CT (ASPECTS  =  10); (c) CTA confirms right MCA occlusion with 
poor distal collaterals (arrow). Quantitative CT perfusion (RAPID soft-
ware, lower panel) shows no estimated core infarct (CBF < 30%) but a 
153 mL area of poor perfusion (Tmax > 6 s), therefore essentially com-
pletes “target mismatch.” Gradations in Tmax are shown in rainbow 
color. The patient underwent urgent thrombectomy with excellent 
recovery. (Reprinted with permission, Springer)
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processing, and artificial intelligence, rapid scanning and 
diagnosis increasingly facilitate emergency triage care, both 
in the emergency department and the inpatient setting. 
Either CT or MRI-based protocols work very well in acute 
stroke triage. However, the details are critical: these proto-
cols require careful workflow adjustments, training, and 
ongoing education for rapid analysis and accurate 
interpretation.
Each modality has its advantages and disadvantages. 
CT is favored in most institutions world-wide due to wide-
spread availability, inherently rapid imaging, relatively 
lower cost, and comfort level for referring providers and 
interpreting physicians; the only major potential disadvan-
tages are radiation exposure and lack of sensitivity for 
brainstem/lacunar strokes and very early ischemia. MRI is 
arguably better, since, for example, diffusion-weighted 
imaging is more sensitive for detection of acute ischemia 
than CT, but this typically comes at higher cost, lower 
availability, need for MRI safety screening, and usually 
longer imaging exam times.
3.4  Advanced Stroke Triage: 3C’s or 4P’s?
Practical and efficient protocols have successfully been built 
with both CT and MR, ensuring accurate characterization of 
parenchymal injury and relevant vascular anatomy using 
CTA or MRA. With CT-based protocols, several groups have 
convincingly argued inclusion of multimodal CTA to assess 
for collaterals which can be particularly helpful in triage 
selection in the setting of large vessel occlusion. A more con-
troversial component is perfusion imaging for either modal-
ity, particularly whether it is required for triage within 6 h of 
symptom onset. However, there is less debate for the 6- to 
24-h time window, where perfusion confers valuable selec-
tion refinement based on level 1A evidence from clinical tri-
als. Mnemonics capturing these strategies, without or with 
perfusion, are summarized by either the 3C’s: Core, Clot, 
and Collaterals [12]; vs the 4P’s: Parenchyma, Pipes, 
Perfusion, and Penumbra [13]. Beyond selection for intrave-
nous or intra-arterial therapies, perfusion imaging also 
enables the proper diagnosis in cases of TIA without visible 
parenchymal injury and can assist the reader in CTA or MRA 
interpretation, pointing to areas for additional scrutiny—
which might have otherwise escaped detection.
3.5  CT: Findings, Protocols, and Cases
For most stroke centers around the world, CT is the workhorse 
of stroke imaging given its speed and ubiquitous availability. A 
CT-based stroke workup includes a non-contrast CT, CT angio-
gram (CTA), and CT perfusion (CTP). A non- contrast CT 
(NCCT) head study is the initial imaging test in a suspected case 
of acute ischemic stroke, most importantly to exclude hemor-
rhage. The early findings of acute ischemic stroke include insu-
lar hypodensity/loss of insular ribbon, hypodensity in the basal 
ganglia with obscuration of gray- white matter and gyral swell-
ing. The Alberta Stroke Programme Early CT Score (ASPECTS) 
is a widely used objective way of assessing early ischemic 
changes in the middle cerebral artery distribution and uses a 
negative ordinal scale of 0–10 (Fig. 3.2). Low ASPECTS scores 
(approximately 7 or less) have been associated with increased 
morbidity and mortality. The recent endovascular trials used 
ASPECTS as a selection criterion, a score of 6 or higher sug-
gesting a small ischemic core. Although an objective scale, 
ASPECTS has multiple limitations including poor interrater 
reliability, poor performance in setting of extensive white matter 
disease, and applicability only to middle cerebral arterial 
infarcts. Currently, there are automated ASPECTS tools using 
artificial intelligence (AI) that may be complimentary to human 
readers. The hyperdense vessel sign is another important finding 
on NCCT to assess intracranial thrombus. This is best visualized 
on thin section NCCT with MIP reconstructions which can 
improve sensitivity and specificity.
A CT angiogram (CTA) is now standard of care in a CT-based 
stroke workup to detect large vessel occlusion (LVO) and global 
assessment of the vascular system, including the neck. CTA has 
distinct advantages; it is quick, readily available, provides a 
comprehensive view of the arterial system, and is highly effec-
tive at identifying LVO, with an accuracy of 99% [14]. (Ref) An 
LVO defined as occlusion of the ICA or MCA-M1 segment 
prompts consideration for EVT.  An “M1 like” proximal M2 
occlusion also may be considered as LVO for possible EVT, 
although the M2 occlusions have not been adequately studied in 
the EVT trials. CTA is also helpful in guiding EVT and proce-
dural planning with depiction of extracranial vasculature for 
occlusions, dissections, aneurysms, or anatomic variations. 
Anatomic coverage of a CTA should begin at the origins of the 
great vessels at the aortic arch and extend through the vertex. A 
CTA can be performed as a single or multiphase study. A multi-
phasic CTA (with arterial, early venous, and late venous phases) 
technique can provide temporal information of collateral 
circulation.
An additional important piece of information that can be 
obtained in a CTA study is collateral circulation. Collaterals are 
now an established independent predictor of outcomes [15, 16]. 
Good collaterals can sustain the ischemic tissue for a longer 
time with slower infarct growth (slow progressors), smaller final 
infarcts, and better outcomes. Poor collaterals are associated 
with faster progressors, larger infarcts, and worse outcomes in 
spite of successful reperfusion. Overlapping, thick section max-
imal intensity projection (MIP) images can be easily recon-
structed on the CT scanners or on PACS stations and are helpful 
for LVO detection and for collateral grading (Fig. 3.1). There 
are numerous collateral grading scores with no consensus on 
optimal score; however, for practical purposes, a “good” versus 
“bad” dichotomized collateral information of the affected arte-
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rial territory as compared to the contralateral side is sufficient. 
Color coded collateral circulation displays using AI are being 
introduced which may aid accurate estimation of the collateral 
circulation, thus helping in timely patient triage.
CT Perfusion (CTP) is now increasingly used in stroke cen-
ters as part of the imaging workup, performed in conjunction 
with NCCT and CTA. CTP gives important information about 
the extent of the ischemic core (irreversibly injured tissue) and 
penumbra (at risk but salvageable tissue). CTP is performed in 
a cine mode by sequentially imaging a defined section of tissue 
after a single high-flow bolus of contrast material is adminis-
tered. The images are post-processed using automated or semi-
automated perfusion software using deconvolution algorithms 
to create multiple CTP maps including cerebral blood flow 
(CBF), cerebral blood volume (CBV), mean transit time 
(MTT), time to peak (TTP), time to maximum (Tmax), and 
delay maps. The commonly used parameter for measuring 
ischemic core volume is CBF using threshold of CBF <30% as 
compared to contralateral tissue. The penumbra (hypoperfused 
area) volume is commonly measured using the threshold of 
Tmax > 6 s. Mismatch ratios can be generated using core and 
penumbral volumes. CTP and CTA results are complimentary, 
facilitating both accurate interpretation and diagnosis (Fig. 3.3).
There has been a recent surge in the use of automated per-
fusion software, which is critical when triage and treatment 
decisions need to be made urgently and every minute counts. 
At the same time, it is important to be aware of the pitfalls of 
automated CTP processing. The pitfalls include motion arti-
fact, poor signal-to-noise ratio from a suboptimal contrast 
material bolus, skull base artifacts, inadequate arterial and 
Fig. 3.2 ASPECTS (Alberta Stroke Programme Early CT Score), 
acute left MCA ischemia. On all 5 mm non-contrast axial images from 
basal ganglia to the centrum semiovale, four subcortical areas (caudate, 
internal capsule, lentiform nucleus, and insula) and six MCA sectors 
(M1–M6) are reviewed for signs of low attenuation suggesting acute 
MCA ischemia. A normal scan or one with only old lesions receives 
ASPECTS = 10. A point is subtracted for each of the ten areas showing 
acute changes, with low scores predicting less favorable outcome. 
Software packages are being developed to automate ASPECTS scoring, 
as shown here (ASPECTS  =  7). (RAPID software images modified 
from PD Dr. med. Carlo Cereda Medico Caposervizio, Neurocentro 
(EOC) della Svizzera Italiana, Stroke Center, Servizio di Neurologia, 
Ospedale Civico, Lugano, Switzerland.) (Reprinted with permission, 
Springer)
H. Rowley and A. Vagal
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venous input selections, and truncated time density attenua-
tion curves. Poor cardiac output and atrial fibrillation can also 
result in poor contrast bolus. In addition, chronic carotid 
occlusion can result in false positive penumbra. Furthermore, 
the thresholds (CBF < 30%) may not always capture the true 
ischemic core, especially for ultra-early acute infarcts and in 
cases of partial reperfusion. One must be aware of these pit-
falls and evaluate the NCCT and CTA in conjunction with 
CTP for correct interpretation. It is also essential to be cogni-
zant of the fact that there is inherent variation in the different 
perfusion software packages and post-processing platforms. 
Even with all of these limitations, CTP is an important tool to 
assess the ischemic core, penumbra, and mismatch.
3.6  MRI: Findings, Protocols, and Cases
An MRI-based approach to stroke imaging offers both 
advantages and disadvantages compared to CT. Key advan-
tages include maximal sensitivity to ischemia using diffusion 
MRI, whole brain coverage with dynamic susceptibility- 
based perfusion, and lack of ionizing radiation. Disadvantages 
include availability, need for safety screening, and typically 
longer imaging times for similar information. A fully func-
tional MRI triage system requires 24/7 availability near the 
point of care. Recognizing the urgent nature of stroke triage 
and to compete with CT, protocols need to be designed to run 
with a room time of about 10 min or less (Figs. 3.4 and 3.5). 
Although these requirements can be hard to meet in many 
centers, MRI should be considered front line in several sce-
narios (see below Key Points).
Fig. 3.3 A 74-year-old man 4  days after cardiac bypass surgery 
with abrupt aphasia and right hemiparesis. (a) non-contrast CT has 
ASPECTS  =  9, with subtle loss of gray-white distinction in the left 
angular region (arrow). (b) a subtle filling defect is seen on thick mul-
tiplanar reconstructions from the CTA (arrow). CT perfusion (below) 
shows a large area of ischemia and small mismatch, suggesting a more 
significant stenosis or occlusion is likely present. (c) CTA was post- 
processed in 3D to show a proximal M2 occlusion (arrow), missed on 
initial CTA review due to tortuous overlapping vessels on 2D images. 
The occlusion site was proven during successful thrombectomy proce-
dure, with good clinical recovery. (Reprinted with permission, Springer)
Key Points
Clinical Scenarios Favoring MR over CT
• Wake-up stroke/unknown time of onset
• Late transfer
• Transient ischemic attack
• Posterior fossa/brainstem localization
• Pediatric stroke
• Concern for amyloid or hemosiderosis
• Known or expected complex lesions (e.g., Moya- 
Moya, stroke vs tumor)
• Iodine allergy
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3.7  Neurocognitive Approach to Acute 
Stroke Imaging: Thinking, Fast 
and Slow
Whether CT or MRI is used, the time pressure and complex-
ity of large stroke protocols is a challenge for radiologists and 
neurovascular specialists. In the rush to make key decisions, 
we run the risk of “having blinders on”—looking for just 
what we think should be there, and overlooking other stroke 
territories or mimics. Other members of the stroke team are 
typically focused on their own key portions of workflow, so it 
is the radiologist who must help see the big picture and make 
both an accurate diagnosis and recommendations. A disci-
plined search pattern and brief pause at the time of reporting 
will add value and help achieve these goals. This philosophy 
is inspired by Daniel Kahneman’s book “Thinking, Fast and 
Slow [17].” In our adaptation of Kahneman’s construct, radi-
ologists can harness their innate fast, reflexive thinking pat-
terns to very quickly find and report the key findings of an 
exam, but they must also impose a slower, orderly approach 
to drive a less biased, more disciplined exam search pattern 
and conclusions. Quick action is needed in stroke evaluation 
but it must always be tempered by a (slightly) slower phase to 
find unexpected lesions and consider stroke mimics. This 
essentially boils down to: “Look for what you are supposed to 
look for—but don’t forget about everything else!”
Fig. 3.4 Fast Stroke MRI Screening Protocol. This 64-year-old woman 
with right anterior cerebral artery stroke 5 days earlier was referred due 
to falls and worsening leg weakness. The screening protocol shown 
took 8 min of total room time, including, in order: sagittal T1 (30 s), 
DWI (30 s), and dynamic perfusion (75 s). Once completed these were 
sent to RAPID, with automated mismatch maps constructed (thresh-
olded ADC and Tmax) which returned to PACS in about 3 min, while 
the post-contrast sequences finished up. Post-contrast images included 
SSFSE T2 (15 s), EPI-GRE T2∗ (25 s), 2D FLAIR (70 s), and a 3D 
phase contrast MRA sequence (130 s) using velocity encoding 50 cm/s 
to capture large arterial or venous occlusions. The MRA sequence was 
designed with large field of view to capture the carotid bifurcations in 
the neck, then post-processed to produce both targeted MIP vascular 
reconstructions from the phase components, and also nominally 
T1-weighted images in three planes from the magnitude components 
(only axial shown). There is an early subacute right ACA infarction 
without large vessel occlusion or significant penumbra (white arrows), 
as well as acute on chronic hemispheric subdural hematomas, right 
larger than left (red arrow). Careful construction of fast protocols can 
refine both stroke diagnosis and capture other significant lesions, 
including stroke mimics
H. Rowley and A. Vagal
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3.8  Optimizing Imaging Workflow
Imaging is increasingly integrated into the workup of an 
acute stroke case and it is critical to establish time efficient 
imaging protocols. Even though the treatment time win-
dows have been extended for up to 24  h, time remains a 
crucial variable for good clinical outcomes. A few key ele-
ments of an optimal workflow in acute stroke are highlighted 
below.
 1. Ideally, it is important to notify the imaging team as soon 
as a stroke patient is identified (for example, using a 
“Code Stroke” pager), which can be during transportation 
or in the emergency department. Serial group pages or 
web-based applications serve to update the entire team 
simultaneously, following the patient’s location, stream-
lining communication, and coordinating care during tri-
age. Patients can be taken straight to CT from ambulance, 
bypassing the ER evaluation to minimize “door to needle’ 
and “door to groin” times.
 2. Imaging including CT angiogram and perfusion studies 
should not delay the administration of intravenous throm-
bolysis or EVT. A parallel workflow should be utilized; 
Fig. 3.5 MRI-based triage in a 46-year-old man with global aphasia 
and right hemiparesis for more than 4.5 h. Upper row shows a small 
diffusion lesion with low ADC, with much larger perfusion defect by 
qualitative “eyeball” method. Lower panel shows left carotid terminus 
near-total occlusion on TRICKS MRA (arrow), with good access via 
patent cervical carotid. Quantitative thresholded maps made using 
RAPID software show a favorable “target mismatch” pattern: a small 
estimated core infarct (ADC < 620 = 11 mL, in pink) but large signifi-
cant perfusion defect (Tmax > 6 s = 63 mL, in green), for an estimated 
mismatch volume/penumbra = 52 mL. He underwent successful endo-
vascular therapy and made a complete clinical recovery. (Reprinted 
with permission, Springer)
Key Points
Acute Stroke Imaging: Thinking, Fast and Slow
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IV tPA can be started in the CT scanner for qualified 
patients after a non-contrast CT is obtained, as CTA/CTP 
is being obtained.
 3. It is not necessary to delay contrast administration to 
check renal function. As per the AHA/ASA guidelines, 
vascular imaging can be obtained without creatinine/GFR 
check in patients without a history of renal impairment. 
There is now convincing evidence that in the absence of a 
history of renal impairment, there is a very low risk of 
transient, contrast-induced nephropathy.
 4. Patient triage decisions are mostly made on the scanner 
console and hence it is important for the radiologist to be 
involved in quick interpretation, for example, a NCCT 
images or DWI sequences should be sent to PACS worksta-
tion without waiting for perfusion or angiographic images.
 5. Automated perfusion imaging is becoming standard of 
care and can expedite the workflow. All recent EVT tri-
als used automated software for post-processing of the 
perfusion studies giving volumetric core, penumbra, 
and mismatch according to methods used in clinical tri-
als. Processing of the perfusion images on a separate 
workstation can produce delays along with user 
variability.
 6. The use of automated ASPECTS and automated LVO 
detection using artificial intelligence (AI) algorithms is 
increasingly being used by stroke teams, requiring the cur-
rent and future generation of radiologists to adapt to this 
new workflow. Multiple expanded uses of AI are in devel-
opment for use in stroke triage (see below Key Points).
 7. It is important for the radiologists to be at the helm for 
designing efficient workflow at their institution. It is 
equally important to work in close collaboration with 
the technologists and stroke team to organize this 
workflow.
3.9  Stroke Mimics
Stroke mimics or non-ischemic etiologies represent up to 
one-third of cases of new neurological deficits [18]. It is 
important to identify these mimics correctly to avoid unnec-
essary acute treatment. MRI has a distinct advantage in iden-
tifying stroke mimics and narrows the differential as 
compared to CT-based workup. Multiple etiologies can 
mimic acute or subacute ischemic stroke including vascular, 
metabolic, medication-related, infectious, inflammatory, 
neoplastic, and traumatic etiologies [19]. Common stroke 
mimics include seizures, migrainous aura, venous thrombo-
sis, PRES, and neoplasms [20].
Seizures: Seizures are one of the most frequent stroke 
mimics, particularly in patients with presenting with Todd’s 
paresis or postictal aphasia/dysphasia. Seizure related cortical 
signal abnormalities may have associated DWI abnormality. 
The distinguishing features from an arterial infarct include a 
nonvascular distribution, gyral or leptomeningeal enhance-
ment, and absence of vascular occlusion. Signal changes are 
usually reversible but may progress to cortical laminar necro-
sis or focal atrophy. There may be mild hyperperfusion or a 
normal perfusion pattern in the epileptic region.
Migraine: An acute migrainous aura may mimic an acute 
stroke including motor symptoms (hemiplegic migraine). 
The neuroimaging is usually normal but uncommonly may 
show restricted diffusion. The perfusion abnormalities are 
frequent in these cases, usually with hypoperfusion at onset, 
sometimes followed by hyperperfusion. An important point 
to note is that usually more than one vascular territory is 
affected, in contrast to the hypoperfusion pattern of a single 
vascular territory in an acute infarct [21].
Neoplasms: Patients with neoplasms may present with 
sudden attacks of “stroke like” symptoms. This is important 
to recognize not only to avoid unnecessary thrombolytic treat-
ment but also not to delay recognizing and managing a brain 
tumor. A common misinterpretation occurs when tumors are 
small, cortical, in an arterial distribution and have varying 
enhancement pattern (mimicking a subacute infarct—see 
Fig. 3.6). Furthermore, DWI can show varying signal charac-
teristics depending on the cellularity of the tumor. Perfusion 
maybe be helpful especially if there is increased perfusion 
including increased CBV in a high-grade glioma (as com-
pared to the expected low CBV in an acute infarct).
Venous infarction: Cerebral venous thrombosis is a life- 
threatening neurological condition which should not be 
missed. A venous infarction has a different topography as 
compared to arterial infarct; distribution depends on the 
location of the venous thrombosis but usually lacks an arte-
rial distribution. The DWI abnormality can be variable in 
a venous infarct. Venous infarcts can also demonstrate a 
flame shaped hemorrhage. Most of the CTA studies have 
an adequate venous opacification and evaluation of the 
Key Points
Stroke Imaging of the Future: Opportunities for 
Artificial Intelligence
• Robust communication systems optimizing regional 
triage/ambulance workflow and transfer decisions
• Data-driven individualized treatment options
• Radiology reading worklist prioritization based on 
ordering context, clinical status, and lesion detec-
tion algorithms
• Automated radiology exam screening/scoring—
ASPECTS, large vessel occlusion detection, collateral 
scoring, volumetric core, and penumbral calculations
• Functional deficit risk predictions based on clinical 
features, lesion location, and volume (at triage and 
follow-up recovery phase)
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venous sinuses should be part of the check list of a CTA 
 interpretation (Fig.  3.7). MR can have variable signal 
depending on the age of the thrombus. Cortical venous 
thrombosis can present with focal convexity subarachnoid 
hemorrhage and is best seen on gradient-echo T2∗ or sus-
ceptibility-weighted sequences.
Posterior reversible encephalopathy syndrome (PRES): 
PRES is an under recognized entity in the ED with present-
ing symptoms of headaches, seizures, altered mental status, 
and visual changes or loss. It is a clinical radiological diag-
nosis characterized by transient failure of vascular autoregu-
lation leading to multifocal vasogenic edema. Patients with 
malignant hypertension, eclampsia, on chemotherapy, or tak-
ing post-transplant drugs seem particularly susceptible. 
Typically, the PRES lesions are bilateral, cortical- subcortical, 
non-enhancing and involve predominantly the parietal- 
occipital regions. Uncommon PRES patterns include poste-
rior fossa involvement, diffusion restriction, enhancement, 
and hemorrhage (Fig. 3.8).
Subdural hematoma: Patients with subacute to chronic 
subdural hematoma can present with clinical symptoms mas-
querading as stroke including confusion, ataxia, and hemipa-
resis. These are easy to recognize on CT and MRI given their 
characteristic imaging findings (Fig. 3.9).
Additional entities mimicking acute arterial ischemic 
stroke include infection (encephalitis, cerebritis, abscess, 
meningitis, sepsis), toxic-metabolic abnormalities (hypogly-
cemia, hepatic encephalopathy, medications, and illicit 
drugs), demyelinating disease, and MELAS (mitochondrial 
encephalopathy, lactic acidosis, and stroke-like events). 
Knowledge of these mimics is imperative to minimize 
 incorrect or delayed diagnosis.
Fig. 3.6 Stroke mimic: tumor. This 83-year-old woman presented to 
an outside hospital with dysarthria. The emergency stroke CT protocol 
showed a focal left parietal lesion with curvilinear cortical enhance-
ment and focal elevation of blood volume and blood flow (white 
arrows), with normal to fast perfusion transit times. This was inter-
preted as subacute infarction with gyral enhancement and “luxury per-
fusion.” As symptoms progressed, a follow-up MRI 1  month later 
showed an expansile heterogeneously enhancing lesion, pathologically 
proven as glioblastoma
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Fig. 3.7 Arterial stroke mimic: venous infarction. This 48-year-old 
woman with a 2-day history of headache presented with sudden left arm 
paresthesias. An emergency non-contrast CT shows heterogeneous den-
sity and swelling in the right parietal lobe, with linear intrasulcal density 
suggesting subarachnoid blood. CT perfusion was symmetrical and the 
CTA was initially interpreted as normal. She worsened and so was 
referred for MRI 6 h later (lower panel), showing signs of bilateral hem-
orrhagic venous infarction, thrombosed superior sagittal sinus, and corti-
cal veins (white arrows), and corresponding dural sinus filling defects on 
post-contrast images (red arrows). In retrospect, an “empty delta” sign 
was clearly present in the sagittal sinus on the initial coronal and sagittal 
CTA reconstructions, but missed due to a focused review done in haste
Fig. 3.8 Stroke mimic: PRES. This 55-year-old presented with acute 
headaches and visual disturbances. MRI demonstrates bilateral, sym-
metric signal abnormalities consistent with vasogenic edema in the 
parieto-occipital region, in a classic PRES-like pattern. There is lepto-
meningeal congestion but no abnormal parenchymal enhancement, and 
only a small focus of diffusion restriction. Follow-up FLAIR at 4 weeks 
shows complete resolution of the signal abnormalities
H. Rowley and A. Vagal
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3.10  Concluding Remarks
Rapid stroke imaging triage is challenging but is key to 
improving outcomes for patients with acute ischemic stroke. 
Radiologists are at the helm of the changing landscape of 
acute stroke. Streamlined protocols, workflow, and analysis 
focus on getting the right diagnosis, adding value not just for 
acute stroke but also for stroke mimics.
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4.1  Introduction
The World Health Organization (WHO) Classification of 
Tumors of Central Nervous System (CNS) provided an 
update in 2016 nearly 10 years after the 2007 version to help 
more systematically categorize brain tumors. The revised sys-
tem for the first time uniquely included molecular and genetic 
parameters of the individual tumor types, in addition to the 
histological features. Accordingly, each tumor is now identi-
fied by both its phenotype (based on histology), and genotype 
(based on its molecular and genetic parameters) [1].
4.2  Goals of the Revised Classification
The goals are multi-fold: (1) To resolve some of the confu-
sion created by classifying brain tumors based only on his-
tology, (2) Provide greater diagnostic accuracy, (3) Aid better 
treatment strategies, and (4) Allow for an improved assess-
ment of the prognosis based on the specific tumor type.
4.3  Background
A classic example of uncertainty created in the past where 
tumors were classified based only on histology included 
the group “oligoastrocytoma.” These were tumors which 
exhibited features of both oligodendroglioma and astrocy-
toma on histology, and were therefore lumped together as 
oligoastrocytomas [2–4]. Accordingly, their management 
was not definitive which in turn influenced their progno-
sis. Categorizing this tumor group based on the underlying 
1p/19q codeletion (genetic mutation) status allows them to 
be clearly distinguished almost always into either (1p/19q- 
codeleted) oligodendroglioma or (1p-19q-intact) astrocy-
toma [5–8]. Only a few tumors cannot be categorized into 
either group, and are known as oligoastrocytoma, NOS (not 
otherwise specified) [1, 9, 10]. This clear distinction allows 
more accurate diagnosis, which therefore influences more 
appropriate tumor specific treatment strategies, and a better 
predictor for the overall prognosis. Another perplexing prog-
nostic feature was noted in terms of the overall survival of 
certain low grade gliomas, which surprisingly were noted to 
perform much worse than Grade III astrocytomas. This can 
now be explained based on their IDH-mutation status, with 
IDH-wildtype Grade I Gliomas performing much poorer 
than IDH-mutant Grade III astrocytomas [5, 6]. Thus, it is 
the mutation status which influences the overall prognosis 
much more than the histology.
Utilizing the background above, the discussion below will 
mention the salient features of how the Revised 2016 classifi-
cation influences our understanding of brain tumors focusing 
on infiltrating gliomas in adults, gliomas in children, and the 
introduction of certain new tumor types. A description of all 
CNS tumor types included in the Revised 2016 Classification 
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Learning Objectives
• To familiarize radiologists with the revised classifi-
cation of CNS tumors in terms of certain important 
mutation profiles including IDH (isocitrate dehy-
drogenase) mutation, 1p/19q-codeletion status, 
TP53 (tumor protein 53) mutation, BRAF mutation, 
and histone H3K27M- mutation and their influence 
on improving diagnostic accuracy, treatment strate-
gies, and overall survival.
• To provide an overview of the imaging phenotypes 
for the different glioma genotypes.
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4.4  Infiltrating Gliomas in Adults
Several mutations are associated with infiltrating gliomas in 
adults. Of these, some of the important ones include IDH 
mutation, 1p-19q codeletion, and TP53 mutation status [11].
The primary deterministic mutation includes the IDH- 
mutation status—presence suggests IDH-mutant, and absent 
an IDH-wildtype tumor [12].
4.5  IDH-Mutant gliomas
There are two types of IDH mutation, IDH1- and IDH2- 
mutated tumors. An overwhelming majority of such tumors 
are IDH1 mutated. Less than 3% of IDH-mutated tumors are 
exclusively IDH2-mutant tumors [13].
4.5.1  Clinical Relevance and Prognosis
IDH-mutant tumors are seen more commonly in the middle- 
aged population (30–60 years of age), than IDH-wildtype 
tumors which are more frequently seen in the older popula-
tion (>60–65 years of age). The overall survival of IDH- 
mutant tumors is far better than IDH-wildtype tumors. In 
fact, as mentioned previously, low grade (grade I by histol-
ogy) IDH-wildtype gliomas have an overall survival close 
to that of grade IV IDH-wildtype glioblastomas, but much 
worse than grade III IDH-mutant gliomas. It is the IDH- 
mutation status which is the driving force in terms of over-
all prognosis, much more than the histological grade. 
Furthermore, even among the Grade IV glioblastomas, it 
has been noted that IDH-mutant glioblastomas have an 
overall survival much better than IDH-wildtype glioblasto-
mas. Supporting this is the fact that most IDH-mutant glio-
blastomas are the secondary type, while most IDH-wildtype 
glioblastomas are the de novo or primary type [14].
It is a known fact in glioma surgery that wider the resec-
tion, better is the overall survival. Knowing preoperatively that 
the tumor is an IDH-mutant type can influence the surgeon for 
a more complete surgical resection, including the FLAIR sig-
nal abnormality surrounding the enhancing mass [15]. The 
radiologist by suggesting the genetic profile preoperatively 
can accordingly influence the extent of surgical resection.
4.5.2  Radiological Features
Both IDH1 and IDH2 mutations change the role of IDH in the 
citric acid cycle. This results in accumulation of 2-HG within 
tumor cells. 2-hydroxyglutarate (2-HG) can be detected on 
MR spectroscopy and is therefore considered to be the imag-
ing hallmark of all IDH-mutant tumors [16]. However, reliable 
detection is challenging, and is possible only at some select 
centers with special MR spectroscopists on site [17–19].
It has been noted that most IDH-mutated tumors occur in a 
single lobe, frontal lobe being the most common, followed by 
temporal, parietal, and occipital lobes [20]. Most such tumors 
demonstrate a sharp margin and inhomogenous but mild contrast 
enhancement. In contrast, IDH-wildtype tumors are frequently 
multilobar in  location. Preferred site involves the insula with 
extension into the adjacent temporal, frontal, and parietal lobes 
[20, 21]. In terms of their morphological appearance, these IDH-
wildtype tumors demonstrate ill-defined margins with the adja-
cent brain. Necrosis and moderate to intense heterogenous, 
especially peripheral enhancement is seen in the IDH-wildtype 
tumors (Fig.  4.1). The presence of necrosis, more intense 
enhancement, and ill- defined margins suggests more oxygen 
demand, more robust neoangiogenesis, and infiltrative nature of 
the wildtype tumors than their IDH-mutant counterparts.
4.6  1p/19q-Codeletion
IDH-mutant gliomas can subsequently be classified into those 
which are 1p/19q-codeleted tumors or 1p/19q-intact tumors. 
Of these, those gliomas which are 1p/19q-codeleted are the 
oligodendrogliomas, while those which are 1p/19q- intact are 
astrocytomas. Astrocytomas typically also show TP53 muta-
tion, a mutation which is never seen in oligodendrogliomas, 
another distinguishing feature that separates these two enti-
ties. As mentioned previously, this 1p/19q- codeleted status 
and TP53 mutation help clearly separate the confusing oli-
goastrocytoma group into either oligodendroglioma or astro-
cytoma (which was not possible based on histological features 
alone), which helps better manage these patients.
4.6.1  Clinical Relevance and Prognosis
It has been shown in two large randomized control trials that 
chemotherapeutic agents including procarbazine, lomustine, 
Key Point
• IDH-mutant tumors, seen more commonly in the 
middle- aged population (third to sixth decade of life), 
have a far better overall survival than IDH-wildtype 
tumors, which are seen more commonly in the older 
patients (>60–65 years of age).
Key Point
• 1p/19q-codeletion status in an IDH-mutant tumor is 
diagnostic of oligodendroglioma; 1p/19q-intact status 
with TP53 mutation is diagnostic of astrocytoma.
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and vincristine (PCV) when added to radiation therapy 
 significantly improve the overall survival in patients with 
1p/19q-deleted tumors when compared with radiation ther-
apy alone [22, 23]. This is now the standard of care for all 
1p/19q-codeleted oligodendrogliomas.
4.6.2  Radiological Features
Frontal lobe is the most common location of 1p/19q- 
codeleted tumors. Other common sites include the parietal 




Fig. 4.1 A 69-year-old male with change in mental status. (a) Coronal 
T2WI demonstrates a heterogenous centrally necrotic mass in the left 
insular region extending to involve the frontal lobe. (b) Axial FLAIR 
image demonstrates FLAIR signal abnormality surrounding this lesion 
which shows indistinct margin with the adjacent brain. (c) Axial T1 
post-contrast image demonstrates heterogenous but predominantly 
peripheral intense enhancement. (d) Corresponding axial DSC 
(dynamic susceptibility contrast) perfusion map demonstrates increased 




seen most often in the temporal lobes and the insular cortex. 
In terms of their morphological appearance, 1p/19q- 
codeleted tumors demonstrate a more heterogenous appear-
ance. Also, calcification is a common feature of such tumors 
(Fig.  4.2). In fact, presence of florid calcification and 
enhancement favors a higher grade (Grade III) oligodendro-
glioma [24, 25]. An intact margin favors a 1p/19q-intact 
tumor, while ill-defined margins can be seen in both types. 
T2-FLAIR mismatch sign corresponding to a predominantly 
hyperintense signal of the mass on T2WI and corresponding 
hypointense signal on FLAIR has a high positive predictive 




Fig. 4.2 A 48-year-old man with seizures. (a) Axial T2WI demon-
strates a heterogenous mass involving the right frontal lobe. (b) 
Corresponding axial T1 post-contrast image demonstrates heteroge-
nous but minimal enhancement. (c) Axial CT scan from the same 
patient demonstrates multiple arcs of calcification within this mass. 
Diagnosis: Oligodendroglioma, IDH-mutant, 1p/19a codeleted tumor
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4.7  Gliomatosis Cerebri
Gliomatosis cerebri as a specific tumor subtype was included 
in the 2007 version of the WHO Classification of CNS 
tumors. This term is deleted from the 2016 Update. A dif-
fusely infiltrating non-enhancing tumor extending to involve 
three or more lobes is no longer to be considered as glioma-
tosis cerebri. It is recognized as a diffuse glioma type, with 
its subtype dependent on further genetic, molecular testing 
and histological evaluation [1].
4.7.1  Gliomas in Children
Gliomas in children have been known to behave differently 
than those seen in the adult population. This is related to 
the fact that mutations seen commonly in gliomas in adults 
including IDH mutation and 1p/19q-codeletion occur only 
uncommonly in children [27]. In fact, the two common 
mutation types commonly seen in children, include BRAF 
mutation and histone H3-K27 m-mutation.
4.8  BRAF Mutation
These tumors are usually well-circumscribed and carry an 
excellent prognosis.
4.9  Radiological Features
Cystic lesion with a mural enhancing nodule are common 
imaging features (Fig. 4.4). This mutation type encompasses 
pilocytic astrocytoma, pilomyxoid astrocytoma, and gangli-
oglioma [5, 11].
a b
Fig. 4.3 A 34-year-old man with headache. (a) Axial T2WI demon-
strates a well-defined expansile mass involving the left insula, which 
appears predominantly bright in its signal intensity when compared to 
the gray matter. (b) Corresponding axial FLAIR image demonstrates 
the mass to be predominantly hypointense to the gray matter. Diagnosis: 
Diffuse astrocytoma, IDH-mutant, 1p/19q-noncodeleted (intact) tumor
Key Point
• Gliomatosis cerebri as a tumor type is no longer 
recognized.
Key Point
• BRAF mutation is one of the most common muta-
tions seen in the pediatric population, and includes 
tumor types such as pilocytic astrocytoma, pilomyx-
oid astrocytoma, and ganglioglioma.
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4.10  Histone H3-K27m-Mutant Tumors
These are diffuse midline gliomas (previously known as dif-
fuse infiltrating pontine glioma) and carry an extremely poor 
prognosis. Location of this tumor type makes it difficult to 
biopsy these tumors or attempt a surgical resection [28, 29]. 
Radiation and chemotherapy are not particularly helpful.
4.10.1  Radiological Features
Brainstem (pons) is the most common location. Other common 
locations include thalami and spinal cord. As previously 
described this is a diffusely infiltrating lesion which results in 
secondary expansion of the structure involved. Only minimal 
enhancement is typically seen. Occasionally however, heterog-
enous enhancement and cyst(s) can be seen [30]. Leptomeningeal 
dissemination is seen in about one-third of all such patients.
4.11  Solitary Fibrous Tumor (SFT) 
and Hemangiopericytoma (HPC)
Both these tumors share the same genetic feature which 
includes genomic inversion at the 12q13 locus, fusing the 
NAB2 and STAT6 genes. Hence, these two previously 
 distinct tumors are now combined as SFT/HPC tumor. Of 
these, the SFT/HPC Grade I is a slowly growing tumor 
with excellent prognosis, while SFT/HPC Grade II and 
III have a slightly poor prognosis, carry a high risk 
to recur following resection, and are associated with 
metastasis [27].
4.12  New Tumors and Patterns
4.12.1  Multinodular and Vacuolating Neuronal 
Tumor
This rare entity has received mention in the 2016 Revised 
CNS Tumor Classification. It is unclear if it is a distinct 
tumor or in the tumor-dysplasia category. It carries an excel-
lent prognosis and is believed to be a “Leave-me-alone” 
lesion.
a b
Fig. 4.4 A 18-year-old boy with seizures. (a) Axial T2WI demon-
strates a well-defined cystic appearing lesion in the right temporal lobe. 
(b) Corresponding axial T1 post-contrast image demonstrates a mural 
enhancing nodule along the lateral aspect of this lesion. Diagnosis: 
Pleomorphic xanthoastrocytoma, BRAF-mutant tumor
Key Point
• H3K27M-mutant glioma now includes the previ-
ously known diffuse infiltrating pontine glioma, and 
carries a dismal prognosis.
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4.12.2  Radiological Features
It is known to occur anywhere in the brain, but commonly in the 
supratentorial compartment and especially in the frontal and tem-
poral lobes. On morphological appearance, the lesion is seen as a 
cluster of FLAIR and T2 bright lesions typically in the subcortical 
white matter. Involvement of the overlying cortex and periven-
tricular white matter has been reported. The lesion appears dark 
on T1WI and does not demonstrate contrast enhancement or dif-
fusion restriction. No susceptibility is seen [31].
4.13  Diffuse Leptomeningeal Glioneuronal 
Tumor
This is a rare glioneuronal neoplasm mainly seen in chil-
dren. It is largely localized to the leptomeningeal compart-
ment. Oligodendroglioma like tumor cells are seen on 
histology.
4.13.1  Radiological Features
Diffuse, somewhat heterogenous leptomeningeal enhance-
ment is noted. Frequently the basal cisterns are involved with 
associated extensive involvement of the subarachnoid space 
along the surface of the cord. Secondary hydrocephalus is 
commonly noted [32]. Parenchymal involvement can also be 
seen. When present, it is seen to involve the spinal cord and 
the brain stem.
4.14  Conclusion
The Revised 2016 classification of CNS tumors by including 
the genetic profile improves diagnostic accuracy of brain 
tumors. This allows neuro-oncologists and the surgeons to 
optimize treatment strategies targeted to the specific tumor 
type, thus allowing for a better prognosis, and improved 
overall survival. The neuroradiologist by identifying the 
imaging phenotype of the particular glioma genotype plays 
an important role in guiding the clinical team in their treat-
ment planning.
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5.1  Introduction
Stroke is a major global health problem with different expres-
sions among the globe but with a significant impact in the 
countries. The global prevalence of stroke varies from 339 to 
1184 per 100,000, being higher among the more developed 
countries that face the problem of aging of the population. 
The prevalence of hemorrhagic strokes also varies among 
countries from 32–270 per 100,000 [1].
Spontaneous intracranial hemorrhage (IH) accounts for 
up to 10–15% of all strokes and is an important cause of 
neurological morbidity and mortality. The intracranial hem-
orrhage incidence is estimated in 10–30/100,000, increasing 
with age (doubles each decade after 35 years of age) [2].
The 1-year survival is only about 30%, ranging the 30-day 
mortality between 35 and 52%, with approximately half of the 
deaths occurring during the first 2 days after presentation [2]. 
The prognosis of IH mainly depends on the severity of intracra-
nial hypertension and associated complications such as brain 
herniation, the development of hydrocephalus, and for subarach-
noid hemorrhage on the development of arterial vasospasm.
Spontaneous intracranial hemorrhage may be parenchy-
mal, intraventricular, subarachnoid, subdural, and epidural, 
the former being the most common location and the latter 
two being uncommon and usually associated with trauma.
Computed tomography (CT) remains the standard method 
to detect intracranial hemorrhage although radiologists need 
also to be familiar with the appearance of hematomas using 
magnetic resonance imaging (MRI). In this paper the authors 
suggest a structured imaging diagnostic approach for sponta-
neous intracranial hemorrhage and review the imaging find-
ings of the most common causes.
5.2  Hemorrhage Imaging
In the presence of a stroke with acute neurological deficit an 
emergent imaging study is warranted to evaluate the pres-
ence of ischemic or hemorrhagic stroke. Generally, CT is the 
initial imaging method used, due to its wider availability, 
rapid acquisition, lack of contraindications, and high accu-
racy to depict intracranial hemorrhage.
Imaging has a crucial role on intracranial hemorrhage 
evaluation. Firstly, it defines the type of stroke (ischemic or 
hemorrhagic), which have completely different manage-
ments. It is also essential to identify the anatomic compart-
ment the lesion is located in, and approximate the age of the 
hemorrhage. The next step is to triage patients into those 
likely to have an underlying cause (Table 5.1) which requires 
urgent diagnosis and treatment, and those who do not require 
urgent interventions. To do this, neuroimaging findings need 
to be considered in combination with the age and medical 
history of the patient. In the setting of acute intracranial hem-
orrhage, CT angiography (or MR angiography) can be used 
to screen for the presence of vascular abnormalities such as 
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• To understand typical imaging characteristics of 
intracranial hemorrhage in CT and MR imaging
• To know the most likely differential diagnosis of 
pathologies responsible for the hemorrhage with refer-
ence to anatomical location and patient characteristics
• To know how to triage patients suffering from an intra-
cranial hemorrhage for further imaging and therapy
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dural arteriovenous fistulas. Thus, imaging is essential to 
evaluate critical situations, to establish the prognosis, and to 
guide the treatment.
It is important to highlight that the blood imaging signs 
will vary over time in both computed tomography (CT) and 
magnetic resonance imaging (MRI), as shown in Table 5.2. 
Evolution over time will vary according to the location of the 
hemorrhage, with a faster clearance in the CSF spaces.
To understand the appearance of blood clots on CT and 
MRI, some knowledge on clot formation is helpful.
Primary acute intracerebral hemorrhages appear as lesions 
of homogenous hyperattenuation (Figs. 5.1 and 5.2) on (non- 
contrast enhanced) CT. The hyperattenuation results from the 
increasing protein density within the hematoma. As the hema-
toma matures, there is progressive clot formation and retraction 
with fluid loss, which then causes the hyperattenuation to 
increase from a range of 40–80 HU to 80–100 HU [3]. In the 
acute phase, the presence of fluid-fluid levels and/or hypoat-
tenuated areas inside the hematoma may represent a hyper-
acute hematoma, active bleeding (with the new incoming blood 
corresponding to these hypoattenuating areas), and/or the pres-
ence of coagulation disorder (acquired or congenital). The 
“swirl sign” characterized by the mixture of different densities 
or MR signal intensities in an acute hemorrhage suggest an 
active bleeding. Typically, clots become isodense to brain on 
CT images at 8–14 days after hemorrhage, then progressively 
hypodense after 2–4 weeks and, finally, at the late subacute and 
chronic phases, they are usually hypodense approaching the 
attenuation of cerebrospinal fluid (CSF).
For MRI it is also important to understand the type of hemo-
globin present at each stage of the hematoma. This allows the 
estimation of the age of the hematoma. Initially, an intracere-
bral hematoma consists of intact red blood cells (RBCs) con-
taining mainly oxygen-saturated hemoglobin (oxyhemoglobin, 
OxyHb). The hemoglobin is then gradually deoxygenated. At 
48  h after hemorrhage the clot consists almost entirely of 
deoxyhemoglobin (DeoxyHb). At this stage, the hematoma is 
surrounded by edema. In the early subacute phase (3–7 days) 
DeoxyHb is gradually converted to methemoglobin (MetHb). 
These changes begin at the periphery of the clot and then prog-
ress towards the center. In the late subacute phase (2–4 weeks) 
the RBCs lyse and MetHb is released from the intracellular into 
the  extracellular space. In this stage the edema gradually dis-
solves. Later on, in the chronic phase (>4 weeks) the hematoma 
Table 5.1 Most common etiologies of nontraumatic intracranial hemorrhage by age group and anatomic location
Adult Pediatric
Elderly Young/middle aged Adolescent/child/infant Newborn
Parenchymal •  Hypertensive hemorrhage
•  Cerebral amyloid angiopathy (CAA)
•  Hemorrhagic transformation of acute 
ischemic infarction
•  Dural AVF
•  Venous thrombosis
•  Coagulopathies
•  Neoplasms
•  Brain AVM
•  Cavernomas
•  Venous thrombosis
•  Hypertensive 
encephalopathies/PRES
•  RVCS
•  Drug abuse
•  Neoplasms
•  Brain AVM
•  Cavernomas
•  Venous thrombosis
•  Tumors
•  Coagulopathies 
(congenital/acquired)
•  Hypoxic- ischemic 
injury
Subarachnoid •  Aneurysm
•  Cerebral amyloid angiopathy (CAA)
•  Perimesencephalic hemorrhage
•  Bleeding diathesis (e.g., excessive 
anticoagulation)
•  Aneurysm
•  Arterial dissection
•  Brain AVM
•  Aneurysm
•  Sickle cell disease (in children)
•  Coagulopathies (congenital/acquired)
Epidural/
subdural
•  Dural AVF
•  Aneurysm
•  Moyamoya syndrome
•  Dural metastases
•  Bleeding diathesis/hematological disorders
Table 5.2 CT and MR characteristics of intracranial hemorrhage
Time NECT CECT T1-weighted T2-weighted T2∗w
Hyperacute (<6 h) Hyperdense Iso Hyper Hypo
Acute (6 h–3 days) Hyper Iso Hypo Hypo
Early subacute (3–7 days) Hyper/iso Iso (center) Hypo Hypo
Hyper (rim)
Late subacute (1–4 weeks) Iso/hypo Rim enhancement Hyper Hyper Hypo
Chronic (months–years) Hypo Hypo Hypo Hypo
Density/signal intensity compared to cortex. NECT non-enhanced CT, CECT contrast enhanced CT
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Fig. 5.1 Hypertensive hematoma. Axial (a) and reformatted coronal 
(b), and sagittal (c) CT images showing an acute hypertensive hema-
toma at the basal ganglia (putamen) dissecting into the corona radiata. 
The 10 day follow up CT images (d) shows the expected peripheral 
hyperattenuation decrease and the presence of edema. The late follow 
up (1 year) CT image (e) shows the hematoma scar as a small area of 
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shrinks to finally form a small cavity, which is often slit-like. 
The cavity often contains ferritin- and hemosiderin-laden 
 macrophages as long-standing markers of bleeding. Again, the 
signal intensity changes occur from the periphery to the center 
in a homogeneously layered fashion and the evolution over 
time will depend on the location of the bleeding [3].
Over the following hours and days it is expected that there 
is an increase of the surrounding brain edema and mass 
effect. The surrounding edema increases during the first 
2 weeks, especially during the first 48–72 h, and is associ-
ated with activation of inflammatory pathways initiated by 
the hematoma products [4, 5].
On post contrast imaging, either by CT or MRI, a thin and 
regular ring-like enhancement at the periphery of the hema-
toma is seen during the subacute phase, resulting from local 
disruption of the blood–brain barrier and associated inflam-
matory reaction.
Over time, the hematoma density will gradually decrease, 
resulting from clot lysis and liquefaction, with a centripetal 
course, from the periphery to the center, at an estimated rate of 
0.7–1.5 HU per day [3]. The edema and mass effect tend to start 
to fade at late subacute phases, generally after the third week.
In the late and chronic phases, the edema and mass effect will 
subside and a hemosiderin scar (slit-like) will prevail as a hypoat-
tenuation on CT and low T1 and T2 WI signal lesion without 
edema and mass effect (Fig. 5.1). Chronic lesions are associated 
e
Fig. 5.1 (continued)
Fig. 5.2 Hypertensive hematoma. Axial CT images showing an acute (hyperattenuating) pontine hypertensive hematoma dissecting into the 
middle cerebellar peduncle and left medulary center
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with brain atrophy with sulcal and/or ventricular enlargement, 
and may exhibit focal calcification and peripheral gliosis.
Microhemorrhages are chronic small punctate brain hem-
orrhages only depicted by MRI using T2∗W susceptibility 
imaging. They are depicted as small (<5 mm) rounded low 
T2∗ lesions which result from presumed ruptures of tiny ves-
sels with diameters smaller than 200 μm. They are commonly 
associated with sporadic small vessel disease (systemic hyper-
tension) and CAA, but can also be found in patients with non-
sporadic small vessel disease, such as CADASIL and 
vasculitis, among others. They are also seen in ageing with 
increasing prevalence with older age and hypertension. The 
differential diagnosis of microbleeds includes non-hemor-
rhagic subcortical mineralization areas; pneumocephalus and 
hemorrhagic lesions such as cavernomas, hemorrhagic diffuse 
axonal injury, and microhemorrhagic brain metastasis.
The microhemorrhage pattern associated with chronic 
hypertension has a central distribution, located at the deep 
gray structures (basal ganglia and thalamus), cerebellum, 
and less importantly at the cerebral cortico-subcortical junc-
tion (Fig. 5.3). The CCA pattern has a peripheral distribution 
at the cerebral lobar cortico-subcortical areas with a poste-
rior predominance (Fig. 5.4).
Subarachnoid and intraventricular hemorrhage manifest 
with hemorrhage into the CSF spaces presenting with 
increased attenuation on CT images (blood). The hemor-
rhage attenuation and MRI signal intensity follow the above- 
mentioned evolution.
CT is the gold standard imaging method to depict acute 
SAH [6, 7]. The sensitivity of CT to depict SAH during the 
first 6–12 h is 98–100% [6, 7]. The same diagnostic accuracy 
may be assumed for intraventricular hemorrhage. Over days, 
especially after the fifth day, the accuracy of CT decreases, 
and in the subacute phase a lumbar puncture may be needed 
to make the diagnosis [6].
Fig. 5.3 Hypertensive microhemorrhages. Axial T2*-weighted MR 
images demonstrating the central pattern of microbleeds (small punctu-
ate low intensity signal lesions) distribution, with thalamic, lenticular, 
caudade, capsular and corona radiata locations, in association with a 
peripheral distribution at the lobar cortical-subcortical junction
Key Points
• CT is the method of choice to detect acute intracra-
nial hemorrhage
• CT and CTA allow the detection of active intracra-
nial bleeding
• In the subacute stage MRI is superior to CT in the 
detection of subarachnoid hemorrhage
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Recently, it has been shown that MRI has a very high 
accuracy, similar to CT, to depict SAH in the acute phase, 
using FLAIR/DF sequences, and a higher accuracy than CT 
in the subacute and chronic phases (using FLAIR/DF and 
susceptibility weighted sequences) [8, 9]. MRI is especially 
sensitive to chronic SAH, depicting the presence of superfi-
cial cortical hemosiderosis. This is an important diagnostic 
sign since its presence can help to suspect prior subarachnoid 
hemorrhage, or to substantiate the differential diagnosis of 
amyloid angiopathy.
The severity of the SAH is measured by the (modified) 
Fisher grade (Table 5.3). The pattern of blood distribution, 
namely basal cistern, superficial, or perimesencephalic dis-
tribution, allows the prediction of the etiology.
5.3  Intracranial Hemorrhage Etiology
There are multiple potential causes of hemorrhagic 
stroke, which can be primarily categorized according to 
the hemorrhage location and patient age, facilitating the 
imaging differential diagnosis approach, as summarized 
in Table 5.1.
Additional imaging to evaluate an intracranial hemor-
rhage includes CT angiography to look for underlying vascu-
lar lesions and MRI to rule out other etiologies of ICH.
Vascular imaging is indicated whenever a vascular lesion 
is suspected, such as arterial aneurysms, pial arteriovenous 
malformations and dural arteriovenous fistula, or vasculitis. 
CT or MR venograms are very helpful to depict the presence 
of cerebral venous thrombosis, especially dural sinus throm-
bosis. CTA and MRA are the initial imaging methods. DSA is 
reserved for inconclusive cases, and for the treatment of some 
of the vascular lesions. The spot sign on CTA, reflecting con-
trast extravasation, depicted as an enhancing focus within the 
acute hematoma, deserves special attention since is associ-
ated with a higher risk of growth of the hematoma [10–14].
Brain hemorrhage accounts for up to 15% of all strokes 
[15]. Among the adult population brain hemorrhage is most 
commonly associated with systemic hypertension (Figs.  5.1, 
5.2, and 5.3), followed by cerebral amyloid angiopathy (CAA) 
(Figs. 5.4 and 5.5). In younger patients and in children, vascu-
lar malformations are an important cause of brain hemorrhage. 
Cerebral venous thrombosis is also an important cause of brain 
hemorrhage in the young patient especially in females and dur-
ing the pregnancy and puerperium. Hemorrhagic transforma-
tion of acute ischemic stroke and hemorrhagic brain tumors are 
also important causes of brain hemorrhage. Other potential 
causes of brain hemorrhage, representing <10% of cases, 
include reversible cerebral vasoconstriction syndrome (RVCS), 
posterior reversible encephalopathy syndrome (PRES), vascu-
litis, coagulopathy disorders, drugs consumption (sympatho-
mimetics, cocaine, amphetamine, ecstasy, among others), 
moyamoya disease, infections, and pre-eclampsia/eclampsia, 
among others.
Fig. 5.4 Cerebral amyloid angiopathy (CAA) microhemorrhages. 
Axial T2-weighted MR images demonstrating the isolated peripheral 
pattern of microbleeds (small punctuate low intensity signal lesions) 
distribution  with distribution at the lobar cortical-subcortical junction 
with posterior cerebral predominance, in association to a right occipital 
lobar hematoma
Table 5.3 Modified Fisher grade
Grade 1 Minimal or diffuse thin SAH 
without IVH
Low risk for symptomatic 
vasospasm
Grade 2 Minimal or thin SAH with 
IVH
Intermediate risk for 
symptomatic vasospasm
Grade 3 Thick cisternal clot without 
IVH
Grade 4 Cisternal clot with IVH High risk for symptomatic 
vasospasm
P. Vilela and M. Wiesmann
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Hypertensive hemorrhage is the leading cause of cerebral 
hematomas in the adult population, being secondary to a 
long-standing hypertensive vasculopathy characterized by 
lipohyalinosis of small-to-medium penetrating arteries. 
Hematomas result from the rupture of small arterioles and 
have a rebleeding rate of up to 2% per year [16]. Typical 
locations for hypertensive hemorrhage (Figs. 5.1 and 5.2) 
include basal ganglia (in 62–65% of cases), thalamus (in 
20–26% of cases), pons (in 5–10% of cases), cerebellum (in 
approximately 6% of cases), and subcortical—cerebral lobar 
(in 1–2%) of cases [17, 18]. The association of leucoaraiosis, 
lacunar infarcts, and microbleeds with a central distribution 
pattern supports the diagnosis.
Cerebral amyloid angiopathy (CAA) is the second most 
common cause of spontaneous intracranial hemorrhage in 
adults and results from the vessel wall deposition of amy-
loid- b peptide in small leptomeningeal and cortical vessels. 
CAA is responsible for up to 50% of spontaneous hemor-
rhages in older patients (>65  years) and its incidence 
increases with patient age, being present in up to one third 
of brain autopsies in patients above 60  years old, which 
reflects that in an ageing population it will be a very impor-
tant cause of hemorrhage. The most common type of CAA 
is the sporadic type occurring in the elderly, but there are 
hereditary types that may present earlier, such as the 
HCHWA-Dutch type and HCHWA-Icelandic type with 
onset in the third/forth decade, and other reported familiar 
types. Imaging is an important criterion for the diagnosis of 
CAA according to the Boston diagnostic criteria (Table 5.4) 
[19]. CAA should be considered in cases of older patients 
with multiple lobar, cortical, and/or subcortical hemor-
rhages; superficial/cortical subarachnoid hemorrhage 
(superficial siderosis); and peripheral distributed microhem-
orrhages. Hemorrhages rarely involve the cerebellum and 
a cb
Fig. 5.5 Cerebral amyloid angiopathy (CAA). Axial T1-weighted MR 
image (a) depicting a frontal lobar hematoma in the subacute stage 
(extracellular methemoglobin). Axial T2-weight (b) and T2*-weighted 
(c) images demonstrate additional cortical (superficial) subarachnoid 
hemorrhage at the right brain convexity and a chronic occipital lobar 
hematoma






•  Lobar, cortical, or cortical/
subcortical hemorrhage
•  Pathological evidence of 
severe cerebral amyloid 
angiopathy






Clinical data and 
pathological tissue 
(evacuated 
hematoma or cortical 
biopsy specimen)
•  Lobar, cortical, or 
corticosubcortical hemorrhage
•  Some degree of CAA in 
specimen




Clinical data •  Patient 55 years or older
•  Absence of other diagnostic 
lesion
•  Absence of other cause of 
hemorrhage or superficial 
siderosis
MRI or CT 
demonstrating
•  Multiple hemorrhages 
restricted to lobar, cortical, or 
corticosubcortical regions 
(cerebellar hemorrhages 
allowed) of varying sizes/
agesOr
•  Single lobar, cortical, or 
corticosubcortical hemorrhage 
and focal (three or less sulci) 
or disseminated (more than 




Clinical data •  Patient 55 years or older
•  Absence of other cause of 
hemorrhage or superficial 
siderosis
MRI or CT 
demonstrating
•  Single lobar, cortical, or 
corticosubcortical 
hemorrhageOr
•  Focal or disseminated 
superficial siderosis
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the microbleeds spare the basal ganglia and brain stem 
(Fig. 5.4) [19].
For brain hematomas, there are some red-flag imaging 
findings that should prompt our special attention. These 
cases may require early surgical treatment. It is essential to 
depict early hematoma expansion, intracranial hypertension 
and/or signs of mass effect, such as brain herniation, and the 
presence of hydrocephalus.
Predictors for worst outcome include hemorrhage volume, 
infratentorial location (brain stem and/or cerebellum), presence 
of intraventricular hemorrhage, and/or hydrocephalus [15, 20].
Hematoma volume can be measured from multipla-
nar reconstruction as the ratio ABC/2, being ABC the 
three orthogonal diameters (the diameters are multiplied—
length × width × height—and divided by 2). It is also essential 
to depict intraventricular extension, since it represents a higher 
risk for hydrocephalus, especially if the clot is inside the aque-
duct and/or IV ventricle. Brain herniation is associated with a 
dismal outcome, and may necessitate surgical decompression.
Other unfavorable factors of brain hematomas include 
advanced age, and high scores on the Glasgow Coma Score 
(GCS) and National Institutes of Health Stroke Scale 
(NHIHSS) at admission.
The ICH score allows an early estimation of the patient 
prognosis [20]. Higher scores are associated with higher 
30 days mortality rates, namely of 13%, 26%, 72%, and 97% 
corresponding to scores of 1, 2, 3, and 4, respectively 
(Table 5.5) [20]. Another brain hemorrhage prognostic score, 
that estimates the functional independence at 90 days, is the 
Functional Outcome in Primary Intracerebral Hemorrhage 
(FUNC) score [21].
It is also worthwhile to stress that up to 30% of brain hema-
tomas will increase in size during the first 24 h, especially dur-
ing the first 3 h after presentation, which may be associated 
with neurological decline [22]. Repeat CT scans at 24 h or 
whenever there is a neurological decline is recommended [22].
Intracranial venous thrombosis (IVT) is an important 
cause of intracranial hemorrhage, especially in young 
patients and children. There is also a higher incidence during 
pregnancy and puerperium and in females under oral contra-
ception. IVT results from the formation and propagation of a 
venous clot leading to the occlusion of the intracranial 
venous system components. Venous thrombosis features a 
wide spectrum of clinical and imaging presentation. 
Headache is the most common symptom. The diagnosis of 
IVT includes the demonstration of the thrombus/venous 
occlusion (direct signs), depicted by CT (which depicts only 
one third of cases as hyperdense thrombus inside the dural 
sinus—dense triangle sign—or cortical vein—cord sign—) 
or by MRI by the loss of the normal venous flow void by a 
clot that follows the same signal intensity progression previ-
ously described for parenchymal hematomas. MRV or CTV 
is also helpful to establish the diagnosis. It is also important 
to depict the presence of intracranial lesions (indirect signs), 
such as brain swelling, brain edema, venous infarction, intra-
cranial hemorrhage, which are better defined by MRI [23].
Vascular malformations are the leading cause of sponta-
neous intracranial hemorrhage in children and young 
patients, including cavernomas and brain arteriovenous mal-
formations (AVMs).
Brain AVMs are composed by abnormal arteriovenous 
shunts, occurring in a central nidus, which is the central area 
towards multiple feeding arteries converge and from which 
(early and enlarged) draining veins start. Most of the cases 
are sporadic, but they may be associated with HHT/ROW 
and RASA 1 mutation or being a part of metameric syn-
dromes. Brain AVMs appear as a tangled cluster of abnormal 
vessels, dilated arteries and veins, which can be sulcal, 
parenchymal, and/or intraventricular. Brain AVMs are con-
stituted by feeding arteries, with the nidus corresponding to 
the shunting area and veins that drain the malformation. The 
vessels present slightly hyperdense on CT and with flow 
voids on MRI. Small AVMs may only be depicted by DSA 
which is the gold standard imaging method. They may be 
associated with surrounding brain changes such as edema, 
gliosis, previous hemorrhage, and/or mass effect. The most 
common brain AVM classification used is the Martin- 
Spetzler classification evaluating the size, location, and 
venous drainage of the brain AVM predicting the surgical 
risk for treatment. The hemorrhagic risk is higher for those 
AVM that have previously bled and for those with infratento-
rial, deep location, and deep venous drainage.
Table 5.5 ICH score
ICH Score Points
GCS score 3–4 2
5–12 1
13–15 0
ICH volume (cm3) ≥30 1
<30 0
Intraventricular hemorrhage Yes 1
No 0






• CAA shows a different lesion pattern than hyper-
tensive hemorrhage pattern and can be recognized 
by the presence of superficial siderosis
• In intracerebral hematomas early hematoma expan-
sion, intracranial hypertension, brain herniation, 
and the  presence of hydrocephalus need to be rec-
ognized early to allow for specific treatment
P. Vilela and M. Wiesmann
53
Cavernomas are venous vascular malformations that are 
seen on CT as isodense or hyperdense lesions with calcifica-
tions in up to 40–60% of cases. On MRI their appearance is 
variable. Most commonly they have a central core with 
mixed signal from blood in different stages (“popcorn like”), 
being hyperintense on T1WI and hyper-hypointense on T2 
WI. There is generally a completely T2 hypointense rim of 
hemosiderin and the contrast-enhancement is variable. The 
T2∗/susceptibility sequences are the most sensitive imaging 
methods to depict cavernomas (Fig. 5.6). Cavernomas may 
appear only as small punctate lesions (more common in 
multiple cavernomas) that are poorly or not seen on T1 and 
T2 and only demonstrated on T2∗/susceptibility sequences. 
DSA is negative for the detection of cavernomas. Most of 
the cavernomas are sporadic but there are some familiar 
forms, such as CCM 1–3, for which cases multiple caverno-
mas are more common and an entire evaluation of the neur-
axis is suggested. The most common presentation of 
cavernomas and brain AVM are hemorrhage, seizures, and 
neurological deficits.
Dural arteriovenous fistulae (AVF) tend to present in 
older patients. They are acquired vascular malformations in 
which there are abnormal connections between arteries that 
normally feed the meninges, bone, or muscles, but not the 
brain, and the dural sinuses or small venules within the dura 
mater. They are difficult to depict since there is no evident 
Fig. 5.6 Cavernoma. Axial CT images (a) showing a slight hyperat-
tenuating superior frontal gyrus lesion with central calcifications. The 
coronal T1-weighted (b) and T2-weighted (c) MR images demonstrate 
the “popcorn-like” appearance with intralesional hyper- and hypoin-
tense components in both sequences corresponding to blood in different 
stages. The axial T2*-weighted images (d) confirms the hemorrhagic 
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nidus and the feeding arteries are not as dilated as in brain 
AVM. The dilatation of meningeal arteries, presence of small 
arteries at the dura sinus and/or arterialized dural sinus, dif-
fuse venous congestion and/or dilated veins should raise the 
suspicion of dural AVF. The hemorrhage risk of dural AVF is 
higher when a cortical venous reflux is present. The most 
common classifications, the Cognard and the Borden classi-
fications, address the type of venous drainage and predict the 
future risk for hemorrhage.
Brain tumors are responsible for approximately 10% of 
intracranial bleedings. Early diagnosis allows for specific 
treatment. The most common causes of hemorrhage associ-
ated with brain tumors are intratumoral and/or extratumoral 
hemorrhage from the tumoral mass, generally in hypervascu-
larized tumors. Other causes of hemorrhagic stroke may 
exist in neoplastic patients, such as malignancy induced 
coagulopathy, side effects from chemotherapy and/or radio-
therapy, hemorrhagic infarcts resulting from thrombotic 
coagulopathy, arterial tumoral emboli (in association with 
heart myxoma), or from venous thrombosis in thrombotic 
coagulopathy or in association with venous compression/
invasion/thrombosis.
The tumors more commonly associated with brain hem-
orrhage are metastases, especially from breast and lung 
(bronchogenic) carcinoma, melanoma, choriocarcinoma, 
renal cell carcinoma, thyroid carcinoma, and primary highly 
vascularized tumors, such as high-grade gliomas.
There are some imaging findings that should raise the sus-
picion of the presence of an underlying tumor, such as atypi-
cal hematoma location; the presence of multiple hemorrhagic 
foci within the lesion; heterogeneous hematoma with differ-
ent hemorrhage stages not following the usual chronological 
evolution or having a delayed evolution (due to hypoxic 
environment); the presence of fluid-fluid levels, that may 
represent blood-blood levels, blood-cystic/necrotic levels; 
the presence of an incomplete hemosiderin rim; the presence 
of irregular margins; the presence of a disproportionately 
larger edema; and/or the presence of non-hemorrhagic 
enhancing areas (Fig. 5.7). In the follow-up studies the pres-
ence of non-hemorrhagic enhancing areas may be more con-
spicuous and there is generally a persisting mass effect and 
edema that does not subside completely.
Congenital or acquired coagulation disorders are impor-
tant causes of spontaneous brain hemorrhages, since the 
number of patients under anticoagulation/antiplatelet ther-
apy has been increasing over the years. These hemorrhages 
can occur in any intracranial compartment, even simultane-
ously. The presence of large or multiple and synchronous 
(same age/stage bleedings at CT/MRI) hemorrhages, and/or 
the presence of fluid-fluid hemorrhagic levels should raise 
the suspicion of coagulation disorder (Fig. 5.8).
It is not common to have brain hemorrhages associated 
with intracranial infections. Some of the typical examples 
include hemorrhagic encephalitis, such as herpes encephali-
tis, dengue fever, Crimean hemorrhagic fever-Congo virus, 
Epstein-Barr virus, and chikungunya virus, among others. 
Hemorrhage may also be a presentation of infectious vascu-
litis, such as varicella-zoster vasculitis. Fungal infection with 
vessel wall invasion may cause hemorrhage, e.g. in cases of 
aspergillosis and mucormycosis. Actinomycosis, paragoni-
miasis, cerebral malaria (due to hemorrhagic infarcts) may 
also present with devastating hemorrhagic lesions. Other 
causes of hemorrhage include infective endocarditis with 
septic emboli, hemorrhage associated with sepsis-induced 
coagulopathy and with infection treatment as in toxoplasmo-
sis. In cases of meningitis, cerebral venous thrombosis and 
hemorrhagic transformation of ischemic infarcts may also 
lead to brain hemorrhage.
5.4  Subarachnoid Hemorrhage 
and Intraventricular Hemorrhage
The overall incidence of SAH is in between 9 and 20 per 
100,000 person-years, accounting for up to 5% of all stroke 
cases [24–26]. The most common cause of spontaneous sub-
arachnoid hemorrhage (SAH) is the rupture of an intracranial 
aneurysm, accounting for up to 80–85% of cases [24–26]. 
Ruptured saccular aneurysms commonly present with SAH 
located in the basal cisterns.
d
Fig. 5.6 (continued)




Fig. 5.7 Hemorrhagic tumor. Axial CT image (a) shows an acute hem-
orrhagic lesion (hyperattenuating) with intraventricular location (left 
frontal horn). The coronal T1-weighted (b) and axial T2-weighted (c) 
MR images demonstrate the heterogeneity of the signal intensities 
within the lesion not following the expected layered pattern of a pri-
mary hemorrhage. The coronal T1-weighted (d) and coronal 
T1-weighted (e) post contrast images of follow up MRI performed after 
3 weeks demonstrate the absorption of the hemorrhage and demonstrate 
the underlying intraventricular contrast-enhancing lesion correspond-
ing to a high grade glioma
Additional causes of SAH include intracranial dissec-
tions, and for the cases with superficial/cortical subarachnoid 
hemorrhage, CAA, cortical venous thrombosis, vasculitis, 
reversible vasoconstriction syndrome (RVCS), distal arterial 
aneurysms, and dural arteriovenous fistulae (dAVF) should 
be considered.
Benign perimesencephalic SAH is a subgroup of SAH 
with an excellent prognosis. It accounts for up to 10% of 
cases and is believed to result from rupture of veins. Typically, 
the blood is collected at the perimesencephalic and prepon-
tine cisterns and CTA and DSA are negative for the presence 
of aneurysm/vascular malformation.
Isolated intraventricular hemorrhage is an uncommon 
location for spontaneous hemorrhage. It generally results 
from the direct expansion of a parenchymal hematoma or the 
recirculation of blood in a SAH case.
Key Points
• DSA is the method of choice to screen for multiple 
aneurysms in all cases of SAH
• In cases of typical perimesencephalic SAH follow-
up DSA studies are not required
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5.5  Epidural/Subdural Hemorrhage
Epidural and subdural hematomas are generally associated 
with head trauma. Exceptionally they may occur spontane-
ously in patients under anticoagulation or antiplatelet ther-
apy. Isolated spontaneous EDH and SDH have been described 
most commonly in association with coagulopathies, dural 
and osteodural arteriovenous fistula, intracranial hypoten-
sion, and dural/bone tumors, especially metastases.
5.6  Conclusions
Imaging is essential for the management of intracranial hem-
orrhage. It allows for the depiction of the bleeding, the classi-
fication of the hemorrhage according to its size and location, 
to detect and/or exclude an underlying disorder, such as a vas-
cular malformation, tumor, infection, among others. It also 
establishes the prognosis and guides the treatment.
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CT and MR imaging findings in meningitis are nonspecific, 
with MR being superior to CT in the detection of meningeal 
pathology. Imaging findings in meningitis include: high sig-
nal intensity of subarachnoid spaces on FLAIR, leptomenin-
geal enhancement, subdural effusions, ventricular debris, 
and hydrocephalus, as well as high signal changes on 
diffusion- weighted MR imaging (DWI), and infarcts [1].
6.1.1  MR Imaging
On fluid-attenuated inversion-recovery (FLAIR) sequences, 
a high signal will be present in the subarachnoid spaces, 
which reflects the high protein content in the cerebral spinal 
fluid (CSF). Differential diagnosis includes metastatic dis-
ease, subarachnoid hemorrhage, with the administration of 
oxygen and some sedation agents. Leptomeningeal enhance-
ment can be best depicted with post-contrast 3D T2-FLAIR 
(Fig. 6.1a–c) [2].
6.1.2  Enhancement Pattern
Intracranial meningeal enhancement patterns are pachy-
meningeal (dura-arachnoid) or pia-subarachnoid (lepto-
meningeal). In a pachymeningeal enhancement pattern, 
the dura and the outer layer of the arachnoid will enhance. 
This pattern will be seen in intracranial hypotension, after 
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• To explain how to use imaging to distinguish 
between infectious and non-infectious meningitis
• To introduce diagnostic algorithm for ring-enhanc-
ing brain lesions
• To discuss imaging findings in autoimmune 
encephalitis
• To review imaging features of CNS vasculitis
• To learn about IgG-related CNS disease
Key Points
• Thin, linear, diffuse meningeal enhancement sug-
gests infectious meningitis, whereas in thick, nodular 
enhancement neoplastic origin should be suspected
• Perfusion MR imaging has a central role in differ-
entiation of infectious and neoplastic ring-like 
enhancing brain lesions
• Use vessel wall MR imaging for evaluation of CNS 
vasculitis
• In unilateral/bilateral thick, dural enhancement suspect 
IgG-related pachymeningitis
Key Points
• Use FLAIR and postcontrast 3D T2-FLAIR
• Be aware of different enhancement patterns
• Look for DWI lesions in suspected meningitis
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surgery, granulomatous diseases, meningioma, and meta-
static disease. Leptomeningeal enhancement follows the 
pial surface of the brain and fills the subarachnoid spaces 
of the sulci and cisterns. This pattern suggests an infec-
tious origin (bacterial, viral, fungal), or, in some cases, 
carcinomatous meningitis. Thin, linear enhancement will 
be seen in meningitis, whereas thick, lumpy, nodular 
enhancement suggests carcinomatous origin (Figs. 6.2 and 
6.3). Unilateral, thin, leptomeningeal enhancement may be 
due to non-infectious diseases, such as neurosarcoidosis, 
vasculitis, IgG-related pachymeningitis, and Sturge–
Weber syndrome (Fig. 6.2).
6.1.3  Diffusion-Weighted MR Imaging (DWI) 
in Meningitis
Hyperintense DWI lesions may be seen in several locations: 
(a) in the ventricles representing purulent fluid; (b) in the 
cortical sulci; and (c) in the Virchow-Robin spaces (VRSs) 
(Fig. 6.4).
6.1.4  Tuberculous Meningitis
In tuberculous meningitis (TBM), FLAIR will show 
hyperintense subarachnoid spaces and the cisterns at the base 
of the brain (interpeduncular fossa, suprasellar, perimesen-
cephalic, and pontine cisterns) with intense leptomeningeal 
enhancement on post-contrast T1WI or post-contrast 
FLAIR. In addition, surrounding brain edema will be recog-
nized as a high signal on T2WI and FLAIR.  In children, 
communicating or non-communicating hydrocephalus may 





Fig. 6.1 Superiority of post-contrast 3D T2-FLAIR (a–c) to post-contrast T1WI (d–f) in the detection of leptomeningeal enhancement
Key Points
• Bilateral basal ganglia infarctions
• Thick leptomeningeal enhancement of the basal 
cisterns
• Hydrocephalus
• Multiple ring-enhancing lesions (tuberculomas)
• Cranial nerve enhancement and perineural spread
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and subsequent thrombosis will lead to arterial infarctions. 
Bilateral infarctions in the basal ganglia region and in the 
internal capsule on DWI should raise the suspicion of tuber-
culous meningitis. Narrowing or occlusion of the arteries 
may be seen on MR angiography (MRA). Cranial nerve 
involvement with thickened enhancing nerves is a common 
finding (Fig. 6.5).
6.2  Brain Abscess
A brain abscess is a focal infection of the brain that begins as 
a localized area of softening of the brain parenchyma (cere-
britis), and develops into a collection of pus surrounded by a 
capsule.
6.2.1  MR Imaging of Brain Abscesses
6.2.1.1  T2-Wi
Bacterial brain abscesses have a T2 high-signal-intensity 














Fig. 6.2 Different enhancement patterns in meningeal diseases
Key Points
• Use MR perfusion to differentiate neoplastic from 
non-neoplastic, ring-enhancing brain lesions
• Use DWI & SWI to further differentiate pyogenic 
from fungal abscesses
• Use MRS to differentiate tuberculomas from pyo-
genic abscesses and neoplasms




Fig. 6.3 Thin, linear enhancement (a, b) 
suggests infectious origin, whereas a thick, 
nodular enhancement will favor neoplastic 
diseases (c, d)
High signal in the ventricles 
(purulent fluid)
High signal in the
subarachnoid spaces
High signal in VR spaces
Fig. 6.4 Diffusion-weighted MRI abnormalities in meningitis
cal edema, and ring-like enhancement on post-contrast 
T1WI. Fungal abscesses usually demonstrate low T2 signal 
in the center. Parasitic abscesses, such as toxoplasma 
abscesses, may show centrally high or low signal.
6.2.1.2  Diffusion-Weighted MR Imaging
A high signal on DWI, with low ADC values in the pyogenic 
abscess cavity, is consistent with restricted diffusion due to 
the high viscosity pus. Fungal abscesses may show high, 
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low, or intermediate signals on trace DWI in the abscess 
cavity. Restricted diffusion may be seen in the walls of the 
 fungal abscess called “intracavitary projections.” High sig-
nal on DWI (with low ADC values) is due to fungal organ-
isms located at the periphery of the lesions and mucoid 
material (Fig. 6.6).
6.2.1.3  Susceptibility-Weighted MR Imaging 
(SWI)
On susceptibility-weighted MR imaging (SWI), pyogenic 
brain abscesses show the “dual rim sign,” (hypointense outer 
layer and hyperintense inner layer) [3]. Fungal abscesses do not 
show the dual rim sign, but rather, are recognized by the thick 
dark rim on SWI. In addition, fungal abscesses may have mul-
tiple, punctate, intralesional dark signals indicative of hemor-
rhage (common in Aspergillus infection) (Fig. 6.6) [4, 5].
In demyelinating lesions, which present as ring- enhancing 
lesions, SWI will demonstrate linear dark structures that run 
through the lesion, representing dilated veins. SWI can also 
be used to differentiate glioblastoma that presents as a 
peripheral or ring-enhancing mass from an infectious 
abscess. Glioblastoma shows dark dots and lines on SWI due 
to hemorrhage and neoangiogenesis.
6.2.1.4  Perfusion MRI
Perfusion MRI demonstrates low regional cerebral blood flow 
(rCBV) in all infectious abscesses regardless of etiological 
agents. Very rarely, in bacterial brain abscesses, high rCBV in 
the enhancing part will be detected due to the vascularization 
present in the early capsular stage. Neoplastic lesions (glio-
blastoma, metastases), as well as demyelinating lesions, may 
present as ring-like enhancing brain lesions, and can mimic a 
brain abscess. Perfusion will be useful as it will show increased 
rCBV in the enhancing part of neoplastic lesions, but low 
rCBV in demyelinating lesions (Fig. 6.6) [1, 5].
6.2.1.5  MR-Spectroscopy
To distinguish between aerobic and anaerobic pyogenic 
abscesses, MR spectroscopy (MRS) can be used. Succinate 
and acetate signal resonances suggest an anaerobic agent. In 
fungal abscesses lipids, lactate, amino acids, and trehalose 
(3.6–3.8 ppm) are commonly detected.
a b c
d e f
Fig. 6.5 Proven tuberculous meningitis with multiple ring-enhancing tuberculomas in the basal cistern (a–c). With disease progression, there was 
perineural spread with thickened and enhancing cranial nerves (d, e, red arrows)
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6.2.2  Tuberculoma and Tuberculous 
Abscesses
Tuberculous granuloma (tuberculoma) is the most common 
parenchymal form of CNS TB. The imaging features depend 
on the stage of infection. Noncaseating tuberculomas have a 
low T1WI and a high T2WI signal and show nodular enhance-
ment. Caseating tuberculomas demonstrate a low T1- and 
T2-WI signal with ring-like enhancement. DWI characteris-
tics will also depend on the stage and content; caseating 
tuberculomas with a T2 high-signal-intensity center show 
restricted diffusion. Caseating tuberculomas with a T2-low-
signal-intensity center have elevated diffusion. MRS can also 
be used to differentiate pyogenic abscesses from tuberculous 
lesions (a large lipid peak will be found in T2-hypointense 
caseating tuberculomas, and large choline and lipid peaks 
will be detected in T2-hyperintense tuberculomas) (Fig. 6.6).
Tuberculous abscesses are large, multiloculated masses, 
with thick enhancement and edema with mass effect.
6.3  Autoimmune Encephalitis
The term “autoimmune encephalitis” generally refers to a family 
of closely related disease processes that share overlapping clinical 
features and neuroimaging findings, but are ultimately differenti-
ated by the specific antibody subtypes driving the underlying 
immune-mediated attack on different CNS structures [6–8].
Autoimmune encephalitis can be classified into two major 




Fig. 6.6 Diagnostic scheme for differentiation of ring-enhancing brain lesions
Key Points
• New-onset altered mental status—consider an auto-
immune cause!
• LOOK at the limbic system, basal ganglia, cerebel-
lum, brainstem
• Contrast enhancement or diffusion restriction is 
rarely present
• No hemorrhage
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A subset of patients with autoimmune encephalitis 
will have no neuroimaging findings despite profound 
neuropsychiatric dysfunction. Serum antibody testing 
will ultimately lead to the diagnosis of autoimmune 
encephalitis.
18FDG-PET could be a helpful alternative with which to 
narrow the diagnosis when MRI and biological tests are neg-
ative. FDG-PET was reportedly more sensitive for AE com-
pared to EEG, MRI, or routine CSF findings. Hypometabolism 
was found in the cortex, whereas hypermetabolism was seen 
in the basal ganglia.
N-methyl D-aspartate receptor encephalitis (NMDAr) is 
one of the most common and best characterized subtypes of 
autoimmune encephalitis, classically seen in young women 
and children. It can be paraneoplastic (associated with ovarian 
cancer) or non-paraneoplastic. Over half of MRIs performed in 
anti-NMDA receptor encephalitis show NO abnormalities. T2/
FLAIR hyperintensity of the medial temporal lobe (Fig. 6.7), 
Fig. 6.7 Axial FLAIR (a) shows bilateral high signal in the hippocampus. On trace DWI (b), high signal is detected with a subtle decrease in ADC 
values (c). On follow-up MR, bilateral hippocampal atrophy is observed (d)
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frontal lobe, subcortical WM, and periventricular region have 
been described. Occasionally, leptomeningeal and cortical con-
trast enhancement will be detected.
Anti-neuronal nuclear antibody 1(Anti-Hu) encephali-
tis is associated with lung cancer and is usually associ-
ated with a bad prognosis. It will less frequently be 
recognized as limbic encephalitis, and usually affects the 
brainstem.
Anti-Yo is associated with ovarian and breast cancer, and 
it typically presents with paraneoplastic cerebellar degenera-
tion (Fig. 6.8).
6.4  Neurosarcoidosis
Neurosarcoidosis is a multisystem granulomatous dis-
ease with sarcoid-type granulomas and epithelial cells 
and its diagnosis is based on the clinical determination of 
multisystem diseases in combination with histologic 
confirmation.
Neurosarcoidosis has been described in 5% of patients 
with sarcoidosis. The disease might present with a variety of 
clinical presentations, such as cranial neuropathy, encepha-
lopathy, meningitis, hydrocephalus, seizures, as well as spinal 
cord abnormalities and peripheral neuropathy and myopathy.
Typical imaging findings, although nonspecific, include 
dural thickening or dural masses, leptomeningeal  involvement 
(Fig.  6.9), enhancing and non-enhancing parenchymal 
lesions (Figs. 6.10 and 6.11), and cranial nerve involvement 
(Fig.  6.12). The latter is the most common finding. Spine 
Fig. 6.8 Initial MR exam in a patient with proven anti-Yo encephalitis (a, b). Follow-up MR 2 years later shows marked cerebellar atrophy (c, d)
Key Points
• Perform complete MRI including T1 after contrast 
administration, FLAIR, T2, DWI, and SWI
• Be aware of possible spine lesions
• Think of neurosarcoidosis when several different 
brain compartments are involved
• Differential diagnosis: meningitis, tuberculosis, 
leukemia, lymphoma, and vasculitis, among others
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a b
Fig. 6.9 Axial FLAIR (a) and T1-weighted post-contrast administration (b) demonstrate diffuse, focal, increased FLAIR signal in the underlying 
brain parenchyma and focal left-sided leptomeningeal enhancement in a patient with neurosarcoidosis
a b
Fig. 6.10 Axial post-contrast-enhancing T1-weighted images (a, b) demonstrating focal periventricular granulomatous contrast-enhancing 
masses
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a b
Fig. 6.11 Axial pre- (a) and post-contrast T1-weighted (b) images demonstrating basal granulomatous contrast-enhancing mass lesions obstruct-
ing the CSF circulation and causing secondary hydrocephalus
a b
Fig. 6.12 Axial (a) and coronal (b) post-contrast T1-weighted images showing thickening and pathological contrast enhancement in the posterior 
pre-chiasmatic portion of the right optic nerve
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involvement may exist, even less frequently, such as lesions 
in the vertebral body, spinal cord lesions, and spinal and 
nerve root enhancement (Fig. 6.13).
Common radiological imaging methods include CT and 
MRI. Imaging findings on CT are, in general, nonspecific and 
might include hydrocephalus, periventricular hypoattenuation 
and contrast enhancement, calcification, meningeal contrast 
enhancement, focal white matter lesions, and lesions in the 
optic nerves or chiasm. The imaging modality of choice for 
the evaluation of suspected neurosarcoidosis is MRI. The pro-
tocol should include FLAIR/T2-weighted, T1-weighted pre- 
and post-contrast administration, DWI and T2∗, or SWI. MRI 
can better depict leptomeningeal abnormalities and lesions in 
the brain parenchyma, as well as demonstrate the cranial nerve 
involvement, which often presents as cranial nerve thickening 
and enhancement. The most common nerves involved are the 
optic nerve and the facial nerves. There may also be involve-
ment of the pituitary gland. Spinal involvement, both of the 
vertebra and the spinal cord, is better seen with MRI. It should 
be noted that MRI can be normal in patients with neurosar-
coidosis, especially in patients on corticosteroids or if the only 
presenting symptom is cranial neuropathy.
6.4.1  Leptomeningeal Involvement
Leptomeningeal involvement occurs in up to 40% of patients 
with neurosarcoidosis. It might be focal, multifocal, or dif-
fuse, or even mass-like, and present as linear or nodular 
enhancement along the brain surface and basal regions. It is 
best depicted after contrast enhancement (Fig.  6.9). 
Differential diagnosis for leptomeningeal enhancement 
should include meningeal carcinomatosis, lymphoma, leuke-
mia, and fungal and bacterial infections.
6.4.2  Dural or Focal Mass Lesions
The granulomatous lesions might, if located in the basal 
regions or adjacent to the ventricles, cause obstruction of the 
CSF (cerebral spinal fluid) circulation and lead to hydro-
cephalus (Fig. 6.10). The dural lesions are usually isointense, 
appearing as a gray mass on T1 sequences of MRI and 
hypointense on T2 sequences of MRI. Potential differential 
diagnosis includes meningiomas, metastases, plasmacytoma, 
and granulomatous infections.
Fig. 6.13 Sagittal pre- (a) and post-contrast-enhancing T1-weighted (b) images over the thoracic spine demonstrating lesions in the vertebral 
bodies and discrete contrast enhancement in the spinal cord at the level of the mid-thoracic region. Axial CT (c) demonstrates the vertebral 
lesions
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6.4.3  Cranial Nerve Involvement
The involvement of the cranial nerves, most commonly 
the optic nerve and the fascial nerves, might be demon-
strated as thickening and enhancement of the involved 
nerves, best seen on T1-weighted post-contrast adminis-
tration and on T2-weighted images (Fig. 6.12a, b). Here, 
the 3D-CISS sequences might be of value for better depic-
tion of the nerves. Note that several nerves might be 
involved.
6.4.4  Spine, Spinal Cord, and Spinal Nerve 
Involvement
Spine and spinal cord involvement are generally uncom-
mon in neurosarcoidosis, but do occur both in combina-
tion with other CNS involvement or as an isolated finding. 
Such involvement may present as leptomeningeal 
enhancement, pachymeningeal, or intramedullary lesions 
and rarely involves the vertebral bodies. Typical vertebra 
lesions can present as focal or diffuse lesions in the ver-
tebral bodies and be misdiagnosed as myeloma, lym-
phoma, or metastasis. Involvement of the spinal cord and 
spinal nerve roots might present as focal lesions with low 
signal intensity on T1, high signal intensity on T2, and 
nodular enhancement on contrast administration. The 
increased signal on T2-weighted images compared to that 
of the gray matter is suspected to be related to inflamma-
tion and edema. In addition, leptomeningeal or focal con-
trast enhancement can be seen along or in the spinal cord 
or along the nerve roots on T1-weighted images after 
contrast administration. The intramedullary lesions will 
normally demonstrate slightly increased diffusivity with 
correspondingly increased values at the ADC map image, 
reflecting vasogenic edema and inflammation, even if 
iso- to high signal intensity with normal to slightly 
increased diffusion on DWI have been reported in a lim-
ited number of patients. Cervical or thoracic involvement 
is more common than lumbosacral. There is a female pre-
dominance for spinal involvement. Potential differential 
diagnosis for vertebral body involvement in neurosar-
coidosis includes, for example, myeloma, lymphoma, 
and metastasis.
6.5  IgG-Related Diseases
IgG-related diseases encompass a spectrum of fibroinflam-
matory disorders characterized by IgG4-positive plasma cell 
infiltration that can affect almost every organ system. They 
respond well to corticosteroid therapy.
CNS involvement is rare.
IgG-related pachymeningitis is a rare manifestation 
of the IgG4-related fibroinflammatory disease spectrum. 
Inflammation leads to a localized or diffuse thickening of 
the meninges overlying the supratentorial hemispheres, 
skull base, or spinal cord. The symptoms are related to 
mass effect, or focal deficits caused by the compression of 
blood vessels or nerves. This was previously described as 
idiopathic, hypertrophic, cranial pachymeningitis (IHCPM). 
Tissue biopsy is the gold standard for diagnosis in most set-
tings (Fig. 6.14).
6.6  Vasculitis
Vasculitis is defined as an inflammation of the vessel wall. 
The classification of CNS vasculitis can be divided into pri-
mary systemic vasculitides and CNS vasculitis associated 
with other underlying disorders. The inflammation of the 
vessel wall can affect vessels of various sizes, i.e., small, 
medium, and large vessels or can affect all the vessels, 
regardless of size.
Giant cell arteritis, Takayasu’s arteritis, granulomatosis with 
polyangiitis (GPA), Churg–Strauss syndrome, Kawasaki dis-
ease, and primary angiitis of the CNS (PACNS) are considered 
primary vasculitides. Nervous system vasculitis can also be 
associated with connective tissue disorders, like systemic lupus 
erythematosus (SLE), Sjögren’s disease, rheumatoid arthritis 
(RA), lymphoproliferative diseases, malignancies, drug and 
substance abuse, or infections. The diagnosis of vasculitis is a 
combination of symptoms, as well as clinical and laboratory 
findings, and imaging. Still, today, brain biopsy is considered 
the gold standard for the final diagnosis of vasculitis.
Key Points
• Thick, dural enhancement—THINK IgG-related 
pachymeningitis
• Brain edema due to compression may occur
• Rarely may present with leptomeningeal enhancement
Key Points
• Vasculitis presents with various imaging findings, 
some quite nonspecific
• The imaging protocol preferably should include 
vessel wall imaging (VWI), DWI, and pre- and 
post-contrast T1-weighted images
• MRA, CTA, or conventional digital subtraction 
angiography demonstrate a “string-of-bead” appear-
ance of the intracranial vessels
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6.6.1  Imaging in Vasculitis
The MR imaging protocol shall include T1-weighted images 
pre- and post-contrast, FLAIR/T2-weighted, DWI, and, for 
the evaluation of microbleeds, SWI or T2∗-w, MRA–3D 
TOF, and, if possible, vessel wall imaging (VWI) [9–11].
If MRI is inconclusive, digital subtraction angiography 
can be added to the radiological work-up.
The MR imaging findings in patients with vasculitis may 
vary depending on the vessels involved. The examination can 
be normal and include different findings, such as acute isch-
emic changes, old infarcts, nonspecific focal or multiple 
hyperintense white matter lesions, confluent white matter 
lesions, patchy or linear contrast enhancement, leptomenin-
geal contrast enhancement, and brain atrophy (Fig.  6.15). 
Microbleeds are rare in contrast to, for example, amyloid angi-
opathy, a common differential diagnosis. On MR angiography 
(3D TOF) shows multiple, focal, irregular stenosis of more 
than one of the medium or large vessels (small vessels are not 
visualized on MRA) (Figs. 6.16 and 6.19b). The digital sub-
traction angiography might demonstrate focal stenosis and the 
string-of-bead sign in various intracranial vessels (Figs. 6.17, 
6.18, and 6.19c).
6.6.2  Primary Angiitis of the CNS (PACNS)
Primary angiitis of the CNS (PACNS) is a rare disease of unknown 
etiology with a predominance in males compared to females 
(7:3). Imaging will demonstrate irregularities in the peripheral 
vessels that results in acute ischemic changes that are secondary 
to the inflammation of the vessel wall, stenosis, or obstruction of 
the vessel lumen, with increased local coagulation and alterations 
in vasomotor tone. A differential diagnosis for PACNS includes 
the reversible cerebral vasoconstriction syndrome (RCVS). 
RCVS more commonly affects women and is characterized by 
severe headaches (thunderclap headache) with or without focal 
neurologic deficits and/or seizures. In RCVS, the  segmental con-
striction of cerebral arteries resolves within 3 months.
6.6.3  Granulomatosis with Polyangiitis (GPA)
Granulomatosis with polyangiitis (GPA) (previously called 
Wegener’s granulomatosis) is a systemic disease of small and 
medium vessels with an unclear pathogenesis. The disease pri-
marily affects the upper and lower respiratory airways, joints, 
eyes, skin, heart, liver, glands, and, in 25–50%, the peripheral 
Fig. 6.14 Thick, dural enhancement is observed bilaterally frontally and along the falx (b–f). T2-high signal intensity is also seen in the paren-
chyma of both frontal lobes, reflecting compression of the brain parenchyma (a)





Fig. 6.15 Different imaging findings in patients with known vasculitis; (a) hyperintense FLAIR lesions, (b) confluent white matter signal abnor-
malities, (c) leptomeningeal contrast enhancement, (d) cortical infracts, (e) multiple acute lacunar infarcts
Fig. 6.16 MRA 3D TOF demonstrating bilateral multiple focal steno-
sis of the anterior and middle cerebral arteries
Fig. 6.17 Coronal view after right, selective, internal carotid artery 
injection, demonstrating focal stenosis in the right pericallosal artery
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a cb
Fig. 6.18 On post-contrast T1wi, enhancement of the branches of the left posterior cerebral artery is noted (a). Intense enhancement of the vessel 




Fig. 6.19 Axial FLAIR (a) 
demonstrates focal and 
confluent areas of increased 
signal in the periventricular 
and deep white matter, (b) 
focal stenosis and lumen 
obstruction of the middle and 
anterior cerebral arteries, and 
(c) multiple focal stenosis of 
several intracranial vessels 
peripherally, on sagittal DSA, 
in a patient with PACNS
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nervous system in the form of necrotizing vasculitis, peripheral 
neuropathies, and cranial nerve palsy. The involvement of the 
CNS is far less frequent, with only 2–8% in the form of CNS 
vasculitis with intracranial granulomas directly or due to spread 
from the sinus and orbits. CNS involvement in this form is 
associated with a very high mortality rate (>90%) if untreated. 
This may present with focal granulomas that have spread from 
the frontal sinus (Fig. 6.20), or focal white matter hyperintesies 
and/or leptomeningeal contrast henhancement (Fig. 6.21).
6.6.4  Neurosyphilis
Neurosyphilis (CNS lues) is a classic infectious cause of cere-
bral vasculitis. The patient often presents with an ischemic event 
predominantly related to the middle cerebral arteries or branches 
of the basilar artery. Typical imaging findings are multiple lacu-
nar infarcts, arteritis changes with focal stenosis, ectasia of the 
basilar artery, focal areas of increased T2 signal in the white 
matter, and the presence of patchy enhancement (Fig. 6.22).
a b c
Fig. 6.20 (a) Sagittal CT (bone window) demonstrates opacification of the frontal sinus. (b, c) Granuloma extension into the frontal lobes bilater-
ally with surrounding edema and gliosis
a b
Fig. 6.21 Axial (a) FLAIR, (b) T2-weighted, and (c, d) T1-weighted image after contrast administration demonstrating focal brain swelling and 
leptomeningeal contrast enhancment





Fig. 6.22 (a) Axial FLAIR demonstrating white matter lesions, (b) CT angiography demonstrating stenosis and irregularities in the basialry 
artery, and (c) stenosis in both middle cerbral arteries and stenosis of the basilar artery in a 67-year-old male with diagnosed neurosyphilis
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6.7  Concluding Remarks
Infectious and inflammatory CNS disorders are difficult clin-
ical diagnoses due to the similarities in clinical symptoms 
and laboratory findings. The role of imaging remains critical 
and the use of advanced techniques and state-of-the-art MRI 
of the brain and spine is mandatory for early detection, dif-
ferentiation, and follow-up.
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Take Home Messages
• Use FLAIR and post-contrast 3D T2-FLAIR for 
detection of meningeal pathology
• Use multimodal MRI approach in ring-enhancing 
brain lesions
• Use vessel wall MR imaging for evaluation of CNS 
vasculitis
• In autoimmune encephalitis MRI may show no 
abnormality
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7.1  Introduction
Traumatic brain injury (TBI) remains a leading cause of 
mortality and disability among young individuals, especially 
in high-income countries [1]. According to a meta-analysis, 
combining reports from 23 European countries between 
1980 and 2003, the incidence rate is about 235 per 100,000 
[2]. Increasingly, imaging techniques play a crucial role in 
the diagnosis and management of patients with craniocere-
bral trauma, and may influence life or death decisions. 
Additionally, the role of imaging in the prediction of progno-
sis is well established and of growing importance in the 
research arena.
7.2  Imaging Techniques
We have moved well beyond the era of projectional radiog-
raphy, as the diagnostic efficacy of plain skull films in TBI 
is poor. At present, for the management of patients with 
traumatic brain injury, plain X-ray films play no role; they 
have entirely been replaced by computed tomography (CT) 
imaging [3].
CT is the initial imaging technique for evaluation of cra-
niocerebral trauma. In most trauma centers and emergency 
rooms, CT is readily available and available within a short 
distance from the trauma bay. Many emergency depart-
ments routinely position one or several CT scanners in the 
receiving area for triage. Moreover, a CT examination can 
be performed in a few seconds with a modern, state-of-
the-art multi-detector CT (MDCT) scanner. MDCT allows 
acquisition of multiple thin sections in a much shorter scan 
time than a single-detector system [4] and has essentially 
replaced them. Image data can be reconstructed in every 
plane as well as in 3D views (Fig.  7.1). Routine utiliza-
tion of these multiplanar reconstructed (MPR) images also 
appears to improve diagnosis of traumatic injuries and has 
been supported in the literature to increase CT accuracy 
[5]. Cranial CT is used for evaluation of all forms of intra-
cranial hemorrhage, fractures, brain edema, herniation and 
other associated injuries, as well as to evaluate foreign bod-
ies. CT angiography (dynamic contrast- enhanced CT to 
visualize vascular structures) may be indicated whenever 
vascular injury is suspected, and also patients with a high-
risk mechanism trauma, such as, for example, intra-oral 
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Learning Objectives
• Understand the role of imaging in the urgent evalu-
ation of patients with CNS trauma
• Review common surgical vs. non-surgical CNS 
abnormalities in trauma patients
• Compare MR and CT for evaluation of brain trauma
Key Points
• CT has become the most important  diagnostic 
test in patients with CNS trauma in the urgent 
setting.
• CT has the ability to depict traumatic lesions that 
will require urgent surgical management and to also 
assess other traumatic lesions that are notable but 
not surgical indications.
• MR can accurately detect a range of CNS injuries 
that are ultimately critical in the prognosis of major 
CNS trauma.
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trauma, high energy crashes,  near- hanging, and fractures 
of skull base and midface [6] or for suspicious hemorrhage 
patterns.
MRI is more sensitive than CT for the detection of paren-
chymal lesions [7, 8]. It is also indicated whenever there is a 
discrepancy between the clinical neurological status of the 
patient and the CT findings.
In this review paper, we aim to present a systematic guide 
towards interpretation of imaging studies in the patient with 
TBI.
7.3  Scalp Lesions
Scalp lesions are common in head trauma victims (Figs. 7.2 
and 7.3). Although they are of little clinical importance, 
identification of scalp lesions may direct the attention of 
the radiologist towards the point of impact [9]. CT is rarely 
performed for isolated scalp injury, but to detect the sus-
pected intracranial injuries. CT not only visualizes the soft 
tissue swelling, but through appropriate window (W) and 
level (L) settings will also illustrate intracranial abnormal-
ities [8]. One important factor influencing the detection 
rate of soft tissue lesions in CT is the perception of density 
differences within the lesions and the surrounding tissues 
such as blood, subcutaneous fatty tissue, or cerebrospinal 
fluid [10].
Table 7.1 provides an overview of some of the most com-
monly encountered scalp lesions.
Fig. 7.1 Volume rendering technique (VRT), obtained from a 3D 
CT-scan data set, reveals multiple skull fractures and displaced bone 
fragments. The sharp outline of the fracture lines is clearly distinct from 
the jagged and serrated edges of the cranial sutures in this young child 
with severe craniocerebral trauma
a b
Fig. 7.2 (a, b) Axial non-contrast CT-scan, revealing a left parietal 
epidural hematoma (“coup” side) with accompanying subarachnoid 
hemorrhage. A fracture was evident on bone images. On the “contre- 
coup” side, there is a hyperdense subdural hematoma overlying the 
right cerebral hemisphere, as well as a basifrontal hemorrhagic 
contusion
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7.4  Skull Fractures
Skull fractures constitute a diverse group of traumatic bone 
injuries with different mechanism of occurrence, topogra-
phy, complications, and required management. They can be 
classified according to various parameters:
• Shape of the fracture: linear, comminuted, stellate
• Depressed, non-depressed, open
• Anatomic location and extent of the fracture: skull vault, 
skull base, craniofacial junction
Simple linear fractures are most common type, especially 
in children younger than 5 years. Temporal bone fractures 
represent 15–48% of all skull fractures and are considered as 
a separate category of skull injury. Skull base and temporal 
bone fractures have their own clinical significance; a detailed 
discussion of these injuries is beyond the scope of this text.
CSF leaks, cranial nerve injuries, orbital injuries, and cra-
niocervical junction injuries are common accompaniments 
of fractures, especially near the skull base.
Depressed skull fractures (with displacement of the outer table 
of the skull to at least the level of the inner table) occur in 75% of 
cases in the frontoparietal region and are often open (75–90%).
Patients with skull fractures have a fivefold increased risk of 
having an intracranial hemorrhage (ICH) and CT is mandatory 
[11]. Linear skull fractures may be occult on skull radiographs 
because of the double-layered skull along fractures, when the 
cross-section is oblique to the direction of the X-rays [12]. 
Similarly, skull fractures may be difficult to see on CT, particu-
a b
Fig. 7.3 (a, b) Hemorrhagic cerebral contusions and subgaleal hema-
toma. MRI examination performed with (a) sagittal SE T1-weighted 
images and (b) axial TSE T2-weighted images. Extracranially, there is 
marked swelling of the subcutaneous soft tissues, due to a massive sub-
galeal hematoma, which extends from the frontal to the posterior pari-
etal region. Intracranially, there are hemorrhagic cerebral contusions in 
the right frontal and anterior temporal lobes
Table 7.1 Overview of scalp lesions
Lesion type Caput succedaneum
Subgaleal hematoma (extracranial 
subdural hematoma) Subgaleal hygroma
Cephalohematoma (extracranial 
epidural hematoma)
Occurrence After normal vaginal 
delivery
After head trauma (or after birth) Birth trauma 
(forceps delivery)
Birth trauma (skull fracture during 
birth)
Location Superficial of the galea 
aponeurotica
Beneath the galea aponeurotica Beneath the galea 
aponeurotica
Subperiosteal (flat skull bones)
Composition Edema (with microscopic 
hemorrhages)
Venous blood Cerebrospinal fluid Subperiosteal hemorrhage
Clinical presentation Pitting edema Diffusely spreading, firm 
fluctuating mass
– Well defined, focal, firm mass
Skull fracture Yes or no Yes Yes
Crosses suture lines? Yes Yes Yes No
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larly when parallel to the display plane. The interpreting physi-
cian may need to correlate MPR images as well as occasionally 
rely on the scout image to depict these linear fractures.
In patients with significant TBI, skull fractures are com-
mon and are often overlooked on clinical examination. 
However, in some cases, there is a poor correlation between 
skull fractures and intracranial injury; severe brain injuries 
can occur, even without the presence of a skull fracture [8].
7.5  Extra-Axial Lesions
There are four types of extra-axial hemorrhage to be consid-
ered: epidural, subdural, subarachnoid, and intraventricular.
7.5.1  Epidural Hematoma
Epidural hematoma (EDH) is an extracerebral collection of 
blood between the inner table of the skull and the dura, essen-
tially underlying a bare bone surface. EDH occurs in <1% of 
patients with head injuries [13]. EDH is typically found on the 
“coup” injury side, and is commonly associated with a skull 
fracture and laceration of the underlying blood vessel(s), nota-
bly the dural vasculature [14]. The recommended imaging 
method is CT, which depicts both the fracture and resulting 
hemorrhage. EDHs are commonly biconvex in appearance and 
typically do not cross suture lines but may cross the tentorium or 
falx; their mass effect is mostly caused by the size of extracere-
bral collection [14]. In the early stage, an epidural hematoma 
may appear heterogeneous on CT with hyperdense areas of clot-
ted blood and hypodense whirls of non-coagulated blood that in 
time becomes more homogeneous [14]. This “swirl sign” is an 
ominous feature, and should be carefully noted and communi-
cated to the treating physicians, as it represents active hemor-
rhage into the collection [15]. Rapid progression has been noted.
EDH may be arterial or venous in origin (Table  7.2). 
Arterial EDH is caused by injury of a meningeal artery, com-
monly the middle meningeal artery. The typical location is 
the temporoparietal region, with 75% of EDH occurring 
adjacent to the temporal bone (Fig. 7.4). When the blood ves-
sel is lacerated, arterial bleeding results in a rapidly expand-
ing hematoma that exerts mass effect on the brain, focal 
deformity of the brain and an increase in intracranial pres-
sure (ICP). The size of the EDH may continue to increase 
until the arterial perfusion pressure is equilibrated with the 
elevated ICP. Emergency decompressive surgery is indicated 
to remove the EDH, stop hemorrhage, and reduce compres-
sion on the brain.
Venous EDH results from rupture/laceration of a dural 
venous sinus, or bleeding from diploic veins, again often 
associated with a skull fracture [16]. Venous EDH is usually 
located near the anterior wall of the middle cranial fossa 
(injury of sphenoparietal sinus and/or fracture of the greater 
wing of the sphenoid bone), the vertex (injury of the superior 
sagittal sinus and/or fracture of the frontal or parietal bone), 
or against the occiput near the tentorium (injury of the trans-
verse sinus and/or occipital fracture) [8] (Fig. 7.5).
Few EDH patients will not undergo craniotomy and evacu-
ation, often on an emergent basis. One unusual and typically 
indolent EDH is known; anterior temporal EDH is often a low-
pressure hemorrhage and typically do not expand. There is no 
usual requirement for surgical intervention [16]. Conversely, 
posterior fossa EDH may urgently require surgical evacuation 
because of early brainstem compression [16].
7.5.2  Subdural Hematoma
A subdural hematoma (SDH) represents an extracerebral 
collection of blood in the potential space between the dura 
mater and the arachnoid membrane, or “epiarachnoid.” 
Table 7.2 Epidural versus subdural hematoma
Epidural hematoma (EDH) Subdural hematoma (SDH)
‘Coup’ side ‘Contre-coup’ side
Associated with skull fracture in ±90% of cases No consistent relationship with skull fractures
Does not cross suture lines Does cross suture lines
Not limited by falx or tentorium (may extend from supra- to  
infratentorial or across midline)
Limited by falx and tentorium (confined to supra- or infratentorial 
compartment, does not cross midline)
Origin
 •  Arterial (majority, due to tearing of one or more branches of the 
meningeal arteries, most commonly the middle meningeal artery),
 •  Venous (minority, due to laceration of a dural venous sinus,  
e.g., along the sphenoparietal sinus)
Origin
•  Venous, due to laceration of superficial bridging cortical veins
Medical emergency May be chronic
Magnitude of the mass effect caused by EDH is directly related  
to the size of the extracerebral collection
Magnitude of the mass effect caused by SDH is more often 
associated with underlying parenchymal injury
CT is preferred imaging technique because
 •  Rapid accessibility
 •  Shows both the hemorrhage and the skull fracture
MR can be useful for
 •  Detection of parenchymal repercussions (edema, mass effect, 
herniations)
MRI is preferred imaging technique because
•  MRI is more sensitive than CT, especially in the detection of 
so-called isodense SDH’s which may be difficult to see on CT
•  Multiplanar imaging capability
•  Better definition of multi- compartmental nature of SDH
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a b
Fig. 7.4 (a, b) Acute left arterial epidural hematoma. Non-contrast 
CT-scan upon admission. The left-sided hematoma is biconvex, and is 
limited by the coronal suture anteriorly and by the lambdoid suture pos-
teriorly. The mass effect causes a shift of the midline structures with 
compression of the left lateral ventricle and dilatation of the right lateral 
ventricle
a b
Fig. 7.5 (a, b) Venous epidural hematomas, shown in two different 
patients. Venous epidural hematomas typically are found (a) anteriorly 
in the middle cranial fossa adjacent to the sphenoparietal sinus and 
greater wing of the sphenoid bone, or (b) adjacent to the transverse 
sinus. They present a typical, biconvex lens-shaped configuration
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SDHs are relatively common and occur in about 30% cases 
of severe head trauma [13]. They are more commonly found 
on the contre-coup injury side and are not as strongly associ-
ated with fractures as EDH [14]. The origin is almost invari-
ably venous, caused by injury of superficial bridging cortical 
veins. They do cross sutures and may be holohemispheric, 
and are typically limited by the falx and tentorium [14].
On CT, an acute SDH is seen as crescentic hyperdense 
structure between brain and the inner border of skull 




Fig. 7.6 (a–c) Acute left subdural hematoma. The CT-scan shows 
hyperdense areas of clotted blood and some hypodense components 
indicating active bleeding. There is mass effect on the left cerebral 
hemisphere, with transtentorial herniation. The high-density area in the 
brainstem indicates a secondary brainstem hemorrhage or so-called 
Duret hemorrhage. There are also hemorrhagic cerebral contusions in 
both cerebral hemispheres
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be seen adjacent to the brain opposing the SDH. SDHs do 
not penetrate into sulci. Over time, the density decreases and 
they may become isodense to the adjacent brain. Therefore, 
MRI may be a preferred imaging method in later stages.
Subacute SDH occurs as hyperintense lesion on T1 and 
T2-weighed images due to extracellular methemoglobin 
[17] (Fig.  7.7). Chronic subdural hematoma is also well 
evaluated by MRI, which can clearly distinguish the size 
and extent of the collection as well as the development of 
the enhancing, capillary-rich membrane associated with 
resorbing SDH [17]. Chronic subdural hematomas are vari-
able in signal but may retain T1 or FLAIR hyperintensity 
(Fig. 7.8).
The development of the vascular membranes, that are 
common in chronic SDH, is an important feature in the 
subsequent development of rehemorrhage into these col-
lections, representing the “acute on chronic” form of 
SDH.  These collections may appear quite complex in 
nature, with mixed and layered signal intensities, and are 
difficult to manage [18].
Finally, the occasional occurrence of an acute low-density 
subdural collection in the trauma patient is a known phenom-
enon. A tear in the arachnoid may allow CSF to enter the 
potential subdural space and produce an enlarging fluid collec-
tion known as a subdural hygroma. These may spontaneously 
resolve but also are monitored for mass effect.
7.5.3  Traumatic Subarachnoid Hemorrhage
Traumatic subarachnoid hemorrhage (SAH) is common and 
often focal. It can be due to superficial cerebral abrasions, 
direct leptomeningeal vascular injury, or intraventricular 
hemorrhage with subarachnoid reflux [8]. The estimated 
incidence rates for SAH are 10–25 per 100,000 per year [19]. 
Acute SAH is easy recognizable on non-contrast CT as gyri-
form high attenuation in the subarachnoid space. It will pen-
etrate sulci. The attenuation of blood on CT decreases as the 
hemoglobin concentration decreases [20]. The combination 
of SWI and FLAIR yields a distinctly higher detection rate 
for SAH due to their complementary detection capabilities 
[21]. FLAIR is sensitive for superficial/convexity SAH, 
while SWI adds value for the centrally located SAH, e.g., the 
interhemispheric fissure, interpeduncular fossa, supracere-
bellar cistern, and intraventricular subarachnoid blood [21]. 
The recognition of subtle SAH is important in the trauma 
setting, as this finding alone will typically result in an 
extended in-hospital evaluation of the patient.
a b
Fig. 7.7 (a, b) Subacute left subdural hematoma. MRI examination 
performed with (a) sagittal SE T1-weighted image and (b) axial TSE 
T2-weighted image. The MR images show the typical appearance of a 
crescent-shaped left subdural hematoma. There are multiple internal 
septations, representing strands of fibrovascular granulation tissue, 
derived from the inner (meningeal) layer of the dura. The hematoma 
extends over the surface of the left cerebral hemisphere from the frontal 
to the occipital region. The blood is hyperintense on T1-WI and on 
T2-WI, indicating the presence of extracellular methemoglobin
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7.5.4  Traumatic Intraventricular Hemorrhage
Traumatic intraventricular hemorrhage (IVH) occurs as a 
result of the tearing of subependymal or choroidal veins or 
reflux of SAH into the ventricular system. It may also be 
seen in association with diffuse axonal injury of the corpus 
callosum. The incidence of IVH in nonpenetrating head 
injury is 1.5–3% and 10–25% of patients with severe head 
injury [22].
On CT IVH may appear as a hyperdense collection in the 
ventricular system. MRI is more sensitive to IVH and DWI 
and FLAIR are the preferred sequences for identifying IVH 
(Fig. 7.9). During the first 48 h IVH appears hyperintense on 
FLAIR, but subsequently the signal intensity may be vari-
able [23]. Pulsatile flow artifacts in the third and fourth ven-
tricle may compromise the usefulness of the FLAIR 
technique [8]. 3D-FLAIR techniques are more useful in this 
regard. SWI is extremely sensitive in detecting intraventricu-
lar hemorrhage. IVH appears as a typical hypointense area of 
susceptibility [24].
7.6  Intra-Axial Lesions
7.6.1  Cerebral Contusion, Hemorrhagic Vs 
Non-hemorrhagic, Coup Versus 
Contre-Coup
Cerebral contusions are focal injuries of the brain surface 
due to direct impact with the skull and are most common at 
sides of bony protuberances or overlying irregular areas of 
the floor of the anterior or middle fossa. They are, in essence, 
to be considered as “a bruise of the brain.” The consequent 
lesions are hemorrhagic or edematous and may progress to 
necrosis [25].
All contusions are hemorrhagic, but the extent of edema 
versus hemorrhage in an individual contusion will determine 
its appearance on CT. MR will consistently depict hemor-
rhage, notably on SWI or GRE sequences. Hemorrhagic con-
tusions are superficial and have either a “salt-and-pepper” 
appearance or may appear more solid [26]. When a traumatic 
brain injury results in a cerebral contusion, they may prog-
a b
Fig. 7.8 (a, b) Chronic left subdural hematoma. MRI examination, 
including (a) axial TSE T2-weighted image and (b) axial turbo-FLAIR 
image with fat saturation. On the T2-weighted scan, the chronic subdu-
ral hematoma overlying the left cerebral hemisphere is hyperintense, 
and appears isointense to cerebrospinal fluid (CSF); however, on the 
FLAIR image, the signal intensity is higher than CSF, indicating a dif-
ferent protein content
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ress during the first several hours and can be associated with 
SAH [27]. Predominantly affected areas are located in the 
supratentorial region—anterior frontal and temporal lobes 
and the gyri around the Sylvian fissure.
On CT, hemorrhagic contusions appear as heteroge-
neous, hyperdense cortical lesions surrounded by an irreg-
ularly marginated hypodense (edematous) component. In 
the acute stage, CT may be more sensitive than MRI, as 
acute hemorrhage can be nearly indistinguishable from 
brain parenchyma on MRI.  Subsequent CT performed 
between 24 and 48  h after traumatic brain injury often 
demonstrates previously undetected contusions or more 
extensive hemorrhage and increased edema. MRI is more 
sensitive than CT to depict cerebral contusions after the 
first 24  h because of the visualization of “non-hemor-
rhagic” contusion, or contusions with predominant edema. 
This is particularly true of FLAIR [8, 25]. The ability of 
MRI to detect hemorrhagic brain lesions increases pro-
portionally to the evolution of blood products in these 
lesions. Hemosiderin and also deoxyhemoglobin have 
increased magnetic susceptibility that make SWI or T2∗ 
gradient-echo sequences very sensitive for detecting hem-
orrhagic lesions [28, 29]. Four to six months after injury 
the lesions become cystic and lose volume and therefore 
hypodense on CT [30], although MR findings of hemor-
rhage persist.
Table 7.3 provides an overview of sequential signal inten-
sity changes of intracranial hemorrhage on MRI.
Contusions may be bihemispheric and occur along the 
vector of the force applied to the skull on the site of impact 
and the opposite region of brain. These injuries are 
referred to as “coup” (side of injury) or “contre-coup” 
(opposite the injury). In closed-head injury, for example, 
after an abrupt stop, the force translation can result in this 
pattern [30]. The coup-injury is on the side of primary 
impact, often identified by scalp lesions or skull fracture. 
“Contre-coup” lesions are the mechanical consequence of 
an acceleration/deceleration trauma and occur on the 
opposite side of impact. They are often larger and more 
extensive than the coup lesions, perhaps because of the 
initial displacement of the brain toward the contre-coup 
location [8, 30, 31].
a b
Fig. 7.9 (a, b) Posttraumatic intraventricular and subarachnoid hemor-
rhage. MRI examination, including (a) axial turbo-FLAIR image with 
fat saturation and (b) axial diffusion-weighted trace image (b = 1000). 
In the left occipital horn, there is intraventricular blood, with a hemor-
rhagic sedimentation level, and markedly restricted diffusion. In addi-
tion, there is evidence of subarachnoid hemorrhage, best seen on the 
FLAIR images
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7.6.2  Diffuse Axonal Injury (DAI)
Diffuse axonal injury is a common type of primary neuronal 
injury in patients with severe head trauma with an incidence up 
to 50% of trauma victims [30, 32]. DAI occurs when the brain is 
exposed to shear-strain forces that leads to lesions at interfaces 
between two adjacent tissues with different densities or rigidities, 
such as gray and white matter [33] or areas where the brain is 
relatively anchored to an adjacent structure, such as the cerebral 
or cerebellar peduncles or corpus callosum. Predominantly 
affected areas in decreasing order of frequency are: gray-white 
matter junction, corpus callosum, basal ganglia, brainstem, and 
mesencephalon. The severity of the lesions increases towards the 
cerebellum, whereas axonal injury in the brainstem is considered 
to be an indicator for degeneration to coma in DAI [8, 33].
Its’ important clinical relevance and various clinical 
manifestations have contributed to the development of 
radiological imaging techniques for detection of DAI.  As 
mentioned, DAI is a common primary injury in brain trauma 
and CT examination is still the mode of choice in severe 
trauma patients in the acute phase because of its great value 
in detecting petechial hemorrhagic lesions, fractures and 
because of its rapid and convenient acquisition. 
Unfortunately, CT significantly underestimates the extent 
and number of DAI lesions, especially of non-hemorrhagic 
lesions [34] (Fig. 7.10). Therefore, whenever there is a dis-
crepancy between the clinical status of the patient and the 
CT findings, MRI can provide very important information. 
In the early stage, diffusion-weighted images are of great 
importance to detect DAI. In addition, FLAIR sequences are 
useful for the detection of areas of gliosis. Gradient-echo 
sequences (GRE) and more recently susceptibility-weighted 
imaging (SWI) are also superior to CT in subacute or 
chronic hemorrhagic head injuries because of paramagnetic 
blood degradation products [33, 34].
New advanced MRI techniques like diffusion tensor imag-
ing (DTI) offer more sensitive detection and  differentiation of 
DAI. In DTI, the specific water diffusion direction in the white 
matter is used to detect microstructural conditions that result in 
restriction in the diffusion of the molecules and alter the values 
seen on FA (fractional anisotropy) maps [35, 36]. A recent 
study showed that DTI is a very qualitative and useful way for 
clinical evaluation of DAI. The authors found decreased anisot-
ropy in the corpus callosum even in patients with normal results 
on FLAIR and GRE [37]. Multiple additional studies demon-
strate the utility of DTI, but application to individual patients 
remains challenging because of a wide number of variables 
[38]. DTI and the derived FA values remain an important 
research tool, and are being widely investigated to determine 
what value they may provide in the individual patient. For the 
present time, these remain largely research tools.
7.7  Vessel Injury
7.7.1  Carotid Artery-Cavernous Sinus 
Fistula (CCF)
In the traumatic carotid artery-cavernous sinus fistula (CCF), 
there occurs a direct communication between the cavernous 
segment of the internal carotid artery (ICA) and the cavern-
ous sinus. The underlying cause is often a laceration of the 
ICA due to blunt or penetration head trauma. The fistula 
leads to engorgement and dilatation of the cavernous sinus 
with successive congestion of the superior ophthalmic vein 
(SOV) and inferior petrosal sinus [28].
Table 7.3 Sequential signal intensity changes of intracranial hemorrhage on MRI (1,5 T)
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Macrophages digest the 
clot
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center of hematoma)
A few days 4–7 days–1 month Weeks–years
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Still intact, severely 
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Diamagnetic (c < 0) Paramagnetic (c > 0) Paramagnetic (c > 0) Paramagnetic (c > 0) FeOOH is 
superparamagnetic
SI on T1-wi ≈ or ↓ ≈ (or ↓) (no PEDD 
interaction)
↑↑ (PEDD interaction) ↑↑ (PEDD 
interaction)
≈ (or ↓) (no PEDD 
interaction)
SI on T2-wi ↑ (high water content) ↓ T2 PRE 
(susceptibility effect)
↓↓ T2 PRE 
(susceptibility effect)
↑↑ No T2 PRE ↓↓ T2 PRE (susceptibility 
effect)
Notes: Hb hemoglobin, e− electrons, FeOOH ferric oxyhydroxide, ↑ = increased SI relative to normal gray matter, ↓ = decreased SI relative to 
normal gray matter
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Specific imaging signs of CCF are enlargement of the 
cavernous sinus or ipsilateral SOV on CT or MR and multi-
ple flow-voids on MRI. MRA may demonstrate arterialized 
flow in the cavernous sinus or SOV.
7.7.2  Traumatic Aneurysms
Traumatic intracranial aneurysms are rare and represent <1% 
of all aneurysms. They are most common in children [39]. 
Predominant locations are the cavernous and infraclinoid 
segment of ICA, as well as along the anterior cerebral artery.
The gold-standard in imaging of traumatic aneurysms is 
cerebral angiography, but CT angiography (CTA) is widely 
used because of its speed and ease of acquisition [40].
7.7.3  Traumatic Vascular Dissection
Traumatic vascular dissections are unusual complications of 
significant head injury. The injury is caused by a tear in the inti-
mal layer of an artery, resulting in several potential findings, 
notably diversion of blood flow into a potential “false” lumen 




Fig. 7.10 (a–f) Diffuse axonal injuries in a 14-year-old boy, 4 days 
after a motor vehicle accident: (a) axial non-contrast CT-scan; (b) 
axial turbo-FLAIR image; (c) axial TSE T2-weighted image; (d) axial 
gradient- echo FLASH T2∗-weighted image (TE  =  25  ms); (e) axial 
diffusion-weighted image (DWI) with b = 1000; (f) axial apparent dif-
fusion coefficient (ADC) map. The non-contrast CT-scan shows sev-
eral punctate petechial hemorrhages at the gray-white matter junction 
of the frontal lobes. These lesions are hyperintense on turbo-FLAIR 
and T2-weighted images. On the T2∗-weighted image, multiple 
hypointense hemosiderin deposits are seen at the gray-white matter 
junction and in the corpus callosum. The appearance, multiplicity, and 
topographical distribution are typical of hemorrhagic shearing injuries. 
On the DWI scan, the lesions are hyperintense, and on the ADC maps, 
the lesions are hypointense, indicating restricted diffusion
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tiguous bony injury (fractures), rotational forces and torsion of 
the vessel in blunt head trauma or less frequently with penetrat-
ing trauma [41]. The incidence in blunt trauma victims is 0.86% 
for ICA and 0.53% for traumatic vertebral artery dissections. A 
common indication for vascular imaging in this setting is frac-
tures of the skull base extending through the carotid canal.
Again, different techniques may provide a diagnosis of 
vessel dissection. Conventional angiography remains a use-
ful examination. Although the intramural hematoma cannot 
be visualized, the “string-sign” and a “flame-shaped taper-
ing” are common radiological features [42]. Ultrasound 
examinations, especially B-mode and Color-flow Doppler, 
are also increasingly used in detection of traumatic dissec-
tions. To detect subtle luminal abnormalities or wall abnor-
malities in dissection, both CT and MRI, as well as CTA and 
MRA are superior to catheter angiography.
7.8  Secondary Lesions
7.8.1  Definition
Secondary brain damage results from the posttraumatic 
pathophysiologic cascade that follows the initial injury and 
contributes to delayed tissue injury and neuronal loss.
7.8.2  Intracranial Hypertension
Intracranial hypertension may occur after severe cerebral 
injury and can be a significant finding, resulting in progres-
sive neural dysfunction. After traumatic brain injury, intra-
cranial hypertension may be caused by cumulative edema, 
hemorrhage, or swelling after contusion. The presence of 
any of these signs is suspicious: loss of gray-white junction 
indicating cerebral edema, midline shift, a significant hema-
toma, herniation, or change in ventricular shape or size [28].
7.8.2.1  Brain Herniation (Table 7.4)
Cerebral herniation is the most common and dangerous sec-
ondary effect of increased ICP [8]. Cerebral herniation is the 
most common secondary effect of an expanding intracranial 
mass. Due to the herniation the subarachnoid spaces and 
basal cisterns become obliterated, hydrocephalus develops, 
vascular compression may result in brain ischemia, and com-
pression on vital brain tissue may cause profound neurologi-
cal deficits.
7.8.2.2  Secondary Brainstem Hemorrhage (Duret 
Hemorrhage)
Secondary brainstem hemorrhage (also known as “Duret 
hemorrhage”), can occur in craniocerebral trauma 
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patients with rapidly evolving descending cerebral her-
niation [43]. It is evident on CT as a hyperdense brain-
stem lesion, typically found in lower mesencephalon and 
ventral pons (Fig. 7.6). It is not clear whether the origin 
is arterial or venous, but in the majority of cases the out-
come is fatal [8, 43].
7.8.3  Ischemic Lesions and Infarction
Posttraumatic ischemic lesions are common craniocerebral 
trauma complications with poor clinical outcome. MRI 
plays an important role in diagnosing this condition by dem-
onstrating multiple areas of abnormal signal intensity on 
T2-weighted and FLAIR images [8]. On diffusion-weighted 
scans, these lesions are seen in the acute phase as 
 hyperintense signal with corresponding hypointense signal 
on ADC [44]. Of all posttraumatic ischemic lesions, the 
classic lesion is an ipsilateral posterior cerebral artery 
infarction in the setting of significant supratentorial mass 
effect, secondary to any traumatic lesion with mass effect. 
The causative lesion may be an extra-axial hemorrhage or 
intracranial hemorrhage associated with edema and mass 
effect. The posterior cerebral artery may be compressed and 
transiently occluded between the brain and the free edge of 
the tentorium. Other intracranial arteries may be occluded 
or compromised secondary to herniation, including the mid-
dle and anterior cerebral arteries [45].
7.8.4  Infections
The risk of local wound infections, meningitis, ventriculitis, 
or cerebral abscess are particularly high among penetrating 
head trauma because of the presence of contaminated foreign 
objects, skin, hair, and bone fragments driven into the brain 
tissue along the projectile track [46].
7.9  Posttraumatic Sequelae
7.9.1  Posttraumatic Encephalomalacia
The term “posttraumatic encephalomalacia” refers to loss of 
brain tissue after craniocerebral trauma. Gross pathology 
shows weakening or cystic cavitation of brain tissue, with 
blurred cortical margins and surrounded by gliotic scar tissue. 
The basal part of the temporal lobes and anterior pole of the 
temporal lobes are most frequently affected. CT scans show 
hypodense areas of tissue loss, particularly in these parts of 
the brain. On MRI, encephalomalacia is identified as (multi-)
cystic areas of tissue loss, surrounded by an irregular rim of 
gliosis, best seen on FLAIR images as a hyperintense rim 
(Fig. 7.11). Posttraumatic encephalomalacia is a very serious 
condition, resulting in life-long disability, neurological dys-
function, epilepsy, or even death in some cases. Another com-
mon form of posttraumatic encephalomalacia involves the 
olfactory nerve, which is frequently injured in shear injury.
a b
Fig. 7.11 (a, b) Posttraumatic encephalomalacia and gliosis. Axial (a) 
and coronal (b) turbo-FLAIR images with spectral fat saturation. MRI 
performed 4 years after severe head injury. There are areas of posttrau-
matic tissue loss in the basal part of the frontal lobes bilaterally. The 
areas of tissue loss are surrounded by gliosis, which is hyperintense on 
the FLAIR images. In addition, there are old diffuse axonal injuries, 
seen as gliotic foci at the gray-white matter interface, e.g., in the upper 
part of the left frontal lobe
7 Traumatic Neuroemergency: Imaging Patients with Traumatic Brain Injury—An Introduction
90
7.9.2  Growing Skull Fracture
A growing skull fracture is a rare but well-known complica-
tion of pediatric head trauma [47]. Its incidence ranges from 
<0.05% to 1.6% [48]. CT and MRI findings include a dia-
static fracture and brain herniation through the skull defect; 
it can also be accompanied by cystic lesions (meningocele) 
within the fracture and encephalomalacia [48].
7.9.3  Traumatic CSF Leaks
Traumatic cerebrospinal leakage is a complication seen in 
2% of all head-injured patients and in 12–30% of cases of 
basilar skull fractures [49]. The most common locations are 
the cribriform plate (forming the roof of the ethmoid) and the 
walls of the frontal sinus [50]. Intracranial air may be an 
important sign. Careful evaluation of fractures that are con-
tiguous to sinuses is key to making a correct diagnosis. 
Persistent opacification of sinuses contiguous to a fracture 
are of particular suspicion. Suggesting the presence of a CSF 
leak will usually result in testing of fluid in the contiguous 
sinus for the presence of beta-2 transferrin, a dependable 
marker of CSF.
7.9.4  Diabetes Insipidus
The prevalence of central diabetes insipidus (DI) after TBI is 
1.7–26%, often resulting from injury or transection of the 
infundibulum. MRI is the technique of choice for pituitary 
imaging. A sagittal T1-weighted image demonstrates a pos-
terior pituitary “bright spot” in healthy individuals. The 
absence of this “bright spot” in diabetes insipidus is a non-
specific sign of DI [51]. In addition to the absence of this 
sign, an ectopic “bright spot” in the proximal stump of the 
transected, retracted proximal stalk or hypothalamus may be 
identified. If there is clinical suspicion of trauma-related DI, 
a dedicated pituitary examination is the appropriate 
examination.
7.10  Quantitative Imaging in Patients 
with Traumatic Brain Injury
7.10.1  Diffusion Weighted Imaging (DWI) 
with ADC Maps
Diffusion-weighted imaging measures the motion of water 
molecules and thus helps visualize the physiologic state in 
the brain [8]. There are physiologic phase-shifts or signal 
loss due to this normal semi-random motion of water mole-
cules. In distinction, areas with abnormal diffusion reflect 
alterations in the normal water diffusion and appear bright on 
DWI [29]. The apparent diffusion coefficient (ADC) values 
indicate the decrease in the diffusion with corresponding 
hypointense signal on ADC maps [29]. DWI has become an 
important tool in diagnosing TBI, acute stroke, and white 
matter diseases [8].
7.10.2  Diffusion Tensor Imaging (DTI), 
Diffusion Kurtosis Imaging (DKI)
Diffusion tensor Imaging (DTI) is derived from specialized 
DWI with multiple directions, and can measure not only the 
degree, but also the direction of water diffusion [52]. It 
allows in–vivo visualization of the integrity of white matter 
tracts. The main application is in diffuse axonal injury.
Diffusion kurtosis Imaging (DKI) is an extended tech-
nique, derived from DTI, and allows diffusional kurtosis to 
be evaluated using diffusion-weighted imaging techniques 
[53]. With DKI, both gray and white matter can be evaluated.
7.10.3  Outcome Prediction with Imaging 
Parameters
Imaging is a very important clinical tool for diagnosis, prog-
nosis, and visualizing therapy outcomes following 
TBI. Although structural imaging techniques such as CT or 
MRI offer a rapid evaluation of the brain status and may help 
predict survival, more information is necessary. Detailed 
information of cerebral perfusion has also proven useful in 
management and in assessing outcomes [29].
Several imaging techniques are available to visualize the 
brain physiology: CT perfusion, MR perfusion, SPECT, 
fMRI (functional MRI), PET, and MRS (MR Spectroscopy). 
While obviously important research tools, these techniques 
are occasionally finding their way into clinical imaging to 
answer clinical questions.
MRI sequences like DTI, FLAIR, GRE/SWI, and DWI 
are increasingly used in many research models predicting 
outcome [54].
7.11  Conclusion
Imaging studies represent an essential element in the man-
agement of patients with significant neurologic trauma. 
Diagnosis of the extent of the initial injury is critical to triage 
patients to surgical or non-surgical management. Repeated 
follow up to determine potential secondary injury patterns 
and also determine the success of management schemes are 
of significant value and improve patient outcomes. Imaging 
techniques have shown considerable promise in improving 
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our knowledge of the patterns and significance of intracra-
nial injury and in suggesting and monitoring therapies to 
treat these patients and determine their prognosis.
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Take Home Messages
• A rapid and thorough CT examination of the acutely 
traumatized patient is standard of care in major 
trauma centers.
• Develop a protocol for urgent CT screening and 
reporting of major trauma patients.
• Rapid access to imaging technologies is critical to 
good outcomes in patients who have been signifi-
cantly injured.
• If the CT study is not adequate to explain the 
patient’s mental status, MR is the next most impor-
tant examination to be performed.
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Accurate image interpretation requires a knowledge base, 
understanding the patient’s clinical features, and experience. 
Radiology is often taught as an apprenticeship of pattern rec-
ognition. However, the best interpretations use pattern analy-
sis instead of pattern recognition: progression of clinical 
course (acute-rapid, subacute-smoldering, chronic- 
prolonged); location of lesion (intra- vs. extraaxial); second-
ary effects (volume, edema, herniation); enhancement (solid, 
ring-like or leading edge, non-enhancing); blood-products; 
MR Spectroscopy (MRS); Diffusion-weighted Imaging 
(DWI and ADC values); response to treatment.
8.1.1  Time Course of Disease
Cerebrovascular events and traumatic lesions usually present 
acutely: skull impact and inertial trauma cause epidural, sub-
dural, subarachnoid, and parenchymal hemorrhage; aneurys-
mal bleeding (“thunderclap headache”) into the subarachnoid 
space (SAH); deep hypertensive bleeds (basal ganglia and 
thalamus); acute neurologic deficit from ischemia-infarction 
(aphasia, paralysis, etc.). At the other end of the time spec-
trum, degenerative diseases and dementia may progress over 
months to years. In between, with symptom duration of 
weeks to months to years, are intracranial neoplasms. More 
rapid onset of symptoms occurs with high-grade glioma 
(glioblastoma) and metastatic disease.
8.2  Intraaxial Vs. Extraaxial
Intraaxial lesions involve the parenchyma of the brain (includ-
ing brainstem and cerebellum). They may follow an anatomic 
distribution (e.g., vascular territory for ischemia/infarction) or 
non-anatomic distribution (abscess). Diffuse gliomas will 
expand the infiltrated white-matter and tracts, causing efface-
ment of ventricles and sulci. Extraaxial lesions will displace the 
brain away from the skull—often enlarging the subarachnoid 
cisternal spaces at the edges adjacent to the mass (Fig. 8.1).
8.3  Pattern Analysis
Radiology (also pathology and dermatology) are often taught 
using “pattern recognition.” This works well once you have 
accumulated—through experience—a built-in library of 
“patterns” that you may match with an unknown case. 
Another approach is a break down of the imaging features, 
analyze them separately, and then synthesize a differential 
diagnosis. Patterns of contrast enhancement may suggest 
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• Distinguish intraaxial from extraaxial and intraven-
tricular masses
• Describe secondary effects: “volume effect” and 
perilesional vasogenic edema
• Distinguish metastatic disease at gray–white junc-
tion from deeper infiltrating gliomas
Key Point
• Every image should be interpreted in the clinical 
context for each patient. When things are inconsis-





Fig. 8.1 (a) Extraaxial mass (meningioma). Axial T2-weighted MR 
shows a right-side gray-matter signal-intensity hemispheric-shape mass 
with enlargement of the SAS at its margins. There is underlying hyper-
ostosis. (b, c) Intraaxial primary CNS lymphoma. Axial T1-weighted 
with gadolinium (b) shows an enhancing intraaxial mass in the genu of 
the corpus callosum. On the T2-weighted image (c), the lesion shows 
lower signal (restricted diffusion) and perilesional vasogenic edema in 
the white-matter and sparing the cortical gray-matter. Infiltrating 
expansile lesions of the corpus callosum are usually diffuse glioma or 
primary CNS lymphoma. (d) Intraventricular meningioma. Axial 
T1-weighted image shows a rounded lesion in the trigone of the left 
lateral ventricle. Ventricular meningiomas arise from arachnoid cells 
within the choroid plexus, and the trigone is the most common 
location
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more specific diagnoses: gyral gray-matter enhancement 
occurs with reperfusion after ischemia, post-ictal or seizures, 
and meningoencephalitis; ring enhancement implies “central 
necrosis”—but may be seen with an organized abscess as 
well as neoplasms [1].
8.4  Neoplastic Vs. Non-neoplastic Disease
Neoplastic diseases are usually “tumefactive”—they take up 
space (“positive volume effect”) and displace adjacent struc-
tures causing secondary damage and herniation. Both pri-
mary and secondary (metastatic) lesions may have added 
volume from accumulation of interstitial fluid—brain 
edema—most often due to abnormal increased permeability 
from breakdown of the blood–brain–barrier (BBB): vaso-
genic edema. In contrast, inflammatory demyelination often 
has minimal mass effect - it’s “volume neutral”. Chronic 
destructive processes (demyelination, healed viral infec-
tions, old infarcts) have “negative volume effect” (Fig. 8.2).
Tumefactive demyelinating lesions (TDL) are a frequent 
differential dilemma. If correctly identified, they should not 
be biopsied. Instead, a trial of immune-modulating therapy 
should be given. Features suggesting a TDL (instead of a 
neoplasm) include: lesion centered in white-matter (includ-
ing corpus callosum); central-vein sign; “garland-like” or 
incomplete rim-enhancement (“open ring” or “horseshoe”); 
less than expected volume effect; rCBV lower than neo-
plasm; ADC values higher than neoplasm (GBM or lym-
phoma); and non-contrast CT showing low attenuation 
(compared to solid portions of GBM and hyper-attenuation 
of lymphoma [2–4] (Fig. 8.3).
8.5  Single Vs. Many Lesions
The vast majority of intracranial lesions may present as a 
single/solitary mass: primary neoplasm; hematoma; abscess; 
infarction. Multiple lesions primarily occur as part of a sys-
temic disease: inflammatory; toxic; metabolic; genetic; or 
hematogenous dissemination (Fig. 8.4). Hematogenous dis-
semination of infection and metastatic neoplasms can pres-
a b
Fig. 8.2 (a) Oligodendroglioma. Axial T2-weighted image shows a single, 
large, deep, expansile lesion effacing both the cortical sulci and the adjacent 
ventricle. A lesion of this size, to present so late in its natural history, must be 
both slowly growing and non-destructively infiltrating. Positive “volume 
effect.” (b) Chronic cerebral infarction. Axial T1-weighted image shows a 
large region of hyperintensity in the territory of the left middle cerebral 
artery. There is compensatory enlargement of the adjacent ventricle, overly-
ing sulci, and subarachnoid space. Negative “volume effect”
Key Point
• Chronic destructive lesions cause a loss of brain vol-
ume or “negative volume effect,” with compensatory 
enlargement of ventricles and sulci. Adding cells 
(blood, pus, neoplasm) usually cause proportionate 
“positive volume effect” with compression of ven-
tricles and effacement of sulci.
Key Point
• Tumefactive demyelination may be distinguished 
from a neoplasm by paucity of mass-effect; mini-
mal/no  perilesional edema; “open ring” enhance-
ment; increased ADC; and low perfusion values.
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ent with solid nodular as well as ring-enhancing lesions. 
Approximately 40–60% of patients with hematogenous 
metastasis will present initially with a single or solitary 
metastasis [5]. Inflammatory and auto-immune diseases 
(without infection) typically show multiple lesions: multiple 
sclerosis—MS, acute disseminated encephalomyelitis—
ADEM (Fig. 8.4e).
8.6  Metastatic Disease
Solid tumors require angiogenesis to enlarge beyond a cou-
ple of millimeters. The bio-machinery to grow new vessels 
can remodel existing vessels and allow embolization of 
tumor cells. Once in circulation, the tumor emboli are dis-
tributed by blood flow: hematogenous dissemination. The 
brain requires about 20% of our cardiac output. It is a vast 
“filtration bed” where platelet thrombi, clots, and tumor 
emboli may lodge. The majority of these “particulates” will 
lodge in two places: in the subcortical gray–white junction, 
and in the penetrating vessels that supply the deep gray- 
matter (Fig. 8.4b, c) [6] Within the brain parenchyma, metas-
tases are remarkably well localized, round solid or ring 
enhancing, often with a rim of reactive gliosis, and sur-
rounded by perilesional vasogenic edema (Fig.  8.4d). 
Metastases from highly cellular primary tumors (such as 
small cell carcinoma) may show restricted diffusion. Survival 
after presentation with parenchymal brain metastasis may be 
as short as 6 months.
a b
Fig. 8.3 (a, b) Tumefactive Demyelination (path-proven). Axial 
proton- density (a) and T1-weighted MR with gadolinium (b) show a 
large expansile lesion of the corpus callosum, extending into both fron-
tal lobes. This is strongly suggestive of a diffuse high-grade astrocy-
toma (glioblastoma). However, there is discontinuous peripheral 
“garland-like” enhancement—more characteristic of inflammatory 
demyelination. The appearance was so suggestive of neoplasm that a 
biopsy was performed
Key Point
• Multiple lesions have many possible causes—some 
neoplastic, others toxic, metabolic, inflammatory, 
or genetic.
Key Point
• Metastatic lesions are usually peripheral cortical 
or subcortical, round, and well-demarcated with 
enhancement and perilesional vasogenic edema. 
At initial presentation with metastatic disease, 
40–60% of patients will have a single or solitary 
(only brain) metastatic lesion.
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8.7  Primary Neoplasms
8.7.1  Extraaxial Neoplasms
Extraaxial neoplasms arise from the supporting tissues of 
the meninges (meningioma) and the nerves passing from 
central to peripheral (schwannoma). These are the two most 
 common extraaxial and most common non-glial tumors. 
Meningiomas occur anywhere around the cerebral convexi-
ties, along the falx and tentorium, and on the skull base. 
Meningiomas arise from the arachnoid and usually have a 
broad base of attachment to the adjacent dura—giving them 
a hemispheric or “globose” shape (Fig.  8.5a). A second 
morphology is the “en plaque” meningioma—a thickening 
growing along the inner table of the skull like a flat bread 
(pita bread) (Fig.  8.5b). Meningiomas usually maintain a 
homogenous CT high attenuation, and MR gray-matter-like 
signal-intensity, and enhancement as they grow larger 





Fig. 8.4 (a) Hemorrhagic glioblastoma (WHO Gr4). Axial non- 
contrast CT shows a heterogenous lesion with multi-focal high attenua-
tion (clots), surrounded by vasogenic edema in the white-matter and 
preservation of normal cortical gray-matter. Vasogenic edema spares 
the gray-matter. Single lesion. (b, c) Metastatic breast carcinoma. Axial 
MR (b) T2-weighted and (c) T1-weighted with gadolinium show mul-
tiple solid nodular lesions in the deep gray-matter (caudate, putamen, 
and thalamus) as well as multiple cortical/subcortical enhancing 
lesions. Multiple lesions, bilateral, but asymmetric. (d) Metastatic 
breast cancer (different patient). Coronal gross brain. There is a solitary, 
sharply demarcated and round lesion in the subcortical white-matter 
near the gray–white junction of the high convexity of the left hemi-
sphere. Metastasis in the brain is usually round and focal. (e) ADEM—
Acute disseminated encephalomyelitis. Axial T1-weighted after 
gadolinium. There are multiple ring-enhancing lesions. Notice they are 
centered in the white-matter, and they are associated with smaller nodu-
lar enhancing lesions. ADEM is usually a monophasic process associ-
ated with an immune stimulus (infection or vaccination) primarily in 
children and young adults. In many cases—but not this one—we would 
see many “open ring” lesions. This appearance is concerning for 
abscesses—like toxoplasmosis. However, the patient was not immune 
suppressed
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hyperostosis and an enhancing “dural tail” [7]. Intraaxial 
vasogenic edema occurs in the majority of meningiomas 
and is only loosely correlated with histology [8]. It is more 
often seen when the tumor does not have a clear visible 
CSF-cleft; has high signal-intensity on T2; and, a pial blood 
supply (rather than dural-only) [9]. On perfusion imaging, 
they usually have increased rCBV and rCBF—while show-
ing prolonged MTT (Meant Transit Time). This is the MR 
equivalent of a prolonged tumor blush and delayed venous 
filling. On routine MRS about 1/2 of well-differentiated 
ba
c
Fig. 8.5 (a, b) Meningioma. (a) Coronal T1-weighted MR after gado-
linium This globose meningioma shows a sharply demarcated, hemi-
spheric, extraaxial lesion with overlying calvarial thickening 
(hyperostosis). The nearby adjacent dura is slightly thickened with avid 
enhancement—the “dural tail.” This represents a reactive process, not 
neoplastic infiltration. (b) Sagittal T1-weighted MR after gadolinium. 
This en plaque meningioma has invaded through the skull, forming a 
large scalp mass. These disturbing imaging features do not correlate 
with up-grade in histology—this was a WHO grade 1 tumor. (c) 
Meningioma. (c) Axial T2-weighted MR shows a bi-frontal soft-tissue 
mass centered on the falx, with non-specific gray-matter signal- 
intensity. There is bi-frontal intraaxial vasogenic edema that skirts the 
gray-matter of the lenticular nuclei. Meningiomas easily infiltrate 
through the dura (not a sign of malignancy)—while other lesions 
(metastasis) usually do not
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meningioma will show an alanine peak (1.35–1.55  ppm), 
and, at 3T, there is a “characteristic” glutamine/glutamate 
MRS peak at 3.8 ppm [10].
An important differential diagnosis of “en plaque” menin-
giomas are dural metastases in the appropriate clinical set-
ting (e.g., in a patient with CA breast).
Schwannomas arise from the peripheral portions of the 
cranial nerves [3–12]—so they are ventral to the brain-
stem, most commonly in the posterior fossa. The most 
common site of origin is the inferior division of the ves-
tibular nerve, at the apex of the internal auditory canal 
(IAC)—VS (vestibular Schwannoma). The tumors will 
compress the adjacent cochlear nerve—causing high-fre-
quency hearing loss, but vestibular dysfunction may be 
retained. They grow out of the IAC into the cerebello-
pontine angle (CPA) cistern—where they present the bulk 
of the mass (Fig.  8.6). Like meningiomas VS will show 
avid enhancement. However, unlike meningioma, large 
Schwannoma become heterogenous from benign cystic 
degeneration. There are no imaging signs that reliably 
predict tumor growth, but larger tumors at presentation 
tend to grow faster [11].
8.7.2  Intraaxial Neoplasms
The overwhelming majority of primary intraaxial neoplasms 
arise from the glia—or glial cell precursors.
After glial tumors, primary CNS lymphoma (PCNSL) 
represents an important intrinsic neoplasm.
There are several types of glioma—usually categorized as 
circumscribed or diffuse (Table 8.1). The most frequent gli-
oma in adults is, unfortunately, glioblastoma multiforme 
(GBM) which has the worst prognosis—median survival 
12–15  months. With the exception of intraventricular neo-
plasms (ependymoma, choroid plexus tumors), most gliomas 
a b
Fig. 8.6 (a) Vestibular Schwannoma. Axial T1-weighted MR after 
gadolinium shows a homogeneously enhancing left-sided mass in the 
cerebello-pontine angle cistern with a conical component inside an 
enlarged internal auditory canal. Note: there is a small “dural tail” along 
the posterior margin of the mass. The “dural tail” is a reactive process 
that may occur with any lesion abutting the dura. (b) Vestibular schwan-
noma. Axial T1-weighted MR after gadolinium. Large extraaxial mass 
in the cerebello-pontine angle cistern. This is an “older” schwannoma 
that has become heterogeneous from benign cystic degeneration. If this 
lesion were incorrectly localized as intraaxial, the complex morphology 
would suggest a glioblastoma
Key Point
• Meningiomas usually remain homogeneous, even 
when large. Vestibular schwannomas are distinguished 
by location at a nerve (e.g., arising within the internal 
auditory canal), and they often become heterogeneous 
as they grow and enlarge. Almost all extraaxial and 
non-glial neoplasms show contrast enhancement.
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are large lesions that arise in the deeper periventricular 
white-matter—only rarely in the gray-matter (most often in 
the thalamus) (Fig. 8.7) Diffuse gliomas follow the white-
matter tracts—using them as a scaffolding for spread—
extending horizontally through the corpus callosum, 
vertically via cortico-spinal tracts, and through the associa-
tion tracts within a single hemisphere (Fig. 8.7). Diffuse gli-
omas may also extend toward the cortical surface and 
infiltrate the gray-matter. The perilesional signal abnormal-
ity—seen best on FLAIR and T2-weighted images—is a 
mixture of vasogenic edema with infiltrating tumor cells. 
However, since vasogenic edema will not involve the cortex, 
cortical signal changes represent neoplastic infiltration.
Gliomagenesis for diffuse gliomas follows several dif-
ferent pathways. Up to 80% of lower-grade (WHO Gr 
2–3) diffuse glioma have a gain-of-function “priming 
mutation” in IDH (isocitrate dehydrogenase—90% IDH1 
and 10% IDH2) that produces a 10,000-fold increase in 
dextro-2- hydroxygutarate (D2HG)—that can be used as a 
tumor marker on 3T MRS [12]. Astrocytoma adds muta-
tions in TP53 and ATRX. Oligodendrogliomas begin with 
the same IDH mutation, but add other mutations (TERT) 
and a codeletion of 1p19q, which is now the de facto stan-
dard marker [13]. Glioblastoma (GBM) arises from a 
more complex series of mutations: 90% are IDH-wild 
type (primary GBM, usually older patients. However, 
about 10% of GBM are secondary, arising from a prior 
lower-grade lesion that has transformed. These are usu-
ally IDH-mutated and present in younger patients, often 
<40 years old.
Lower-grade diffuse gliomas (WHO Gr2,3) are deeply 
infiltrating masses without necrosis. They expand and non- 
destructively spread through the brain—often delaying the 
onset of a neurologic presentation. Diffuse lower-grade astro-
cytoma (WHO Gr 2,3) is usually homogeneous low attenua-
tion on CT with water-like signal-intensity on MR. WHO Gr 
2 astrocytomas do usually do not enhance, because they do 
not produce neovascularity. Instead, the tumor cells disperse 
and infiltrate into the surrounding brain and are supplied by 
normal pre-existing capillaries. Should enhancement appear 
on serial imaging of a known low-grade astrocytoma, it usu-
ally indicates transformation to a higher grade tumor.
IDH-mutant astrocytoma is usually in the frontal lobe, 
sharply demarcated, and often display the “T2-FLAIR mis-
match” sign [14]. IDH-wild type astrocytoma often has 
blurry margins—without the mismatch sign (Fig. 8.7e, f).
IDH-mutant gliomas have a much better prognosis than 
IDH-wild type. Virtually all (probably all) oligodendroglio-
mas have IDH mutations—and they enjoy the best prognosis 
of all diffuse gliomas. Next in survival is the IDH-mutant 
astrocytoma—about 70% of lower-grade WHO Gr 2,3 
tumors. IDH-wild type astrocytoma (30% of WHO Gr 2,3) 
tends to have the same poor prognosis as IDH-wild glioblas-
tomas. In some centers, they are monitored closely for pro-
gression and may then be treated like glioblastoma [15].
Oligodendrogliomas present at all ages—with the major-
ity seen in the 4th–6th decades. They are more slowly grow-
ing than astrocytoma with a prolonged clinical history that 
often spans a decade. The long clinical course is often (30–
90%) associated with dense nodular calcifications (Fig. 8.8). 
Somewhat different from astrocytoma, they tend to grow 
toward the cortical surface of the cerebral hemispheres—and 
they may produce remodeling of the inner table of the skull. 
Oligodendrogliomas usually have a fine network of capillary 
vessels, and they may show contrast enhancement, even if 
they are low grade. Their vascularity may be associated with 
symptomatic hemorrhage.
Circumscribed gliomas may be intraventricular (ependy-
moma and choroid plexus neoplasms) or parenchymal. 
Circumscribed parenchymal gliomas are astrocytic: pilocytic 
(PA) WHO Gr1; pleomorphic xanthoastrocytoma (PXA); 
WHO Gr2,3 pilomyxoid astrocytoma (PMA) WHO Gr2; 
subependymal giant-cell astrocytoma (SEGA) WHO Gr1; or 
ganglioglioma (GG) WHO Gr1—a mixed glioneuronal neo-
plasm. Circumscribed astrocytoma usually has mutations in 
BRAF: BRAF-fusion for infratentorial pilocytic tumors; and 
BRAF V600E (substitution) for supratentorial PXA, PMA, 
and GG [16]. SEGA has one of the two mutations associated 
with tuberous sclerosis: TSC1 on chromosome 9 or TSC2 on 
chromosome 16. Most circumscribed gliomas show avid 
contrast enhancement. Yet, these neoplasms enjoy a much 
better prognosis compared to non-enhancing diffuse glio-
Table 8.1 Glial and mixed neoplasms
Circumscribed glioma
Diffusely infiltrating gliomas






























Gr WHO grade, mut mutant, wt wild-type
Note: Oligodendrogliomas are invariably IDH-mut and 1p19q co-deleted
Key Point
• Cortical gray-matter signal changes with a large 
white- matter lesion suggest neoplastic infiltration—a 
differential feature favoring diffuse gliomas, not seen 
with metastasis nor tumefactive demyelination.
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mas. The other curiosity is that most BRAF-mutant neo-
plasms are “fluid-secreting”—producing the characteristic 
appearance of a solid nodule of enhancement and a homog-
enous fluid-pool without peripheral enhancement (Fig. 8.9).
Pilocytic astrocytoma is most common in young patients 
(9–15  years of age) in the cerebellar hemispheres. 
Pleomorphic xanthoastrocytoma is present in children and 
mostly younger adults, typically in a superficial location of 
the cerebral hemispheres. Ganglioglioma usually present 
with seizures in young adults and most commonly located in 
the temporal lobe. Pilomyxoid astrocytoma is usually around 
the third ventricle (Fig. 8.9).
8.8  Primary CNS Lymphoma
Whereas the incidence of PCNL in immunocompromised 
patients has declined following the introduction of effective 
antiviral therapy, there has been a steady increase of PCNSL 
in immunocompetent patients.
PCNSL are mostly large B-cell lymphomas and com-
monly found in the periventricular regions or deep gray 
nuclei. Owing to their high cellularity, they demonstrate 
typically restricted diffusion. They enhance strongly with a 
homogenous enhancement pattern in immunocompetent 
a cb
d e f
Fig. 8.7 (a, b) Diffuse Glioma a,b Glioblastoma. Coronal T2-weighted 
MR (a) and T1-weighted after gadolinium (b) demonstrates expansion 
of the mid-body of the corpus callosum with abnormal hyperintensity. 
The lesion shows heterogenous patchy enhancement, but without mac-
roscopic necrosis. (c) Glioblastoma WHO Gr4. Axial T1-weighted MR 
with gadolinium shows a large and heterogenous left insular mass with 
heterogeneous enhancement. This appearance is “classic” for glioblas-
toma multiforme with macroscopic areas of necrosis. (d). Astrocytoma 
WHO Gr2,3. Coronal T2-weighted MR clearly shows abnormal hyper-
intense signal extending toward the surface. This neoplasm has infil-
trated and expanded the cerebral cortex, effacing the sulci. This is not 
vasogenic edema, which usually spares the gray-matter. (e, f) Diffuse 
astrocytoma WHO Gr 2 (c, d). Axial T2-weighted (c) and FLAIR (d) 
IDH-mutated diffuse astrocytomas are usually well-demarcated and 
homogeneous non-enhancing areas of water-like signal-intensity. They 
often display the “T2-FLAIR mismatch” sign—as shown here, where 
the center is dark on FLAIR despite hyperintensity on T2
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patients and ring enhancement in the immunocompromised. 
On perfusion imaging, the rCBV is only minimally increased 
(much less than, e.g., in glioblastomas), as lymphoma grows 
angiocentrically and does not stimulate neoangiogenesis.
8.9  Concluding Remarks
There are multiple tools for triangulating a short differential 
diagnosis list, and it is important to use “pattern analysis” 
rather than simple “pattern recognition.” Key features include 
lesion location, relative “volume effect”; secondary vaso-
genic edema; homogeneity or heterogeneity of the lesion; 
and patterns of contrast enhancement (homogeneous, patchy, 
closed or open ring). Multiple lesions usually represent a 
systemic process: inflammatory; toxic; metabolic; genetic; 
or hematogenous dissemination. Extraaxial masses are non- 
glial, while intraaxial neoplasms may be metastatic from 
extra-CNS sources, or primary gliomas.
a b
Fig. 8.8 (a, b) Oligodendroglioma WHO Gr2 (same patient as Fig 
8.2a). Axial non-contrast CT (a) and T2-weighted MR (b) show a very 
large area of low attenuation and corresponding high signal-intensity. 
Surprisingly, the conglomerate hyper-attenuating calcifications do not 
cause corresponding signal voids on the MR. This tumor was proven to 
have 1p19q codeletion by FISH (fluorescent in-situ hybridization) anal-
ysis. It was also IDH- mutant, like the majority of diffuse lower-grade 
gliomas
Key Point
• Glioblastomas are usually (90%) IDH-wild type 
with enhancement and necrosis. Diffuse lower-grade 
gliomas (WHO Gr2,3) overwhelmingly harbor IDH 
mutations and do not enhance. The T2-FLAIR mis-
match sign indicates an IDH-mutant astrocytoma, 
distinguishing from oligodendroglioma and IDH-
wild type astrocytoma. Dense calcifications suggest 
oligodendroglioma. Circumscribed gliomas usually 
show prominent contrast enhancement, a fluid com-
ponent, and have BRAF mutations.
Take Home Messages
• Lesions with vasogenic edema should also demon-
strate contrast enhancement
• Solitary deep lesions are more likely to be primary 
gliomas
• Round nodular lesions at the gray–white junction 
are more likely to be metastatic
• Diffuse gliomas affect the cortex, vasogenic edema 
does not
• IDH-mutant diffuse astrocytoma shows T2-FLAIR 
mismatch sign
• Extraaxial lesions are meningioma, schwannoma, 
and congenital cysts




Fig. 8.9 (a, b, c, d) BRAF-mutated circumscribed astrocytoma. Axial 
T1-weighted MR after gadolinium: (a) pilocytic astrocytoma; (b) pleo-
morphic xanthoastrocytoma; (c) ganglioglioma; and (d) pilomyxoid 
astrocytoma. Fluidsecreting neoplasms usually show contrast enhance-
ment limited to a nodule with a peripheral puddle of fluid (a–c). The 
absence of a complete rim of enhancement is strongly suggestive of a 
“fluid-secreting” circumscribed glioma - rather than necrosis in a high-
grade tumor. However, in some cases (d), fluid producing tumors can 
show extremely heterogeneous patterns of enhancement- and may 
mimic an aggressive and necrotic tumor. The fluid attenuation and sig-
nal-intensity may deviate from CSF usually due to protein and rarely 
from hemorrhage
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Toxic and Metabolic Disorders: 
Metabolic Diseases
Marco Essig
9.1  Most Common Congenital Metabolic 
Disorders Presenting or Persisting 
into Adulthood
9.1.1  X-Linked Adrenoleukodystrophy
This is a disorder of peroxisomal fatty acid beta oxidation 
leading to accumulation of long chain fatty acids, which can 
manifest itself in childhood (typically around 7 years of age) 
or in adult life. Adult onset cerebral ALD accounts for about 
5% and usually presents with psychiatric features followed 
by dementia, ataxia, and seizures. As an X-linked disorder 
ALD is more frequent in males but around 15–20% of het-
erozygote females carriers become symptomatic.
The typical MRI appearance are T2 and FLAIR hyperin-
tense white matter abnormalities staring in the parieto- 
occipital regions with early involvement of the splenium of 
the corpus callosum and corticospinal tracts. These signal 
abnormalities correspond to areas of demyelination. Active 
demyelination at the edge of the lesions is associated with 
contrast enhancement and restricted diffusion on DWI.
Adrenomyeloneuropathy (AMN) is a later onset adult 
phenotype presenting with slowly progressive spastic para-
paresis, bladder and bowel dysfunction, sexual dysfunction, 
and peripheral neuropathy. Typical imaging appearances 
include increased T2/FLAIR signal in the posterior limbs of 
the internal capsules, brainstem and cerebellar white matter 
which may be followed by spinal cord atrophy [1].
9.1.2  Globoid Cell Leukodystrophy (Krabbe 
Disease)
Globoid cell leukodystrophy (GLD) has been linked to a 
mutation in the GALC gene on chromosome 14, leading to a 
deficiency of galactosylceramide β-galactosidase that causes 
accumulation of sphingolipids in the lysosomes.
Late adolescent and adult forms (10%) present with slowly 
progressive gait abnormalities or spastic paresis. Other 
features include cognitive decline, seizures, and cortical 
blindness.
MRI shows predominantly posterior T2/FLAIR hyperin-
tense white matter changes with sparing of the U fibres and 
involvement of the splenium of the corpus callosum, extend-
ing along the corticospinal tracts into the posterior limbs of 
the internal capsules and the pyramidal tracts.
9
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• To be able to detect typical imaging findings in con-
genital metabolic diseases
• To be able to detect typical imaging findings in 
acquired metabolic diseases
• To understand the use of the different imaging modal-
ities, mainly CT and MRI in metabolic diseases
Key Points
• Metabolic diseases lead to changes in the imaging 
studies that we need to be aware of to trigger further 
investigation as the exact differential diagnosis 
might be challenging
• Toxic changes to the brain and spine are common 
and need to be identified in both an emergency and 
non-emergent situation
• MRI is the imaging method of choice and func-
tional imaging techniques like MR spectroscopy 
and perfusion methods may add important addi-
tional information
106
9.1.3  Metachromatic Leukodystrophy (MLD)
Several variants have been described, all of which have defi-
cient activity of arylsulfatase A, which results in defective 
degradation of sulfatides in the lysosomes.
Approximately 20% of MLD present in adulthood often 
with psychiatric symptoms, followed by spastic paraparesis, 
cerebellar ataxia, and cognitive decline.
MRI demonstrates symmetrical areas of T2 prolongation 
in the periventricular white matter with sparing of the sub-
cortical U fibres. Early involvement of the peritrigonal white 
matter, corpus callosum, and cerebellar white matter is com-
mon, showing typically a “tigroid” pattern of radiating 
stripes. As opposed to ALD, there is no contrast enhance-
ment of the lesion edge.
9.1.4  Mitochondrial Encephalomyopathy 
with Lactic Acidosis and Stroke-like 
Episodes (MELAS)
Mitochondrial encephalomyopathy with lactic acidosis and 
stroke-like episodes (MELAS) syndrome is a typical exam-
ple of a mitochondrial disorder. About 40% of patients pres-
ent in late childhood or early adulthood.
Clinical features are led by encephalomyopathy, lactic 
acidosis, and stroke-like episodes; other features include sei-
zures, hearing loss, and neuropsychiatric dysfunction.
MRI demonstrates T2/FLAIR hyperintense areas involv-
ing cortical and deep grey matter, not confined to any of the 
major vascular territories. On diffusion-weighted imaging, 
ADC values can be elevated or decreased, depending on the 
acuity of symptoms.
9.1.5  Fabry Disease (Galactocerebrosidase 
Deficiency)
Fabry disease is a lysosomal storage disease related to a defi-
ciency of a-galactosidase. It is an X-linked inherited disorder 
with varied clinical presentations and an estimated preva-
lence of one in 50,000 persons.
The deposition of globotriaosylceramide-3  in the endothe-
lium and smooth muscles leads to involvement of multiple 
organ systems, including the blood vessels, heart, and kidneys.
Macro and microvascular complications are the leading 
CNS manifestations, with the first cerebrovascular event 
usually occurring around 40 years of age.
CT and MRI features are those of macrovascular disease 
(acute or chronic infarcts and parenchymal haemorrhage), 
and signs of microvascular disease (hyperintense foci in the 
periventricular and subcortical white matter and cerebral 
microhaemorrhages).
Characteristic MRI features of Fabry’s disease are T1 
hyperintensity within the pulvinar nuclei of the thalamus (the 
“pulvinar sign”) and ectasia of the basilar artery on MRA, 
which has been found to be one of the best indicators of the 
presence of the disease in adults.
9.1.6  Alexander Disease
Defects in the glial fibrillary acidic protein gene have been 
identified as the underlying cause of this disease, in which 
approximately 25% of patients present in adulthood, most 
commonly with bulbar dysfunction, pyramidal involvement, 
cerebellar ataxia, and sleep abnormalities.
The MRI findings of the infantile and juvenile form 
include extensive white matter change with frontal predomi-
nance, a periventricular rim with high signal on T1-weighted 
images and low signal on T2-weighted images, abnormali-
ties of the basal ganglia and thalami, brainstem abnormali-
ties and contrast enhancement.
In adult onset disease, MRI findings consist of atrophy 
and abnormal signal within the medulla and upper cord, 
which has been termed a “tadpole” appearance and may be 
accompanied by periventricular white matter change.
9.1.7  Primary Familial Brain Calcification
Primary familial brain calcification, idiopathic basal ganglia 
calcification, and bilateral strioapallidodentate calcinosis are 
terms used for what was formerly called Fahr disease. This is 
a group of genetic disorders with currently four known muta-
tions that are inherited in an autosomal dominant pattern. 
Symptomatic patients present in the late 40s with a mostly 
Parkinsonian movement disorder, followed by cognitive 
decline, cerebellar features, and speech disorders. 
Symmetrical calcification involving the lentiform nuclei, 
caudate nuclei, thalami and dentate nuclei is mostly readily 
detected by CT. On MRI, the structures involved may show 
high signal on T1-weighted spin echo sequences and signal 
loss on susceptibility-weighted imaging.
9.2  Acquired Metabolic Disorders
These are mostly seen in young adults or adults and present 
with typical imaging findings.
9.2.1  Wernicke’s Encephalopathy
Wernicke’s encephalopathy (WE) is caused by a deficiency 
of vitamin B1 (thiamine), which may be due to alcohol 
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abuse, malabsorption, poor nutrition, increased metabolism, 
or iatrogenic elimination (haemodialysis).
Thiamine depletion leads to failure of conversion of 
pyruvate to acetyl-CoA and α-ketoglutarate to succinate 
and the lack of Krebs cycle resulting in cerebral lactic aci-
dosis with intra- and extracellular oedema, swelling of 
astrocytes, oligodendrocytes, myelin fibres, and neuronal 
dendrites.
The classic clinical triad of ocular dysfunctions (nystag-
mus, conjugate gaze palsy, ophthalmoplegia), ataxia, and 
confusion is observed only in 30% of cases. Treatment con-
sists of thiamine infusion, which can prevent progression to 
Korsakoff’s dementia or death.
MRI shows T2/FLAIR hyper intensities in the periaque-
ductal and medial thalamic regions, mammillary bodies, 
hypothalamus, tectum, and cerebellum (Fig. 9.1).
Contrast enhancement occurs in 80% in the mammillary 
bodies (often prior to T2 hyperintensities) and in 50% in the 
peri-acqueductal regions.
Imaging abnormalities can regress with treatment, but the 
prognosis is usually poor once there is cortical involvement 
or T1 hyperintensity in the thalami and mammillary bodies 
indicating haemorrhagic change.
Chronic cases show atrophy of the mammillary bodies.
9.2.2  Subacute Combined Degeneration
This is a disorder of the spinal cord secondary to vitamin 
B12 deficiency, characterised by gliosis and spongiform 
degeneration of the posterior and lateral columns. 
Clinical presentations are in spastic paraparesis and spi-
nal ataxia.
MRI demonstrates T2 hyperintensities in the posterior 
and lateral columns of the spinal cord, which can reverse 
after adequate B12 administration. Chronic non- or under-
treated cases show spinal cord atrophy.
9.2.3  Osmotic Myelinolysis Syndrome
This entity includes central pontine myelinolysis (CPM) and 
extrapontine myelinolysis and occurs usually in patients 
with hyponatremia that has been corrected too quickly.
The traditionally proposed pathophysiological mecha-
nism is a disruption of the blood–brain–barrier resulting 
in vasogenic oedema, fibre tract compression, and myelin-
olysis. Additional implicated mechanisms are cerebral 
dehydration, intramyelinic oedema, and oligodendrocyte 
degeneration. The most common damage is in the central 
pontine fibres (CPM). Extrapontine demyelination (in 
sites such as basal ganglia, thalami, lateral geniculate 
body, cerebellum and cerebral cortex) may occur together 
with CPM or in isolation (in approximately 10%).
Clinical symptoms of CPM include paralysis, dysphagia, 
dysarthria, and pseudobulbar palsy.
Typical MRI features of central pontine myelinolysis are 
T2/FLAIR hyperintensity in the central pons showing a 
symmetric “trident” or “bat-wing”-pattern, due to sparing 
of the peripheral fibres and the axons of the corticospinal 
tracts.
In the acute phase DWI shows restricted diffusion with a 
decreased ADC.  This may occur within 24  h of symptom 
onset and precede the signal abnormalities seen on T2 or 
FLAIR images. The ADC values usually return to baseline 
within 3–4 weeks.
CPM can appear moderately hypointense in T1 and may 
infrequently show contrast enhancement. If the patient sur-
vives the acute phase, the pontine lesions can cavitate and 
appear markedly hypointense on T1 weighted images.
9.2.4  Hepatic Encephalopathy
The term hepatic encephalopathy includes a spectrum of 
neuropsychiatric abnormalities in patients with liver dys-
Fig. 9.1 Typical FLAIR hyperintense tissue changes in the medial thalamus, the periaqueductal area, mammillary bodies, and tectal plate
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function. Most cases are associated with cirrhosis and portal 
hypertension or portal-systemic shunts, but the condition can 
also occur in acute liver failure.
Classical MR abnormalities in chronic hepatic 
encephalopathy include high signal intensity in the glo-
bus pallidus on T1-weighted images, and less frequently, 
in the substantia nigra and the tegmentum of the mid-
brain, secondary to increased concentrations of manga-
nese (Fig. 9.2) [2].
Magnetisation transfer imaging, fast FLAIR, and DWI 
sequences may demonstrate white matter abnormalities sec-
ondary to increased CNS ammonia concentration. These 
return to normal with restoration of liver function, and are 
thought to reflect mild diffuse interstitial brain oedema, 
which appears to play an essential role in the pathogenesis of 
hepatic encephalopathy.
In acute hepatic encephalopathy, bilateral symmetric 
T2-hyperintensities of the cortical grey matter are often asso-
ciated with restricted diffusion. There may be additional 
involvement of the subcortical white matter, basal ganglia, 
thalami, and midbrain. These imaging abnormalities are 
thought to reflect cytotoxic oedema secondary to acute 
hyperammonemia.
9.2.5  Hypoglycemic Encephalopathy
An acute decrease in serum glucose levels can arise from an 
excess of exogenous or endogenous insulin and hypoglycae-
mia inducing drugs. This causes a decline of the cell mem-
brane ATPase pump activity and release of excitatory 
neurotransmitters such as aspartate.
CT can demonstrate enhancing hypodensities in the basal 
ganglia, cerebral cortex, hippocampus, and substantia nigra.
MRI is more sensitive and shows T2 hyperintensities as 
well as restricted diffusion in the posterior limb of the inter-
nal capsules, hippocampi, the basal ganglia and cortical 
areas and splenium of the corpus callosum. These changes 
are likely to reflect cytotoxic oedema and extensive DWI 
changes in the basal ganglia and deep white matter are asso-
ciated with poor clinical outcome.
9.2.6  Hyperglycaemic Encephalopathy
Hyperglycaemia occurs in uncontrolled diabetes mellitus 
and can lead to osmotic derangements the basal ganglia and 
subthalamic region.
Fig. 9.2 Hepatic Encephalopathy—typical T1 hyperintense tissue changes in the basal ganglia based on manganese deposition
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Imaging findings are hyperdense changes on CT and T1 
hyperintensities on MRI within the putamen and caudate nuclei, 
which may be uni- or bilateral. SPECT has been reported to 
show hypoperfusion in the basal ganglia. After correction of 
blood glucose, the imaging abnormalities usually regress [3].
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Take Home Messages
• Both congenital and acquired metabolic diseases 
present with typical imaging findings.
• Even sometimes subtle, the course will enable to 
identify patterns that help in the differential process.
• Only the combination between clinical information, 
laboratory findings, and imaging will allow to make 
a solid differential diagnosis.
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Approximately 4% of the general population will experience 
a seizure during their lifetime. Imaging findings of “first- 
ever” seizure patients are in most cases normal, and abnor-
malities are only present in approximately 15% of patients as 
seizures can be provoked by fever, sleep deprivation, strobo-
scopic lights, or drugs. However, an underlying lesion will 
lower the seizure threshold and thus make a patient more 
susceptible to experience a seizure. As “first-ever” seizures 
are a medical emergency the initial imaging modality of 
choice in these cases is an unenhanced CT head scan to 
exclude acute medical emergencies that may go along with 
seizures prior to a more extensive workup depending on clin-
ical history and presentation. Imaging abnormalities encoun-
tered in patients experiencing their first-ever seizures include 
(but are not restricted to) virtually all diseases affecting the 
brain. As such you may find vascular abnormalities (such as 
microangiopathy, arteriovenous malformations (AVM), 
sinus thrombosis, hemorrhage, cavernomas, or stroke), 
tumors (metastases, primary tumors), infections (encephali-
tis, meningitis, abscess), sequelae of previous head injury, 
and toxic or metabolic conditions (e.g., PRES) in these 
patients.
In contrast to the “first-ever” seizure, patients diagnosed 
with “epilepsy” have recurrent and unprovoked seizures. 
Approximately 1% of the general population will be diag-
nosed with this condition and as seizures are recurrent and 
unprovoked, an underlying lesion is far more common as 
compared to patients with their first-ever seizure. Being 
“unprovoked,” lesions that can irritate the brain (i.e., are 
“epileptogenic”) may be present. On brain imaging, lesions 
will be seen in nearly 50% of patients; however, these are 
non-specific and can encompass a wide variety of underlying 
conditions that can provoke the recurrent seizure attacks. 
Imaging findings in patients with seizures include but are not 
restricted to: vascular conditions such as microangiopathy, 
previous ischemia, vascular malformations, previous hemor-
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Learning Objectives
• To understand typical imaging criteria to identify 
and differentiate causes of medication refractory 
epilepsy
• To understand the limitations of imaging for patients 
with medication refractory epilepsy if no dedicated 
Epilepsy MR protocol is used.
• To appreciate the importance of additional clinical 
information when evaluating the patient with medi-
cation refractory epilepsy.
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rhage or cavernomas, tumors (metastases, primary tumors), 
remote infections (encephalitis, abscess), previous head 
injury, congenital malformations, or toxic metabolic condi-
tions. Imaging of choice in patients with epilepsy is MRI 
given the larger variety of potential underlying diseases.
The vast majority of patients with epilepsy can be treated 
satisfactorily with antiepileptic drugs. However, 0.4% of the 
general population will have recurrent and unprovoked sei-
zures that do not respond to medication. These patients are 
potentially treatable with surgery, and surgical intervention 
is an appropriate consideration for 3% of people who 
develop epilepsy [1]. The major focus of this chapter will be 
on the imaging findings in those patients who are diagnosed 
with “medication refractory” epilepsy, i.e., patients where 
the  seizure focus is too strong to be controlled by medica-
tion which indicates that the underlying lesion has to have a 
strong epileptogenic potential. In these patients, structural 
imaging will find abnormalities in up to 85% of patients. 
Lesions with a strong epileptogenic potential are either 
close to epileptogenic structures or consist of abnormal neu-
rons. Lesions that are often involved in medication refrac-
tory epilepsy are: mesial temporal lobe sclerosis (MTS) 
(primary or secondary to a long standing seizure disorder), 
malformations of cortical development, certain epilepto-
genic tumors (e.g., dysembryoplastic neuroepithelial tumors 
(DNET), temporal lobe gliomas gangliogliomas), vascular 
malformations, trauma, remote infection, and certain pha-
komatoses. Imaging findings in some of these conditions 
will be subtle which necessitates both a dedicated imaging 
protocol (as compared to a standard MR) and an “expert” 
experience in reading these types of scans. In a landmark 
study of von Oerzten et  al. [2], the sensitivity of “non-
expert” reports of standard MRI reports for focal lesions 
was 39%, while sensitivity of “expert” reports of standard 
MRI increased to 50%. “Expert” reports of epilepsy dedi-
cated MRI protocols further increased the sensitivity in 
detecting subtle lesions to 91%. Dedicated MRI showed 
focal lesions in 85% of patients with “non-lesional” stan-
dard MRI. Neuropathological diagnoses were predicted cor-
rectly in 22% of “non-expert” standard MRI reports but by 
89% of dedicated MRI reports. Thus, the combination of 
dedicated MRI protocols and dedicated radiologists trained 
in evaluating patients with medication refractory seizures 
increases significantly the sensitivity of MRI in this sub-
group of patients. A multidisciplinary approach that involves 
close communication between epilepsy neurologists, neuro-
radiology, EEG, nuclear medicine, neuropsychology, and 
neurosurgery is an important feature of modern epilepsy 
management.
The necessity of expert MR reading with a dedicated 
imaging protocol is further highlighted by the fact that post-
surgical seizure freedom is achieved significantly more often 
when a circumscribed, resectable epileptogenic lesion can be 
identified on MRI preoperatively compared to patients that 
are rated non-lesional [3]. As pointed out by Wellmer et al. in 
2013 [4, 5], the possible reasons for undetected epileptic 
lesions in standard outpatient MRI are insufficient clinical 
information from the referring clinician, routine MR proto-
cols not optimized for the spectrum of epileptogenic lesions, 
and unfamiliarity with the spectrum of epileptogenic lesions. 
Wellmer pointed out that “because even the best focus 
hypothesis and most profound knowledge of epileptogenic 
lesions do not permit the detection of lesions when they are 
invisible on the MRI scan, the starting point for any improve-
ment of outpatient MRI diagnostics should be defining an 
MRI protocol that is adjusted to common epileptogenic 
lesions.”
This indicates that a specific imaging protocol to iden-
tify these lesions is necessary. This protocol should take 
into account that—as small epileptogenic lesions are usu-
ally those that provide the best chance for postoperative 
seizure freedom—slice thickness should be adjusted to 
detect small lesions and multiple (coronal, axial, sagittal) 
cut planes are acquired to ensure that physiologic structures 
or partial volume effects within the folded cortex are not 
taken for pathology and vice versa. Coronal sequences have 
to be angulated perpendicular to the hippocampal axis to 
allow hippocampal volume estimation and caution has to 
be taken that they are oriented in a plane that ensures direct 
comparison with the contralateral hemisphere. In our prac-
tice, we employ this coronal angulation for both T2FLAIR 
and T1 IR sequences. High resolution T1-weighted 
sequences with isotropic voxel sizes allow for multiplanar 
reformation and further evaluation (including 3D refor-
mats, “pancake” views, surface rendering, and volumetric 
assessments). T2 gradient echo or susceptibility weighted 
sequences are highly sensitive to detect blood products or 
calcifications and should therefore be part of a seizure 
imaging protocol (Fig. 10.1).
In a recent analysis performed by Wellmer et al. on the 
prevalence of epileptogenic lesions among 2740 patients the 
following pathologies were found: mesial temporal lobe 
sclerosis (32%), tumors (including low and high grade 
tumors as well as malformative tumors and benign epilepsy 
associated tumors) in approximately 17% of patients, corti-
cal dysplasias in 11%, glial scars (including posttraumatic, 
post-ischemic, post-hemorrhagic, postinfectious/abscess, 
ulegyria, and postsurgical scars) in 11%, vascular diseases 
(cavernoma AVM, pial angiomatosis) in 5%, malformations 
of cortical development including nodular heterotopia, sub-
cortical band heterotopia, polymicrogyria, lissencephaly, 
pachygyria, agenesis of corpus callosum, craniocephalic 
malformations, hemiatrophy, lobar dysgenesis, hemimega-
lencephaly, or hamartomas in 3%, and sequelae of encepha-
litis in 1% while in approximately 20% no lesion could be 
detected.
Lesion location—presumably related to the different epi-
leptogenic potential in different brain regions—demonstrates 
preponderance for the temporal lobes (60%) followed by the 
frontal lobe (20%), the parietal lobe (10%), the periventricu-
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lar white matter (5%), and the occipital lobe (5%). Lesions 
within the cerebellum or brainstem are not known to cause 
epilepsy.
The suitability of MR imaging to detect these findings 
varies between different sequences. It is generally recom-
mended that for an epilepsy-specific protocol T2FLAIR, T2/
STIR in two parallel planes, T2 gradient echo/SWI sequences, 
and an isotropic 3D-T1 are necessary. We strongly recom-
mend these imaging sequences to be done on a 3T scanner 
given the higher spatial resolution [6, 7]. The use of even 
higher field strengths (7T) (Fig. 10.2) will probably further 
increase the detection rate of epileptogenic substrates such as 
mesial temporal lobe sclerosis (MTS), focal cortical dyspla-
sia (FCD), and polymicrogyria [8–11]. Epilepsy imaging at 
1.5T is in the opinion of the authors no longer acceptable. 
There are multiple adjunct imaging techniques:
• Functional MRI (fMRI) can map eloquent cortex and pro-
vide information regarding language lateralization [12] 




Fig. 10.1 (a–c) Some examples of sequences employed in our institu-
tional dedicated epilepsy protocol: (a) coronal T2 FLAIR, perpendicu-
lar to the hippocampal axis; (b) axial T1 inversion recovery (IR) parallel 
to the hippocampal axis; (c) T1 3D image set presented as “pancake 
view” for a better overview of the gyral pattern
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and tractography may help to avoid injury to the optic 
radiation during temporal lobe resection [13].
• Radionuclide imaging can add useful information 
in selected cases [14]. Subtraction of ictal and interic-
tal SPECT co-registered to MRI (SISCOM) can show a 
seizure- induced hyperperfusion (Fig.  10.4), whereas 
18FFDG-PET may show hypometabolism in the 
seizure onset zone. This is particularly useful in later-
alization of temporal lobe epilepsy in the MR-negative 
patient.
• Dipole source analysis using either EEG or MEG data can 
also be added for the localization of seizure activity.
Imaging evaluation should be standardized using a step-
wise approach to evaluate the hippocampus and mesial 
temporal lobe structures, the ventricular outline, the gyral, 
and the sulcal anatomy. Particular emphasis should be paid 
upon the T2/FLAIR signal within the cortex and hippocam-
pus, its similarity to other regions of neo- and archicortex, 
the internal architecture of the hippocampus, the indenta-
tions of the pes hippocampi, the fornix and mammillary 
bodies, and the gray–white matter interface of the neocor-
tex (blurring, gray matter thinning or thickening). Selection 
of narrow window width better optimizes contrast between 
the gray and white matter which can assist in lesion detec-
tion (Fig. 10.5).
In the following we will discuss the imaging features of 
epileptogenic lesions highlighting imaging pearls and pitfalls.
10.1.1  Mesial Temporal Lobe/Hippocampal 
Sclerosis
Patients with mesial temporal sclerosis (MTS) often harbor 
complex partial seizures with a seizure semiology (given its 
temporal lobe origin) that is characterized by déjà vu (or 
jamais vu) sensations, epigastric auras, lip smacking, or 
other oral automatisms and often have in their past medical 
history febrile seizures as a child with progressive worsening 
of seizure frequency and severity over time. Understanding 
the normal hippocampal internal architecture is critical to 
make the correct diagnosis. The hippocampus is composed 
of four distinct cellular layers with stratum oriens as the most 
superficial layer followed by stratum pyramidale, stratum 
radiatum, and stratum lacunosum as the inner most layer. 
Histopathologic correlation with 3T MRI of resected speci-
men of hippocampi revealed the inner hypointense band on 
the coronal T2-weighted sequence as the stratum lacunosum 
(Fig.  10.6). MTS is characterized with extensive gliosis 
Fig. 10.2 axial T2 at 7T parallel to the hippocampal axis. Excellent in 
plane resolution provides detailed imaging of hippocampus
Fig. 10.3 Functional MRI. Red areas indicate activation during a simple 
word generation task. Activation is seen predominantly in the left hemi-
sphere in the frontal language region; typical language lateralization
Key Point
• In selected patients, i.e., those with medication refrac-
tory epilepsy, abnormalities can be found in a high 
percentage if images are performed with a dedicated 
imaging protocol, and expert read-out. A variety of 
non-radiological adjunct tests are available that may 
help in the localization of the seizure focus and pref-
erably these challenging cases are therefore discussed 
in multidisciplinary conferences.
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throughout the cornu ammonis (CA) regions, but early in the 
course of the disease there is loss of tissue in the stratum 
pyramidale most pronounced in CA1 region [15]. 
Identification of the stratum lacunosum as a landmark pro-
vides an imaging reference point for qualitative and quantita-
tive analysis of tissue loss in MTS.  Atrophy of the 
hippocampus and gliosis within the hippocampus will mani-
fest itself as increased signal intensity on T2/FLAIR 
sequences (Fig. 10.7). The atrophy will lead to loss of the pes 
hippocampi interdigitations, widening of the temporal horn 
and atrophy of the white matter of the temporal lobe. As a 
consequence of Wallerian degeneration, there will be atro-
phy of the projecting pathways of the hippocampus, i.e., the 
Papez circuit, with atrophy of the ipsilateral fornix and the 
mammillary body. In the early stages of MTS the imaging 
findings are subtle with loss of the internal architecture of the 
hippocampus with or without associated FLAIR signal 
changes. Hard windowing of the FLAIR weighted sequences 
will make identification of the diseased hippocampus easier. 
In nearly 20% of patients with MTS, dual pathology is pres-
ent with a second epileptogenic focus. It is believed that in 
these cases the other epileptogenic lesion triggered the 
mesial temporal lobe sclerosis (similar to febrile seizures as 
a child can trigger or “kindle” a mesial temporal lobe sclero-
sis). Identification of the second focus is of great importance 
as failure to do so may result in surgical failure if only a 
selective amygdalohippocampectomy is performed thus 
leaving the “primary” focus behind. On the other hand, fail-
ure to identify MTS in patients with other lesions may also 
lead to surgical failure following lesionectomy. Dual pathol-
ogy may consist also of bilateral mesiotemporal lobe sclero-
sis as one hemisphere may trigger the other hippocampus to 
become sclerotic thus constituting bilateral abnormalities. 
As the internal reference (i.e., the contralateral hippocam-
pus) is similarly affected, comparison of the signal with 
other regions of archicortex (3–4 layered cortex) can identify 
whether a mesial temporal lobe sclerosis is present bilater-
ally. Thus, if the T2/FLAIR signal of the hippocampus is 
bilateral symmetrical but higher as compared to the cingu-
lum or insula, you have to consider bilateral mesial temporal 
lobe sclerosis.
a b
Fig. 10.4 (a, b) SISCOM: (a) axial T1 with small subcortical area in the right temporal lobe with prolonged T1; (b) co-registration of SPECT on 
MR-images shows ictal hyperperfused area exactly in the same spot as the suspected lesion
Key Point
• Mesial temporal lobe sclerosis is the most com-
monly seen cause for medication refractory epilepsy 
and is characterized by an indistinct gray–white 
matter differentiation, abnormal high signal on T2/
Flair sequences, and atrophy. In up to 20% of cases 
additional epileptogenic pathology is found in 
patients with mesial temporal lobe sclerosis.





Fig. 10.5 (a, b) Right lateral precentral gyrus type II FCD. (a) axial and (b) coronal FLAIR images at standard window level setting as compared 
to narrowed window width setting of the same images in (c, d) which makes the lesion more conspicuous
10.1.2  Malformations of Cortical Development
In order to understand the different types of malformations 
of cortical development it is important to briefly review the 
embryology of normal brain development: During the 
 seventh week of gestation, neuronal proliferation in the sub-
ependymal germinal matrix occurs. After the eighth week 
these cells migrate outward in multiple waves of radial out-
ward migration aided by radial glial cell guidance in a pro-
cess coined chemotaxis. The third and last part of the cortical 
development, the lamination, is the organization of the cells 
within different cortical layers, a process that is orchestrated 
C. C.-T. Hsu et al.
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a b
Fig. 10.6 (a, b) Right hippocampus internal architecture: (a) coronal T2 at 3T showing an inner hypointense layer of the hippocampus represent-
ing the stratum lacunosum; (b) at 1.5T the ultrastructural detail of the hippocampus is obscured due to the decreased spatial resolution and SNR
a b
Fig. 10.7 (a, b) Mesial temporal sclerosis (MTS): (a) coronal 
T2FLAIR shows increased signal in the left hippocampus; (b) axial 
T1IR demonstrates volume loss in the left hippocampus. The findings 
shown are relatively subtle. MRI fails to recognize pathologically 
detected mesial temporal lobe sclerosis in up to 20% of the cases
by the subplate (the lowest layer of cortex). Chromosomal 
mutations, destructive events (ischemia/infections), or toxins 
may inhibit either of these three processes (proliferation, 
chemotaxis, or cortical organization) which will lead to 
abnormalities in stem cell development, migration, or 
lamination.
Malformations of cortical development are present in up 
to 25% of patients with intractable childhood epilepsy. They 
are associated with chromosomal alterations, congenital 
infections, or in utero ischemia. In addition to epilepsy these 
patients may have developmental delay and focal neurologi-
cal deficits.
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Malformations related to abnormal stem cell development 
include the focal or transmantle cortical dysplasias (balloon 
cell or type II FCDs) and the hemimegalencephalies.
Type II FCD is characterized on histology by dysmorphic 
neurons with or without balloon cells in addition to cortical 
dyslamination and are identical to cortical hamartomas in 
tuberous sclerosis. The transmantle sign is a specific radio-
logic feature of FCD type II, which is more frequently 
detected in patients with FCD type IIb than FCD type IIa. 
Histologically the transmantle sign reflects abnormal cells 
extending from the ventricle to the cortex manifesting as a 
linear T2-weighted or FLAIR hyperintensity from ventricle 
towards the cortex (the radial band or foot) and can be seen 
in association with a subcortical FLAIR hyperintensity. The 
abnormal FLAIR hypersignal is again better seen with a nar-
rowed window width. The junction between cortex and white 
matter is indistinct and the cortical gray matter may be 
focally thickened (Fig. 10.8).
Signal intensity of the transmantle sign on the T1-weighted 
sequence could reveal the histologic composition of the type 
II FCD. Traditionally transmantle sign appears T2-weighted 
and FLAIR hyperintense and T1-weighted hypointense. 
More recently a study by Kumura et  al. revealed that 
T1-weighted hyperintense transmantle sign is associated with 
higher density of balloon cells without significant differences 
in the number of dysmorphic neurons or the severity of glio-
sis (Fig. 10.9) [16]. Identifying a T1 hyperintense transmantle 
sign may have clinical relevance. Although the exact role of 
balloon cells remains uncertain, some studies have suggested 
a protective role in reducing spread of the epileptogenic 
activity.
In hemimegalencephaly a diffuse hamartomatous over-
growth as a result of abnormal stem cell proliferation is 
present resulting in broad gyri, shallow sulci, and a blurred 
gray–white matter junction. The ipsilateral ventricle is 
often enlarged and demonstrates an abnormal straight 
course of the frontal horn (Fig. 10.10). Clinically, patients 
present with macrocephaly, hemiplegia, developmental 
delay, and seizures. The affected hemisphere has no func-
tion and thus hemispherectomy can be proposed to these 
patients. Pre- operative detailed clinical and radiologic 
assessment is required to determine if there are co-existing 
abnormalities in the contralateral hemisphere. In addition, 
diffusion tensor imaging has shown a subset of patients 
with hemimegalencephaly harbor aberrant midsagittal fiber 
tracts with intra- or interhemispherically connection which 
may need to be surgically addressed to improve surgical 
outcome [17].
Malformations related to abnormal migration are the 
lissencephalies, the agyria-pachygyrias, and the 
heterotopias.
In the lissencephalies, there has been a global halt in the 
migration due to an impaired last phase of neural migration 
leading to paucity of the gyral and sulcal development with a 
smooth brain surface and diminished white matter. Patients 
present with global developmental delay and seizures. Two 
different types of lissencephaly can be distinguished: the 
posterior agyria (related to an alteration on Chromosome 17) 
and the anterior agyria which is an x-linked disease 
(Fig. 10.11).
Female carriers of the affected X-chromosome present 
with band heterotopias that is more present in the frontal 
lobes compared to the parietal lobes. Thus, if females pres-
ent with band heterotopias, genetic counseling may be indi-
cated as half of their male offspring may be affected by 
anterior agyria. The band may be thin or thick depending on 
the amount of arrested neurons during migration. Patients 
with a thick band have less normal cortex (that can be 
thinned) and thus present with a more severe developmental 
delay.
In addition to the “band heterotopia,” focal subcortical 
heterotopia can be present, on imaging, swirling, curvilin-
ear bands of gray matter as well as thinned cortex, and pau-
city of the white matter are seen. The ipsilateral ventricle 
may be distorted and there can be an associated callosal 
hypogenesis.
The third type of heterotopia is called periventricular nod-
ular heterotopia or subependymal heterotopia. On imaging 
an exophytic smooth ovoid mass in the residual germinal 
matrix, i.e., along the ventricle is seen (Fig. 10.12). Again, 
you may have associated anomalies including Chiari malfor-
mations, cephaloceles, corpus callosum agenesis, or a Dandy 
Walker syndrome. In contrast to the other malformations of 
abnormal migration, the periventricular nodular heterotopia 
may exhibit quite mild symptoms with normal development 
and late onset of seizures. If the periventricular heterotopia 
completely lined the walls of both ventricles, a familiar form 
has to be considered. Periventricular nodular heterotopia can 
have different inheritance patterns. Specifically, mutation in 
the FLNA gene is inherited in an X-linked dominant pattern 
with male offspring experiencing more severe symptoms of 
the disorder than females, and in most cases die before birth. 
Hence genetic counseling for female patient of reproductive 
age with extensive periventricular heterotopia may be 
considered.
Malformations related to abnormal cortical organization 
encompass polymicrogyria, schizencephaly, and FCD type I 
(non-balloon cell). In polymicrogyria, neurons reach the cor-
tex but distribute abnormally, thus multiple small gyri are 
formed (Fig.  10.13). Polymicrogyria is most commonly 
found around the posterior Sylvian fissures, when bilaterally 
present in the perisylvian region patients present with pseu-
dobulbar palsy.
In open-lip schizencephaly a cleft that is lined by gray 
matter reaches from the periphery to the ventricle, while 
in the closed-lip schizencephaly gray matter is 
reaching from the periphery to the ventricle and a dimple 
is seen in the ventricular wall. Schizencephaly can be 
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Fig. 10.8 Three cases of FCD type II. (a, b) patient 1; (a) coronal T2 
with large subcortical area in the right temporal lobe with prolonged 
T2. The increased signal stretches in to the temporal horn of the right 
ventricle; (b) coronal T1 with gadolinium. The corresponding area has 
decreased signal on T1-weighted image. No enhancement. (c, d) patient 
2; (c) axial T1IR with very subtle signal changes at the bottom of a 
sulcus lateral in the frontal lobe; (d) coronal T2FLAIR shows increased 
signal in the same are with a faint band stretching towards the lateral 
ventricle. (e) patient 3, boy, 3 months old, axial T1IR shows a region 
with thickened cortex in the right frontal lobe. Notice the premature 




• Malformations of cortical development are com-
monly seen in pediatric patients with medication 
refractory  epilepsy. Often these patients have some 
form of cognitive impairment or developmental delay.
multifocal and bilateral. The cortex lining the defect is 
polymicrogyric with  ill- defined margins to the white mat-
ter. Finally, FCD type I (non-balloon cell) is a disorder of 
lamination. Imaging features are very subtle and only 
mild focal blurring of the gray–white matter junction may 
be present. This type of dysplasia is often undetectable on 
MRI.
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10.1.3  Epileptogenic Tumors
While virtually all tumors may cause epilepsy, there are cer-
tain tumors that have a very high propensity of eliciting med-
ication refractory seizures. As most of these are benign and 
just by means of location (i.e., within the cortical–white mat-
ter interface and with temporal lobe predilection) cause the 
seizures, these are often very good candidates for surgery. As 
a general discussion of all tumors is beyond the scope of this 
chapter, we will focus only on three tumors that are com-
monly associated with seizures: the gangliogliomas, the 
DNETs, and the tuber cinereum hamartomas.
Gangliogliomas are cortically based, partly cystic tumors 
that may calcify and that harbor an enhancing nodule 
(Fig.  10.14). Gangliogliomas occur in young adults and 
older children, when present under the age of 10 they are 
often larger with more cystic components. They are mainly 
located in the temporal lobes but can also occur in parietal 
and frontal lobes. Cortical dysplasias (coined type III) can be 
associated with a ganglioglioma. Differential diagnoses for 
gangliogliomas are DNETs, pilocytic astrocytomas, pleo-




Fig. 10.9 Left frontal type II FCD. (a, b) axial and coronal FLAIR 
images demonstrate focal gyral thickening posteriorly in the left frontal 
gyrus with an associated curvilinear hypointense band following the 
bottom of the sulcus. (c) T1 inversion recovery reveal hyperintensity in 
this area
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sis. In adults, solid appearing ganglioglioma may mimic 
high grade glioma and advanced imaging techniques such as 
MR perfusion maybe a useful tool for pre-operative evalua-
tion (Fig. 10.15).
DNETs are well demarcated, bubbly, intracortical masses 
that also are most common in the temporal, parietal, and 
frontal lobes (Fig.  10.16). They may calcify and enhance-
ment is very rare and if present should lead to more intensive 
follow-up as the enhancing portion of a DNET may recur 
following surgery. Top differential diagnoses for DNETs are 
cortical dysplasia, ganglioglioma, pilocytic astrocytoma, 
glioma, neuroepithelial cysts, and dilated VR spaces.
Tuber cinereum hamartomas present with the combina-
tion of gelastic seizures and precocious puberty. They are 
located at the floor of the third ventricle (i.e., the tuber cine-
reum) do not enhance and are isointense to cortex (Fig. 10.17). 
They are non-neoplastic tumors with disorganized collection 




Fig. 10.10 (a, b) Boy, 6 months. Hemimegalencephaly. (a) axial T2; 
(b) coronal T1. The left hemisphere is enlarged with broad gyri and 
shallow sulci. The ipsilateral ventricle is enlarged with an abnormal 
shape of the frontal horn. Indistinct gray/white matter is noted through-
out the entire hemisphere
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10.1.4  Miscellaneous: Vascular Malformations/
Trauma/Infection/Phakomatoses
Similar to the previous paragraph, it is beyond the scope to in 
detail describe imaging features of vascular malformations, 
infections or trauma that can go along with seizures and most 
of the entities are described in other chapters of this syllabus. 
We therefore only want to highlight few epilepsy-relevant 
facts and features of these miscellaneous conditions.
Brain AVMs can cause seizures due to previous hemor-
rhage and scarring, hemosiderin deposition (especially when 
close to the cortex), or gliosis. AVMs in the temporal lobe 
have a higher likelihood of producing seizure due to interfer-
ence of the normal blood supply and drainage of potentially 
epileptogenic structures such as the hippocampus.
While cavernomas that are deeply located in the white 
matter rarely cause seizures, those that are cortically located 
and have hemosiderin staining reaching the cortex, and in 
particular the mesial temporal lobe structures, are very often 
associated with seizures as the hemosiderin stain is believed 
to have a strong irritative potential for neurons. They are best 




Fig. 10.11 (a, b) X-linked lissencephaly, boy, 2 weeks old. (a) sag t2; 
(b) coronal T1. Lissencephaly with agyria more pronounced in the ante-
rior part of the brain. In addition, callosal hypogenesis. (c, d) The 
mother of the boy in (a, b) female carrier. (c) Axial T2 (detail); (d) coro-
nal T1; Subtle subcortical band heterotopia in both frontal lobes





Fig. 10.12 (a–c) Periventricular nodular heterotopia: (a) coronal T1; (b) sagittal T2; (c) axial T1IR. Well delineated smooth ovoid masses lateral 
to the trigone and temporal horn of the left ventricle. Note that the signal is identical to that of cortex in all sequences
demonstrate with the classical blooming artifact (Fig. 10.18). 
Cavernomas may be multiple and they can be associated 
with developmental venous anomalies (DVA). New intra- 
cavernomatous thrombosis or hemorrhage may lead to 
change in seizure frequency.
Patients with previous trauma can experience posttrau-
matic seizure disorder, especially after having sustained con-
tusional hemorrhages of their temporal lobes as gliosis and 
hemosiderin staining can cause irritation of the surrounding 
cortex.
Neonatal anoxic ischemia or hypoxemia can cause ulegy-
ria—i.e., a scar/defect of the cerebral cortex that mainly involves 
the cortex in the depth of the sulcus whereas the cortical crowns 
remain relatively unaffected. This peculiar pattern can be 





Fig. 10.13 (a–c) Two patients with polymicrogyria. (a) Axial T1IR; 
(b): sagittal T1. Patient 1. Abnormal gyration in the right hemisphere 
with a large region with polymicrogyria. (c) Patient 2, “pancake view” 
from a 3D T1-sequence gives a very good overview of the migration 
anomalies in the right hemisphere. It also increases the chance to detect 
subtle changes—see small area with polymicrogyria in the left 
hemisphere!
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Fig. 10.14 (a, b) Ganglioglioma close to the right postcentral sulcus. (a) axial T2FLAIR with a small, cortical/subcortical, nodular high-signal 
area in the right parietal lobe close to the postcentral sulcus; (b) coronal T1 with gadolinium shows contrast enhancement in the nodulus
a b c
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Fig. 10.15 Right superior temporal gyrus ganglioglioma in a middle- 
aged patient. Pre-operative MRI (a, b) axial T2FLAIR and post gado-
linium enhanced axial T1 images showed an avidly enhancing cortically 
based mass with moderate peri-lesional edema. (c, d) Despite the avid 
lesional enhancement, MR perfusion showed low rCBV value consis-
tent with a low-grade glioma. (e, f) Diagnosis of ganglioglioma was 
confirmed following mesial sparing temporal lobectomy





Fig. 10.16 Two patients with DNET. (a, b) Patient 1. (a) coronal T2; 
(b) sagittal T1 with gadolinium; well delineated cortical/subcortical 
bubbly mass in the right frontal lobe with prolonged T2 and no contrast 
enhancement typical of a DNET. (c, d) Patient 2: (c) sagittal T1; (d) 
coronal T2 FLAIR; This DNET in the left parietal lobe is associated 
with a FCD type II.  Notice the streak with signal changes which 
stretches towards the lateral ventricle
explained by the vascular supply of the gyri in the newborn that 
leads to a better perfusion of the apices of the gyri as compared 
to the depth of the sulci. There will be paucity of the white mat-
ter and, as the lesion occurred prior to complete myelination, a 
relatively mild gliosis. If the perinatal ischemia has only 
involved one hemisphere (perinatal stroke) a Dyke Davidoff 
Mason syndrome will ensue where stable hemiatrophy is pres-
ent with hypertrophy of the skull and the sinuses, paucity of 
white matter, ventricular enlargement, and mild gliosis.
Virtually any infection (bacterial, fungal, parasitic) can 
produce epileptogenic lesions, and world-wide, infections are 
the leading cause of epilepsy. A typical example is neurocys-
ticercosis which is a very common cause of focal epilepsy in 
the developing world. In the early vesicular, colloidal or gran-
ular nodular stages, the ictal focus is likely to originate from 
the cysticercus zone. Recurrent seizures might cause hippo-
campal damage or dysfunction. In the late nodular calcified 
stage the cysticercus zone becomes less active and but dam-
ages to the mesial temporal structures may lead to acquired 
MTS which becomes the new ictal focus (Fig. 10.19).
Rasmussen’s encephalitis is a presumably autoimmune 
mediated chronic inflammation of the brain that presents 
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Fig. 10.17 (a, b) Hypothalamic hamartoma. (a) Coronal T2 with a lobular mass close to the left wall of the third ventricle. (b) Axial T1 with gado-
linium detects no contrast enhancement in the mass
a b c
Fig. 10.18 (a–c) Cavernoma in the right frontal lobe with an associ-
ated DVA. (a) axial T2 shows the superficial lesion with heterogenous 
signal; (b) axial T1 with gadolinium shows an associated vascular 
structure, a DVA; (c) axial SWAN-sequence. This susceptibility sensi-
tive sequence shows the classical blooming artifact of the blood prod-
ucts within the cavernoma
with progressive gliosis and volume loss. Patients experience 
seizures and a progressive hemiparesis.
Antero-basal temporal lobe encephaloceles are lesions 
that are either related to a congenital defect of the bone or to 
previous trauma. Brain tissue can extend into the pterygo-
palatine fossa through the bony defect at the base of the 
greater sphenoid wing in the region of the foramen rotundum 
and pterygoid process. The herniated brain demonstrates 
high T2/FLAIR signal and is believed to be the epileptogenic 
focus. Following resection of the abnormal brain tissue sei-
zure freedom can be obtained in a very large proportion of 
cases.




Fig. 10.19 Nodular calcified neurocysticercosis in the left hippocam-
pus leading to acquired MTS. (a–c) Coronal T2 images show a small 
circumscribed hypointense lesion in the left hippocampal head with 
associated significant volume of the left hippocampus and obscuration 
of the internal hippocampal architecture. (d, e) SWI and phase image 
show positive phase shift suggestive presence of calcification. (f) CT 
scan confirms the calcification
a b c
Fig. 10.20 (a–c) Tuberous sclerosis; (a) axial T2 and (b) coronal 
T2FLAIR show subependymal hamartomas and widespread cortical 
and subcortical signal changes; (c) axial T1 with gadolinium with a 
large giant cell astrocytoma in a classical position, close to the foramen 
of Monroe in the left lateral ventricle
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The two phakomatoses commonly associated with sei-
zures are tuberous sclerosis and Sturge–Weber syndrome. In 
tuberous sclerosis, multiple hamartomas are present within 
the cortical/subcortical region (Fig. 10.20). These are similar 
in histology to the FCD type II and are therefore believed to 
be epileptogenic. In addition, patients may develop subepen-
dymal calcification as well as a subependymal giant cell 
astrocytoma; however, the latter two lesions are not believed 
to be epileptogenic. In Sturge–Weber syndrome the cortical 
calcification as well as the pial angiomatosis along the cortex 
is presumably related to the seizures. In addition, patients 
may present with choroid plexus hypertrophy and brain 
hemiatrophy as well as a facial port-wine stain (Fig. 10.21).
10.2  Conclusion
Neuroimaging in patients with refractory epilepsy will find 
abnormalities in as high as 85% of cases and therefore plays 
a crucial role in the identification of epileptogenic lesions 
and their possible surgical removal. A dedicated epilepsy 
protocol is necessary to identify these lesions and the MR 
should be interpreted in conjunction with EEG, MEG, neu-
ropsychological testing, and clinical semiological data to 
increase the likelihood of identifying these often very subtle 
lesions.
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11.1  Dementia: A Syndrome, Not a Disease
Dementia is an acquired syndrome in which a person suffers 
from progressive impairment in one of the following six cog-
nitive domains: complex attention, executive function, learn-
ing and memory, language, perceptual-motor function, and/
or social cognition. These cognitive deficits cannot be attrib-
uted to another mental disorder (e.g., depression or schizo-
phrenia) and must be severe enough to interfere with 
independent daily functioning to be classified as a “major 
neurocognitive disorder” (major NCD) according to the 
DSM-V 2013 edition [1]. This new choice in terminology in 
the DSM-V was chosen in order to be able to also define a 
“mild neurocognitive disorder” (equivalent to mild cognitive 
impairment (MCI) and/or prodromal dementia), with the key 
distinction that persons with mild NCD remain independent 
in daily functioning. This shift to diagnose NCD as early as 
possible stems from the understanding that these diseases 
have a long prodromal phase, in which early diagnosis and 
early treatment may have beneficial effects. Importantly, 
mild NCD is not always a precursor to major NCD (demen-
tia), and the diagnosis does not require further decline.
The syndrome of dementia has a multitude of underlying 
causes and the diagnostic work-up is primarily aimed at 
identifying these and to assign a “subtype.” The clinical 
work-up relies heavily on history taking, clinical and neuro-
psychological (cognitive) assessment and can be comple-
mented by a number of ancillary tests, of which neuroimaging 
is one of the most important.
11.2  Dementia: Population Prevalence 
and Subtype Proportions
Due to the aging of populations worldwide, the absolute num-
ber of cases of dementia is estimated to double worldwide 
between 2020 and 2040, to a staggering 81 million over the 
age of 60 living with dementia in the year 2040, with the 
highest rise in developing countries [2]. Pooled prevalence 
data of 11 European population-based studies published in 
2000 showed the following estimates of prevalence of demen-
tia in the elderly (>65  years): age-standardized prevalence 
was 6.4% for dementia (all causes), 4.4% for Alzheimer’s dis-
ease (AD), and 1.6% for vascular dementia (VaD). Prevalence 
of dementia was higher in women than in men and nearly 
doubled with every 5 years increase of age: from 0.8% in the 
group age 65–69 years to 28.5% over the age of 90 years [3].
In the elderly, the most common underlying cause (or 
subtype) of dementia is Alzheimer’s disease (45–54%), fol-
lowed by vascular dementia (14–16%), Lewy body (5%), 
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• Understanding that dementia is a clinical syndrome 
with a variety of underlying pathologies or subtypes 
(varying by age of presentation of the patient); and 
that neuroimaging plays an important role in guid-
ing clinical diagnostic assessment.
• Gaining insight into the distinction between imaging find-
ings in “normal aging” versus those in neurodegeneration.
• Being able to list the most typical imaging findings 
of the most common subtypes of dementia.
• Acquiring knowledge on the recommended imag-
ing protocol in the memory clinic setting as well as 
the elements essential for the radiological report.
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frontotemporal dementia (2%), and alcohol induced demen-
tia (0.7%) [4, 5] (Fig. 11.1).
It is important to realize that in early onset dementia 
(<65 years), these subtype proportions differ, with the primary 
clinical subtypes still being Alzheimer’s disease (18–34%) 
and vascular dementia (13–18%), but now with a much higher 
proportion of frontotemporal dementia (11–12%) [6, 7]. Also 
other causes such as alcohol-related dementia (9–18%), trau-
matic brain injury, Huntington’s disease, and HIV-related 
dementia are more prevalent in early onset dementia versus 
late onset (Fig.  11.1). Due to the fact that younger patients 
(<65 years) more often have alternative diagnoses or a genetic 
cause of dementia, imaging plays an even more important role 
in this group to aid clinical diagnosis, in particular since differ-
ent subtypes bring about different prognostic consequences.
It is crucial to understand that in many cases, especially in 
the elderly, there are multiple causative factors, of which a 
combination of Alzheimer pathology and vascular pathology 
is one of the most prominent (“mixed pathology,” not yet 
indicated in Fig. 11.1 but in late onset dementia responsible 
for up to 30–40% of dementias) [8]. This should be recog-
nized in the diagnosis and should be kept in mind when read-
ing imaging exams of memory clinic patients.
Furthermore, the proportion of subtypes differ according 
to autopsy versus clinical diagnosis [9] indicating that cur-
rent clinical criteria for subtyping dementia may not ade-
quately capture the true underlying pathology. This is also 
the reason why in the field of research, biomarkers have 
become an essential component which have also been incor-
porated in new, unbiased descriptive classification schemes 
that do not specify disease labels. One of these is the “A/T/N” 
system [10], in which seven major AD biomarkers are used 
to define three binary categories for presence/absence of 
these markers (amyloid in PET or CSF (“A”); tau on PET or 
in CSF (“T”) or neurodegeneration on FDG PET, MRI, or 
CSF total tau (“N”)). Each biomarker category is rated as 
positive or negative. An individual score might, for example, 
appear as A+/T+/N−, or A+/T−/N−, etc. Given the present 
lack of consensus among AD specialists on terminology 
across the clinically normal to dementia spectrum, a bio-
marker classification scheme will have broadest acceptance 
if it is independent from any clinically defined diagnostic 
scheme. Though such a biomarker-based classification will 
not be implemented in clinical practice in the short term, it is 
important for radiologists to be aware of the shifting views in 
the field on traditional disease labels.
Fig. 11.1 Subtype proportions of dementia according to age of onset. Adapted from van der Flier and Scheltens [5]
Key Points
• Dementia is a syndrome with a multitude of under-
lying causes, the proportions of these differ for 
early onset (<65 years) versus late onset dementia.
• Alzheimer’s disease and vascular dementia are at all 
ages the most common subtypes according to clinical 
 diagnosis, but neuropathology studies show a very 
high proportion of mixed pathology (AD pathol-
ogy + vascular pathology), up to 30–40% in old age.
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11.3  Dementia: Role of Neuroimaging
Neuroimaging is one of the most important ancillary tests in 
the clinical work-up of a patient suspected of dementia. The 
primary aim of imaging used to be the exclusion of treatable 
causes of cognitive impairment (such as subdural hemato-
mas, brain tumors, or normal pressure hydrocephalus), but 
imaging is increasingly helpful in the identification of under-
lying causes of dementia. Though for the majority of dis-
eases causing dementia, no specific imaging criteria have 
been formulated in the clinical diagnostic criteria, it is nota-
ble that more recent revisions of criteria are increasingly 
including imaging (for positive as well as negative predictive 
value) [11].
Though Alzheimer’s disease is at any age the most preva-
lent dementia subtype, the most important differential diag-
noses of AD, depending on age of onset, are vascular 
dementia (VaD), FTD, non-fluent and semantic subtypes of 
primary progressive aphasia (PPA), dementia with Lewy 
bodies (DLB), and Creutzfeldt–Jakob disease (CJD). 
Especially in the early stages of the disease, when symptoms 
are often unspecific, differential diagnosis may be challeng-
ing. Accurate differentiation between the several types of 
dementia, however, is of especially great relevance in the 
early stages, when most can be gained in terms of symptom 
reduction, informing the patient on the prognosis and 
increased quality of life. Also, early and accurate differentia-
tion is important for inclusion into clinical drug trials and 
therapy evaluation in a trial setting. Neuroimaging may play 
an important role in this regard.
11.4  Dementia Versus Normal Aging
This section contains text extracts that are reprinted with per-
mission from Vernooij and Barkhof [12].
In the evaluation of brain imaging in a memory clinic set-
ting, knowledge on the background of “normal” brain aging 
and its associated changes is important but often overlooked. 
Autopsy studies in brains of aged people without neurologi-
cal disease invariably show the presence of plaques, tangles, 
Lewy bodies, and neuronal loss. These are pathological find-
ings that are also considered hallmarks of neurodegenerative 
diseases, but are more abundantly present and regionally 
clustered in those diseases. This observation that almost all 
aged brains show characteristic changes that are strongly 
linked to neurodegeneration has led to the hypothesis that 
normal brain aging and neurodegenerative diseases form a 
continuum, and that pathological neurodegeneration perhaps 
is an expression of accelerated aging. Though this is likely a 
too simplified view, it is a fact that there is considerable over-
lap between patterns of brain pathology in aging and neuro-
degenerative disease and that knowledge on changes in brain 
aging is indispensable as a background against which to 
evaluate neurodegenerative disease.
The most important imaging findings in aging which 
overlap with those found in neurodegenerative diseases 
are brain atrophy and imaging markers of small vessel 
disease. Below we describe shortly those findings in the 
age-related setting, and when these can still be considered 
normal for aging or when they can provide an explanation 
for dementia.
11.4.1  Brain Atrophy in Aging
Regarding brain atrophy, there is consistent evidence that 
brain volume declines with aging, and that age-related vol-
ume loss appears as early as the age of 30 (0.2% loss of total 
brain volume per year), and accelerates after the age of 70 up 
to 0.5% total brain volume loss per year (5% per decade) in 
cognitively healthy elderly [13]. At the age of 75, this roughly 
equates to a 10% brain volume loss, which is readily appre-
ciable to the naked eye (Fig. 11.2).
The most important rules of thumb to distinguish atrophy 
in aging from neurodegeneration are that age-related brain 
atrophy is generally symmetric and generalized, whereas in 
neurodegeneration we see specific lobar patterns (further 
described below) and can see asymmetries. Semi-quantitative 
visual rating scales such as the global cortical atrophy scale 
(GCA) and medial temporal atrophy scale (MTA) (Tables 
11.1 and 11.2, Figs. 11.3 and 11.4) are be helpful to distin-
guish “normal” from “abnormal” based on a visual assess-
ment. Though these scales are quite crude and not sensitive 
to subtle or longitudinal changes, they have consistently 
been shown to correlate well with pathology data and with 
volumetric assessments and are easy to use in everyday clini-
cal practice.
Yet, without absolute quantification it is very hard to 
assess what “normal” or even “expected” is for a specific age 
and sex, in particular when assessing atrophy on a regional 
or substructure level. Advances are being made in image 
analysis algorithms to perform fully automated tissue and 
structure quantification on individual level scans and com-
pare these to normative databases, in order to aid everyday 
radiology assessments (Fig. 11.2).
On visual rating, asymmetry and focal brain atrophy 
should be considered abnormal, as is a GCA score of 3 
(“knife-blading”) in all persons or a score of 2 (clear gyral 
shrinking) in persons aged <75 years.
In individuals until age 75 years, the cutoff for abnor-
mal MTA lies at an average of ≥1.5, i.e., having a score of 
2 (or higher) on one side is considered abnormal. In those 
over age 75 years, having an MTA score of 2 (or higher) 




Fig. 11.2 Automated volumetry in the memory clinic. Screenshot example showing brain tissue volumetric results and application of reference 
curves to assess individual brain atrophy. (Reprinted with permission from Vernooij and Barkhof [12])
Table 11.1 Visual rating scale of global cortical atrophy (GCA)
Degree of atrophy Gyri Sulci
GCA = 0 No Normal volume Normal 
width
GCA = 1 Mild (may be 





GCA = 2 Moderate Reduced Enlarged




Data from Pasquier et al. [14]
Table 11.2 Visual rating scale of medial temporal lobe atrophy (MTA)
Choroid fissure Temporal horn
Hippocampal 
height
MTA = 0 Normal Normal Normal








MTA = 4 Severely widened Severely widened Severely reduced
Data from Scheltens et al. [15]
Fig. 11.3 Global cortical atrophy scale. Illustration showing the differ-
ent categories on the GCA scale (see also Table 11.1): no atrophy in the 
parietal lobe (GCA 0), some opening of sulci (GCA 1), reduced volume 
of gyri and further widening of sulci (GCA 2), and severe volume 
reduction (knife-blading) in the left parietal lobe (GCA 3)
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11.4.2  Vascular pathology in aging
Vascular pathology commonly seen in aging and which may 
overlap with vascular pathology in mild and major NCD, are 
white matter hyperintensities (MH), silent brain infarcts 
(usually lacunes), and cerebral microbleeds.
Studies in community-dwelling subjects have shown that 
after the age of 45 years, only 5–10% of persons are com-
pletely free of WMH, and that their presence and volume 
increase steeply with age. Large observational studies have 
provided compelling evidence of links of WMH with risk of 
stroke, dementia, cognitive dysfunction (in particular execu-
tive function and information processing speed), gait distur-
bance, and falls as well as depression. All of these 
observations have led to WMH being considered an expres-
sion of cerebral small vessel disease and not an innocuous 
finding, especially when larger in volume. In everyday clini-
cal practice, standardized visual rating scales such as the 
Fazekas scale as described in Fig. 11.5 can be applied. Due 
to ease of use, this scale shows very high intra- and inter- 
rater reliability. In general, a Fazekas score of 1 can be con-
sidered normal, whereas scores 2 and 3 indicate the presence 
of small vessel disease. A score of 3 is abnormal at any age, 
and found both in frontal and parietal lobes, is indicative of a 
large % (>25%) of white matter being pathologic and con-
tributes to the clinical criteria for vascular dementia.
Silent brain infarctions are highly frequent in asymptom-
atic aging individuals, with prevalence estimates ranging 
from 8% to as high as 28% and increase with age [18]. Most 
of these infarcts are lacunes in the basal ganglia or deep 
white matter, presumed to be caused by underlying hyperten-
sive small-vessel disease or small emboli. Although by defi-
nition silent infarcts go without overt clinical symptoms, 
there is compelling evidence that they are associated with 
subtle deficits in physical and cognitive function [18]. 
Moreover, the presence of silent infarcts, both lacunes and 
microinfarcts, more than doubles the risk of stroke and 
dementia, especially when multiple lesions are present.
Microbleeds, visible as hypointense focal lesions on T2∗-
weighted sequences susceptible to the paramagnetic proper-
ties of blood-break down products, are thought to represent 
small chronic hemorrhages caused by damaged small vessels. 
Fig. 11.4 Medial temporal atrophy scale. Coronal T1-weighted images 
of the hippocampus for stages 0–4 of the MTA rating scale (see 
Table  11.2). Note progressive widening of the choroid fissure (from 
stage 1 onwards) and temporal horn (from stage 2 onwards), as well as 
hippocampal body volume loss (stages 3 and 4). (Reprinted with per-
mission from Vernooij and Smits [16]. Copyright Elsevier (2012))
Fig. 11.5 Fazekas scale for white matter lesions. From left to right, Fazekas scale 1 (punctiform lesions), 2 (early confluent lesions), and 3 (con-
fluent lesions) (not shown: score 0 = no lesions). (Reprinted with permission from Vernooij and Smits [16]. Copyright Elsevier (2012))
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Population cohorts in healthy elderly describe prevalence esti-
mates ranging from 5 to 30%, with increasing prevalence with 
age, but also with magnetic field strength, hindering easy com-
parison between populations or pooling of results. The topo-
graphic distribution of microbleeds is thought to reflect the 
type of underlying vasculopathy. Lobar microbleeds, espe-
cially those that are multiple and strictly lobar (cortico-subcor-
tical junction of cerebral lobes) in location, are presumed to be 
caused by amyloid angiopathy, whereas deep microbleeds 
(basal ganglia, thalamus, brainstem, cerebellum) reflect hyper-
tensive arteriopathy. Generally, a single microbleed in any 
brain location can be considered to be not of clinical relevance. 
However, having multiple (two or more) microbleeds in 
strictly lobar brain locations in a person aged over 55 years 
without other causes for microbleeds (e.g., previous radiother-
apy, head trauma) classifies as “probable CAA” according to 
the Boston criteria. Due to the frequent co-occurrence of CAA 
and AD pathology, multiple lobar microbleeds can often be 
observed in patients fulfilling the clinical criteria of AD. The 
clinical diagnosis of CAA is further supported if superficial 
siderosis is also present (see Fig. 11.6). Similarly, having mul-
tiple microbleeds in deep brain locations or in the brainstem 
should trigger the presence of hypertensive arteriolosclerosis. 
Cerebellar microbleeds can occur both in the context of CAA 
or hypertension and thus are not contributing meaningfully to 
differential diagnosis.
11.5  Imaging Characteristics of Most 
Common Subtypes of Dementia
This section contains text extracts from Vernooij and 
Smits [16]. Copyright Elsevier (2012); reprinted with 
permission.
11.5.1  Typical Imaging Presentation 
of Alzheimer’s Disease
The radiological hallmark finding of AD is cortical atrophy 
due to neuronal degeneration and loss. Atrophy is diffuse, 
but more prominent in the temporal and parietal lobes with 
the hippocampus most severely, and disproportionately 
Fig. 11.6 Superficial 
siderosis and lobar 
microbleeds. T2∗ gradient- 
echo images (or 
susceptibility-weighted 
images) showing linear 
hypointensity on the cortical 
surface (left), compatible with 
superficial siderosis, and 
multiple focal hypointensities 
in the brain parenchyma in a 




• The aging brain shows characteristic changes that 
are strongly linked to neurodegeneration.
• On visual rating, asymmetry and focal brain atrophy 
should be considered abnormal, as is a GCA score 
of 3 (“knife-blading”) in all persons or a score of 2 
(clear gyral shrinking) in persons aged <75 years.
• In individuals up to 75 years, an MTA score of 2 or 
higher on one side is abnormal, whereas in persons 
over the age of 75, a score of 2 or higher on both 
sides is considered abnormal.
• A Fazekas score of 2 or 3 is indicative of underlying 
small vessel disease.
• Silent brain infarcts, even though very frequent in 
aging subjects, more than double the risk of stroke 
and dementia and should be considered as indica-
tive of small vessel disease.
• Microbleeds in lobar, deep, or cerebellar locations 
occur frequently in old age (up to 30%). Generally, a 
single microbleed is considered not relevant, whereas 
the presence of multiple microbleeds raises suspicion 
of underlying cerebral amyloid angiopathy (when 
strictly lobar in location) or hypertensive arteriopathy 
(when deep or in brainstem).
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affected (Fig. 11.7). The primary motor and sensory cortices 
are relatively spared until late in the disease. Findings are 
bilateral and generally symmetrical, but a certain degree of 
asymmetry may occur.
Sensitivity and specificity to use MTA in distinguishing 
patients with AD from healthy controls are in the range of 85 
and 88%, respectively. Note that hippocampal atrophy is also 
common in other types of dementia, such as dementia with 
Lewy bodies, frontotemporal dementia, and the Heidenhain 
variant of Creutzfeldt–Jakob disease. Consequently, diag-
nostic accuracy to distinguish AD from other dementia is 
considerably lower than from healthy controls.
Asymmetry of the hippocampus does not exclude AD, 
although marked asymmetry suggests alternative diag-
nosis, most notably frontotemporal dementia (FTD, see 
further).
11.5.2  Atypical Presentation of Alzheimer’s 
Disease
Distinctly different patterns of brain atrophy from typical 
AD may be observed in patients with the so-called atypical 
AD. These are often patients without the APOE ε4 genotype 
or those presenting below the age of 65  years. In these 
patients, hippocampal atrophy, the hallmark finding in typi-
cal AD, is far less prominent and may even be absent. These 
syndromes include posterior cortical atrophy (PCA) and 
logopenic progressive aphasia (LPA), both being associated 
with a posterior pattern of atrophy. One of the areas that is 
primarily affected in early onset AD is the precuneus 
(Fig. 11.8).
Patients with posterior cortical atrophy have an early and 
prominent impairment of visual and visuospatial skills with 
Fig. 11.7 Typical atrophy 
pattern in AD. Seventy-year- 
old female with clinical 
dementia. Coronal 
T1-weighted images show 
bilateral hippocampal atrophy 
(MTA 3 both sides, panels 1 
and 2) and axial T1-weighted 
image shows bilateral 
symmetric cortical atrophy, 
most prominent in parietal 
lobes. This pattern is typical 
for atrophy in (late onset) 
Alzheimer’s disease
Fig. 11.8 Posterior cortical 
atrophy (precuneus atrophy) 
in atypical AD. Fifty-six-year- 
old female with clinical 
dementia. Sagittal 
T1-weighted image shows 
precuneus atrophy (and 
widening of the parieto- 
occipital sulcus), whereas 
there is a normal hippocampal 
volume on coronal 
T1-weighted image (MTA 1). 
This pattern is typical for 
posterior cortical atrophy in 




less prominent memory loss and show associated atrophy of 
the parieto-occipital and posterior temporal cortices. Atrophy 
is generally asymmetrical, the right hemisphere being more 
affected than the left. Though the underlying pathological 
substrate may differ, Alzheimer pathology was found to be 
most prevalent in these patients.
Logopenic progressive aphasia has been described as a 
clinically, neuropathologically, and radiologically distinct sub-
type of primary progressive aphasia (PPA, see more informa-
tion in Sect. 11.5.4). The syndrome is characterized by language 
disorders rather than memory impairment, which consists of 
slow speech and deficits in sentence repetition. On brain imag-
ing there is marked asymmetrical atrophy of the posterior tem-
poral cortex, including the posterior superior and middle 
temporal gyri, and the inferior parietal lobule, with the left 
hemisphere more affected than right. Clinically, LPA is diffi-
cult to distinguish from the other PPA subtypes, which have 
predominantly underlying FTD pathology. Structural brain 
imaging plays an important role in differential diagnosis.
11.5.3  Frontotemporal Dementia (FTD)
FTD is in particular in patients under the age of 65 years a fre-
quent occurring cause of dementia, occurring in up to 12–15% 
of early onset dementia. While also characterized by neuronal 
loss, FTD is histopathologically distinct from AD due to the 
presence of tau-positive or ubiquitin-positive inclusions. The 
three main variants are the behavioral or frontal variant (bv-
FTD; 40%), progressive non-fluent aphasia (PNFA; 20%), and 
semantic dementia (SD; 40%). The latter two are clinically 
characterized by a predominance of language impairment and 
considered subtypes of primary progressive aphasia, which is 
discussed separately below (Fig. 11.9).
Brain imaging in bv-FTD shows frontal and temporal corti-
cal atrophy with an anterior to posterior gradient, which is 
bilateral and may be asymmetrical. There may be associated 
white matter hyperintensities on T2-weighted/T2-FLAIR 
imaging. Atrophy of the frontal lobe, especially if there is con-
current atrophy of the caudate head, results in disproportionate 
widening of the frontal horns of the lateral ventricles. In the 
early stages widening of the sulci in the orbitofrontal region 
may be seen as an early manifestation of orbital frontal atrophy. 
Compared with AD, medial temporal lobe atrophy in FTD is 
more pronounced anteriorly and more asymmetrical.
11.5.4  Primary Progressive Aphasia
PPA is a slowly progressive impairment of language, with 
three subtypes: logopenic progressive aphasia (LPA) (com-
monly AD pathology, see Sect. 11.5.2), PNFA, and SD (the 
latter two mainly FTD pathology).
Patients with PNFA have slow, effortful speech with 
errors in the production of speech sounds and grammatical 
deficits. On brain imaging, atrophy is seen in the anterior 
perisylvian region, involving the inferior, opercular, and 
insular regions, with a left-hemispheric predominance.
SD is clinically characterized by impairment of semantic 
performance. Brain imaging shows atrophy of the ventral 
and lateral regions of the anterior temporal lobes, including 
the anterior hippocampus and the amygdala. Again, atrophy 
is often asymmetrical with the left hemisphere more affected 
than the right, and there is an anterior to posterior gradient.
11.5.5  Vascular Dementia
In the elderly, cerebrovascular disease is the second most com-
mon pathology underlying dementia after AD. VaD is a hetero-
geneous entity, including both large and small vessel disease, 
and involving the gray and/or white matter. By far the most 
common underlying pathology is small vessel disease, leading 
to diffuse confluent white matter changes and multiple lacunar 
infarcts of the deep white and (notably the thalamic) gray mat-
ter. Typically, the subcortical U-fibers are spared. When infarc-
tion of the deep perforating arteries is complete, lacunar infarcts 
occur, which are visualized on MRI as small lesions with signal 
intensity of CSF on all sequences, surrounded by a rim of 
T2-weighted hyperintensity. A multilacunar state is also known 
as “état lacunaire,” not to be confused with “état criblé,” which 
is the term used for multiple enlarged perivascular spaces in the 
basal ganglia. Both states are considered pathological and man-
ifestations of small vessel disease. Large vessel disease mani-
fests as multiple (strategic infarcts.
Since cerebrovascular changes are common in healthy 
elderly, as outlined earlier in this chapter, there are strict cri-
teria to diagnose VaD set out by the National Institute of 
Neurological Disorders and Stroke and Association 
Internationale pour la Recherché et l’Enseignement en 
Neurosciences (NINDS-AIREN) [19]. A patient must meet 








Fig. 11.9 Clinical subtypes of frontotemporal dementia
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brovascular disease on clinical examination and on imaging, 
and there has to be a temporal relationship between the onset 
of dementia and cerebrovascular disease.
Radiological criteria are crucial to diagnosis and specified 
in detail:
• Confluent white matter lesions need to involve at least 25% 
of the total white matter to reach the diagnosis of VaD.
• Lacunar infarcts need to involve multiple basal ganglia 
and the frontal white matter, and thalamic lesions need to 
be bilateral.
• Strategic—large vessel—infarcts meet the criteria when 
they involve the following territories: bilateral anterior 
cerebral artery, paramedian thalamic, inferior medial tem-
poral lobe, parieto-temporal and temporo-occipital asso-
ciation areas and angular gyrus, superior frontal and 
parietal watershed areas in the dominant hemisphere.
There seems to be a complex interrelationship between AD 
and cerebrovascular disease that extends beyond the co- 
existence of these two disease processes. Cerebrovascular dis-
ease and AD often coexist, while stroke often exacerbates 
pre-existing, sometimes previously subclinical, pathology. 
Furthermore, AD and VaD share common risk factors, such as 
diabetes and hypertension, as well as genetic factors for brain 
tissue vulnerability (presenilins, amyloid precursor protein, 
APOE genes). Microbleeds, considered to be a manifestation of 
cerebral amyloid angiopathy (CAA), are seen at high frequency 
in patients with AD. CAA is a microangiopathy with β-amyloid 
deposition in the vessel walls. On brain imaging, the presence of 
two or more microbleeds in a lobar distribution is suggestive of 
CAA, while other features include subpial siderosis and evi-
dence of past lobar hemorrhage. Although sporadic CAA is 
commonly seen in the elderly, being the leading cause of lobar 
hemorrhage, in its severe form it is also recognized as a risk fac-
tor for dementia. This typically constitutes a subcortical vascu-
lar dementia, but severe CAA is also considered a feature of 
AD, sharing the APOE ε4 allele as a common risk factor.
11.5.6  Dementia with Lewy Bodies (DLB)
DLB is clinically distinguished from AD by the presence of 
visually hallucinations, which occur in 80% of cases. Visual 
hallucinations may, however, also occur in AD.  On brain 
MRI, there is medial temporal lobe and global cortical atro-
phy with relative sparing of the primary motor and sensory 
cortex, as is seen in AD.  Atrophy, however, is less pro-
nounced than in AD when the severity of disease is taken into 
account. In the early stages of the disease, medial temporal 
lobe volume may be preserved. Similar to AD, hyperinten-
sity of the white matter on T2-weighted images is seen at 
higher frequency in DLB than in healthy controls.
11.5.7  Creutzfeldt–Jakob Disease
Sporadic CJD, accounting for 85–90% of cases, generally 
presents as a subacute dementia syndrome between the ages 
of 50 and 70 years. Rapid progression and concomitant focal 
neurological deficits and myoclonus will clinically distin-
guish CJD from AD during the course of the disease, but 
initially cognitive symptoms may be similar. Brain MRI 
typically shows marked hyperintensity on T2-weighted 
sequences bilaterally in the caudate nucleus and the puta-
men, and to a lesser extent in the thalamus and neocortex. 
Diffusion weighted imaging, showing restricted diffusion in 
the affected gray matter, seems to be the most sensitive 
sequence to detect CJD-related abnormalities (Table 11.3).
Table 11.3 Summary of structural MR imaging findings for the most 
common dementia subtypes
Typical Alzheimer’s disease
 •  Disproportionate hippocampal atrophy with temporoparietal 
atrophy
 • Relative sparing of the primary motor and sensory cortex
 • Bilateral, more or less symmetrical
 • Microbleeds in a lobar, subcortical distribution
Atypical Alzheimer‘s disease
 • No or little hippocampal atrophy
 • Focal cortical atrophy
    – Precuneus: early onset AD
    – Parieto-occipital and posterior temporal lobe: PCA
    – Posterior temporal cortex and the inferior parietal lobule: LPA
Frontotemporal dementia
 •  Bilateral frontal and temporal atrophy with anterior to posterior 
gradient
   – Left more than right anterior perisylvian region: PNFA
   – Left more than right ventrolateral temporal region: SD
 •  (Asymmetrical) hippocampal atrophy, more pronounced 
anteriorly
 • Disproportionate widening of the frontal horns: Bv-FTD
 • Relative sparing of the parietal and occipital lobes
Creutzfeldt–Jakob disease
 •  T2-hyperintensity and diffusion restriction bilaterally in the 
caudate nucleus and putamen, and to a lesser extent in the 
thalamus and neocortex
Dementia with Lewy bodies
 • Medial temporal lobe and global cortical atrophy
 • Relative sparing of the primary motor and sensory cortex
 • Less extensive than AD when accounting for disease severity
From Vernooij and Smits [16]; reprinted with permission
Key Point
• Structural neuroimaging can help identify underly-
ing causes of dementia through the identification of 
patterns of atrophy (including symmetry and lobar 




11.6  Other Dementia Causes
11.6.1  Normal Pressure Hydrocephalus (NPH)
NPH is still a poorly understood disease which seems to 
result from a disbalance in CSF production and resorption, 
though an alternative hypothesis is that periventricular white 
matter damage is a causative factor. The clinical picture is 
typically characterized by a triad of gait apraxia, dementia, 
and urinary incontinence; yet, this full trias is only present in 
less than 33% of patients. NPH is uncommon under the age of 
60 years, and increases in frequency thereafter. As the name 
suggests, CSF pressure on lumbar puncture is in the normal 
range. Regardless of underlying etiology, in a number of 
patients with NPH the clinical symptoms improve with CSF 
shunting, making this a potentially treatable cause of 
dementia.
The imaging diagnosis of NPH is challenging. Most strik-
ing is the widening of the central CSF spaces (in particular 
the lateral and third ventricle), with a marked discrepancy 
between ventricular width and sulcal width. In other words, 
the ventricular widening cannot be explained by the amount 
of brain atrophy. A disproportionate widening of the Sylvian 
fissure can be seen in comparison to the other sulci which 
appear rather small (Fig.  11.10). Also, some sulci may 
focally dilate over the convexity or medial surface (“trans-
port sulci”). As the ventricles enlarge, shearing forces are 
exerted on the white matter, causing in particular the medial 
lying fibers of the corticospinal tract to be damaged, hence 
leading to the gait disturbance. This is on imaging exempli-
fied by sharpening of the callosal angle (normal 100–120°, in 
NPH 50–80°) and upward bowing of the corpus callosum, 
leading to tight high convexity sulci at the vertex and the 
parafalcine region.
11.6.2  Corticobasal Syndrome (CBS)
Corticobasal syndrome is characterized by asymmetric 
involuntary movements (rigidity, tremor, myoclonus) and 
apraxia and alien limb phenomena. Additionally, many 
patients show cognitive deficits or dementia. CBS has sev-
eral distinct histopathologies, including corticobasal degen-
eration (tauopathy, related to FTD), and Alzheimer’s 
disease.
Progressive supranuclear palsy, and DLB. While there are 
no specific imaging findings, CBS with underlying AD 
pathology usually shows posterior temporal and inferior 
parietal atrophy, whereas focal atrophy in the premotor 
 cortex or supplemental motor area (often asymmetric) may 
suggest CBD [20].
11.6.3  Overlap Between Dementia 
and Movement Disorders
There is an overlap between dementia and movement disor-
ders. Parkinson’s disease, as the most common neurodegen-
erative movement disorder, has a cumulative prevalence of 
dementia of 75–90% (PD-dementia or PDD). Cognitive dys-
function or dementia is also common in several other move-
ment disorders such as atypical parkinsonism: PSP, DLB, 
and CBS (see Sect. 11.6.2). Among hyperkinetic disorders, 
Huntington’s disease, spinocerebellar ataxia, and Wilson’s 
disease are best known for their cognitive correlates. Imaging 
findings are usually dominated by the typical pattern of 
imaging findings associated with the movement disorder. In 
some patients cognitive decline may be the dominant clinical 
manifestation, notably during early stages of the disease, 
putting a larger emphasis on neuroimaging to aid in the clini-
cal diagnosis.
11.7  Recommended MR Imaging Protocol 
in Patients Suspected for Dementia
The description of imaging findings for the various subtypes 
above means that the first aims in the imaging evaluation of 
a patient suspected for dementia should be:
Fig. 11.10 Normal pressure hydrocephalus. Seventy-year-old male 
with cognitive problems and gait imbalance. MRI shows widening of 
central CSF spaces, a disproportionate widening of Sylvian fissures 
relative to other sulci, and crowding of gyri at the vertex/parafalcine 
region. Corpus callosum angle, measured at the level of the posterior 
commissure, is 78° (normal > 100°)
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 (a) To assess the extent and pattern of brain atrophy, in par-
ticular lobar cortical atrophy (with GCA) and medial 
temporal lobe atrophy (MTA; for evidence of Alzheimer’s 
pathology);
 (b) To determine the degree of vascular damage, including 
the occurrence of strategic vascular lesions.
We recommend that the MRI scanning protocol includes 
T1-weighted, T2-weighted, T2-FLAIR, diffusion weighted, 
and T2∗-weighted sequences (Table 11.4). Routine applica-
tion of contrast is not indicated, although it may be needed 
in atypical cases when granulomatous disease, vasculitis, 
and infection are considered as differential diagnoses. 3D 
T1-weighted images should be reconstructed in a coronal 
plane perpendicular to the long axis of the hippocampus for 
adequate assessment of medial temporal atrophy.
11.8  Reporting Findings in Dementia
Reporting MRI findings in dementia includes both those 
pointing towards the pathology underlying the dementia syn-
drome and those suggesting an alternative cause of neuro-
cognitive degeneration. The latter would include focal 
abnormalities such as brain tumor or subdural hematoma. 
The hippocampus needs to be scrutinized for signal abnor-
mality on T2-weighted sequences to diagnose ischemia or 
sclerosis. Areas of diffusion restriction may indicate patholo-
gies such as acute ischemia, herpes simplex encephalitis, 
alcoholic encephalopathy, or CJD. T2-weighted hyperinten-
sity in certain brain regions may point to a specific diagnosis, 
such as in the periaqueductal gray or mammillary bodies in 
case of alcoholic encephalopathy.
The radiological report further needs to include a struc-
tured and standardized assessment of the global cortical atro-
phy, the medial temporal lobe and white matter lesion load, 
according to, for instance, the GCA, MTA, and Fazekas 
visual rating scales, respectively (see Tables 11.1 and 11.2, 
Figs. 11.3, 11.4, and 11.5). Atrophy should always be rated 
on the same imaging sequence, preferably the FLAIR or 
T1-weighted sequence. The degree of asymmetry, as well as 
focal regions of atrophy should be reported separately. Both 
the number and distribution of microbleeds need to be 
reported. Large and small vessel cerebrovascular changes 
need to be specified according to the topographic and sever-
ity operational NINDS-AIREN criteria to enable diagnosis 
of VaD.
11.9  Concluding Remarks
The dementia syndrome encompasses a wide variety of 
underlying causal pathologies, for many of which neuroim-
aging can give additional information in the diagnostic work-
 up. It is important for (neuro)radiologists to read imaging 
exams from memory clinic patients against a background of 
normal aging brain pathology. Patterns of atrophy and 
 vascular lesions can direct towards specific underlying diag-
noses. Standardized image acquisition and structured report-
ing (including the use of semi-quantitative visual rating 
scales) will increase diagnostic yield and facilitate commu-
nication with referring clinicians.
References
 1. Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen 
JS, et  al. Classifying neurocognitive disorders: the DSM-5 
approach. Nat Rev Neurol. 2014;10(11):634–42.
 2. Rizzi L, Rosset I, Roriz-Cruz M.  Global epidemiology of 
dementia: Alzheimer’s and vascular types. Biomed Res Int. 
2014;2014:908915.
 3. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler 
MM, et al. Prevalence of dementia and major subtypes in Europe: 




T1-weighted Assessment of atrophy (GCA, 
MTA)
Coronal plane: hippocampal 
atrophy.
Sagittal plane: precuneus atrophy
2D/3D T2-FLAIR Atrophy, white and gray matter 
signal abnormalities















T2∗-weighted Microbleeds, superficial siderosis
Take Home Messages
• Dementia is a complex clinical syndrome with mul-
tiple underlying causes, of which presentation and 
prevalence differ according to patient demographics.
• Knowledge on typical and less typical imaging pre-
sentations of the various causes of dementia is 
essential in order to exploit the value of neuroimag-
ing in the memory clinic to its full potential.
• Radiologists should perform a standardized imaging 
protocol, which enables both the assessment of pat-
terns of atrophy and vascular lesions, and employ a 
systematic assessment (using semi-quantitative visual 
rating scales) in order to improve diagnostic yield.
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• To know the imaging appearance of the most fre-
quent cranial nerve lesions and be aware of associ-
ated CN disorders
• To understand that different lesions can be found on 
the different anatomical segments of the cranial 
nerves (intraaxial, extraaxial intracranial, extracra-
nial) and that dedicated imaging techniques are 
needed to investigate these different segments and 
various pathologies
Key Points
• Intraaxial lesions usually cause multiple CN disor-
ders in association with CNS dysfunctions
• Extraaxial intracranial lesions may cause unique or 
multiple CN disorders with meningeal syndrome 
and intracranial hypertension
• Skull base lesions usually cause unilateral unique or 
multiple CN disorders.
• Extracranial lesions may cause unilateral unique or 
multiple CN disorders with craniocervical objective 
lesions.
• Painful CN disorder may reveal aneurysm and 
dissection
Key Points
• Be aware of clinical history, presentation, and bio-
logical tests for imaging interpretation
• Master CN anatomy including nucleus, apparent 
origin, route, and target
• MRI is the modality of choice to investigate CN 
disorder
• CT is useful to depict calcification and skull lesion
• Add MRA and CTA when painful CN disorder
12.1  Introduction
Cranial nerves (CN) are 12 pairs of symmetrical nerves 
that apparently originate from the cerebrum (I, II) and the 
brainstem (III–XII). Beyond this regional common thread, 
CN imaging encompasses complex anatomical and techni-
cal considerations that need to be known for clinical 
practice.
CN disorders are caused by a wide spectrum of diseases 
and imaging plays a major role in the etiological inquiry and 
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the therapeutic planning. Guided by medical history and 
clinical examination, and completed by neurophysiological 
and biological tests, radiologists have to select the  appropriate 
modalities, to adapt the spatial coverage, and to choose the 
most relevant protocol.
CN imaging has to demonstrate the location of the dis-
ease: into the brain (intraaxial), out of the brain and into the 
skull (extraaxial intracranial), out of the skull (extracranial). 
According to the location, CN imaging allows to suggest 
pathophysiological hypotheses and etiologies including vas-
cular, inflammatory, infectious, tumoral, traumatic, or dys-
functional disorders.
This chapter briefly reviews most common diseases that 
cause CN disorders. Additional details can be found in [1–8].
12.2  Anatomical and Technical Challenges
12.2.1  Anatomical Challenge
The CN anatomy is complex regarding their number, brain 
nuclei and connections, apparent origins, cisternal and foraminal 
courses, end organs. Mastering the CN anatomy and function is 
necessary to investigate CN disorders appropriately (Table 12.1).
Table 12.1 Cranial nerves disorders and apparent routes
CN name Main dysfunctions CNS coverage Skull base coverage Face and neck coverage
I: Olfactory Anosmia Basal forebrain: olfactory 
tracts, bulbs, and striae. Uncus, 
parahippocampal and cingular 
gyri
Anterior skull base: 
cribriform plate
Nasal mucosa







Basal forebrain: optic 
radiation, chiasma, lateral 
geniculate bodies, occipital 
calcarine sulci
Anterior skull base: 
optic canal
Orbit: eye ball retina








Orbit: oculomotor m. (superior, 
medial, inferior recti, inferior 
oblique), levator palpebrae m., 
ciliary m.





V: Trigeminal Facial anesthesia
Trigeminal neuralgia
Pons: anterolateral Middle skull base: 








V3: Jaw, sensory tongue (2/3 ant)





VII: Facial Facial palsy. Hemifacial 
spasm
Medullopontine s. (lat.) Posterior skull base: 
internal auditory 
canal, stylomastoid f.




Hearing loss, tinnitus, 
dizziness
Medullopontine s. (lat.) Posterior skull base: 
internal auditory 
canal








Medulla: retroolivary s. Posterior skull base: 
jugular foramen
Stylopharyngeus m.; sensory tongue 
(1/3 post)
X: Vagus Dysphagia, dysphonia Medulla: retroolivary s. Posterior skull base: 
jugular foramen
Pharyngeal m.
XI: Accessory Impairment of head 
rotation, scapula elevation
Medulla: retroolivary s., lateral 
cervical cord
Posterior skull base: 
jugular foramen
Sternocleidomastoid, trapezius m.
XII: Hypoglossal Palsy of the tongue Medulla: preolivary s. Posterior skull base: 
hypoglossal canal
Tongue muscles
m. muscle, s. sulcus, ant. anterior, lat. lateral, post posterior
A. Krainik and J. W. Casselman
145
Olfactory (I) and optic (II) nerves have both an apparent 
origin from the basal forebrain, passing through the foramina 
of the anterior cranial fossa. Both olfactory and optic nerves 
are tracts of the central nervous system (CNS).
All other CN originate apparently from the brainstem: 
oculomotor (III) and trochlear (IV) nerves from the mid-
brain; trigeminal (V) from the pons; abducens (VI), facial 
(VII), and cochleovestibular (VIII) nerves from the medullo-
pontine sulcus; glossopharyngeal (IX), vagus (X), accessory 
(XI), and hypoglossal (XIII) nerves from the medulla oblon-
gata. CN III–VI merge into the cavernous sinuses and pass 
through the foramina of the middle cranial fossa. CN VII–
XII pass through the foramina of the posterior cranial fossa.
Because of this anatomical distribution of the CN along 
the basal brain, the brainstem, and the skull base, there is a 
close relationship between the lesional location and the 
symptoms. Indeed, CN impairment depends on the location 
of the macroscopic lesion. When unique, distal extracranial 
lesions are associated with specific CN deficit while proxi-
mal intraaxial lesions may cause multiple CN impairment 
with additional central symptoms.
In clinical practice, imaging is used to explain CN impair-
ments related to: (1) intraaxial lesions that compromise 
supranuclear connecting fibers, CN nuclei, and intramedul-
lary fibers; (2) extraaxial intracranial lesions that compro-
mise cisternal and intraforaminal CN fibers; (3) extracranial 
lesions that compromise facial and cervical portions of CN.
Further anatomical and functional details can be found in 
textbooks [3–6].
12.3  Technical Challenge
12.3.1  Conventional Imaging
MRI is the best imaging modality to investigate CN disor-
ders. However, computed tomography (CT) is useful to bet-
ter visualize bone lesion, especially in case of trauma, 
inflammation (abscess) or in patients with compromised air-
ways. CT still offers an immediate availability, a short acqui-
sition time, and a non-magnetic environment.
Based first on the clinical data, MRI protocols have to be 
adjusted on CN regional anatomy by optimizing spatial cov-
erage and selecting most appropriate sequences [2, 8]. 
Complementary contrast media injection has to be justified 
in accordance with the clinical presentation, lesional hypoth-
eses, and initial imaging findings (Table 12.2).
The best way to detect cranial nerve pathology is to com-
pare the size and signal intensity of the paired nerves. Due to 
the course of the cranial nerves this comparison is best 
achieved in the coronal plane for nerves I–VI and in the axial 
plane for nerves VII–XII. However, imaging in both axial and 
coronal planes decreases the chance to overlook pathology.
Frequently nerve enhancement is the only sign indicating 
cranial nerve involvement and therefore the use of gadolin-
ium is recommended in most cases.
A phased array head coil is best suited to image all cranial 
nerves down to the level of the mandible but an additional 
neck coil is needed to visualize the lower cranial nerves in 
the neck and upper mediastinum (left CN X).
Pathology at the level of the CN nuclei and intramedul-
lary fibers is best seen on selective proton density, 
T2-weighted, and multi-echo (m-FFE, Medic, Merge) 
images. 3D-FLAIR are more reliable than 2D because of 
better flow saturation. It decreases repetition artifacts and 
allow a better visualization of the brain stem. Post-contrast 
3D-FLAIR is also useful to demonstrate abnormal menin-
geal and neural enhancements. Additional diffusion- 
weighted images (DWI) are often needed to rule out stroke 
and to characterize tissular and cystic masses.
The cisternal segment of CN is surrounded by CSF and 
therefore submillimetric heavily T2-weighted images (WI) 
are best suited. All these sequences perform well in the cen-
ter of the image and region around the brainstem and some of 
the steady state sequences can even cover all 12 cranial 
nerves. However, the steady state sequences (e.g., CISS, 
balanced- FFE, etc.) are prone to susceptibility artifacts at the 
level of the more peripheral located cisternal segments such 
as the olfactory bulbs and tracts, cranial nerve VII and VIII 
inside the internal auditory canal. Therefore these peripheral 
segments are better imaged with TSE sequences (e.g., 
DRIVE, 3D-TSE, etc.) that unfortunately have a smaller 
coverage.
Once the nerves are surrounded by a venous plexus (cav-
ernous sinus, basilar plexus behind the clivus, jugular fora-
men, and hypoglossal canal) they are best depicted as black 
structures surrounded by high signal intensity enhancing 
venous structures on 2DSE or TSE, 3DTSE or FFE post- 
contrast T1-WI.  The extracranial segments of the cranial 
nerves and surrounding lesions can best be depicted on high- 
resolution axial and coronal T1 and T2-WI.
Fat around the cranial nerves will disappear when fat sat-
uration is used and renders visualization of the normal nerves 
more difficult. On the other hand abnormal enhancement of 
the nerves will be recognized more easily on fat-saturated 
images. The use of DIXON sequences avoids this sometimes 
difficult choice and provides both fat and non-fat-saturated 
(FS) images in one sequence.
New isotropic 3D unenhanced MR neurography 
sequences allow detailed visualization of the normal and 
abnormal extracranial branches and course of nerves V, VII, 
IX–XII.  The sequences are based on a 3D TSE sequence 
with fat saturation and a motion sensitized driven equilib-
rium function (black blood function parallel to the nerves) 
[8]. To acquire all the above mentioned high-resolution 
images or isotropic submillimetric images in an acceptable 
12 Imaging Evaluation of Patients with Cranial Nerve Disorders
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time parallel imaging and if available compressed sense 
should be used.
12.3.2  Tractography
Advances in DWI clinical research have led to the develop-
ment of cranial nerves tractographie based on diffusion ten-
sor imaging. The visual results depend on the anatomy of the 
cranial nerve tracked, acquisition parameters, and the post-
processing steps. Currently, cranial nerves tractography 
techniques only allow to display the thicker nerves, includ-
ing six isolated cranial nerves (II, III, V, VI, VII/VIII) and 
IX/X/XI nerves as a group [9] (Fig. 12.1).
The acquisition of high-angular resolution DWI data (at 
least 32 directions) is required to estimate the local fiber 
orientation distribution, a prior step to manage voxels with 
multiple fibers population. Such diffusion signal modeling 
is required, for example, when tracking nerves with second-
ary branches or in diseased condition. The other crucial 
point relies on the susceptibility distribution of the subjects’ 
head, which needs to be corrected by specific postprocess-
ing. It typically uses two b-zero acquisitions with opposing 
polarities of the phase-encode blips. In addition, the polarity 
of the diffusion directions has a major impact to pass through 
skull base foramina. For example, optic nerves tractography 
would require a postero-anterior acquisition to be feasible 
along the optic canal, while inner auditory canal nerves 
would take advantage of an antero-posterior MR 
acquisition.
It is well-known that probabilistic algorithms are the 
method of choice to track cranial nerves, including in tumor 
condition. Global tractographic reconstructions on the whole 
acquisition volume have also proved efficiency to map cra-
nial nerves ischemia, for example, in anterior optic ischemic 
neuropathy [10]. Global tractographic approach also allows 
to obtain cranial nerves reconstructions at a submillimeter 
scale, regardless to the voxel size acquisition. Technical 
advances such as faster imaging acquisition and 
 implementation of recent postprocessing developments in 
clinical software promise new perspectives in neuroradiol-
ogy, skull base surgery, and neuroanatomy [9, 11, 12].
Table 12.2 Technical recommendations to investigate CN disorders
CN nuclei and 
segments
Brainstem: nuclei and 
intramedullary fibers Cisternal segment










DRIVE TSE T2 (3D)
MRA (3D) unenhanced
T1-weighted TSE HR (2D)
FFE (3D)
Black blood TSE T1 (3D)
T1-weighted TSE HR (2D)
T2-weighted TSE HR (2D)
Neurography (3D)
Plane Axial 3D sequences, isotropic. Measured 








3D sequences: reformatted any 
plane
Axial + coronal



















T1-weighted TSE HR: 
0.40 × 0.45 × 2.3 mm











T1-weighted  TSE HR: 69 mm
FFE: 59 mm
Black blood: 39 mm
T1-weighted TSE HR: 
69 mm









b-FFE XD: 4 min 43 s (CS 10)
DRIVE T2: 2 min 47 s (CS 3.3)
MRA: 6 min 50 s (CS 3)
T1-weighted TSE HR: 7 min 
30 s (S 1.5)
FFE: 4 min 8 s (S 1.4)
Black blood: 5 min 5 s (CS 4)
T1-weighted TSE HR: 
7 min 30 s (S 1.5)
T2-weighted TSE HR: 
3 min 15 s (CS 2.5)
Neurography: 8 min 17 s 
(CS 3)
2D two dimensional, 3D three dimensional, b-FFE balanced fast field echo, CN cranial nerve, CS compressed sense factor, DRIVE driven equilibrium, 
DWI diffusion-weighted imaging, FFE fast field echo, medic multi-echo data image combination, merge multiple echo recombine gradient echo, m-FFE 
merged fast field echo, HR high resolution, MRA magnetic resonance angiography, PD proton density, S sense factor, TSE turbo spin echo
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12.4  Intraaxial Lesions
Intraaxial lesions such as stroke, meningoencephalitis, cen-
tral pontine myelinolysis, or glioma might have a spontane-
ous poor short-term prognosis without specific care. Then, 
identifying intraaxial lesion in case of CN impairment 
remains a diagnostic priority. Despite both olfactory (I) and 
optic (II) nerves are tracts of the CNS, their lesions are pre-
sented in their apparent location.
Because of the complex anatomy of the brainstem, intra-
axial lesions are prone to be revealed by a rich clinical semi-
ology, associating multiple CN impairment and central 
disorders such as hemiplegia, hemiparesia, extrapyramidal 
syndrome, dysautonomic syndrome, awareness impairment, 
nausea, cardiorespiratory dysregulation, etc. Recent imaging 
details are available in [1, 7].
12.4.1  Vascular Diseases
12.4.1.1  Ischemic Stroke
Stroke is the major cause of neurologic deficits with acute onset. 
Ischemic stroke is more frequent than hemorrhage. Except for 
acute ischemic optic neuropathy, CN disorders secondary to 
ischemic stroke is usually due to an occlusion of the basilar 
artery and its perforating arteries. Occlusion of the distal portion 
of the vertebral artery, the postero-inferior cerebellar artery and 
its branches is responsible of ischemia of the medulla. 
Intravenous thrombolysis is recommended within 4.5  h after 
onset. Recommendations for mechanical thrombectomy in the 
posterior circulation are under investigation, even after 6 h.
Imaging in emergency is needed for brainstem stroke: (1) 
to distinguish ischemic from hemorrhagic stroke; (2) to esti-
mate the duration of stroke in case of unclear history or 
awake stroke, (3) to identify intravascular thrombus, occlu-
sion, and stenosis.
MRI is an excellent modality to demonstrate very acute 
infarction as a DWI hyperintensity due to a low apparent dif-
fusion coefficient (ADC) (Fig. 12.2). T2 FLAIR hyperinten-
sity reveals stroke after 4 h. T2∗ or CT are helpful to rule out 
hemorrhage. CT angiography (CTA) or MR angiography 
(MRA) using time of flight (TOF) is useful to identify vascu-
lar occlusion or stenosis. Perfusion CT and MR are also use-
ful to show penumbra, this reversible ischemia after 
reperfusion [13].
12.4.1.2  Intraparenchymal Hemorrhage
Spontaneous hemorrhage of the brainstem is usually due to 
vascular malformation, such as cavernoma. Arteriovenous 
malformation and fistula are less frequent. Cavernoma or 
cavernous hemangioma is a sporadic or familial vascular 
malformation, characterized by blood cavities due to 
dilated blood vessels. Abnormal structural support of the 
vessels may cause leakage and hemorrhage in the surround-
ing tissue. CT may show hyperdensities due to calcifica-
tions and hemorrhage. MRI may show a “pop-corn” like 
lesion with caverns of varied intensities. T2 may show a 
hypointense rim. Hemosiderin depositions are best seen 
using T2∗ and SWI.  Post-contrast T1 images may show 
subtle enhancement and additional developmental venous 
anomaly.
12.4.2  Infectious Diseases
12.4.2.1  Listeria
Listerial rhombencephalitis is due to Listeria monocytogenes 
septicemia, which may occur in pregnancy, infant, elderly, 
and immunocompromised patients after oral contamination 
of infected fresh products such as cheese. Antiobiotherapy is 
required in emergency. MRI is the best modality to show 
pontine enlargement and T2 hyperintensities (Fig.  12.2). 
Perilesional enhancement might be associated with 
a b c
Fig. 12.1 Global tractography of the cranial nerves, brainstem, and 
cerebellum: (a) axial view of normal oculomotor nerves (III) arising 
from the interpeduncular fossa; (b, c) 3D rendering in a healthy volun-
teer. When compared to surgery, reliable tractography is obtained in 
most CN but IV and VI [9]
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 leptomeningeal and adjacent V4 ependymal enhancements. 
Foci of low ADC would have a poorer prognosis.
Any septicemia of different origins may also cause intra-
axial abscesses.
12.4.2.2  CMV
Cytomegalovirus infection in immunocompromised patients 
may cause ventriculitis and encephalitis. MRI shows an epen-
dymal enhancement with adjacent T2 hyperintense foci of 
inflammation that may insult CN nuclei and intraaxial fibers.
12.4.3  Non-infectious Inflammatory Diseases
12.4.3.1  Demyelinating Diseases
Demyelinating diseases is a heterogeneous group of inflam-
matory disorders, such as multiple sclerosis, neuromyelitis 
optica spectrum disorders (NMOsd) with anti-AQP4 or anti- 
MOG antibodies, acute disseminated encephalomyelitis, etc. 
Clinical presentation and biological studies are helpful to 
discuss among diagnoses. Imaging of the brain and the spi-
nal cord is also critical. All these diseases might be respon-
sible of CN disorders due to nodular lesions involving the 
brainstem (Fig.  12.2). NMO with anti-AQP4 antibodies is 
often associated with periventricular and especially area pos-
trema lesions [14, 15]. Acute lesions may appear T2 hyperin-
tense, DWI hyperintense due to low ADC within the first 
days after onset, and open ring perinodular enhancement 
during the first month. Optic neuritis may have suggestive 
presentations according to the diseases (see extracranial).
12.4.3.2  Behcet’s Disease
Behcet’s disease is a multisystem vascular-inflammatory dis-
ease of unknown origin that associates recurrent orogenital 
ulcerations, uveitis, and skin lesions. Males originating from 
countries along the Silk Road are more affected from 
Fig. 12.2 Intraaxial lesions with CN disorders: (a) ischemic stroke of 
the left hemi-pons, DWI hyperintense pontine triangle, revealed by 
right hemiparesia and diplopia; (b) multiple sclerosis with a T2 hyper-
intense nodule close to CN III nucleus with a right oculomotor palsy 
and ptosis; (c) listerial rhombencephalitis as a T2 hyperintense infiltra-
tion of pons and cerebellar peduncles in a pregnant woman revealed by 
febrile confusion with bilateral oculomotor paresis; (d) midline diffuse 
glioma of the pons as aT2 hyperintense pontine mass, revealed by bilat-
eral CN palsies (oculomotor and facial) and headaches; (e) primary 
CNS lymphoma, post-contrast T1 enhancing homogeneous right pon-
tine mass, revealed by right trigeminal anesthesia and left hemiparesia; 
(f) left hypertrophic olivary degeneration (T2∗ hyperintensity) revealed 
by left palatal myoclonus, 6 months after ipsilateral mesencephalic cav-
ernoma hemorrhage
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Mediterranean to Far East. CNS involvement is rare but clas-
sical. Besides venous cerebral thrombosis, intraaxial ill- 
defined lesions are often described in the pons, the midbrain, 
and the diencephalon. Irregular lesional contrast enhance-
ment is possible.
12.4.4  Tumor
12.4.4.1  Midline Infiltrating Glioma
Midline infiltrating glioma is rare, usually diagnosed in chil-
dren and young adults with a poor prognosis. The lesion typi-
cally arises in the pons or the thalamus. Rapidly progressive 
brainstem and cranial nerves disorders develop over few weeks 
in association with an obstructive hydrocephalus and intracra-
nial hypertension. The lesion is a large expansive mass T1 
hypointense, T2 hyperintense (Fig. 12.2). Although considered 
as a high grade glioma, intralesional necrosis and contrast 
enhancement are possible but unconstant. Spectroscopy dem-
onstrates a malignant profile, with low NAA, high choline and 
choline/creatine ratio, and the presence of lactates and lipids.
12.4.4.2  Other Intraaxial Tumors
Other tumors that may infiltrate the brainstem are primary 
ependymoma, medulloblastoma, CNS lymphoma (Fig. 12.2), 
metastases. Tumoral hypercellularity appears as a DWI 
hyperintensity due to low ADC. This feature is common in 
medulloblastoma and lymphoma. Post-contrast enhance-
ment is usually heterogeneous except in lymphoma which 
remains homogeneous in immunocompetent patients despite 
the large size of the tumor.
12.4.5  Trauma
12.4.5.1  Diffuse Axonal Injuries and Contusions
Severe traumatic brain injury is defined by Glasgow coma 
scale <8. In case of midbrain lesions, conscientiousness and 
awareness impairments are predominant. MRI may demon-
strate diffuse axonal injuries due to structural neural shearing 
in case of high velocity trauma. These punctuate lesions, 
T2∗/SWI hypointense, T2 hyperintense may also cause cra-
nial nerve palsies and movements disorders. Additionally, 
CT and MRI may show post-traumatic contusion of the pos-
terolateral aspect of the midbrain onto the tentorium as an 
edema and a superficial hemorrhage.
12.4.6  Toxic/Metabolic
12.4.6.1  Central Pontine Myelinolysis
Osmotic demyelination syndrome is usually observed after a 
rapid correction of electrolyte disturbance such as hypona-
tremia. Central pontine myelinolysis is T2 hyperintense with 
a classical trident or piglet shape. Extrapontine myelinolysis 
may involve basal ganglia and deep white matter.
12.4.7  Degeneration
12.4.7.1  Progressive Supranuclear Palsy
Progressive supranuclear palsy is a neurodegenerative dis-
ease that is responsible of oculomotor disorders, especially 
with vertical gaze and convergence impairments. An extra-
pyramidal syndrome poorly responsive to L-Dopa adminis-
tration is usually associated. On axial plane, the mesencephalic 
atrophy is responsible of a concavity of the posterior aspect 
of the midbrain, the “morning glory” sign. On mid-sagittal 
plane, the atrophy is responsible of the concavity of the supe-
rior aspect of the midbrain, the “hummingbird” sign.
12.4.7.2  Hypertrophic Olivary Degeneration
The hypertrophic olivary degeneration is secondary to a 
focal lesion, usually a hemorrhage or an ischemia involving 
the dento-rubro-olivary pathway. The olivary degeneration 
appears T2 hyperintense and hypertrophic several months 
after the initial injury (Fig. 12.2). When present, cerebellar 
changes, including superior cerebellar peduncles are contra-
lateral to the olivary degeneration. Bilateral hypertrophic oli-
vary degeneration is also possible.
12.5  Extraaxial Intracranial Lesions
Extraaxial intracranial lesions might insult the cisternal and 
the transdural portions of CN.  These diseases include pri-
mary diseases of the nerves, secondary neural inflammation, 
and compression by vascular, meningeal, and skull bases dis-
eases. CN disorders reveal the location and the extent of the 
lesions. Patient’s history is critical for diagnosis. CN disor-
ders can be unique or multiple. Additional symptoms such as 
pain may also suggest particular etiologies such as menin-
geal and neural inflammation, vascular disorders such as 
aneurysms and neurovascular conflicts. Headaches with nau-
sea, vomiting, papillary edema, and abducens palsy suggest 
intracranial hypertension. When neuroimaging is normal, 
CSF study is needed. In clinical practice, CT is useful in 
emergency to rule out intracranial hypertension before lum-
bar puncture and for osseous skull study. MR is usually 
needed to refine the diagnosis [2, 8, 16–18].
12.5.1  Vascular Diseases
The close vicinity of CN and vessels explains why focal vas-
cular diseases may cause CN disorders.
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12.5.1.1  Aneurysm and Arterial Dissection
First, life-threatening aneurysm and arterial dissection have 
to be ruled out in case of unilateral painful CN. Aneurysms of 
the first portion of the posterior cerebral artery and the cere-
bral portion of the internal carotid artery may have a mass 
effect on the superior aspect of the oculomotor nerve (III), 
responsible of complete extrinsic and intrinsic oculomotor 
nerve palsy. Because preganglionic parasympathetic pupillo-
motor fibers to the ciliary ganglion are located on the supero-
medial surface of the CN III, the loss of pupillary function 
occurs in about 14% secondary to the peripheral fibers com-
pression. In most cases, CN III palsy is limited to extrinsic 
oculomotricity secondary to central fibers ischemia, such as 
in diabetic patients. Diabetic ophthalmoparesia accounts for 
25% of ocular motor nerve palsies and imaging is still normal 
in such cases of vasculopathic cranial neuropathy [19].
Painful lower CN disorders may also reveal dissection of 
the distal part of the vertebral artery or cervical portion of the 
internal carotid artery. Both CTA and MRA with non- 
enhanced FS T1 SE images are necessary.
12.5.1.2  Arterio-Venous Fistula
Carotido-cavernous fistulas can eventually cause raised 
intraocular pressure which can interfere with the blood sup-
ply of the optic nerve and can lead to blindness. These fistu-
las can best be detected on non-enhanced MRA. Abnormal 
high signal intensity can then be seen inside the cavernous 
sinus due to the increased speed of the venous flow caused 
by the fistula with the carotid. A congestive chemosis with a 
dilation of the superior ophthalmic vein is common.
12.5.1.3  Neurovascular Compression 
Syndromes
Neurovascular compression syndromes (NVCS) are usually 
caused by arteries or veins that directly compress and insult 
the cisternal portion of CN (Fig.  12.3). Common NVCS 
involve CN V with a trigeminal neuralgia (V), CN VII with 
hemifacial spasm, CN VIII with vestibular paroxysmia 
(VIII), CN IX with glossopharyngeal neuralgia.
Indeed vessels in the posterior fossa elongate and become 
more tortuous with aging. Among all neurovascular contacts, 
few are symptomatic. While heavily T2-WI are very efficient 
in displaying nerve to vessel contact, the relationship with 
patient symptoms remains debated. In fact, one challenge is 
to determine which neurovascular contact could be symp-
tomatic. The most common pathophysiological hypothesis 
relies on the natural weakness of CN in their transition zone, 
a short 1–2  mm segment in which the central myelin that 
originates from oligodendrocytes and covers the proximal 
intracisternal portion of CN, turns into peripheral myelin 
from Schwann cells. Therefore, the correlation between clin-
ical symptoms and the exact location of the neurovascular 
contact is crucial.
Trigeminal neuralgia (V) secondary to NVC is suspected 
when neural deformation by vascular contact is located approxi-
mately 4 mm from the apparent CN V origin from the brainstem, 
hemifacial spasm (VII) at 2 mm, vestibular paroxysmia (VIII) at 
10 mm, and glossopharyngeal neuralgia at <2 mm [20].
Venous conflicts are possible but most NVCS are caused 
by arteries, especially the superior cerebellar artery (V), the 
anterior inferior cerebellar artery (VII, VIII), the posterior 
inferior cerebellar, and the vertebral artery (VII, VIII, IX).
Besides the exact location of the contact, reliable signs 
are a perpendicular neurovascular crossing and the displace-
ment of the nerve. To confirm NVCS, nerves, arteries, and 
veins are distinguished using heavily T2-WI for nerves, 
unenhanced TOF MRA for arteries, and post-contrast 
3D-submillimetric T1 WI for veins (Fig. 12.3).
Fusion software with selective color coding for each ana-
tomical structure can be helpful, especially after decompres-
sive surgery to recognize the position of the material (e.g., 
Teflon, etc.).
12.5.2  Infectious Diseases
12.5.2.1  Viral Neuritis
Bell’s palsy accounts for a peripheral facial palsy secondary 
to herpes simplex virus related neuritis. Most patients recover 
spontaneously facial nerve function in <2  months without 
therapy. Imaging is usually performed in case of atypical 
clinical presentation, including persisting deficit and recur-
rence. Thin post-contrast FS T1-WI and 3D-FLAIR show a 
fundal “tuft” and labyrinthic facial nerve (VII) enhancement. 
Intrameatic and intralabyrinthic enhancements of the CN VII 
are always abnormal. Nodular enhancement may suggest 
differential diagnoses such a schwannoma, hemangioma, 
metastases, etc. Enhancement of the geniculate ganglion, 
tympanic, and mastoid segment of the nerve has to be inter-
preted with caution as these segments are surrounded by an 
arteriovenous plexus that may also enhance in normal sub-
jects. To avoid this problem, it is recommended to use 
sequences that do not show the surrounding vessels enhance-
ment like millimetric heavily T2-WI and post-contrast black 
blood 3DT1-WI (Fig. 12.3). Comparison with the contralat-
eral side is useful to distinguish an excessive CN VII 
enhancement. Main differential diagnoses include facial 
nerve schwannoma, hemangioma, perineural tumor spread 
from parotid tumor, and Ramsay Hunt syndrome.
Ramsay Hunt syndrome accounts for a varicella zoster 
virus infection responsible of both sensory fibers of facial 
and cochleovestibular nerves. A facial palsy and a sensori-
neural hearing loss are associated with an external ear vesic-
ular rash. Fever, vertigo, nausea, and burning pain of the ear 
are common. CN disorders may occur before the rash. Thus, 
MRI is helpful to identify a unilateral facial and cochleoves-
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tibular enhancement into the fundus and the inner ear on thin 
post-contrast FS T1-WI and 3D-FLAIR. Additionally, heav-
ily T2-WI shows a thickening of the nerves into the internal 
auditory canal and the inner ear. Comparison with the con-
tralateral side is very helpful [21]. Other viruses such as HIV 
may also cause neuritis [5, 22].
12.5.2.2  Infectious Meningitis
CN disorders may reveal meningeal diseases. Indeed, a CSF 
study is often necessary to set the final diagnosis. In case of 
meningitis, CN disorders may consist in a non-specific abdu-
cens palsy (VI) to a multiple and bilateral CN palsies associ-
ated with a meningeal syndrome.
Fig. 12.3 Extraaxial intracranial lesions associated with CN disorders: 
(a–c) left Bell’s palsy, a viral neuritis, axial 0.55 mm thick black blood 
3D TSE T1-WI show unilateral left facial nerve enhancement in the 
fundus of the internal auditory canal and along the labyrinthine seg-
ment, and the geniculate ganglion (a arrow). Coronal reformatted 
images show an enhancement of the tympanic (b arrow) and mastoid 
segment (c arrow) of the left facial nerve. Note that these black blood 
images suppress both arterial and vein enhancement, making the diag-
nosis easier; (d–f) right trigeminal neuralgia in a neurovascular com-
pression syndrome, axial 0.3  mm thick 3D TSE heavily T2-WI (d) 
shows the displacement of the transitional zone of the CN V by the right 
superior cerebellar artery (gray arrows) on TOF MRA (e) and post- 
contrast 0.5 mm thick 3D T1-WI (f); (g) tuberculous leptomeningitis, 
T2 FLAIR hyperintensities of the basal leptomeninges, revealed by 
bilateral oculomotor and facial palsies and headaches (hydrocephalus); 
(h, i) Tolosa–Hunt syndrome revealed by a painful right ophthalmople-
gia, initial post-contrast T1-WI (e) show a right cavernous thickening 
without other potential diagnosis (white arrow), high-dose corticoid 
therapy amended symptoms and 6 months follow-up MRI (f) show nor-
mal cavernous sinus
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Neuroimaging would demonstrate a meningeal enhance-
ment of 3D post-contrast CT, T1, and Flair images. 
Leptomeningitis is characterized by an enhancement and a 
thickening of the leptomeninges contiguous to the 
CNS. Pachymeningitis is characterized by an enhancement 
and a thickening of the pachymeninges contiguous to the 
skull. Additional intraparenchymal lesions are common in 
case of diffuse meningeal diseases, suggestive of meningo-
encephalitis. Besides pyogenes meningitis, tuberculosis is a 
common bacterial cause of leptomeningitis involving the 
skull base and the brainstem (Fig.  12.3). This meningeal 
inflammation may cause a regional vasculitis and ischemic 
stroke.
12.5.2.3  Skull Base Infections
Multiple unilateral CN disorders are suggestive of skull base 
disease. In addition to clinical and biological data, CT and 
post-contrast MRI allow to identify symptomatic osteomy-
elitis usually secondary to naso-sinusal and otomastoid 
infections.
12.5.3  Non Infectious Inflammatory Diseases
12.5.3.1  Non-infectious Meningitis
Among non-infectious leptomeningitis, neurosarcoidosis is 
the most common cause of CN disorders. An additional dia-
betes insipidus is classical. Besides a diffuse leptomeningeal 
enhancement of post-contrast FS 3D-FLAIR and 3DT1-WI, 
MRI shows the loss of the bright spot of the posterior pitu-
itary on non-enhanced T1 with thickened infundibulum and 
stalk.
Non-infectious pachymeningitis is a possible additional 
feature of granulomatosis and systemic diseases such as 
Wegener’s disease, Langerhans cells, and non-Langerhans 
cells histiocytosis. Besides pachymeningeal thick enhance-
ment and tumor-like appearance, a possible infundibular and 
stalk lesion responsible of diabetes insipidus, CT is useful to 
identify lytic lesions of the skull and the face.
12.5.3.2  Tolosa–Hunt Syndrome
Tolosa–Hunt syndrome is an idiopathic non-neoplastic non- 
infectious inflammation of the cavernous sinus and the 
orbital apex. A unilateral painful ophthalmoplegia usually 
reveals the disease. MR demonstrates an abnormal apical 
enhancement extended to the cavernous sinus and Meckel’s 
cave that are enlarged with a lateral bulging. After having 
excluded infections and neoplasms on clinical, biological, 
and imaging presentation, high dose of steroids is required. 
Normal MRI at 6-months follow-up is required to set the 
final diagnosis [23] (Fig. 12.3).
Idiopathic inflammatory infiltration can also be detected in 
orbital pseudotumor as a T2 hypointense ill-defined infiltration 
which enhances on post-contrast FS T1-WI. Additional infil-
tration of the pituitary, infundibulum, lacrimal, and salivary 
glands is possible in case of IgG4-related disease. A thickening 
of infraorbitary nerve (V2) would very suggestive [24].
12.5.4  Tumors and Cysts
12.5.4.1  Neural Sheath Tumors
Schwannoma is the most common neural tumor. This tumor 
that arises from the nerve sheath after the TZ may involve 
any CN but I and II that do not have Schwann cells. Most 
common CN are the vestibular nerve (VIII) within the cere-
bellopontine angle and the internal auditory meatus, the tri-
geminal nerve (V) in the Meckel’s cave, the mixed nerves 
(IX, X, XII), and the hypoglossal nerve. The tumor is usually 
well-defined, homogeneously enhanced on post-contrast 
T1-WI.  Cystic changes may occur in large schwannomas. 
Multiple schwannomas may occur. Indeed, bilateral vestibu-
lar schwannomas is specific of neurofibromatosis type 2 
(Fig. 12.4).
In case of single neural mass, main differential diagnoses 
include facial hemangioma (VII), a small intrameatic hetero-
geneous lesion, and neuroma that may occur after focal 
insult [16–18]. Perineural spread of extracranial schwanno-
mas may also extend into the skull.
In case of multiple neural tumors, main differential diag-
noses include leptomeningeal metastases and carcinomatosis 
of extracranial solid tumors, leukemia, and lymphoma. 
Metastases of intraaxial primary neoplasms such as glioblas-
toma, medulloblastoma, ependymoma, germinoma are also 
possible. None of these metastases has a specific appearance. 
Appropriate diagnosis relies on patient’s history, poor gen-
eral condition, CSF study, and whole body imaging 
(Fig. 12.4).
12.5.4.2  Meningeal Tumors
Primary meningeal tumors such as meningioma are com-
mon. Unique or multiple in case of meningiomatosis, 
meningioma may displace and shear the CN. Meningioma 
of the planum sphenoidale and the olfactory groove is a 
classical cause of anosmia (Fig. 12.4). In the cerebellopon-
tine angle, meningioma is the main differential diagnosis of 
vestibular schwannoma. On CT, meningioma is often asso-
ciated with hyperostosis, while schwannoma is responsible 
of a scalloping of the internal auditory meatus. Meningioma 
may extent anteriorly to the internal auditory meatus, while 
vestibular schwannoma usually does not. And perfusion 
imaging demonstrates the hypervascularization of the 
meningioma.
Intracranial meningiomas may extent throughout the skull 
base foramina, along the CN routes. The optic nerve is the 
nerve which is most frequently involved in its extracranial 
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course, followed by the mandibular nerve (V3) and the lower 
cranial nerves IX–XI. Involvement of the later CN is seen as 
a mass in the carotid space which must be differentiated from 
a schwannoma or a paraganglioma. The strong enhancement, 
dural tail enhancement adjacent to the intracranial compo-
nent of the meningioma and its iso-intensity with gray matter 
on all sequences help to recognize them.
Secondary leptomeningeal and pachymeningeal carcino-
matosis of CNS tumors and extracranial solid tumors, leuke-
mia, and lymphoma are better revealed on 3D post-contrast 
T1 and Flair images. Differential diagnosis with granuloma-
tous meningitis can be difficult on imaging only.
12.5.4.3  Skull Base Tumors and Tumor-like 
Lesions
Multiple unilateral CN disorders are suggestive of skull base 
disease. In addition to clinical and biological data, CT and 
post-contrast MRI allow to identify symptomatic fibrous 
dysplasia, and bone tumors such as chordoma, chondrocarci-
noma, or metastasis.
12.5.4.4  Sellar Tumors and Cysts
Intrasellar and Perisellar Tumors
Intrasellar and perisellar lesions may cause vision loss, espe-
cially bitemporal hemianopia due to chiasmatic compression 
(Fig.  12.4). Oculomotor disorders may occur in case of 
extension into the cavernous sinus. Most common lesions 
include pituitary macroadenoma and craniopharyngioma. 
The tumor is tissular and cystic-like, respectively. Both 
enhance on post-contrast images. A common Rathke cleft 
cyst should not be misdiagnosed.
Rathke Cleft Cyst
Rathke cleft cyst, a common incidental finding located 
within the pars intermedia of the pituitary or along the 
Fig. 12.4 (a) neurofibromatosis type 2, post-contrast T1 bilateral CPA 
and intrameatic masses, revealed by bilateral sensorineural hearing 
loss. (b) bilateral trigeminal metastases of leukemia appearing as post- 
contrast T1 bilateral trigeminal tumoral thickening. (c) epidermoid cyst 
along the right aspect of the midbrain, DWI hyperintense mass, revealed 
by right trochlear palsy. (d) meningioma of the cribriform plate, post- 
contrast T1 enhancing mass, revealed by anosmia. (e) pituitary mac-
roadenoma, intra- and suprasellar mass, that shifts upwards the chiasma 
was revealed by bitemporal hemianopia. (f) paraganglioma of the left 
glomus jugular is a contrast-enhanced T1 mass infiltrating the jugular 
foramen with discrete “salt-and-pepper” appearance on post-contrast 
FS T1-WI (white arrow) revealed by motor palsies of the left lower 
nerves (IX–XII)
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 pituitary stalk, may rarely cause vision and oculomotor defi-
cit. When symptomatic, the location of the cyst and the pres-
ence of small T2 hypointense nodules within the cyst are 
suggestive. The absence of peripheral and tissular enhance-
ment allows to distinguish the cyst from craniopharyngioma.
12.5.4.5  Pineal Tumors and Cysts
Pineal tumors such as pinealocytoma and germinoma may 
cause a Parinaud syndrome, an oculomotor disorder associ-
ating up-gaze palsy, convergence-retraction nystagmus, and 
dilated pupils that react to accommodation but not to light. 
Additional non-specific symptoms are possible, including 
those related to obstructive hydrocephalus by compression 
of the aqueduct of the midbrain, and intracranial hyperten-
sion. Pineal tumors are suggested in case of nodular enhance-
ment and tissular lesions, even when cystic component is 
present. Hypercellular germinomas may harbor hyperintense 
DWI due to restricted diffusion coefficient.
Pineal Cyst
Pineal cysts are common and usual non-symptomatic, their 
size is usually below 1  cm. When larger, pineal cyst may 
cause a Parinaud syndrome and obstructive hydrocephalus 
that may require surgical CSF derivation in emergency. 
Pineal cyst contains CSF-like fluid. As protein concentration 
increases, T1 signal might increase and T2 signal decreases. 
A thin peripheral enhancement is possible while nodular and 
tissular enhancements suggest pineal tumors.
12.5.4.6  Other Cysts and Cystic-like Lesions
Cysts and cystic-like lesions are common findings around the 
CNS and CN. These lesions are often incidental findings or 
may be revealed by CN disorders secondary to compression.
Epidermoid Cyst
Epidermoid cyst is related to the inclusion of ectodermal epi-
thelial elements. It can be slow growing and revealed by CN 
disorders. The insinuating mass has well-defined borders. CT 
demonstrated a hypodense, similar to CSF. Marginal calcifica-
tions are possible. MR shows a CSF-like cyst that may change 
with protein concentration. The lesion does not enhance. 
Besides these features that may suggest an arachnoid cyst, a 
typical incidental finding in adults, MR demonstrates a typical 
restricted diffusion with hyperintense appearance (Fig. 12.4). 
Surgery consists in CN decompression.
Neurenteric Cyst
Neurenteric cyst is a congenital endodermal cyst that might 
arise in front of the medulla and the pons. CN disorders, such 
as abducens or mixed nerves palsies (VI), are possible. CT 
usually shows a prepontine lobular hyperdensity. MRI con-
firms a cyst with high proteins content as T2 hypointensity 
T1 spontaneous hyperintensity, no enhancement.
Dermoid Cyst
Dermoid cyst is well-circumscribed unilocular cyst arising 
from the midline, often close to the sellar and parasellar 
region. This squamous epithelial cyst contains dermal ele-
ments with fatty compounds from sebaceous secretion. 
Calcifications are common. Rupture of the cyst causes a 
chemical meningitis and hydrocephalus. CT and MR eas-
ily demonstrate the fat density of the cyst content with 
parietal calcifications. Rupture is suspected in case of dif-
fuse fatty droplets scattered into the subarchnoïd spaces. 
Surgical treatment is discussed when symptomatic, such as 
CN disorders and rupture in association with CSF 
drainage.
Lipoma
Lipoma is a non-neoplastic mass of mature adipose tissue. 
Usually, lipomas do not grow over time and are incidental 
findings. However, lipomas might be diagnosed in case of 
CN disorders when located onto the quadrigeminal plate or 
into the cerebellopontine angle. CT demonstrates a homog-
enous low density mass (−50 to −100 HU) without calcifi-
cation. MR demonstrates a hyperintense T1 mass which 
becomes hypointense after fat saturation. The lesion does 
not enhance. Surgical removal is difficult. When symptom-
atic, surgery consists in partial removal for CN 
decompression.
12.5.5  Trauma
Post-traumatic anosmia is usually due to contusion of olfac-
tory bulbs or to olfactory fibers shearing through the cribri-
form plate that occur after occipital head trauma. 
High-resolution T2 WI may illustrate olfactory bulbs inju-
ries. Beside this contrecoup anosmia, all other post-traumatic 
CN disorders are usually due to shearing or compression sec-
ondary to skull base fracture. Intraforaminal portions of CN 
are at risk of compression by surrounding hematoma or bone 
fragment displacement. Optic nerve contusion and shearing 
can also be observed.
Skull base fracture including petrous bone might be 
revealed by CN disorders. When clinically driven, high- 
resolution CT is very sensitive to demonstrate to symptom-
atic fracture. MRI allows to depict adjacent edema and focal 
hemorrhage like in the internal ear. MRI and CTA may also 
demonstrate vascular injury such as arterial dissection and 
venous thrombosis.
Parenchymal herniations may also compress CN. Indeed, 
CN disorders may reveal slow growing lesion. Transtentorial 
herniation of the internal temporal gyrus might be revealed 
by oculomotor (III) and trochlear (IV) palsies. Transoccipital 
herniation of the cerebellar amygdala might be revealed by 
mixed nerves (IX–XI) and hypoglossal nerve palsies.
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12.5.6  Degeneration
12.5.6.1  Superficial Siderosis
Meningeal superficial siderosis may cause CN degeneration 
and disorders, especially sensorineural hearing loss. Chronic 
meningeal deposition of hemosiderin occurs in repeated 
trauma, subarachnoid hemorrhage, and slow growing tumor 
or in cerebral amyloid angiopathy. MRI demonstrated a 
characteristic hypointense rim coating the CNS and the CN 
on T2∗ and SWI.
12.6  Extracranial Lesions
Primary extracranial CN diseases are rare and include esthe-
sioneuroblastoma of the olfactory nerves (I) and optic nerve 
(II) glioma, while schwannoma and neurofibroma may arise 
from all other nerves but CN VIII which has no extracranial 
segment.
Most extracranial CN disorders are secondary to a sur-
rounding disease that may insult the nerves. Unilateral symp-
toms are most common.
Nasal and ethmoidal diseases may cause anosmia due to 
olfactory nerves (I) impairment.
Orbital diseases may cause partial or complete monocular 
visual loss (scotoma) because of optic nerve (I) involvement. 
Diplopia may be due to oculomotor (III), trochlear (IV), and 
abducens (VI) nerves dysfunctions. Intraorbital apical CN III 
lesion associates ptosis and mydriasis when the ciliary gan-
glion that receives afferent parasympathetic fibers is affected.
Superficial and deep facial lesions may cause trigeminal 
neuropathy when the extracranial branches of CN V are 
injured. Specific signs may suggest particular branches, 
especially when unilateral: hypoesthesia, numbness, or 
burning of the forehead (V1), the chick (V2), the jaw (V3.); 
diminished or absent corneal reflex (ophthalmic branch 
V1); atrophic or weak muscles of mastication (motor branch 
V3). Facial pain is a very unspecific sign but numbness, 
progressive symptoms and motor weakness should always 
be taken seriously and are frequently linked to a structural 
lesion.
Perimastoid and parotid lesion may cause an extracranial 
CN VII dysfunction with isolated peripheral facial nerve 
palsy but preserved lacrimal function, stapedius reflex and 
taste in the anterior two thirds of the tongue.
In the suprahyoid region, CN IX to XII have close rela-
tionships explaining why they are often injured simultane-
ously. Association of CN IX and X disorder is frequent and 
result in otalgia, dysphagia, absent gag reflex, uvular devia-
tion away from the side of the lesion, endolaryngeal symp-
toms (hoarseness, dysphagia in cervical esophagus, vocal 
cord palsy), loss of taste to the posterior 1/3 of the tongue, 
tachycardia or bradycardia, etc. Isolated disorders of CN XI 
and XII are common. CN XI palsy is suggested on shoulder 
drop and inability to raise the arm. CN XII palsy is diag-
nosed on deviation of the tongue to the side of the lesion, 
amyotrophy of the intrinsic and extrinsic tongue muscles, 
and orobuccal dysarthria.
In the infra-hyoid region, lesions would result in an iso-
lated CN X injury and vagus related oropharyngeal signs 
will be absent and only the endolaryngeal symptoms will be 
present. Muscle denervation atrophy is an indirect sign of 
involvement of the motor cranial nerves and should always 
be checked [25].
Besides the above mentioned lesions, neural disorders 
also occur in case of vasculitides, neurotoxin, after 
radiotherapy.
Because of the large spectrum of extracranial diseases, 
here are presented most common etiologies.
12.6.1  Vascular Lesions
Intraorbital cavernous hemangioma is an ovoid well- 
delineated enhancing lesion in the orbit and can compress 
the optic nerve (Fig. 12.5). Venous varix can be recognized 
on flow void, vascular enhancement, and size increase on 
procubitus.
Internal carotid artery dissection or (pseudo)aneurysm 
may cause deficits of the lower cranial nerves IX–XII, due to 
the compression on the nerves into the carotid space 
(Fig.  12.6). These nerves can also be damaged during 
endarterectomy.
Aneurysms of the aortic arch and even cardiomegaly can 
cause irritation of the left recurrent laryngeal nerve [26].
12.6.2  Infectious Diseases
Aggressive bacterial and fungal infections arising from 
sinuses, temporal bone, and skull base can insult the adjacent 
cranial nerves. Aspergillus and mucormycosis can be recog-
nized on the very low signal inside the sinuses on T2-WI and 
the destruction of the bony walls of the sinuses.
All extracranial cranial nerves close to the sinuses and 
temporal bone can be affected by fungal infection and 
aggressive bacterial infection: frontal sinus (V1), ethmoid 
and sphenoid (II, III, IV, V1, V2, VI—orbital apex and 
 superior orbital fissure), temporal bone (VII). Periapical and 
periodontal dental disease may cause maxillary (V2) and 
mandibular (V3) neuropathy which can be seen on post- 
contrast FS T1-WI or MR neurography [27].
The facial nerve can be involved in malignant otitis 
externa, a pseudomonas infection in diabetic or immuno-
compromised patients. Skull base osteomyelitis can also 
affect the lower cranial nerves IX–XII while mandibular 
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osteomyelitis can cause inferior alveolar nerve irritation 
with pain and numbness. This mandibular osteomyelitis 
should be differentiated from osteoradionecrosis. Both will 
result in loss of the high signal inside the mandible and both 
can enhance. However, osteoradionecrosis can be distin-
guished when bone sequesters are present, hypointense 
defects are seen in the cortex and when periosteal bone is 
formed.
Abscess formation in the carotid space can cause lower 
cranial nerve IX–XII symptoms and mediastinitis and medi-
astinal inflammatory adenopathy can cause left sided CN X 
or recurrent laryngeal nerve deficits.
12.6.3  Non-infectious Inflammatory Diseases
12.6.3.1  Demyelinating Diseases
In young adults, spontaneous vision loss is often due to an 
optic neuritis, which can be a particular feature of demyelin-
ating diseases such as multiple sclerosis (MS) and neuromy-
elitis optica spectrum disorders (NMOsd) with anti-AQP4 or 
anti-MOG antibodies. Accurate diagnosis assessment is 
needed because of different treatments with potential delete-
rious effects when inappropriate. Besides clinical and bio-
logical data, whole CNS imaging that includes optic nerves 
is mandatory. Optic nerve lesions are best identified using 
post-contrast FS T1-WI and 3D-FLAIR.
In MS, optic neuritis is usually unilateral, short, involving 
the middle portion of the nerve.
In anti-AQP4+, optic neuritis is usually bilateral, long, 
involving the posterior portion of the nerves with chiasmatic 
extension.
In anti-MOG+, optic neuritis is usually bilateral, long, 
involving the anterior portion of the nerves.
Additional CNS imaging abnormalities are helpful for 
differential diagnosis.
In MS, MRI demonstrates scattered nodules in the brain 
and the upper half of spinal cord. Spinal lesions are small 
Fig. 12.5 (a) cavernous hemangioma of the orbital apex revealed by 
unilateral vision loss, the enhancement of the lesion and relation to the 
optic nerve is clear on this isotropic 0.55 mm thick post-contrast black 
blood 3D TSE T1-WI; (b) schwannoma of the left maxillary nerve (V2) 
in the pterygopalatine fossa, as an expansive slightly heterogeneously 
enhanced on post-contrast T1-WI, scalloping the adjacent bones; (c) 
neurofibromatosis type 2 with multiple schwannomas of the left vagus 
nerve (X) (white arrow) and the right Meckel cave (gray arrow) on post- 
contrast coronal T1-WI; (d) neurofibromas on paracoronal 3D neurog-
raphy with black blood pulse as bilateral thickening and hyperintensity 
of both inferior alveolar nerves (V3) (white arrows), external to lingual 
nerves (gray arrows). (e) Perineural tumor spread along the left maxil-
lary nerve (V2) of an epithelial carcinoma of the nostril (gray arrow), 
post-contrast FS T1 show a thickened enhancing V2 in the pterygopala-
tine fossa, the rotundum foramen (white arrows); (f) post-traumatic left 
accessory nerve palsy (XI) with sternocleidomastoid (white arrow), 
trapezius muscles (gray arrow), and levator scapulae (black arrow) 
muscles degeneration
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extending over <2 vertebral segments on sagittal images, and 
occupying <50% of the cord diameter of axial images. 
Dissemination in time accounts for plaques of varied con-
trast uptake.
In anti-AQP4+, brain lesions are mostly periventricular 
with a suggestive involvement of the area postrema. Spinal 
cord lesions are usually located in the upper half of the cord, 
involving three or more vertebral segments on sagittal 
images, more than 50% of the cord diameter.
In anti-MOG+, brain lesions are involving more often 
basal ganglia, thalamus, and the pons. Spinal cord lesions are 
usually located in the lower half of the cord, involving three 
or more vertebral segments on sagittal images, more than 
50% of the cord diameter [14, 15].
12.6.3.2  Granulomatous Diseases
Extracranial lesions of various granulomatous diseases, such 
as Wegener’s disease, Langerhans cells and non-Langerhans 
cells histiocystosis, can insult the anterior optic pathways in 
association with orbital and naso-sinusal lesions. Involvement 
of the adjacent orbit can occur with potential optic nerve and/
or maxillary nerve involvement. Intracranial extension fol-
lowing the neural routes is possible.
Optic nerves and anterior optic pathways can be affected 
in 1–5% of sarcoidosis patients. Sarcoidosis is an inflamma-
tory granulomatosis that can mimic optic nerve meningioma. 
In these patients careful examination of the systemic signs 
should lead to the diagnosis. However, bilateral optic nerve 
involvement, enhancement of the complete optic nerve from 
Fig. 12.6 (a, b) post-traumatic left vision loss, sagittal FS T2 (a) 
shows a retrobulbar edema and an optic nerve hyperintense contusion, 
optic nerve probabilistic tractography suggests a nerve section of poorer 
prognosis; (c) facial nerves tractography showing the left posterior dis-
placement of the nerve by a parotid cystadenolymphoma; (d) hypoglos-
sal nerves tractography showing the contact with the right internal 
carotid dissection in a patient referred for a painful hypoglossal palsy
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the globe to the chiasm, bilateral enlargement of lacrimal and 
parotid glands, leptomeningitis, and infundibular thickening 
are imaging signs indicative of sarcoidosis [1, 2, 5, 7].
12.6.3.3  Orbital Pseudotumor
Orbital pseudotumor is a benign non-infectious inflamma-
tory condition of the orbit. As a diagnosis of exclusion, sys-
temic causes such as infections and neoplasms should be 
ruled out. Patients present with sudden painful proptosis, 
ophthalmoplegia (III, IV, VI), vision loss (II), uveitis and 
retinal detachment. An ill-defined enhancing pseudo-mass 
involving any area of the orbit is best detected on post- 
contrast FS T1-WI.  A very fast response to corticosteroid 
treatment is necessary to confirm the diagnosis.
12.6.3.4  Grave’s Ophtalmopathy
Graves’ disease is an autoimmune disease affecting the thy-
roid and Graves’ ophtalmopathy is found in more than 25% of 
the patients. Extraocular muscle hypertrophy and adipogene-
sis cause increased ocular pressure and proptosis, possible 
diplopia (extraocular muscle involvement) and vision loss (II).
12.6.4  Tumors
12.6.4.1  Primary Nerve Lesions
Esthesioneuroblastoma
Esthesioneuroblastoma or olfactory neuroblastoma is a rare 
tumor arising from the olfactory neurosensory receptor cells 
in the olfactory epithelium of the high nasal vault. Nasal 
obstruction, rhinorrhea, epistaxis, anosmia, headaches are 
common. CT and MRI show a dumbbell tissular mass, 
enhanced on post-contrast images with peripheral cysts. 
Bone destruction allows spreading into the ethmoid and the 
sphenoid sinuses, through the cribriform plate and the ante-
rior cranial fossa.
Optic Nerve Glioma
As the optic nerve is an extension of the brain, primary tumor 
is an optic nerve glioma, usually a pilocytic astrocytoma. 
This glioma occurs under the age of 20 years. The typical 
appearance is a fusiform lesion on the optic nerve with T2 
hyperintensity and a variable enhancement. It causes a kink-
ing of the optic nerve and the lesion may reach the optic 
chiasm. Optic nerve glioma can be associated with neurofi-
bromatosis type I (NF1), especially when bilateral. NF1- 
associated optic tumors rarely extend beyond the optic 
pathway and are usually not cyst-like, whereas those not 
associated with NF1 usually involve the optic chiasm, extend 
extra-optically, and are frequently cyst-like [28].
12.6.4.2  Nerve Sheath Tumors
As extracranial extension of CNS, intraorbital optic nerves 
are surrounded by CSF and meningeal sheath. Optic nerve 
sheath meningioma appears as a fusiform mass surrounding 
the optic nerve. Post-contrast T1-WI demonstrates a perineu-
ral homogeneous enhancement with a “tram track” appear-
ance. CT may show linear calcifications. CSF may be trapped 
between the tumor and the eyeball.
Optic nerves and olfactory tracts and bulbs have no Schwann 
cells. However, the olfactory filia which are connecting the 
olfactory mucosa with the olfactory bulbs do have Schwann 
cells and hence “olfactory schwannomas” are reported although 
they do not originate on the olfactory nerve itself.
All other CN but VIII have an extracranial course with 
Schwann cells on which nerve sheath tumors can arise, 
including schwannomas, neurofibromas, and rarely malig-
nant tumors.
They are less often found on the short orbital apex segment 
of CN III, IV, and VI. The chance to find such tumors on the 
end branches of the trigeminal nerve (V) is higher (Fig. 12.5) 
but far less frequent than on its intracranial portion.
Nerve sheath tumors along intraparotid branches of CN 
VII do occur but one is most frequently dealing with exten-
sions of a mastoid segment lesion into the parotid gland.
Nerve sheath tumors can be detected on all four lower 
cranial nerves but schwannomas of CN X are most frequent. 
Extracranial schwannomas of CN XII frequently pass 
through the hypoglossal canal into subarachnoid space. 
Extracranial schwannomas of CN IX and XI are rare.
Schwannomas are well-circumscribed, fusiform in shape 
and have intense enhancement (Fig. 12.5). Cystic, fatty, and 
hemorrhagic degeneration are possible. Schwannomas are 
solitary and sporadic in most cases in old adults. However, 
autosomic dominant neurofibromatosis type 2 (NF2) is likely 
when multiple schwannomas are present, and bilateral ves-
tibular schwannomas are pathognomonic. In case of heredi-
tary NF2, patients are younger. And the tumoral onset occurs 
at a younger age than the affected parent.
Schwannomas might be difficult to distinguish them from 
neurofibromas, discovered at about 20–30  years. 
Neurofibromas appear as a mild to non-enhancing thicken-
ing of a longer segment of the nerve (Fig. 12.5). Similarly, 
most neurofibromas are solitary and sporadic. However mul-
tiple neurofibromas and plexiform neurofibromas almost 
assure the diagnosis of NF1.
12.6.4.3  Secondary Nerve Involvement
Head and Neck Malignancies
Squamous cell carcinomas, adenoid cystic carcinomas, ade-
nocarcinomas, lymphomas, melanomas arising in the face, 
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sinus, orbit, supra- and infra-hyoid neck can all cause dis-
placement of or invasion of the extracranial CN.
The causative tumors can be different in more specific 
areas like uveal melanoma and retinoblastoma for the optic 
nerve, esthesioneuroblastoma for the olfactory bulbs and 
ophthalmic nerve (V1), rhabdomyosarcoma (V3), malignant 
parotid gland tumors such as adenoid cystic carcinoma and 
mucoepidermoid carcinoma for the facial nerve (VII) and 
bronchogenic carcinoma and thyroid malignancies for the 
infra-hyoid vagus nerve (recurrent laryngeal nerve) (X).
Tumoral infiltration of extracranial nerves could be diffi-
cult to see but the presence of a tumor at the CN endpoint or 
along its extracranial route allows to make the diagnosis. 
Post-contrast FS T1-WI are helpful to follow thickened 
enhanced CN. Diffusion tractography is promising for clini-
cal practice, showing nerve displacement and suggesting 
tumoral infiltration [11] (Fig. 12.6).
It should not be forgotten that the left recurrent laryngeal 
nerve, branch of the vagus nerve (X), passes through the aorto-
pulmonary window and can therefore be affected by mediasti-
nal adenopathies and malignancies of the aerodigestive tract.
Perineural Tumor Spread
Adenoid cystic carcinoma, squamous cell carcinoma and 
lymphoma are the most frequent malignant head and neck 
lesions with perineural spread, although other malignant 
tumors also have the potential to follow the cranial nerves 
[29]. The most frequently involved nerves are the V1 (skin and 
lacrimal malignancies), V2 (skin, oral and nasal cavity and 
sinus malignancies) (Fig.  12.5), V3 (oral cavity- sublingual 
and submandibular gland and masticator space malignancies) 
[30], VII (parotid malignancies), and rarely the CN XII.
The perineural spread can be seen as an abnormal 
enhancement and thickening of the nerve on post-contrast FS 
T1-WI (Fig. 12.5). Comparison with the contralateral nerve 
facilitates the diagnosis. It is crucial to detect intracranial CN 
extension as it diminished therapeutic options and result in a 
poorer prognosis.
CN V and VII have several connections, often involved in 
perineural tumor spread, which allow tumoral spread along 
both nerves and their branches. Involvement of the connec-
tion between the maxillary nerve (V2) and vidian nerve (VII) 
at the level of the pterygopalatine fossa is the most frequently 
involved connection. Hence, the pterygopalatine fossa 
should always be checked in detail as its involvement often 
heralds intracranial extension along the above mentioned 
branches.
Paragangliomas
Paragangliomas are vascular tumors arising from glomus 
bodies located along carotid bulb and the vagus nerve in the 
carotid space, the jugular foramen, and the middle ear cav-
ity. They are easy to recognize on MRA as the typical fast 
blood flow in the arterial feeders can be recognized on 
these images, setting the final diagnosis. A “salt-and- 
pepper” appearance on post-contrast T1-WI is also classi-
cal (Fig. 12.4). These lesions can cause compression on any 
of the four lower CN into the carotid space. It is important 
to detect possible intracranial extension for surgical 
planning.
Metastases
Hematogenous metastases from malignant breast, kidney, 
lung, melanoma, prostate tumors to the head and neck region 
can involve all extracranial nerves with secondary CN 
disorders.
In the orbit, metastases from breast carcinomas are most 
frequent and compression on the nerve by orbital metastases 
is far more frequent than direct metastasis to the optic nerve 
itself.
Other CN III–XII can all be directly involved by the above 
mentioned metastases or indirectly by metastatic lymph 
nodes. CN involvement is best seen on post-contrast FS 
T1-WI in both axial and coronal planes.
12.6.5  Trauma
In addition to skull base fractures that threaten foraminal 
segment of CN, facial bones fractures may also insult extra-
cranial segment of CN (Fig. 12.6).
Branches of the trigeminal nerve (V) are at risk of injury, 
especially in case of: orbital roof and superior orbital fis-
sure fracture (V1); orbital floor and inferior orbital fissure 
fracture (V2), mandible (collum and between the mandibu-
lar and the mental foramina) and central skull base frac-
tures (V3).
Optic canal fracture threatens CN II and orbital apex frac-
ture CN III, IV, VI.
CT is needed to identify fractures and bone fragments dis-
placement which damage CN. CN contusions or shears are 
best seen on MR inversion recovery images through the 
nerves. Post-traumatic neuropathy can be recognized as 
thickened hyperintense nerves on MR neurography [8].
CN disorders may also be iatrogenic after sinonasal and 
periorbital surgery (II, III, IV, VI), tooth implant and man-
dibular surgery (V3), parotid surgery (VII), etc. Neck dissec-
tions can result in lower CN deficits (Fig. 12.5) and surgery 
in the lower neck can even damage the recurrent laryngeal 
nerve causing vocal cord palsy. The postsurgical scar 
 formation replaces the fat around the nerves on T1-WI and 
can enhance in the early postsurgical period.
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12.7  Conclusion
Cranial nerves disorders are frequent and reveal a broad vari-
ety of diseases. Imaging investigation has to be conducted in 
agreement with the medical history and presentation. Imaging 
CN coverage has to be discussed from nucleus to target. CT 
and CTA are useful to rule out symptomatic aneurysm and 
dissection and to better identify skull lesions and calcifica-
tions. MRI remains the best imaging modality for CN, and 
diffusion tractography can illustrate CN structural changes.
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Demyelinating disorders of the central nervous system (CNS) 
that affect the brain and spine have a variety of etiologies and 
can be separated into primary such as multiple sclerosis (MS) 
and other idiopathic inflammatory-demyelinating diseases 
(IIDDs) and secondary (e.g., infectious, ischemic, metabolic, 
or toxic) diseases. MRI is the imaging modality of choice to 
assess demyelinating disorders of the brain and the cord and, 
together with the clinical and laboratory findings, can accu-
rately classify them in most cases [1–3]. This review will high-
light the important imaging manifestations of some acquired 
demyelinating diseases that allow more specific diagnosis.
13.2  Idiopathic Inflammatory- 
Demyelinating Diseases (IIDDs) 
of the CNS
The term IIDD encompasses a broad spectrum of CNS disor-
ders that can be differentiated according to their severity, 
clinical course, and lesion distribution, as well as their imag-
ing, laboratory, and pathological findings. The spectrum 
includes monophasic, multiphasic, and progressive disor-
ders, ranging from highly localized forms to multifocal or 
diffuse variants [2]. Relapsing–remitting (RR) and second-
ary progressive (SP) MS are the two most common forms of 
IIDD.  MS can also have a progressive course from onset 
(primary progressive [PP]). Fulminant forms of IIDD include 
a variety of disorders that have in common the severity of the 
clinical symptoms, an acute clinical course, and atypical 
findings on MRI. The classic fulminant IIDD is Marburg dis-
ease but is extremely rare. Baló’s concentric sclerosis and 
acute disseminated encephalomyelitis (ADEM) can also 
present with severe, acute attacks.
Some IIDDs have a restricted topographic distribution, as 
is the case with neuromyelitis optica spectrum disorders 
(NMOSD), which can have a monophasic, but more often 
follows a relapsing course.
13
F. Barkhof (*) 
Department of Radiology and Nuclear Medicine, VU University 
Medical Center, Amsterdam, The Netherlands 
UCL Institutes of Neurology and Healthcare Engineering,  
London, UK
e-mail: f.barkhof@vumc.nl 
K. K. Koeller 
Section of Neuroradiology, Department of Radiology,  
Mayo Clinic, Rochester, MN, USA
Learning Objectives
• To be familiar with the differential diagnosis of 
white matter diseases
• Understand the importance of clinical setting, mode 
of presentation and lab results in idiopathic inflam-
matory disorders
• Be able to apply MS and NMO diagnostic criteria
• Appreciate the value of spinal cord imaging in the 
work- up of MS
• Recognize the most important variants and mimics 
of MS
Key Points
• Age-related white matter changes are extremely 
prevalent and affect the deep white matter with 
sparing of the U-fibers and spinal cord
• The McDonald criteria for MS include cortico/jux-
tacortical, periventricular, infratentorial and spinal 
cord lesions
• Longitudinally extensive spinal cord lesions and 
large/atypical brain lesions should prompt antibody 
testing to rule out NMOSD
• The differential diagnosis of symmetric white 
lesions includes toxic and metabolic disorders
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13.3  Multiple Sclerosis
MS is a progressive inflammatory, demyelinating and neuro-
degenerative autoimmune disease characterized pathologi-
cally by perivascular infiltrates of mononuclear inflammatory 
cells, demyelination, and axonal loss and gliosis, with the 
formation of focal and diffuse abnormalities in the brain and 
spinal cord, mainly affecting the optic nerves, brainstem, spi-
nal cord, and cerebellar and periventricular white matter, 
although cortical and subcortical gray matter damage is also 
prominent, resulting in chronic progressive disability for the 
majority of people with the disorder.
The high sensitivity of MRI in depicting brain and spinal 
cord demyelinating plaques has made this technique the most 
important paraclinical tool in current use, not only for the 
early and accurate diagnosis of MS, but also for understand-
ing the natural history of the disease and monitoring and pre-
dicting the efficacy of disease-modifying treatments [4].
MRI is the most sensitive imaging technique for detecting 
MS plaques throughout the brain and spinal cord. Proton den-
sity (PD) or T2-weighted MR images (especially acquired 
using the fluid-attenuated inversion recovery (FLAIR) 
sequence) show areas of high signal intensity in the periven-
tricular white matter in >90% of MS patients (the remainder 
may have cord lesions only). MS plaques are generally round 
to ovoid in shape and range from a few millimeters to more 
than 1 cm in diameter. They are typically discrete and focal at 
the early stages of the disease, but become confluent as the 
disease progresses, particularly in the posterior hemispheric 
periventricular white matter. MS plaques tend to affect the 
periventricular and juxtacortical white matter, whereas small 
vessel ischemic lesions tend to involve the deep white matter 
more [4]. The total T2 lesion volume of the brain increases by 
approximately 5–10% each year in the relapsing forms of MS.
Both acute and chronic MS plaques appear hyperintense 
on T2/FLAIR sequences, reflecting their increased tissue 
water content. The signal increase indicates edema, inflam-
mation, demyelination, reactive gliosis, and/or axonal loss in 
proportions that differ from lesion to lesion. The vast major-
ity of MS patients have at least one ovoid periventricular 
lesion, whose major axis is oriented perpendicular to the 
outer surface of the lateral ventricles. The ovoid shape and 
perpendicular orientation derive from the perivenular loca-
tion of the demyelinating plaques noted on histopathology 
(Dawson’s fingers).
MS lesions tend to affect specific regions of the brain, 
including the periventricular white matter, the inferior sur-
face of the corpus callosum, the cortico-juxtacortical regions, 
the temporal lobes, and the infratentorial regions. Focal 
involvement of the periventricular white matter in the ante-
rior temporal lobes is typical for MS and rarely seen in other 
white matter disorders, especially not in aging/hypertension 
(see table below). The lesions commonly found at the 
calloso- septal interface are best depicted by sagittal 
T2-FLAIR images—a sequence highly recommended for 
diagnostic MRI studies.
Characteristic differences between small-vessel disease (SVD) and 
MS
Involvement SVD MS
Corpus callosum Rare Common
U-fibers Rare Often
Brainstem Central pons Peripheral






Black holes Rare Typical
Lacunes Typical Never
Spinal cord Never Common
aWith the exception of cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy (CADASIL)
Histopathological studies have shown that a substantial 
portion of the total brain lesion load in MS is located within 
the cerebral cortex. Presently available MRI techniques are 
not optimal for detecting cortical lesions because of poor 
contrast resolution between normal-appearing gray matter 
(NAGM) and the plaques in question, and because of the 
partial volume effects of the subarachnoid spaces and CSF 
surrounding the cortex. Cortical lesions are better visual-
ized by 2D or 3D FLAIR sequences and newer MR tech-
niques such as 3D double inversion recovery (DIR) MR 
sequences which selectively suppress the signal from white 
matter and cerebrospinal fluid (CSF). Juxtacortical lesions 
that involve the “U” fibers are seen in two-thirds of patients 
with MS.
Posterior fossa lesions preferentially involve the floor of 
the fourth ventricle, the middle cerebellar peduncles, and the 
brainstem. Most brainstem lesions are contiguous with the 
cisternal or ventricular CSF spaces, and range from large 
confluent patches to solitary, well-delineated paramedian 
lesions or discrete “linings” of the CSF border zones. 
Predilection for these areas is a key feature that helps to iden-
tify MS plaques and to differentiate them from focal areas of 
ischemic demyelination and infarction that preferentially 
involve the central pontine white matter.
Approximately 10–20% of T2 hyperintensities are also 
visible on T1-weighted images as areas of markedly 
decreased signal intensity compared with gray matter. These 
so-called T1 black holes have a different pathological sub-
strate that depends, in part, on the lesion age. Temporary 
hypointensity is present in up to 80% of recently formed 
lesions and probably represents marked edema, with or with-
out myelin destruction or axonal loss. In most cases, the 
acute lesions become isointense within a few months as 
inflammatory activity abates, edema resolves, and reparative 
mechanisms like remyelination become active. Less than 
40% evolve into persisting or chronic “black holes” [5], 
which correlate pathologically with the most severe demye-
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lination and axonal loss, indicating areas of irreversible tis-
sue damage. Chronic black holes are more frequent in 
patients with progressive disease than in those with RRMS 
disease, and more frequent in the supratentorial white matter 
as compared with the infratentorial white matter. They are 
rarely found in the spinal cord and optic nerves.
MS lesions of the spinal cord resemble those in the brain. 
The lesions can be focal (single or multiple) or diffuse, and 
mainly affect the cervical cord segment. On sagittal scans, 
the lesions characteristically have a cigar shape and rarely 
exceed two vertebral segments in length (the so-called short- 
segment lesions in contrast to longitudinally extensive 
lesions in NMO). On cross-section, they typically occupy the 
lateral and posterior white-matter columns, border the sur-
face but may extend to involve the central gray matter, and 
rarely occupy more than one half the cross-sectional area of 
the spinal cord [6].
Acute spinal cord lesions can produce a mild to moderate 
mass effect with some spinal cord swelling and may show 
contrast enhancement. Active lesions are rarer in the spinal 
cord than the brain and are more frequently associated with 
new clinical symptoms. The prevalence of spinal cord abnor-
malities is as high as 74–92% in established MS, and depends 
on the clinical phenotype of MS. Asymptomatic spinal cord 
lesions are found in 30–40% of patients with a clinically iso-
lated syndrome (CIS), even if the presenting symptoms do 
not involve the spinal cord clinically. In RRMS, the spinal 
cord lesions are typically multifocal. In secondary progres-
sive MS, the abnormalities are more extensive and diffuse 
and are commonly associated with spinal cord atrophy. In 
primary progressive MS, spinal cord abnormalities are quite 
extensive as compared with brain abnormalities. This dis-
crepancy may help to diagnose primary progressive MS in 
patients with few or no brain abnormalities.
Longitudinal and cross-sectional MR studies have shown 
that the formation of new MS plaques is often associated with 
contrast enhancement, mainly in the acute and relapsing stages 
of the disease [7]. The gadolinium enhancement varies in size 
and shape, usually lasting a few weeks, although steroid treat-
ment shortens this period. Incomplete ring enhancement on 
T1-weighted gadolinium-enhanced images with the open bor-
der facing the gray matter of the cortex or basal ganglia is a 
common finding in active MS plaques and is a helpful feature 
for distinguishing between inflammatory- demyelinating lesions 
and other focal lesions such as tumors or abscesses which will 
have a closed ring of enhancement [8].
Contrast enhancement is a relatively good predictor of 
further enhancement and of subsequent accumulation of T2 
lesions, but shows no (or weak) correlation with progression 
of disability and development of brain atrophy. In RRMS 
and early SPMS, enhancement is more frequent during 
relapses and correlates well with clinical activity. For patients 
with primary progressive MS, serial T2-weighted studies 
show few new lesions and less frequent enhancement. 
Contrast-enhanced T1-weighted images are routinely used in 
the study of MS to provide a measure of inflammatory activ-
ity in vivo.
MRI-based disease activity is 5–10 times more frequently 
than clinical evaluation of relapses, suggesting that most of 
the enhancing lesions are clinically silent. Subclinical dis-
ease activity with contrast-enhancing lesions is 4–10 times 
less frequent in the spinal cord than the brain, a fact that may 
be partially explained by the large volume of brain as com-
pared with spinal cord. High doses of gadolinium and a long 
post-injection delay can increase the detection of active spi-
nal cord lesions.
The diagnosis of MS relies heavily on MRI information, 
certainly when there is a clinically isolated syndrome sug-
gestive of demyelination. MRI can be used to show dissemi-
nation in space (lesions 2 of 4 locations - juxtacortical, 
periventricular, infratentorial or spinal cord) and to demon-
strate dissemination in time (enhancement or new t2 lesions 
at follow-up).
13.4  Multiple Sclerosis Variants
13.4.1  Baló’s Concentric Sclerosis
Baló’s concentric sclerosis is a rare IIDD subtype, consid-
ered a variant of MS, with characteristic radiologic and 
pathologic features. The disease was formerly considered an 
aggressive MS variant, leading to death in weeks to months 
after onset, and in which the diagnosis was made on histo-
pathologic findings at postmortem examination. However, 
with the widespread use of MRI, this MS variant is often 
identified in patients who later have a complete or almost 
complete clinical recovery [9]. The pathologic hallmarks of 
are large demyelinated lesions showing a peculiar pattern of 
alternating layers of preserved and destroyed myelin. One 
possible explanation for this pattern is that sublethal tissue 
injury is induced at the edge of the expanding lesion, which 
would then stimulate expression of neuroprotective proteins 
to protect the rim of peri-plaque tissue from damage, thereby 
resulting in alternating layers of preserved and non-preserved 
myelinated tissue [10]. These alternating bands are best 
identified with T2-weighted sequences, which typically 
show thick concentric hyperintense bands corresponding to 
areas of demyelination and gliosis, alternating with thin 
isointense bands corresponding to normal myelinated white 
matter. This pattern can be also identified on T1-weighted 
images as alternating isointense (preserve myelin) and 
hypointense (demyelinated) concentric rings. These bands, 
which may eventually disappear over time, can appear as 
multiple concentric layers (onion-skin lesion), as a mosaic, 
or as a “floral” configuration. The center of the lesion usually 
shows no layering because of massive demyelination (“storm 
center”). Restricted diffusion followed by contrast enhance-
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ment is common in the outer rings (inflammatory edge) of 
the lesion.
The Baló pattern on MRI can be isolated, multiple, or 
combined with typical MS-like lesions, and the lesion struc-
ture can vary from one or two to several alternating bands, 
with a total size from one to several centimeters. Lesions 
occur predominantly in the cerebral white matter, although 
brainstem, cerebellum, and spinal cord involvement has also 
been reported [11].
13.4.2  Neuromyelitis Optica Spectrum 
Disorders
Neuromyelitis optica (NMO) is an autoimmune inflamma-
tory disorder of the CNS with a predilection for the optic 
nerves and spinal cord [12]. The discovery of an NMO-
specific autoantibody directed against aquaporin- 4 
(AQP4-Ab), the major water channel in the CNS, clearly 
identified NMO as a disease separate from MS—and requir-
ing a different treatment than MS [13, 14].
This uncommon and topographically restricted form of 
IIDD is characterized by severe unilateral or bilateral optic 
neuritis and complete transverse myelitis, which occur 
simultaneously or sequentially over a varying period (weeks 
or years). The index events of new-onset NMO are severe 
unilateral or bilateral optic neuritis, acute myelitis, or a 
combination of these symptoms. The myelitis attacks appear 
as complete transverse myelitis with severe bilateral motor 
deficits, sensory-level, bowel and bladder dysfunction, pain 
and significant residual neurologic injury. Optic neuritis 
attacks are generally more severe than those typically seen 
in MS.
Approximately 85% of patients have a relapsing course 
with severe acute exacerbations and poor recovery, which 
leads to increasing neurologic impairment and a high risk of 
respiratory failure and death due to cervical myelitis. Patients 
who experience acute optic neuritis and transverse myelitis 
simultaneously or within days of each other are much more 
likely to have a monophasic course. On the other hand, a 
relapsing course correlates with NMO-IgG seropositivity, a 
longer interval between attacks, older age at onset, female 
gender, and less severe motor impairment after the myelitic 
onset. Although the initial attacks are more severe in patients 
proven to have monophasic NMO, the long-term neurologic 
prognosis is somewhat better in this group because patients 
do not accumulate disability from recurrent attacks.
Clinical features alone are insufficient to diagnose NMO; 
CSF analysis and MRI are usually required to confidently 
exclude other disorders. CSF pleocytosis (>50 leukocytes/
mm3) is often present, while oligoclonal bands are seen less 
frequently (20–40%) than in MS patients (80–90%). 
AQP4-Ab detection is best performed using cell-based 
assays that have greater sensitivity. AQP4-Ab distinguish 
this form of IIDD from MS and it can predict relapse and 
conversion to NMO in patients presenting with a single 
attack of longitudinally extensive myelitis. NMO-IgG is pos-
itive in 52% of patients with relapsing transverse myelitis 
and in 25% of patients with recurrent idiopathic optic neuri-
tis [15].
Wingerchuk et al. [16] proposed a revised set of criteria 
for diagnosing NMO.  These criteria remove the absolute 
restriction on CNS involvement beyond the optic nerves and 
spinal cord, allow any interval between the first events of 
optic neuritis and transverse myelitis, and emphasize the 
specificity of longitudinally extensive spinal cord lesions on 
MRI and NMO-IgG-seropositive status. More recently the 
International Panel for NMO Diagnosis developed new diag-
nostic criteria that define the unifying term NMOSD, which 
is stratified by serologic testing (with or without AQP4-IgG) 
[17]. These new criteria require, in patients with AQP4-IgG, 
core clinical and MRI findings related to optic nerve, spinal 
cord, area postrema, other brainstem, diencephalic, or cere-
bral presentations. However, more stringent clinical and 
MRI criteria are required for diagnosis of NMO-spectrum 
disorders without AQP4-IgG or when serologic testing is 
unavailable.
Diagnostic Criteria for NMOSD Without or Unknown 
AQP4-IgG Status
 1. At least two core clinical characteristics occurring as a 
result of one or more clinical attacks and meeting all of 
the following requirements:
 a. At least one core clinical characteristic must be optic 
neuritis, acute myelitis with LETM, or area postrema 
syndrome
 b. Dissemination in space (two or more different core 
clinical characteristics)
 c. Fulfillment of additional MRI requirements, as appli-
cable (see below)
 2. Negative tests for AQP4-IgG using best available detec-
tion method or testing unavailable
 3. Exclusion of alternative diagnoses
Additional MRI Requirements
 1. Acute optic neuritis: requires brain MRI showing
 a. Normal findings or only nonspecific white matter 
lesions
 b. Optic nerve MRI with T2w-hyperintense lesion or 
T1-weighted gadolinium-enhancing lesion extending 
over >1/2 optic nerve length or involving optic 
chiasm
 2. Acute myelitis: requires associated intramedullary MRI 
lesion extending over ≥3 contiguous segments (LETM) 
or ≥3 contiguous segments of focal spinal cord atrophy in 
patients with history compatible with acute myelitis
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 3. Area postrema syndrome: requires associated dorsal 
medulla/area postrema lesions
 4. Acute brainstem syndrome: requires associated periepen-
dymal brainstem lesions
MRI of the affected optic nerve demonstrates swelling and 
loss of blood–brain barrier integrity with gadolinium enhance-
ment that can extend into the optic chiasm. The spinal cord 
lesions in NMO typically extend over three or more contigu-
ous vertebral segments and occasionally the entire spinal cord 
(longitudinally extensive spinal cord lesions); they are cen-
trally located (preferential central gray-matter involvement) 
and affect much of the cross-section on axial images. During 
the acute and subacute phase, the lesions are tumefactive and 
show contrast uptake. In some cases, the spinal cord lesions 
are small at the onset of symptoms, mimicking those of MS, 
and then progress in extent over time. The presence of very 
hyperintense spotty lesions on T2-weighted images (“bright 
spotty sign”) is a specific feature that helps differentiate NMO 
from MS, particularly in patients without longitudinally 
extensive spinal cord lesions [6, 11, 12], and likely reflects the 
highly destructive component of the inflammatory lesion. 
Spinal cord lesions can progress to atrophy and necrosis and 
may lead to syrinx-like cavities on T1-weighted images.
NMO was long considered a disease without brain 
involvement, and a negative brain MRI at disease onset was 
considered a major supportive criterion for the diagnosis of 
NMO. However, various studies have shown that brain MRI 
abnormalities exist in a significant proportion (50–85%) of 
patients [18]. Brain MRI lesions are often asymptomatic, but 
sometimes are associated with symptoms even at disease 
onset. The brain lesions are commonly nonspecific. They can 
be dot-like or patchy, <3 cm in diameter, and located in the 
deep white matter, brainstem, or cerebellum. Nonetheless, 
some brain MRI features appear to be quite characteristic 
and distinct from MS lesions. These abnormalities may par-
allel sites with high AQP4 expression adjacent to the ven-
tricular system at any level, such as the hypothalamus, 
periependymal areas surrounding the third and lateral ven-
tricles, cerebral aqueduct, corpus callosum, and dorsal brain-
stem adjacent to the fourth ventricle. The appearance of 
periventricular lesions in NMO is quite characteristic. In 
contrast to MS, where periventricular lesions are discrete, 
oval-shaped, and perpendicular to the ependymal lining due 
to their perivenular distribution (Dawson’s fingers), NMO 
lesions are not oval-shaped, located immediately adjacent to 
the lateral ventricles following the ependymal lining in a dis-
seminated pattern, and are often edematous and heteroge-
neous [18]. As opposed to what occurs in MS, NMO lesions 
do not affect the cortical gray matter.
Involvement of the corpus callosum has been described in 
18% of AQP4-seropositive NMO patients. The lesions are 
multiple, large, and edematous, show heterogeneous signal 
intensity on T2-weighted images, and sometimes affect the 
entire thickness of the corpus callosum.
Lesions may also affect areas where AQP4 expression is 
not particularly high, such as the corticospinal tracts. These 
lesions, which can be unilateral or bilateral and may affect 
the posterior limb of the internal capsule and cerebral pedun-
cle of the midbrain, are contiguous and often longitudinally 
extensive [19].
Other brain MRI findings described in NMO include 
extensive and confluent hemispheric white-matter lesions 
and radial hemispheric lesions (sometimes corresponding to 
an extension of periventricular lesions), which are likely 
related to vasogenic edema involving the white-matter tracts. 
These lesions usually do not show mass effect or contrast 
enhancement, but there may be a “cloud-like” pattern of 
enhancement, defined as multiple patches of enhancing 
lesions with blurred margins [18]. In fact, the finding of large 
hemispheric lesions in a patient suspected of MS should trig-
ger the option of NMO and testing for AQP4 antibodies.
Some of the typical brain MRI findings may be specific to 
clinical presentations, such as intractable vomiting and hic-
cup (linear dorsal medullary lesions involving the area pos-
trema and nucleus tractus solitarius), or a syndrome of 
inappropriate antidiuretic hormone secretion (hypothalamic 
and periaqueductal lesions) [18].
Distinguishing NMO from MS is critical, particularly in 
the early stages, since the treatment and prognosis of these 
disorders differ. In fact, some evidence suggests that 
MS-modifying treatments such as interferon-ß, natalizumab, 
and laquinimod exacerbate NMO.  By contrast, several 
immunosuppressants (e.g., azathioprine, rituximab, mito-
xantrone) seem to help in preventing NMO relapses.
NMOSD can be associated with systemic autoimmune 
diseases such as systemic lupus erythematosus and Sjögren’s 
syndrome). Whether the neurologic manifestations are solely 
due to NMO-spectrum disorder or are a manifestation of 
these diseases is controversial, although optic neuritis and 
transverse myelitis are rare presentations of them, and sev-
eral studies have shown that patients with systemic autoim-
mune diseases and NMO-IgG-positive antibodies always 
have optic neuritis, myelitis, or NMO.
13.4.3  Acute Disseminated Encephalomyelitis 
(ADEM)
ADEM is a severe, immune-mediated inflammatory disorder 
of the CNS that predominantly affects the white matter of the 
brain and spinal cord. In the absence of specific biologic 
markers, the diagnosis of ADEM is based on clinical and 
radiologic features [20]. This disorder affects children more 
commonly than adults, and, in contrast to MS, shows no 
 gender preponderance. The estimated incidence is 0.8 per 
13 Demyelinating Diseases of the CNS (Brain and Spine)
170
100,000 population per year. In most cases, the clinical onset 
of disease is preceded by viral or bacterial infections, usually 
nonspecific upper-respiratory-tract infections. ADEM may 
also develop following a vaccination (postimmunization 
encephalomyelitis). Patients commonly present with non-
specific multifocal symptoms, which developed subacutely 
over a period of days, frequently associated with encepha-
lopathy (relatively uncommon in MS), defined as an altera-
tion in consciousness (e.g., stupor, lethargy) or a behavioral 
change unexplained by fever, systemic illness, or postictal 
symptoms. Although ataxia, encephalopathy, and brainstem 
symptoms are frequently present in both pediatric and adult 
cases, certain signs and symptoms appear to be age-related. 
In childhood ADEM, long-lasting fever and headaches occur 
more frequently, while in adult cases, motor and sensory 
deficits predominate. In general, the disease is self-limiting 
and the prognostic outcome favorable.
Although ADEM usually has a monophasic course, multi-
phasic forms have been reported, raising diagnostic difficul-
ties in distinguishing these cases from MS. This multiphasic 
form, which accounts for <4% of ADEM cases, is defined as 
a new encephalopathic event consistent with ADEM, sepa-
rated by 3 months after the initial illness but not followed by 
any further events. The second ADEM event can involve 
either new or re-emergent neurologic symptoms, signs, and 
MRI findings. Relapsing disease following ADEM that 
occurs beyond a second encephalopathic event is no longer 
consistent with multiphasic ADEM but rather indicates a 
chronic disorder, most often leading to the diagnosis of MS or 
NMO [21] and should prompt testing for myelin oligodendro-
cyte glycoprotein (MOG) antibodies, especially in children.
An ADEM event as the first manifestation of the classic 
relapsing form of MS occurs in 2–10%. According to the 
International Pediatric Multiple Sclerosis Study Group, the 
diagnosis of MS is met if, after the initial ADEM, a second 
clinical event meets the following three requirements: (1) it 
is non-encephalopathic; (2) it occurs 3 months or more after 
the incident neurologic illness; and (3) it is associated with 
new MRI findings consistent with the McDonald criteria for 
dissemination in space [21]. The presence of hypointense 
lesions and two or more periventricular lesions are MRI fea-
tures that support an MS diagnosis in children with acute 
CNS demyelination [21]. Unlike the lesions in MS, ADEM 
lesions are often large, patchy, and poorly marginated on 
MRI, especially when there are MOG antibodies [22]. There 
is usually asymmetric involvement of the subcortical and 
central white matter and cortical gray–white junction of the 
cerebral hemispheres, cerebellum, brainstem, and spinal 
cord. Lesions confined to the periventricular white matter 
and corpus callosum are less common than in MS. The gray 
matter of the thalamus and basal ganglia is often affected, 
particularly in children, and typically in a symmetric pattern 
[23]. However, the frequency of thalamic involvement in 
adult ADEM does not differ from that of adult MS. This can 
be explained by the fact that involvement of this structure is 
less common in adult ADEM than in childhood ADEM. Four 
patterns of cerebral involvement have been proposed to 
describe the MRI findings in ADEM [24]: (1) ADEM with 
small lesions (<5 mm); (2) ADEM with large, confluent, or 
tumefactive lesions, and frequent extensive perilesional 
edema and mass effect; (3) ADEM with additional symmet-
ric deep gray-matter involvement; and (4) acute hemorrhagic 
encephalomyelitis. Gadolinium enhancement of one or more 
lesions occurs in 14–30% of cases [21]. The pattern of 
enhancement varies and can be complete or incomplete ring-
shaped, nodular, gyral, or spotty. Although ADEM is usually 
a monophasic disease, new lesions may be seen on follow-up 
MRI within the first month of the initial attack.
Most MRI lesions appear early in the course of the dis-
ease, supporting the clinical diagnosis of ADEM. Nonetheless, 
in some cases, there may be a delay of more than 1 month 
between the onset of symptoms and the appearance of lesions 
on MRI. Therefore, a normal brain MRI scan obtained within 
the first days after the onset of neurologic symptoms sugges-
tive of ADEM does not exclude this diagnosis.
The spinal cord is affected in <30% of ADEM patients 
[24], predominantly in the thoracic region. The spinal cord 
lesion is typically large, causes swelling, and shows variable 
enhancement. In most ADEM patients, partial or complete 
resolution of the MRI abnormalities occurs within a few 
months of treatment. This course is positively associated 
with a final diagnosis of ADEM.
13.5  Infectious Inflammatory 
Demyelinating Disorders
13.5.1  Progressive Multifocal 
Leukoencephalopathy
Progressive multifocal leukoencephalopathy (PML) is over-
whelmingly a disease of the immunocompromised patient 
and most (55–85%) cases are related to acquired immunode-
ficiency syndrome (AIDS). There is a wide age range of 
involvement, with the peak age of presentation in the sixth 
decade. The disease is caused by reactivation a papovavirus 
(JC virus) that selectively attacks the oligodendrocyte, lead-
ing to demyelination. Treatment with monoclonal antibody 
therapy (natalizumab, rituximab, efalizumab) or other immu-
nomodulatory drugs, commonly used in patients with MS and 
other disorders has also been linked with PML [25]. Untreated 
patients with PML have an extremely poor prognosis, with 
death common in the first 6 months following establishment 
of the diagnosis. Although there is no specific treatment, 
combination anti-retroviral therapy (cART) has not only 
resulted in a lower incidence of PML in AIDS patients, but 
also substantially improved survival times of afflicted 
patients, now at 50% 1-year survival [25]. Unfortunately, 
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about 20% of PML cases are linked to a robust inflammatory 
response to pathogens associated with recovery of the immune 
system after a period of immunosuppression. This condition, 
known as PML-IRIS (Immune Reconstitution Inflammatory 
Syndrome), has been associated with intracranial masses with 
generous amounts of surrounding vasogenic edema on 
MRI. Enhancement may also occur [25].
The lesions of PML are characterized by little mass effect 
or enhancement. Most lesions involve the subcortical white 
matter and deep cortical layers of the parieto-occipital or 
frontal white matter, although gray matter and posterior 
fossa lesions are also common, occurring in up to 50% of 
cases. PML lesions tend to be more confluent in their appear-
ance than ADEM lesions and scalloping of the lateral margin 
of the lesion at the gray matter-white matter junction is com-
mon. Subtle signal intensity changes in the white matter may 
precede clinical suspicion of the PML-IRIS. While develop-
ment of mass effect and temporary enhancement in the early 
phase of cART has been linked to better survival, similar 
imaging manifestations may also be seen in monoclonal- 
antibody treated PML patients [25].
13.5.2  Human Immunodeficiency Virus 
Encephalopathy
Human immunodeficiency virus (HIV) encephalopathy 
results from direct infection of the brain by the virus itself. 
Since the advent of cART, the prevalence of the disease has 
markedly decreased and the temporal progression has been 
slowed. Most patients are severely immunocompromised at 
the time of onset and exhibit psychomotor slowing, impaired 
mental status, and memory difficulties. Histologically, demy-
elination and vacuolation with axonal loss are noted, along 
with occasional microglial nodules. Mild cerebral atrophy is 
the first and sometimes only imaging feature of AIDS demen-
tia complex, also know as HIV dementia, HIV-associated 
dementia complex, or as HIV- associated neuron-cognitive 
disorder (HAND). Involvement of the central white matter, 
basal ganglia, and thalamus is characteristic. Typically, bilat-
erally symmetric abnormal T2 hyperintensity in the basal 
ganglia and small focal areas in the periventricular regions 
are noted on T2-weighted MR images [26]. Regression of 
these findings has been seen following institution of cART.
13.6  White Matter Disease from Toxic 
Imbalance
13.6.1  Chronic Alcohol Ingestion  
and its Consequences
Brain abnormalities in alcoholics include atrophy, 
Marchiafava–Bignami disease, Wernicke encephalopathy, 
osmotic myelinolysis, and consequences of liver cirrhosis 
such as hepatic encephalopathy and coagulopathy [27]. All 
the reported entities are not specific of alcohol and can be 
found in many other toxic or metabolic conditions. Ethanol 
direct brain toxicity is caused by under-regulation of recep-
tors of N-methyl-D-aspartate, abnormal catabolism of homo-
cysteine, resulting in an increased susceptibility to glutamate 
excitatory and toxic effects. Moreover, immune response 
occurs mediated by lipid peroxidation products that bind to 
neurons resulting in neurotoxicity. Neuroimaging studies 
show a characteristic distribution of loss of volume: initially 
there is infratentorial predominance with atrophy of the cer-
ebellar vermis and hemispheres. Frontal and temporal atro-
phy is subsequently evident, followed by diffuse atrophy of 
the brain. The possibility of partial reversibility of these 
alterations is also observed. In pregnancy, ethanol deter-
mines inhibition of maturation of Bergmann’s fibers of cer-
ebellum, with consequential marked cerebellar atrophy.
13.6.2  Hepatic Encephalopathy
The term hepatic encephalopathy (HE) includes a wide spec-
trum of neuropsychiatric abnormalities occurring in patients 
with liver dysfunction. Most cases are associated with cirrho-
sis and portal hypertension or portal-systemic shunts, but the 
condition can also be seen in patients with acute liver failure 
and rarely, those with portal-systemic bypass and no associ-
ated intrinsic hepatocellular disease. Although HE is a clini-
cal condition, several neuroimaging techniques, particularly 
MRI, may eventually be useful for the diagnosis because they 
can identify and measure the consequences of CNS increase 
in substances, which, under normal circumstances, are effi-
ciently metabolized by the liver. Classical MR abnormalities 
in chronic HE include high signal intensity in the globus pal-
lidum on T1-weighted images, likely a reflection of increased 
tissue concentrations of manganese, and an elevated gluta-
mine/glutamate peak coupled with decreased myo-inositol 
and choline signals on proton MR spectroscopy, representing 
disturbances in cell-volume homeostasis secondary to brain 
hyperammonemia [28]. Recent data have shown that white 
matter abnormalities, also related to increased CNS ammonia 
concentration, can also be detected with several MRI tech-
niques: magnetization transfer ratio measurements show sig-
nificantly low values in otherwise normal-appearing brain 
white matter, T2-Flair sequences reveal diffuse and focal high 
signal intensity lesions in the hemispheric white matter, and 
DWI discloses increased white matter diffusivity. All these 
MR abnormalities, which return to normal with restoration of 
liver function, probably reflect the presence of mild diffuse 
interstitial brain edema, which seems to play an essential role 
in the pathogenesis of HE.
In acute HE, bilateral symmetric signal-intensity abnor-
malities on T2-weighted images, often with associated 
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restricted diffusion involving the cortical gray matter, are 
commonly identified. Involvement of the subcortical white 
matter and the basal ganglia, thalami, and midbrain may also 
be seen. These abnormalities that can lead to intracranial 
hypertension and severe brain injury reflect the development 
of cytotoxic edema secondary to the acute increase of brain 
hyperammonemia.
13.6.3  Marchiafava–Bignami Disease
Marchiafava–Bignami disease is a rare complication of 
chronic alcoholism, characterized by demyelination and 
necrosis of the corpus callosum, with rare involvement of 
extracallosal regions. Etiology remains unknown but is 
believed to be caused by toxic agents in red wine of low 
quality and lack of group B vitamins. Rarely, the disease has 
also been reported in non-alcoholic patients. Symptoms are 
mainly represented by cognitive deficits, psychosis, hyperto-
nia, and interhemispheric disconnection, until coma and 
death. Typical MRI features in the acute phase are corpus 
callosum hyperintensity on T2-weighted sequences and 
FLAIR, without significant mass effect, with peripheral 
enhancement. Diffusion is restricted due to cytotoxic edema. 
In chronic forms, necrosis of the genu and splenium can be 
detected [29].
13.6.4  Wernicke Encephalopathy
Wernicke encephalopathy is an acute condition first 
described by the French ophthalmologist Gayet in 1875, and 
later by the German neurologist Wernicke in 1881, caused 
by a deficiency of B1 (thiamine). It develops frequently but 
not exclusively in alcoholics. Other potential causes include 
extended fasting, malabsorption, digitalis poisoning, mas-
sive infusion of glucose without B1 in weak patients. The 
autoptic incidence is reported to be 0.8–2% in random 
autopsies, and 20% in chronic alcoholics. The classic clini-
cal triad of ocular dysfunctions (nystagmus, conjugate gaze 
palsy, ophthalmoplegia), ataxia, and confusion is observed 
in only 30% of cases. Treatment consists of thiamine infu-
sion, and avoids irreversible consequences including 
Korsakoff dementia or death. Memory impairment and 
dementia are related to damage of the mammillary bodies, 
anterior thalamic nuclei and interruption of the dience-
phalic-hippocampal circuits. Depletion of thiamine leads to 
failure of conversion of pyruvate to acetyl-CoA and 
α-ketoglutarate to succinate, altered pentose monophos-
phate shunt, and the lack of Krebs cycle, with cerebral lactic 
acidosis, intra- and extra-cellular edema, swelling of astro-
cytes, oligodendrocytes, myelin fibers, and neuronal den-
drites. Neuropathological aspects include neuronal 
degeneration, demyelination, hemorrhagic petechiae, pro-
liferation of capillaries and astrocytes in peri-aqueductal 
gray substance, mammillary bodies, thalami, pulvinar, III 
cranial nerves nuclei, and cerebellum. On MRI, bilateral 
and symmetrical hyperintensities on T2-weighted sequences 
and FLAIR are evident at the level of the already mentioned 
structures, mainly mammillary bodies and thalami [30, 31]. 
Rarely, cortex of the forebrain can be involved. DWI shows 
areas of reduced apparent diffusion coefficient (ADC) due 
to cytotoxic edema, although the ADC can sometimes be 
high due to the presence of vasogenic component. Rarely, 
T1-weighted images show bleeding ecchymotic hemor-
rhages in the thalami and mammillary bodies, a sign consid-
ered clinically unfavorable. In 50% of cases, contrast 
enhancement is present in periaqueductal regions. Marked 
contrast enhancement of mammillary bodies is evident in 
80% of cases, even prior to the development of visible 
changes in T2-weighted sequences and is considered highly 
specific for WE.  In chronic forms, change of signal in 
T2-weighted sequences becomes less prominent due to the 
diffuse brain atrophy, more pronounced at the level of mes-
encephalon and mammillary bodies.
13.6.5  Osmotic Demyelination Syndrome
Osmotic demyelination syndrome (ODS) usually occurs in 
the setting of osmotic changes, typically with the rapid cor-
rection of hyponatremia. This causes destruction of the 
blood–brain barrier with hypertonic fluid accumulation in 
extracellular space, resulting in a non-inflammatory demye-
lination. The most common damage is in the pontine fibers 
[32]. ODS is observed in alcoholics with nutritional defi-
ciency. The most common symptoms include paralysis, dys-
phagia, dysarthria, and pseudobulbar palsy. Death is frequent. 
Rarely, ODS affects other regions, especially basal ganglia, 
thalami, deep white matter. MRI usually shows an area of 
high signal on T2-weighted sequences in the central part of 
the pons (central pontine myelinolysis), sparing ventro-lat-
eral portions and corticospinal tracts. The lesion is moder-
ately hypointense in T1 and may show positive contrast 
enhancement. If the patient survives, the acute phase can 
evolve into a cavitated pontine lesion.
13.7  White Matter Disease Associated 
with Radiation Therapy 
and Chemotherapy
Treatment strategies designed to target cancer cells are com-
monly associated with deleterious effects to multiple organ 
systems, including the CNS. As both radiation and chemo-
therapy alone can be associated with significant toxicity, the 
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combination of radiation and chemotherapy may be particu-
larly harmful to the CNS. With advanced treatment regimens 
and prolonged survival, neurological complications are 
likely to be observed with increasing frequency.
Neurotoxicity can result from direct toxic effects of the 
drug or radiation on the cells of the CNS, or indirectly 
through metabolic abnormalities, inflammatory processes, or 
vascular adverse effects.
Recognition of treatment-related neurologic complica-
tions is critically important, because symptoms may be con-
fused with metastatic disease, tumor progression, 
paraneoplastic disorders, or opportunistic infections, and 
discontinuation of the offending drug may prevent irrevers-
ible CNS injury.
13.7.1  Radiation Injury and Necrosis
It is widely accepted that the white matter of the CNS is 
prone to radiation-induced injury, compared with gray mat-
ter. Radiation encephalopathy has been classically divided 
into three stages according to its timing after radiotherapy: 
early, early-delayed, and late-delayed reactions [33]. Within 
the first several weeks of therapy, patients may experience 
acute declines with focal neurologic deficits. These effects 
are possibly related to increased edema, which has been 
supported by the observation that steroid treatment often 
results in clinical improvement. Early-delayed adverse 
effects usually occur within 1–6  months of treatment and 
are thought to be a result of demyelination. This syndrome 
is characterized by somnolence, fatigue, and cognitive dys-
function, consistent with dysfunction of the frontal network 
systems. Late- delayed side effects occur months to years 
after cessation of treatment and are largely irreversible and 
progressive. These late changes are commonly associated 
with progressive cognitive deficits. In more severe cases of 
late-delayed radiation injury, imaging and histopathological 
studies may demonstrate leukoencephalopathy and/or focal 
necrosis.
In all types of white matter radiation-induced damage, CT 
and mainly MRI may demonstrate variable degrees of white 
matter signal changes related to an increase in free tissue 
water in the involved areas. This may result from endothelial 
damage, causing increased capillary permeability and vaso-
genic edema, or from demyelination. However, the degree of 
these white matter changes correlates poorly with the func-
tional deterioration observed in the patients. MRI findings in 
early reactions occurring during course of treatment are non-
specific. MRI may be normal or demonstrate poorly defined 
multifocal lesions in both hemispheres that usually disappear 
spontaneously. MRI in early-delayed reactions also may 
show signal changes involving not only the hemispheric 
white matter but also the basal ganglia and the cerebral 
peduncles, which resolve completely without treatment. 
These early-delayed changes have been reported in children 
with acute lymphatic leukemia who have been treated with 
both whole brain irradiation and chemotherapy. These 
changes have no correlation with clinical manifestations and 
have no clear prognostic significance. Late-delayed reactions 
can be subdivided into diffuse and focal radiation necrosis 
injury.
Diffuse radiation injury is characterized by white mat-
ter changes that are “geographic” in nature, i.e., the areas 
of abnormal signal intensity or attenuation are limited to 
the regions of the brain that conform to the radiation por-
tal. This can produce striking differences between the 
involved zones and the spared surrounding white matter. 
The involved territories are often symmetric and do not 
enhance on post- contrast studies. While originally 
reported in children with leukemia, diffuse necrotizing 
leukoencephalopathy has also been observed following 
treatment for many other malignancies in both children 
and adults. The disease may occur following chemother-
apy alone, but the incidence of disease is highest when 
chemotherapy is combined with radiation therapy. Both 
the histologic findings and imaging features bear resem-
blance to radiation necrosis. Axonal swelling, demyelin-
ation, coagulation necrosis, and gliosis dominate the 
histologic picture.
Diffuse white matter changes, with hypoattenuation on 
CT and T1 and T2 prolongation on MRI, are common and 
often involve an entire hemisphere. Microbleeds can occur 
as a sign of vasculopathy. Radiation-induced leukoenceph-
alopathy may be associated with progressive brain atro-
phy, and patients may present with cognitive decline, gait 
abnormalities, and urinary incontinence. However, the 
more common mild-to-moderate cognitive impairment is 
inconsistently associated with radiological findings, and 
frequently occurs in patients with normal-appearing scans. 
Recently, more sensitive tools to quantify the damage to 
brain tissue, such as diffusion tensor imaging (DTI) have 
been applied in patients treated with brain radiotherapy 
and have shown early and progressive diffuse changes in 
normal-appearing white matter indicating radiation-
induced demyelination and mild structural degradation of 
axonal fibers, which are undetectable with conventional 
MRI.
Focal radiation necrosis usually manifests as a ring-like 
or irregular enhancing mass lesion located in the white mat-
ter, which may become hemorrhagic. The MRI features 
 commonly seen in radiation necrosis include a soap bubble-
like interior and Swiss cheese-like interior. Compared with 
lesions with the soap bubble pattern, Swiss cheese lesions 
are larger, more variable in size, and more diffuse. This pat-
tern can be visualized as a result of diffuse necrosis affecting 
the white matter and cortex with diffuse enhancement at the 
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margins with intermixed foci of necrosis. The rim of enhance-
ment is often thinner, more uniform, and more aligned to the 
gray matter-white matter junction than in malignant tumors. 
As radiation necrosis progresses, it can lead to severe shrink-
age of the white matter and cortex and result in focal brain 
atrophy with hydrocephalus.
Quite frequently is impossible to distinguish radiation 
necrosis from recurrent malignant brain tumor, such as glio-
blastoma multiforme, using conventional MRI.  Metabolic 
imaging (e.g., positron emission tomography) may facilitate 
differentiating between the two diseases as radiation necrosis 
is iso-to-hypometabolic while recurrent high-grade tumors 
are typically hypermetabolic. MR spectroscopy (MRS) may 
also be useful as radiation necrosis frequently shows a char-
acteristic lactic acid peak and near-normal peaks for N-acetyl-
aspartate (NAA) and choline while recurrent high- grade 
gliomas typically show elevated choline levels compared to 
NAA without or with elevated lactic acid levels. Perfusion 
imaging can identify the areas of increased blood flow associ-
ated with tumor recurrence, whereas radiation necrosis is not 
expected to contain any increased blood flow [34].
13.7.2  Chemotherapy-Associated 
Neurotoxicity
Neurotoxicity has been observed with virtually all categories 
of chemotherapeutic agents [35]. Neurologic complications 
may range from acute encephalopathy, headache, seizures, 
visual loss, cerebellar toxicity, and stroke to chronic side 
effects, including chronic encephalopathy, cognitive decline, 
and dementia.
Among the most puzzling aspects of cancer therapy- 
related toxicity is the occurrence of delayed and progressive 
neurological decline, even after cessation of treatment. 
Anticancer agents affect brain function through both direct 
and indirect pathways. It is also conceivable that additional 
variables play important roles, including the timing of treat-
ment, combination of different treatment modalities, patient 
age, integrity of the blood–brain barrier, and cognitive func-
tion prior to treatment initiation.
Imaging studies have provided evidence that structural 
and functional CNS changes occur in a significant number of 
patients treated with chemotherapy. Some agents, such as 
methotrexate or carmustine, are well known to cause a leu-
koencephalopathy syndrome, especially when administered 
at a high dose, intrathecally, or in combination with cranial 
radiotherapy. Nonenhancing, confluent, periventricular 
white matter lesions, necrosis, ventriculomegaly, and corti-
cal atrophy characterize this syndrome. White matter abnor-
malities following high-dose chemotherapy have been 
detected in up to 70% of treated individuals and usually have 
a delayed onset of several months.
A delayed leukoencephalopathy syndrome with distinct 
DWI abnormalities on MRI indicative of cytotoxic edema 
within cerebral white matter has been recently described. 
This syndrome appeared to mimic a stroke-like syndrome 
and has seen mainly in patients receiving methotrexate, 
5-fluorouracil (5-FU), carmofur, and capecitabine.
13.8  Vascular Causes of White Matter 
Disease
13.8.1  Posterior Reversible Encephalopathy 
Syndrome (PRES)
Although not a truly demyelinating condition, reversible 
encephalopathy syndrome is noteworthy because of its affin-
ity for the posterior cerebral white matter territories and is 
important in the differential diagnosis of demyelinating dis-
ease. Under normal circumstances, cerebral perfusion pres-
sure is maintained at a relatively constant level by 
autoregulation, a physiologic mechanism that compensates 
for wide changes in systemic blood pressure. Hypertensive 
encephalopathy is believed to result from loss of normal auto-
regulation, with competing regions of vasodilatation and 
vasoconstriction, and endothelial dysfunction. The vessels of 
the posterior cerebral circulation, lacking less sympathetic 
innervation compared to those of the anterior circulation, are 
unable to vasoconstrict in a normal manner and bear the brunt 
of these vascular changes. Reversible vasogenic edema is the 
result and is associated with visual field deficits, as well as 
headaches, somnolence, and an overall impaired mental sta-
tus. The terms posterior reversible encephalopathy syndrome 
(PRES) and reversible posterior leukoencephalopathy syn-
drome (RPLS) have been popularized in the literature to 
describe this scenario that is most commonly seen in hyper-
tensive states and/or the presence of immunosuppression 
(particularly cyclosporine A and tacrolimus), chemotherapy, 
eclampsia, and renal failure. While it commonly involves the 
posterior cerebral white matter, other sites may also be 
affected including unilateral cerebral hemispheric or isolated 
brainstem involvement in patients following aortic valve sur-
gery [36, 37]. Accordingly, it has been suggested that perhaps 
the terminology should be changed to simply “reversible 
encephalopathy” [38].
On MR studies, bilaterally symmetric abnormal T2 hyper-
intensity, representing vasogenic edema, is most commonly 
seen in the distribution of the posterior circulation, although 
other sites including the frontal lobes and corpus callosum 
may be noted as well. Cortical and subcortical lesions may 
be better detected on FLAIR sequences. DWI may be normal 
or show restricted water diffusion in regions of infarction 
that correlate with poorer prognosis [23]. Susceptibility- 
weighted imaging may show areas of hemorrhage within 
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involved territories. With early treatment and limited involve-
ment of the brain, many of these imaging abnormalities will 
completely resolve and most patients recover within 2 weeks 
[39]. However, when larger areas or regions of infarction are 
involved, permanent neurologic deficits or even death are 
possible. Vascular narrowing has been observed on angio-
graphic studies. Perfusion studies reported in the literature 
indicate normal to increased perfusion in these zones. When 
biopsies of these regions have been performed, white matter 
edema is seen histologically.
13.8.2  Aging and Ischemic Demyelinating 
Disorders
Small focal lesions on T2-weighted images are quite common 
in the white matter of adult subjects [40]. They are not associ-
ated with mass effect, do not enhance, and are typically isoin-
tense compared to normal white matter on T1-weighted 
images. When these lesions have been biopsied, histologic 
examination reveals a spectrum of findings including gliosis, 
(partial) loss of myelination, and vasculopathy. They tend to 
be located in the deep white matter of the centrum semiovale. 
In contrast to MS, lesions do not involve the corpus callosum 
or the juxtacortical U-fibers, important distinguishing fea-
tures [3]. Since the lesions are so ubiquitous and appear to be 
a part of “normal” aging, various terms have been proposed: 
senescent white matter changes or disease, deep white matter 
ischemia, leukoaraïosis, etc. In general, the more lesions 
present, the more likely it is that the patient will have cogni-
tive problems or difficulties with neuropsychological testing. 
However, it is not possible to predict a particular patient’s 
status simply based on the imaging appearance alone.
In adult patients between 30 and 50 years of age, the pres-
ence of periventricular and subcortical lesions in a patient 
with a family history of similarly affected relatives should 
raise the possibility of cerebral autosomal dominant arteri-
opathy with subcortical infarcts and leukoencephalopathy 
(CADASIL). A defect in the notch3 gene on the long arm of 
chromosome 19 has been identified and apparently evokes 
an angiopathy affecting small and medium-sized vessels. 
Most lesions occur in the frontal and temporal lobes and less 
commonly in the thalamus, basal ganglia, internal and exter-
nal capsules, and brain stem [41].
13.9  Conclusion
MRI of the brain and spinal cord is of vital importance in the 
diagnosis of MS, the most important idiopathic inflamma-
tory CNS disorder [42]. Dissemination in space and time on 
MRI is not limited to MS and can occur in NMO, and spinal 
cord imaging is important in the differential diagnosis. 
Increasingly, MRI is used to monitor MS treatment and their 
complications such as PML.
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Children with Acute Neurological 
Emergency
Gunes Orman, Andrea Rossi, Avner Meoded, 
and Thierry A. G. M. Huisman
Children with acute neurological emergencies frequently pres-
ent to the emergency room (ER) with various combinations of 
headache, fever, nausea, vomiting, physical signs of trauma, 
altered mental status, coma, or focal neurological symptoms. 
Neuroimaging is often needed in children with acute neuro-
logical emergencies due to the difficulties of gathering an 
adequate and comprehensive patient history or a detailed and 
reliable neurological examination [1]. The radiologist plays an 
important role in the ER. Firstly, the radiologist should be able 
to answer if the child needs neuroimaging emergently. 
Secondly, the radiologist should be able to answer which 
imaging modality is appropriate for the child. Different imag-
ing modalities may be chosen based on the institutional avail-
ability and clinical status of the patient. Computed tomography 
(CT) and magnetic resonance imaging (MRI) are the most 
frequently used imaging modalities in the emergency setting. 
CT is usually the initial modality of choice in most of the situ-
ations. Modern multidetector CT scanners render highly 
detailed multiplanar submillimeter images of the pediatric 
brain; however, the main disadvantage of CT is that it requires 
the use of ionizing radiation [2]. MRI is a valuable tool to 
confirm and characterize the entities seen in children with 
acute neurological emergency. MRI is easy to perform, does 
not use ionizing radiation, offers multiple different tissue con-
trasts, superior anatomical details, especially for evaluation of 
the posterior fossa, and offers multiple advanced, and func-
tional sequences enhancing a sensitive and specific diagnosis 
[2, 3]. These advantages made MRI an increasingly preferred 
modality for the diagnostic evaluation of children with acute 
neurological symptoms even in time-sensitive settings. 
Ultrafast MRI protocols should be considered whenever pos-
sible as the initial choice of imaging instead of CT [3, 4]. 
Advanced MRI techniques including susceptibility-weighted 
imaging (SWI), diffusion weighted imaging (DWI), or diffu-
sion tensor imaging (DTI) with apparent diffusion coefficient 
(ADC) mapping and perfusion-weighted imaging (PWI) are 
progressively used in acute pediatric neuroimaging protocols 
[2]. Last but not least, the radiologist should be able to give a 
reliable differential diagnosis to guide patient management, in 
order to reduce morbidity and mortality. In addition, when 
evaluating brain MRIs of children, the radiologist should be 
aware that the pediatric brain may be immature and depending 
on the child’s age different states of brain development and 
maturation may be encountered. A neonatal brain MRI looks 
very different compared to a teenager’s brain MRI. Thus, the 
radiologist should understand normal brain development and 
must be familiar with age-specific changes of the developing 
pediatric brain [2].
The goal of this chapter is to discuss the neuroimaging 
findings of a number of common acute pediatric neurologi-
cal emergencies including stroke, hemorrhage, infections, 
and several less frequently encountered disorders.
14.1  Stroke
Arterial ischemic stroke (AIS) is relatively rare in children but 
can lead to significant morbidity and mortality rates ranging 
between 4% and 14%. Understanding that children with AIS 
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• To understand common acute pediatric neurologi-
cal disorders that are encountered in the emergency 
setting.
• To understand basic neuroimaging findings of acute 
pediatric neurological emergencies.
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present clinically differently than adults and often present with 
unique child specific risk factors will impact the diagnostic 
approach, treatment, and outcome. The risk factors for AIS in 
children include cardiac disorders, infection, head and neck 
trauma, sickle cell disease, vascular malformations, genetic 
disorders, and autoimmune diseases [5–7]. The clinical pre-
sentation in neonates and infants can be very subtle relative to 
the severity of imaging findings (Fig. 14.1a). In children with 
suspected stroke, MRI is the preferred imaging modality. 
Radiologists should embrace an “MRI first” service whenever 
possible. Recommended sequences include DWI/DTI and 
ADC mapping to diagnose acute ischemia, gradient-recalled 
echo (GRE) or SWI to detect intracranial blood and its break-
down products, and T1-weighted imaging (WI) and T2-WI to 
assess for myelination, extra-axial blood, and edema [8].
Furthermore, combined analysis of DWI/PWI data can 
identify tissue at risk of progression to infarction, e.g., “isch-
emic penumbra” [9]. The penumbra shows critical hypoperfu-
sion without matching diffusion restriction (DWI/PWI 
mismatch), as opposed to the ischemic core represented by 
matching areas of hypoperfusion and restricted diffusion. Early 
and reliable identification of potentially salvageable brain tis-
sue is essential and could serve as a guide to treatment [10].
In addition, simultaneous imaging of the head and neck 
vasculature should always be considered/included in the 
acute workup if possible. Magnetic resonance angiography 
(MRA) of the brain is useful to detect vascular abnormalities 
(Fig. 14.1b). In children with AIS rapid treatment with neu-
roprotection, antithrombotic medications, and potential use 
of tissue plasminogen activator (tPA) are recommended to 
limit infarct progression/severity and stroke recurrence [11].
Hemorrhagic venous stroke (VS) may occur as complica-
tion of cerebral venous sinus thrombosis (CVST). The most 
common predisposing factors are systemic or local infection, 
hypercoagulable state, and dehydration [1]. CVST should be 
suspected in any child with hemorrhage or brain injury that 
cannot be explained by an arterial distribution of infarction 
or history of trauma or infection. If there are features of hem-
orrhage, additional MR venography (MRV) may be needed 
to provide diagnostic confidence (Fig. 14.1c). Post-contrast 
3D-T1-WI ultrafast GRE sequence may also be helpful to 
detect venous filling defects [12]. CVST most frequently 
affects the superior sagittal sinus followed by the transverse 
sinus, with resulting VS mostly in these venous drainage 
regions. VS may not demonstrate the same degree of 
restricted diffusion as AIS due to associated vasogenic 
edema. Physicians should hold an increased level of clinical 
suspicion especially in children with risk factors [1]. Rapid 
imaging and correct diagnosis is very important.
Clinical mimickers of pediatric stroke include systemic 
hypoglycemia, hemiplegic migraine, seizure, postictal pare-
sis, acute disseminated encephalomyelitis (ADEM), infec-
tion and may be seen in up to 21% of children with the initial 
clinical suspicion of an acute stroke [12–14]. The frequency 
of these disorders underlines the value of MRI in the emer-
gent evaluation of suspected stroke [12].
14.2  Hemorrhages
Intracranial hemorrhages (ICH) are a frequent cause of 
severe neurological morbidity and mortality in children. 
Excluding head trauma which is an important cause of ICH, 
other causes of spontaneous ICH include arteriovenous mal-
formations (AVM), aneurysms, cavernous malformations, 
hematological disorders, and brain tumors in children. In 
addition, ICH may be observed as a complication of AIS and 
VS. Children may present with headache, vomiting, impaired 
consciousness, convulsions, and focal neurological deficits. 
Spontaneous ICH can also present with non-specific symp-
toms in children especially younger than 3  years of age. 
Subacute courses are common and may result in a diagnostic 
delay which may result in a higher mortality and morbidity, 
especially for infratentorial hemorrhages, in aneurysms, 
children younger than 3 years and children with underlying 
hematological disorders [15].
ICH imaging appearances follow a well-known evolution 
with five distinct phases identified: hyperacute, acute, early 
subacute, late subacute, and chronic. Neuroimaging find-
ings and appearance vary with the phase (Table 14.1) [16]. 
On CT, early hyperacute ICH are isodense to normal brain, 
could be missed if not carefully observed. However, multi-
planar reconstructed CT images increase the sensitivity of 
CT for detection of ICH [17]. Acute and early subacute ICH 
reveal hyperdensity due to progressive blood clot retraction, 
while progressive red blood cell lysis decreases the density 
in the late subacute phase. In the chronic phase, progressive 
blood resorption results in a hypodense, cerebrospinal fluid 
(CSF)-filled brain defect. Similar temporal signal changes 
are observed for the various MRI sequences (Fig. 14.2). The 
imaging characteristics of ICH are summarized in 
Table 14.1. T2∗, GRE, or SWI sequences are most sensitive 
to blood products and should be included in the MRI proto-
col when ICH are suspected in the emergency setting. 
Neuroimaging should not only focus on diagnosis of ICH 
and its complications but should also focus on finding the 
underlying cause of the ICH. MRA and MRV sequences and 
contrast-enhanced MRI may be necessary to exclude the 
underlying cause such as vascular malformations and 
tumors [16].
Key Point
• Neuroimaging is extremely time sensitive in chil-
dren suspected of arterial or venous stroke. MRI 
with DWI/DTI and ADC is the established imaging 
modality of choice for the diagnosis.
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Fig. 14.1 (a, top row) In this 25-day old girl with prior surgery for intes-
tinal atresia and recent onset of clonic fits involving the right limbs, axial 
T2-weighted MRI shows ill-defined cortico-subcortical blurring of the 
left parietal lobe. Trace DWI and corresponding ADC map clearly reveal 
restricted diffusion consistent with an acute ischemic stroke involving the 
posterior portion of the left MCA territory. (b, middle two rows) In this 
13-year old boy with a subacute presentation with ataxia, coronal FLAIR 
shows multiple hyperintense areas involving the cerebellum and occipital 
lobe, suggesting a thromboembolic mechanism involving the posterior 
circulation. Intracranial TOF MR angiography is normal. Cervical 
CE-MR angiography, however, shows focal irregularity (arrow) of the left 
vertebral artery which was confirmed by catheter angiography showing a 
string-of-beads pattern (arrow) consistent with the eventual diagnosis of 
fibromuscular dysplasia. (c, lower row) In this 16-year-old girl with 
recent posterior fossa surgery, sagittal T2-W MRI shows deceivingly nor-
mal appearance of the superior sagittal sinus, due to hypointense acute 
thrombus. Contrast- enhanced axial T1-weighted MRI shows the empty 
delta sign (arrow) consistent with intraluminal sinus thrombosis, which is 
confirmed by phase contrast MR venography showing absent flow signal 
involving the totality of the superior sagittal and straight sinuses
a
b
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14.3  Infections
Pediatric central nervous system (CNS) infections are high 
on the list of differential diagnosis when a child present with 
fever and altered mental status. Neuroimaging is important 
in the early diagnosis of CNS infections and should be cor-
related conjunction with laboratory findings. CNS infections 
may result in significant morbidity and mortality in children 
[2, 12].
Meningitis is the most common form of bacterial infec-
tion of the CNS in children. Causative bacteria vary by age 
and clinical presentation is different for different age groups. 
While older children present with fever, headache, photo-
phobia, nausea, vomiting, and meningismus, neonates may 
present with less obvious vague symptoms. Meningitis is 
most commonly caused by hematogenous spread from bac-
terial infections outside of CNS. Less commonly, it develops 
from an adjacent infective focus, i.e., sinusitis, mastoiditis, 
or direct invasion after a skull fracture. In general, neuroim-
aging is not routinely used for the diagnosis of an uncompli-
cated meningitis, especially if a lumbar puncture already 
demonstrated an abnormal number of white blood cells in 
the CSF confirming diagnosis. If there is no complication, 
neuroimaging may reveal mildly increased meningeal 
enhancement. Complications of meningitis may however 
include areas of adjacent vasogenic or cytotoxic edema, 
focal ischemic injury, CVST, hydrocephalus, and subdural, 
epidural, or parenchymal abscesses/empyemas. MRI with 
contrast is the imaging modality of choice to evaluate the 
complications of bacterial meningitis (Fig. 14.3a–e) [18].
Parenchymal brain infections include cerebritis and cere-
bral abscess. Symptoms are variable but typically include 
fever, headache, nausea/vomiting, focal neurological defi-
cits, and seizures. Visual field defects or personality changes 
can also be seen. If the abscess collection is large, significant 
mass effect may cause increased intracranial pressure. 
Neuroimaging is the key to the diagnosis of parenchymal 
brain infections. MRI with contrast is the most sensitive and 
specific modality for the radiology diagnosis (Fig. 14.3a–e). 
Cerebritis may be treated conservatively with intravenous 
antibiotics, but cerebral abscess requires surgical interven-
tion or drainage [18].
Pyogenic ventriculitis is a life threatening form of 
CNS infections. The infectious agents are similar to men-
ingitis and abscess. MRI is key to diagnosis; ependymal 
enhancement after IV contrast injection is usually very 
prominent. DWI/DTI may show restricted diffusion with 
c
Fig. 14.1 (continued)
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Key Point
• ICH are a frequent cause of severe neurological mor-
bidity and mortality in children. Depending on the 
etiology and evolutionary phase of the ICH, CT and/
or MRI imaging characteristics change over time.
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reduced ADC values, especially if pus is collecting within 
the ventricles [18].
Subdural empyema is an infectious fluid collection 
between dura and arachnoidea (Fig.  14.3a–e). The acute 
form develops as a result of spread from, e.g., a paranasal 
sinus infection and is characterized by high fever, headache, 
meningismus or focal neurological deficits, more rarely sei-
zures. The complications include CVST, cerebral infarction, 
cerebral edema, or cerebritis. MRI with contrast is the diag-
nostic modality of choice [18].
Other acute pediatric CNS infections include: (1) viral 
meningitis and its complications which include ADEM, 
transverse myelitis, Guillain–Barré syndrome, and cranial 
neuritis; (2) fungal CNS infections which are most com-
monly seen in premature or immunocompromised children; 
and (3) parasitic CNS infections. Early and correct recogni-
tion of the neuroimaging findings of these diseases is critical 
to guide treatment [19].
a b
c d
Fig. 14.2 In this 17-year old 
boy presenting acutely with 
ictal headache, vomiting, and 
bradycardia, axial CT (a) 
shows fresh hematoma 
involving the left parietal lobe 
with contralateral midline 
shift and intraventricular 
blood at the foramen of 
Monro. CT angiography (b) 
did not reveal abnormal 
vessels. MRI performed after 
12 hours confirms a large 
intraaxial bleed which is 
grossly isointense with gray 
matter on T1-weighted MRI 
(c) and hyperintense on 
T2-weighted MRI (d), 




• The diagnosis of uncomplicated meningitis is usu-
ally confirmed with lumbar puncture by demonstrat-
ing an increased number of white blood cells in the 
CSF. Neuroimaging should be saved to evaluate for 
life threatening complications of meningitis, includ-
ing empyema or parenchymal infections. MRI with 
contrast is the diagnostic modality of choice.
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14.4  Trauma
Traumatic brain injury (TBI) is a significant cause of lifelong 
disability and mortality in children. The diagnosis of pediat-
ric head trauma requires a multidisciplinary approach. 
Trauma mechanisms differ from adults and their impact on 
the developing brain results in unique primary and secondary 
brain lesions. Birth trauma is responsible for almost all cases 
of neonatal trauma (parturitional injury); child abuse is a 
 frequent cause of trauma in the first 2 years, whereas falls 
and motor-vehicle accidents are responsible for the majority 
of TBI in toddlers and adolescents [20].
Primary TBI lesions include (1) calvarial and maxillofa-
cial fractures; (2) extra-axial: epidural hematoma, subdural 
hematoma, subarachnoid hemorrhage, and intraventricular 
hemorrhage; (3) intraaxial: diffuse axonal injury, cortical 
contusion, and intracerebral hematoma; and (4) vascular: 
dissection, carotid cavernous fistula, arteriovenous dural fis-
tula, and pseudoaneurysm. Secondary TBI includes both (1) 
acute: diffuse cerebral edema, brain herniation (subfalcine, 
uncal, transtentorial), infarction, or infection and (2) chronic 
injuries: hydrocephalus, encephalomalacia, CSF leak, and 
leptomeningeal cyst [21]. Different imaging modalities may 
identify treatable primary TBI and lead to prevention or limi-
tation of secondary TBI. A recommended minimal standard 
MRI protocol includes (1) a 3D T1-WI, preferably in the 
sagittal plane, which allows multiplanar reconstruction, (2) 
an axial T2-WI, (3) an axial DWI/DTI with ADC mapping, 
a b c
d e
Fig. 14.3 In this 12-year-old boy with suppurative sinusitis (not 
shown), trace DWI (a) and corresponding ADC map (b) show right 
frontal subdural empyema and a focal area of restricted diffusion 
involving the right frontal lobe, corresponding to an ill-defined hyperin-
tense lesion with perifocal edema and mass effect on T2-W MRI (c). 
Contrast-enhanced axial T1-weighted MRI (d) shows mild, irregular 
peripheral enhancement consistent with cerebritis, and also reveals ipsi-
lateral arachnoiditis. Follow-up MRI after 4 days (e) shows develop-
ment of a well-defined enhancing ring corresponding to evolution 
towards a frank abscess
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and (4) an axial SWI from the skull base to the vertex 
(Fig. 14.4) [20].
It is important to keep child abuse in mind when dealing 
with trauma in children in the emergency setting. Abusive 
head trauma diagnosis is challenging both clinically and 
radiologically; the provided trauma history might not always 
reflect the truth and no single imaging finding is specific or 
diagnostic for abusive head trauma by itself. A multiplicity of 
trauma related findings and severity of findings inconsistent 
with the provided mechanism of trauma provide clues for the 
diagnosis. The radiological findings may vary for different 
types of injury. The common injury mechanisms related to 
abusive head trauma can be summarized as non- impact shak-
ing injury, direct impact blunt trauma, whiplash- shaking 
injury of the craniocervical junction, strangulation injury, and 
stabbing injury. Further diagnostic workup should include a 
skeletal survey and possible additional cross- sectional studies 
to exclude other non-CNS solid organ injury [1, 21].
Spinal cord injury mechanisms in children differ from 
adults. Vertebral column fractures and spinal cord injuries 
are less common in children than adults. Pediatric spinal 
injuries primarily involve the cervical spine mostly in the 
proximal part including the craniocervical junction [22]. 
Thoracolumbar fractures often occur at T11 to L2 levels but 
may also involve other levels. However, if the injury mecha-
nism is of the seat-belt flexion-distraction type, it typically 
occurs at L2-L4 levels with high association of accompany-
ing visceral injury. In children of all ages, spinal MRI evalu-
ation is important in the setting of unexplained instability, 
persistent or delayed symptoms, decreased consciousness, or 
abnormal X-ray or CT findings. MRI findings including spi-
nal cord transection, intramedullary hemorrhage, edema 
extending over more than one spinal segment, and persistent 
compression of the spinal cord are predictive of poor neuro-
logical outcome [12].
14.5  Drowning/Near Drowning
Drowning is a leading cause of accidental death and 
severe neurologic morbidity. Anoxic brain injury is a 
common consequence of non-fatal drowning and may 
cause severe lifelong disability. Irreversible injury devel-
ops in the hippocampi, basal ganglia, and cerebral cortex 
within 4–10  min following the hypoxic incident. 
Therefore, early neuroimaging after drowning allows 
detection of the injury that requires intervention and may 
also be helpful for the prediction of brain injury severity 
[23]. CT is usually limited to detect head and neck trauma, 
but it may detect the loss of gray white matter differentia-
tion and cerebral edema. However a normal looking brain 
parenchyma on initial/acute CT does not rule out brain 
injury. MRI especially DWI/DTI with ADC mapping can 
detect brain injury more reliably, even within minutes 
after the incident and improves the ability to predict the 
outcome (Fig. 14.5). Cortical and deep gray matter DWI/
DTI abnormalities and lower ADC values are associated 
with poor outcomes.
a b c
Fig. 14.4 In this 12-year-old boy with a severe blunt head trauma, sag-
ittal T1-weighted MRI (a) and axial T2-W MRI (b) show ill-defined 
signal abnormality involving the corpus callosum (arrows). SWI (c) 
reveals more extensive hypointensities consistent with hemorrhagic 
traumatic axonal injury
Key Point
• TBI is a leading cause of lifelong disability and 
mortality in children. Birth trauma is responsible 
for many cases of neonatal TBI; child abuse is a 
frequent cause of TBI in the first 2 years, falls and 
motor-vehicle accidents are responsible for the 
majority of TBI in toddlers and adolescents. CT or 
MRI are the primary diagnostic imaging modalities 
of choice depending on the etiology of TBI and the 
age of the child.
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14.6  Seizures
New onset seizures are the most common neurologic emer-
gencies of children presenting to the ER [1, 2]. Seizures are 
abnormal movements or behavior resulting from abnormal 
electrical activity in the brain. Acute symptomatic seizures 
occur at the time of a systemic insult or following brain insult 
with incidence reaching 29–39/100000 per year. Traumatic 
brain injury, cerebrovascular disease, drug withdrawal, 
infarction, and metabolic insults are the most common 
causes [1, 2]. Unprovoked seizures occur in the absence of 
precipitating factors, and may be single or recurrent 
(epilepsy).
A detailed neurological examination with general physi-
cal examination and electroencephalogram should be per-
formed initially [1]. Neuroimaging may not be necessary for 
every child with seizure or epilepsy. For example, neuroim-
aging is not indicated in children with simple febrile seizures 
but it should be considered in children with long seizures 
with focal onset and focal neurological deficits, also it should 
be strongly considered in neonates with seizures, because an 
identifiable cause for seizures can be found in up to 90% of 
full term newborns [1, 2]. When neuroimaging is necessary, 
MRI is the modality of choice in most of the cases. The aim 
is to investigate acute focal disorders that need immediate 
intervention including acute hydrocephalus, acute stroke or 
hemorrhage, hypoxic ischemic injury in newborns, encepha-
litis, or tumors. Other relevant disorders include leukodys-
trophies, metabolic disorders, mesial temporal sclerosis, and 
malformations [2].
14.7  Autoimmune CNS Diseases 
with Acute Presentation
Children with autoimmune CNS diseases may also present 
to the ER with acute signs and symptoms.
ADEM is a monophasic, immune-mediated demyelinating 
CNS disorder. Patients usually present 1–3 weeks following 
an upper respiratory infection or vaccination and may present 
acutely with significant mass effect due to a tumefactive 
a b c
Fig. 14.5 In this 8-year-old boy with severe anoxia due to near- 
drowning, trace DWI (a) and corresponding ADC map (b) show 
restricted diffusion involving the basal ganglia, thalami, and parieto- 
occipital cortex consistent with cytotoxic edema. Axial FLAIR (c) is 
relatively unrevealing in the acute phase
Key Point
• The pediatric brain is extremely sensitive to hypoxia 
and irreversible brain damage develops within 
4–10 min after drowning. MRI with DWI/DTI and 
ADC mapping should be acquired and evaluated 
promptly for the children with a drowning history.
Key Point
• When dealing with children with seizures in the 
ER, neuroimaging should be saved for cases with 
history of long time seizures with focal onset and 
focal neurological deficits, it should also be strongly 
considered in neonates with seizures.
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lesion, with seizures and coma or with behavioral distur-
bances, headaches, vomiting, fever, or focal neurological 
signs. Brain MRI typically shows diffuse, poorly demarcated, 
bilateral, or asymmetrical T2 and FLAIR hyperintense lesions 
affecting both gray and white matter. The spinal cord may 
also be involved, showing ill-defined, multiple T2 hyperin-
tense lesions usually involving 2–3 vertebral segments 
(Fig. 14.6a). ADEM is usually a diagnosis of exclusion.
Multiple sclerosis (MS) is an idiopathic inflammatory 
disorder characterized by demyelination and degeneration 
of the CNS, affects most commonly adults, but 3–10% of 
patients present their first clinical event during childhood. 
Pediatric onset MS has higher relapse rates and a less 
favorable prognosis [24]. Therefore, early diagnosis and 
prompt treatment of pediatric onset MS is necessary 
(Fig. 14.6b). Ruling out ADEM and neuromyelitis optica 
spectrum disorder (NMOSD) is important, because 
although the clinical presentation of these three disorders 
is similar, the treatment is different in each one. 
Characteristic MRI criteria of MS on brain MRI are help-
ful to differentiate MS from ADEM and NMOSD but CSF 
and serum laboratory findings are also required to confirm 
the diagnosis [25].
NMOSD is an inflammatory demyelinating disease 
characterized by optic neuritis and acute longitudinally 
extending myelitis involving at least three vertebral seg-
ments. Most clinical, neuroimaging, and laboratory char-
acteristics of pediatric onset NMOSD are similar to those 
of adult onset disease [26]. Identification of aquaporin-4 
immunoglobulin antibodies serves as an important bio-
marker for the diagnosis. Longitudinally extending myeli-
tis during an acute attack is T2 hyperintense on sagittal 
spinal cord MRI with central cord predominance and may 
matching show contrast enhancement on T1-WI.  Optic 
nerve MRI shows unilateral or bilateral T2 hyperintensity 
or contrast enhancement on T1-WI within the optic 
a b
Fig. 14.6 (a) In this 3-year-old girl with a subacute onset of parapare-
sis and stupor, axial FLAIR shows ill-defined hyperintensities involving 
the deep cerebellar and supratentorial white matter. Sagittal T2-weighted 
MRI of the spine shows quasi-holocord swelling and hyperintensity. 
After treatment with IVIG and steroids, follow-up MRI at 3 months was 
normalized (not shown), consistent with acute disseminated encephalo-
myelitis (ADEM). (b) In this 5-year-old girl presenting with headaches 
and left hemiparesis, trace DWI and corresponding ADC map show a 
large right inferior frontal lesion with a necrotic center and an incom-
plete peripheral ring of restricted diffusion. Another small lesion with 
similar characteristics is seen in the left parietal lobe. On T2-weighted 
MRI, the larger lesion shows a concentric onion-bulb appearance. 
Contrast-enhanced axial T1-weighted MRI shows incomplete periph-
eral ring enhancement corresponding to the areas of restricted diffu-
sion, consistent with tumefactive demyelination
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nerve(s) or optic chiasm. Typical brain lesions are T2 
hyperintense involving the dorsal medulla, peri-ependy-
mal surfaces of the fourth ventricle, hypothalamus, thala-
mus, or peri-ependymal surfaces of third ventricle, as well 
as large, confluent, unilateral or bilateral subcortical or 
deep white matter lesions or long, diffuse, heterogeneous 
corpus callosum lesions or long corticospinal tract lesions 
[26].
14.8  Toxic/Metabolic Imbalances
Diabetic ketoacidosis (DKA) is an acute serious complication 
in children with diabetes mellitus type 1. This state may cause 
significant long-term neurological morbidity and mortality. 
Brain edema is the most common neuroimaging finding in 
children with DKA and may cause brain herniation with sub-
sequent cerebral infarctions due to vascular compression. 
Also, primary ischemic or hemorrhagic stroke during the 
acute DKA episode may be seen in 10% of cases [27].
Neonatal hypoglycemia is an important issue in term 
neonates and can cause severe brain injury. Neuroimaging 
typically shows focal edema or infarcts most commonly in 
bilateral parieto-occipital lobes, basal ganglia, corpus cal-
losum, and thalami [12]. Because the urine strip test diag-
nosis of hypoglycemia can be made simply, neuroimaging 
is usually used to evaluate the degree of brain injury and 
estimation of prognosis rather than to confirm the 
diagnosis.
Osmotic demyelination syndrome is an acute demyelin-
ation process that usually occurs several days after a rapid 
change in serum osmolality and is uncommon in children. 
It can present with central pontine myelinolysis or extra-
pontine myelinolysis. MRI is the diagnostic modality of 
choice. Central pontine myelinolysis is seen with charac-
teristic trident- shaped, bat-winged, or piglet hyperinten-
sity on T2-WI, hypointensity on T1-WI with no mass 
effect in the central pons, with sparing of the ventrolateral 
pons, tegmentum, and corticospinal tracts. Extrapontine 
lesions are usually bilateral and most commonly seen in 
the cerebellar peduncles, globus pallidus, thalamus, lateral 
geniculate body, putamen, external and extreme capsule, 
splenium of corpus callosum, and supratentorial white 
matter [28].
14.9  Hydrocephalus
Hydrocephalus in children could be either due to overpro-
duction of CSF by a tumor, ventricular obstruction, or dys-
functional Pachionic granulations along the subarachnoid 
space. Children can present to the ER with (1) acute findings 
of hydrocephalus or (2) complications of shunted hydro-
cephalus including malfunction and infection.
Clinical presentation of hydrocephalus varies with age; in 
infants abnormally rapidly increasing head circumference, 
irritability, vomiting, bulging of the fontanelle; in older chil-
dren headache, vomiting, diplopia, or papilledema can be 
seen [29]. Neuroimaging should be directed to identify the 
underlying cause. MRI is the imaging modality of choice in 
suspected hydrocephalus cases. Next to axial T1-WI or 
T2-WI, a thin section, high resolution, T2-WI in sagittal 
plane is the most helpful MRI sequence to evaluate these 
cases [1, 2]. Contrast administration would be necessary if a 
tumor is suspected.
Shunt malfunction is the most common complication of 
ventricular shunts. Children present with headache, nau-
sea, vomiting, and altered mental status. Multiple radio-
graphs of the skull, neck, chest, and abdomen to evaluate 
the shunt integrity are often the initial imaging in some 
institutions [1, 2]. CT is often used as primary cross-sec-
tional imaging because it is readily available, able to detect 
changes in the ventricular size and configuration, identify 
intracranial hemorrhages or infarction, shunt catheter dis-
continuity and catheter migration [2]. Scout views should 
not be ignored, because occasionally, axial or recon-
structed cross-sectional CT images may miss relevant find-
ings. A possible disconnection of a shunt may be within 
the neck region below or outside of the scanned region; 
however, the information may be visible on the scout view 
which is a standard component of each CT study [30]. 
Children with infection due to a shunted hydrocephalus 
present with altered mental status, fever, nausea, and vom-
iting. CSF cultures are usually sufficient for the diagnosis 
Key Point
• Children with autoimmune CNS diseases may pres-
ent to the ER with acute signs and symptoms. In 
addition to CSF and serum laboratory findings, 
brain and spinal cord MRI is helpful to differentiate 
MS from ADEM and NMOSD.
Key Point
• Neuroimaging with MRI may be necessary when 
dealing with children with metabolic imbalances in 
the ER when brain edema is suspected. In addition, 
MRI is the diagnostic modality of the choice to 
evaluate the osmotic demyelination syndrome.
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in almost 95% of the cases and neuroimaging has a limited 
role in the diagnosis [1]. Uncommonly, infection presents 
with abdominal symptoms from a peritoneal CSF pseudo-
cyst. Abdominal ultrasound or CT is useful to evaluate 
these cases [2].
14.10  Concluding Remarks
Children with acute neurological emergency present to the 
ER with a wide spectrum of symptoms and signs. 
Neuroimaging is often needed in children with acute neuro-
logical emergency due to the difficulties of gathering a good 
and reliable patient history or limited physical/neurological 
examination. The radiologist should be able to answer if the 
child needs neuroimaging emergently, and which imaging 
modality is appropriate for the child. Different modalities 
may be chosen based on the institutional availability and 
clinical status of the patient. CT and MRI are the most fre-
quently used imaging modalities in the emergency setting. 
Finally, the prompt diagnosis is essential when dealing with 
children with acute neurological emergency especially in the 
time sensitive pathologies, i.e., stroke, drowning.
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Key Point
• Children could present to the ER with acute find-
ings of hydrocephalus or complications of shunted 
hydrocephalus including shunt malfunction and 
infection. MRI or CT should be used to differentiate 
the etiology.
Take Home Messages
• Radiology is an integral part of the ER.
• Children, especially infants and young children 
may present to the ER with non-specific symptoms 
or subtle findings.
• The threshold for neuroimaging should be held low 
especially for infants and young children.
• Neuroimaging should be promptly acquired and 
evaluated when dealing with children with acute 
neurological emergencies in the ER.
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Tinnitus and hearing loss in the adult can have profound 
effects on the quality of life. Tinnitus is the perception of 
sound when no external sound is present and may be described 
as ringing, buzzing, swishing, or clicking sensations. Hearing 
loss ranges from partial to a total inability to hear sounds. 
Hearing loss and tinnitus can occur concurrently or in isola-
tion. The role of imaging is to help identify the etiology of 
these symptoms and evaluate for the extent of disease.
15.2  Causes of Tinnitus and Hearing Loss
15.2.1  Tinnitus
Tinnitus may be categorized as (1) pulsatile or non-pulsatile, 
(2) primary (idiopathic) or secondary (due to another condi-
tion), and (3) subjective or objective. Evaluation of tinnitus 
starts with otoscopic examination to determine if there is a 
vascular retro-tympanic mass, audiometric examination, and 
review of medical history and medications. This evaluation 
helps to determine if imaging is necessary and if so, what 
study(ies) are indicated.
15.2.1.1  Pulsatile Tinnitus
Causes include vascular masses (glomus tympanicum), aber-
rant arterial or venous anatomy, vascular malformations, and 
intracranial hypertension. Objective tinnitus (auscultation of 
a bruit on physical examination) is uncommon and has been 
attributed to turbulent flow in the setting of dural fistulas, 
atherosclerotic carotid artery disease, jugular bulb abnormal-
ities, and large condylar or mastoid emissary veins.
15.2.1.2  Non-pulsatile Tinnitus
Causes are wide ranging and include cerumen impaction, mid-
dle ear infection, mass, medications, noise-induced hearing 
loss, presbycusis or chronic bilateral hearing loss, hemorrhage, 
neurodegeneration, and spontaneous intracranial hypotension.
15.2.2  Hearing Loss
Clinical assessment and audiometric testing can determine 
the type of hearing loss as conductive, sensorineural, or 
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Learning Objectives
• Identify key anatomical structures in the temporal bone.
• Describe role of CT and MRI for temporal bone 
imaging.
• Differentiate between diseases of the temporal bone 
on imaging and describe their clinical presentation.
Key Points
• Imaging can identify the cause and evaluate the 
extent of disease for surgical planning.
• The common causes of tinnitus and hearing loss 
without a mass include otospongiosis, labyrinthitis 
ossificans, superior semicircular canal dehiscence, 
and enlarged vestibular aqueduct syndrome.
• Otospongiosis affects the bony labyrinth, while laby-
rinthitis ossificans affects the membranous labyrinth.
• Vestibular schwannomas often present with non-
pulsatile tinnitus and high frequency sensorineural 
hearing loss.
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mixed and guide subsequent diagnostic imaging. Conductive 
hearing loss results from diseases affecting the conduction of 
mechanical sound wave energy to the cochlea. Sensorineural 
hearing loss is caused by diseases that impair the cochlear 
function or the transmission of electrical signal along the 
auditory pathway.
15.2.2.1  Conductive Hearing Loss
Causes include otospongiosis (commonly mixed), ossicular 
erosion or fusion, round window occlusion, dehiscence of 
the superior semicircular canal, and cholesteatoma or neo-
plasm with suspected intracranial or inner ear extension.
15.2.2.2  Sensorineural Hearing Loss
Causes include labyrinthine ossificans, vestibular schwan-
noma, and fractures extending across the otic capsule.
15.3  Anatomy
The temporal bone forms part of the middle and posterior 
cranial fossae and is comprised of five parts: petrous, tym-
panic, mastoid, styloid, and squamous temporal bone. The 
first three listed parts form the external auditory canal, mid-
dle ear, inner ear, and internal auditory canal. These are the 
segments to review for hearing loss and tinnitus.
15.3.1  External Auditory Canal
The external auditory canal (EAC) extends from the auricle 
to the tympanic membrane. The lateral one-third of the EAC 
is fibrocartilaginous, while the medial two-thirds are sur-
rounded by the tympanic portion of the temporal bone.
15.3.2  Middle Ear
The middle ear cavity contains the ossicular chain which 
conducts sound from the tympanic membrane laterally, to 
the oval window and inner ear structures medially. The roof 
of the middle ear is the tegmen tympani and the jugular wall 
is the floor. The middle ear can be subdivided into the epi-
tympanum (attic) superior to the level of the tympanic mem-
brane, mesotympanum at the level of tympanic membrane, 
and hypotympanum inferior to the level of tympanic mem-
brane. The epitympanum communicates with the mastoid via 
the aditus ad antrum.
The mesotympanum contains the majority of the ossicu-
lar chain. The ossicular chain is composed of three bones: 
the malleus, incus, and stapes. Since the stapes is anchored to 
the oval window, a mnemonic for the order of the ossicles is 
“MISO” representing malleus, incus, stapes, and oval win-
dow. The manubrium of the malleus is attached to the tym-
panic membrane, and the head of the malleus articulates with 
the body of the incus in the epitympanum forming the incu-
domalleal joint, which has a characteristic “ice cream cone” 
configuration on axial sections. The lenticular process of the 
incus extends at approximately a right angle from the long 
process of the incus to articulate with the capitulum (head) of 
the stapes, forming the incudostapedial joint.
An important middle ear structure is the scutum, a sharp 
bony projection to which the tympanic membrane is attached 
superiorly. Prussak space, the location for pars flaccida cho-
lesteatomas, is bounded by the scutum laterally and the neck 
of the malleus medially.
The posterior wall of the middle ear is irregular and 
includes the sinus tympani, pyramidal eminence, and facial 
recess.
15.3.3  Inner Ear
The inner ear comprises the osseous labyrinth, which 
includes the cochlea, vestibule, and semicircular canals. The 
cochlea contains the end organ for hearing while the vesti-
bule and semicircular canals are responsible for balance and 
equilibrium. The densest portion of the temporal bone that 
surrounds the osseous labyrinth is termed the otic capsule. 
The osseous labyrinth encapsulates the membranous laby-
rinth, which contains endolymph and is surrounded by 
perilymph.
The cochlea is a spiral-shaped structure with 2½–2¾ 
turns, including the basal, middle, and apical turns, which 
are separated by interscalar septa. The lateral aspect of the 
basal turn of the cochlea bulges into the middle ear cavity, 
forming the cochlear promontory. The nerve of Jacobson 
(branch of cranial nerve IX) courses over the cochlear prom-
ontory. The cochlear nerve passes from the internal auditory 
canal through the bony canal for the cochlear nerve (also 
referred to as the cochlear fossette or cochlear aperture) into 
the modiolus, which is a crown-shaped structure centered 
within the cochlea that transmits branches of the cochlear 
nerve to the organ of Corti. The organ of Corti is the end 
organ for hearing and is not visible on CT images.
The bony vestibule is an ovoid space located superior and 
posterior to the cochlea, which connects to the semicircular 
canals. There are three semicircular canals—superior, poste-
rior, and lateral which are oriented orthogonal to one another. 
The endolymphatic duct extends from the posterior aspect of 
the vestibule toward the posterior cranial fossa, and ends in a 
blind pouch, the endolymphatic sac, at the posterior margin 
of the petrous ridge. The bony vestibular aqueduct surrounds 
the endolymphatic duct and normally measures up to 1 mm 
at the midpoint and 2 mm at the operculum, according to the 
Cincinnati criteria [1].
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The cochlear aqueduct should not be mistaken for a frac-
ture. It is a narrow bony channel that surrounds the perilym-
phatic duct and extends from the basal turn of the cochlea to 
the subarachnoid space adjacent to the pars nervosa of the 
jugular foramen.
15.3.4  Internal Auditory Canal
The internal auditory canal (IAC) is a channel in the petrous 
bone. It extends from the fundus which abuts the labyrinth to 
the porus acusticus. At the fundus, a transverse crest (crista 
falciformis) divides the IAC into superior and inferior com-
partments. A vertical crest (“Bill’s bar”) divides the superior 
compartment into anterior and posterior components. The 
facial nerve is located in the anterosuperior compartment, 
the cochlear nerve in the anteroinferior compartment, and 
the superior and inferior vestibular nerves in the superopos-
terior and inferoposterior compartments, respectively. A 
mnemonic for the location of the nerves in the anterior com-
partment is “Seven (cranial nerve VII) Up Coke (cochlear 
nerve) down.”
15.4  Imaging Modalities and Techniques
While CT is often the first modality utilized to assess sus-
pected pathology involving the inner ear structures (cochlea 
and labyrinth), certain lesions such as a cochlear schwan-
noma and labyrinthine hemorrhage are better detected with 
MRI. In the work-up of subjective pulsatile tinnitus, CT is 
frequently the preferred modality. However, MR imaging 
with MRA and MRV may be more appropriate in the work-
 up of objective pulsatile tinnitus (audible bruit on ausculta-
tion by the clinician). Conventional catheter angiography 
may then follow to further characterize the vascular abnor-
mality as well as to provide therapeutic management (embo-
lization) of lesions such as dural fistulas. MR imaging is the 
primary modality for evaluating the non-osseous compo-
nents of the temporal bone, suspected retrocochlear pathol-
ogy, and sensorineural hearing loss. Magnetic resonance 
imaging is required when temporal bone pathology is sus-
pected to involve the intracranial compartment.
15.4.1  Computed Tomography
15.4.1.1  Temporal Bone CT Technique
Dual acquisition temporal bone CT (separately acquired 
direct axial and direct coronal images) has largely been 
replaced with multidetector row CT (MDCT) in which a 
single set/volume of axial images are acquired and reformat-
ted in multiple planes. Thoughtfully performed MDCT 
reduces radiation dose, and its rapid acquisition minimizes 
artifact from patient motion. Intravenous contrast is typically 
not used with temporal bone CT because when contrast is 
necessary (tumors, vascular pathology such as dural fistulas), 
then higher resolution MRI, MRI with MRA, or CTA are 
usually obtained.
For temporal bone CT the patient is placed supine in the 
gantry with the head angled superiorly and posteriorly. The 
neck is hyperextended so that the orbits are canted out of the 
pathway of the X-ray beam to minimize exposure to the lens. 
Gantry tilt may need to be avoided to facilitate image recon-
struction and reformats. Scan coverage is from the roof of 
the temporal bone (the arcuate eminence) through the mas-
toid tip. Thin collimation to achieve high resolution is 
extremely important as the anatomy of the temporal bone 
involves very small structures. A collimation of 0.6–1.0 mm 
provides appropriate resolution. The raw data from each ear 
is most often reconstructed into 0.6–0.75  mm thin axial 
images in bone algorithm at a DFOV of 100 mm that effec-
tively magnifies the images. Technologists provide recon-
structed images including 0.6–1.0 mm reformats in the axial 
plane parallel to the lateral semicircular canal created from a 
sagittal plane, and 0.6–1.0  mm reformats in the coronal 
plane. Axial images with 2–3 mm section thickness of the 
entire scan volume are also provided in soft tissue 
algorithm.
Reformats may be obtained in sagittal or oblique planes 
to improve the detection of pathology in specific clinical set-
tings such as superior semicircular canal dehiscence.
Stenver reformat: On the console the technologist scrolls 
through the sagittal plane until a view of the lateral semicir-
cular canal is obtained. A reformatted axial plane parallel to 
the lateral semicircular canal is made. The technologist then 
scrolls through this axial data set and Stenver reformats are 
made by tracing a line perpendicular to the long axis of the 
summit of the superior semicircular canal at submillimetric 
intervals. This plane is perpendicular to the roof of the supe-
rior semicircular canal displaying it in cross section.
Poschl reformat: On the console the technologist scrolls 
through the sagittal plane until a view of the lateral semicir-
cular canal is obtained. A reformatted axial plane parallel to 
the lateral semicircular canal is made. The technologist then 
scrolls through this axial data set and Poschl reformats are 
made by tracing a line parallel to the long axis of the summit 
of the superior semicircular canal at submillimetric 
intervals.
15.4.2  Magnetic Resonance Imaging
MRI of the temporal bones is performed in a head coil and 
should include thin section unenhanced and enhanced axial 
T1-weighted images, and enhanced coronal T1-weighted 
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images. Fat suppression in at least one enhanced plane 
should be performed to distinguish fat from enhancement, 
especially in the region of the petrous apex. A maximum sec-
tion thickness of 3 mm with no interslice gap and a small 
FOV are required to provide images able to depict the fine 
detail of the anatomy and pathology in the temporal bone. 
Thin section (1  mm or submillimetric), 3D T2-weighted 
techniques are valuable in temporal bone imaging to evaluate 
the relationship of pathologic processes such as a vestibular 
schwannoma with the surrounding nerves, the patency of 
labyrinthine structures, the size of the endolymphatic duct 
and sac, and the extent of cochlear dysplasia in congenital or 
developmental hearing loss. Reformatted oblique sagittal 
images perpendicular to the long axis of the internal auditory 
canal are helpful in identifying cranial nerve hypoplasia or 
aplasia. Diffusion-weighted imaging (DWI) can help in dis-
tinguishing cholesteatoma which typically have restricted 
diffusion from inflammatory middle ear cavity opacification 
which has facilitated diffusion.
Axial T2-weighted, flair, and enhanced T1-weighted 
images of the brain should be performed to assess for intra-
cranial extension of temporal bone pathology, and also to 
exclude central nervous system pathology that might pro-
duce tinnitus, vertigo, hearing loss, or cranial nerve symp-
toms such as demyelinating disease, stroke, or inflammation/
infection.
15.5  Tinnitus and Hearing Loss 
without a Mass
When no mass is seen on imaging, the radiologist should 
closely review the inner ear structures. The common causes 
of tinnitus and hearing loss without a mass include otospon-
giosis, labyrinthitis ossificans, superior semicircular canal 
dehiscence, and enlarged vestibular aqueduct syndrome.
15.5.1  Otospongiosis
Otospongiosis is an idiopathic progressive disease of patho-
logical bone remodeling that causes conductive, sensorineu-
ral, or mixed hearing loss. It results in spongiosis or sclerosis 
of portions of the petrous bone. Conductive hearing loss is 
usually secondary to abnormal bone encroaching on stapes 
with impingement on the stapes footplate. Therefore, stapes 
surgery is the traditional initial treatment for otosclerosis, but 
is being augmented or replaced by innovations in hearing aid 
technology and cochlear implants.
Symptoms typically start in the second or third decade of 
life and presentation is with progressive conductive hearing 
loss (80% bilateral) with a normal tympanic membrane, and 
no evidence of middle ear inflammation. On otoscopic exam-
ination, the promontory may have a faint pink tinge reflect-
ing the vascularity of the lesion, referred to as the Schwartze 
sign.
On imaging, the disease is seen as lucency in the otic cap-
sule. The most common location of involvement of otoscle-
rosis is the bone just anterior to the oval window at a small 
cleft known as the fissula ante fenestram (fenestral otoscle-
rosis) (Fig. 15.1). Involvement of the otic capsule separable 
from the oval window is referred to as “retrofenestral oto-
sclerosis” or “cochlear otosclerosis” and can give a sensori-
neural component to the hearing loss.
A later presumably less active phase can occur where the 
bone becomes more dense and sclerotic. The bone still 
appears to encroach on the footplate but has a density closer 
to that of the otic capsule and thus may be difficult to 
identify.
15.5.2  Labyrinthitis Ossificans
Labyrinthitis ossificans is the late stage of labyrinthitis, in 
which there is pathologic ossification of spaces within the 
membranous labyrinth. Profound bilateral hearing loss from 
labyrinthitis ossificans is most commonly due to bacterial 
meningitis with onset of symptoms 3–4  months after the 
 episode [2]. Other causes include trauma, hemorrhage, auto-
immune disease, vascular obstruction of labyrinthine artery, 
and surgical insult.
Imaging can detect the evolution of labyrinthitis in three 
stages: acute, fibrous, and ossification. In the acute stage, 
enhancement of the inner ear is noted on MR images, but the 
CT scan may appear normal. In the intermediate fibrous 
stage of labyrinthitis, there is loss of fluid signal intensity on 
heavily T2-weighted sequence images (Fig. 15.2), while the 
Fig. 15.1 Fenestral otospongiosis on the left with signs of lucency in 
the fissula ante fenestram (arrow)
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CT scan may still appear normal. In the late ossific stage, one 
sees replacement of the normal cochlea, vestibule, and/or 
semicircular canals by bone attenuation on CT scans.
15.5.3  Superior Semicircular Canal Dehiscence
Superior semicircular canal dehiscence is the most common 
type of a group of disorders known as third window abnor-
malities. The labyrinth is normally in a closed hydraulic sys-
tem with the oval and round windows. Defects in the integrity 
of the bony structure of the inner ear can decompress/dampen 
the energy of the sound wave resulting in conductive hearing 
loss.
In addition to conductive hearing loss, superior semicir-
cular canal dehiscence can present with characteristic symp-
toms of vertigo when exposed to loud sounds (Tullio 
phenomenon). This is because of movement of fluid in the 
superior canal without movement in other canals. Other 
symptoms include autophony and pulsatile tinnitus. At audi-
ometry, there is a characteristic low-frequency air-bone gap 
due to decreased air conduction and increased bone 
conduction.
On imaging, there is a defect in the superior semicircular 
canal, best seen in the coronal plane, and on reformatted 
oblique images in the Stenvers plane (perpendicular to the 
canal). The Pöschl plane shows the superior canal as a ring 
and helps to determine the length of a dehiscence (Fig. 15.3). 
The defect is typically along the superior arc of the superior 
canal along the floor of the middle cranial fossa. However, a 
defect can also occur along the posterior limb of the canal 
facing the posterior fossa.
Other third window abnormalities present with similar 
symptoms and include enlargement of the opening of the 
vestibular aqueduct, dehiscence of the scala vestibuli side of 
the cochlea, erosion of the lateral semicircular canal by cho-
lesteatoma, and abnormal bony thinning between the cochlea 
and vascular channels. Presence of a defect does not mean 
that the patient will necessarily have symptoms or will ben-
efit from surgery. Asymptomatic defects are rare (2% of the 
population) so further audiometric evaluation is recom-
mended for all patients with imaging findings [3].
15.5.4  Enlarged Vestibular Aqueduct 
Syndrome
Most congenital hearing malformations are detected after 
birth on newborn hearing screening. The exception is 
enlarged vestibular aqueduct syndrome (EVA) which can 
progress in childhood or less commonly early adulthood [4]. 
Stable hearing is observed in 67% of ears with EVA of which 
34% will demonstrate fluctuations in hearing. Progression of 
hearing loss is seen in 33% of ears of which half will demon-
strate fluctuations [5].
During fetal development, the vestibular aqueduct starts 
out as a wide tube. By the fifth week it narrows, and by mid-
term it approaches adult dimension and shape. However, the 
vestibular aqueduct continues to grow and change until a 
child is 3–4  years old. As yet incompletely understood 
genetic and/or environmental conditions cause EVA.
It is believed that an EVA does not cause hearing loss, but 
instead EVA and hearing loss are caused by the same under-
lying defect (gene mutations). Syndromic EVA includes 
Pendred syndrome or branchiootorenal syndrome. Syndromic 
hearing loss associated with EVA can affect other areas of 
the body. More commonly, the hearing loss associated with 
EVA is nonsyndromic, affecting only ear function.
On clinical exam, hearing loss can be conductive, mixed, 
or sensorineural, and the loss may be stable or fluctuating. 
Imaging is both diagnostic and prognostic (Fig. 15.4). There 
Fig. 15.2 Labyrinthitis ossificans on the right with loss of fluid signal 
intensity on heavily T2-weighted sequence images
Fig. 15.3 Superior semicircular canal dehiscence on the left. There is 
a bone defect (arrow) in the superior semicircular canal. Pöschl plane 
shows the superior canal as a ring and helps to determine the length of 
a dehiscence
15 Evaluation of Tinnitus and Hearing Loss in the Adult
198
are several definitions of an enlarged vestibular aqueduct. 
The most sensitive criteria is the Cincinnati criteria which 
defines abnormal as >0.9 mm at the midpoint or >1.9 mm at 
the operculum in the axial view [1]. Other criteria are using 
the semicircular canal as reference—enlarged if width at the 
proximal intraosseous portion exceeded that of the adjacent 
posterior semicircular canal. A retrospective study has found 
the severity of hearing loss in patients with an EVA is influ-
enced by degree of widening of the vestibular aqueduct mid-
point width [6].
15.6  Tinnitus and Hearing Loss with a Mass
15.6.1  Vestibular Schwannoma
Vestibular schwannomas typically arise from perineural 
Schwann cells of the superior or inferior vestibular nerve in 
the internal auditory canal near the porus acusticus. They fre-
quently extend into the cerebellopontine angle. Vestibular 
schwannomas often present with non-pulsatile tinnitus and 
high frequency sensorineural hearing loss. Less often, they 
may present with symptoms related to mass effect upon the 
middle cerebellar peduncle, lateral pons, and/or the cisternal 
trigeminal nerve. The presence of bilateral vestibular 
schwannomas is diagnostic of neurofibromatosis type II.
Vestibular schwannomas are typically difficult to identify 
on CT unless quite large. Expansion of the internal auditory 
canal may be present. On MR imaging, they are heteroge-
neous on T1- and T2-weighted images, and enhance follow-
ing contrast administration. When large (>2 cm), they often 
show cystic degeneration. Five to 10% of vestibular schwan-
nomas may have a co-existent arachnoid cyst. Hemorrhage 
may be seen in 5%. Calcification is rare. When evaluating a 
patient with a vestibular schwannoma, it is important to iden-
tify the full extent of the neoplasm including extension to the 
cochlear aperture and/or cerebellopontine angle, and to 
describe the presence of mass effect on the middle cerebellar 
peduncle and brainstem. Approximately 60–75% of vestibu-
lar schwannomas involve the internal auditory canal and the 
cerebellopontine angle.
The goal of management of vestibular schwannomas over 
the last decade has shifted from “complete resection” to 
hearing preservation. Treatment may include surgical resec-
tion, stereotactic radiosurgery, and for small, stable tumors 
clinical and radiologic observation is now common [7].
15.6.2  Cholesteatoma
Cholesteatoma is an expansile erosive mass lined by keratin-
izing stratified squamous epithelium. It may result from a 
congenital inclusion of squamous epithelium in the middle 
ear cavity (congenital cholesteatoma), or more commonly 
from abnormal migration of squamous epithelium into the 
middle ear cavity through a perforated tympanic membrane 
as a result of chronic infection/inflammation. Otoscopic 
examination typically reveals a pearly white mass behind the 
tympanic membrane. Erosive enzymes and osteoclast- 
stimulating agents within the epithelial debris result in bone 
destruction which is the radiologic hallmark of cholesteato-
mas. Acquired cholesteatomas most often occur in the set-
ting of an under-pneumatized mastoid, a perforation of the 
pars flaccida (Shrapnell’s membrane), involve Prussak space, 
and erode the adjacent bone including the scutum and ossi-
cles (the mallear head and incus body). The ossicles may be 
displaced medially. Cholesteatomas related to pars tensa per-
forations are less common. In these lesions the sinus tym-
pani, pyramidal eminence, and facial nerve recess may be 
involved and eroded. The long process of the incus and the 
stapes suprastructure may also be involved or eroded.
In the imaging evaluation of patients with a cholestea-
toma, it is important to comment on the extent of middle ear 
cavity opacification. Specifically, it is important to note if 
there is involvement of the anterior epitympanic recess, 
round window niche, sinus tympani, and/or facial recess. 
The integrity of adjacent bone including the roof of the epi-
tympanum (the tegmen tympani), the lateral semicircular 
canal, and the facial nerve canal should be commented upon. 
Involvement of important regional anatomy relevant to surgi-
cal planning such as the presence of high or dehiscent jugu-
lar bulb, or an anteriorly positioned sigmoid sinus plate 
should also be addressed in the radiologic interpretation. 
Diffusion-weighted MR imaging may be valuable in distin-
guishing cholesteatomas (which typically have restricted dif-
fusion) from inflammatory opacification in the middle ear 
Fig. 15.4 Enlarged vestibular aqueduct. The vestibular aqueduct 
extends from the posterior aspect of the vestibule toward the posterior 
cranial fossa (arrow)
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cavity. Frequently both are present, and DWI can distinguish 
the cholesteatoma form the areas of inflammation [8].
15.6.3  Glomus Tumor
When imaging the patient with a suspected glomus tympani-
cum, the radiologist should evaluate for and exclude other 
causes of pulsatile tinnitus including vascular anomalies 
such as an aberrant internal carotid artery, high riding dehis-
cent jugular bulb, jugular vein or sigmoid diverticulum (out-
pouching of the jugular bulb or sigmoid sinus, respectively, 
into adjacent pneumatized temporal bone), and large condy-
lar or mastoid emissary veins that traverse air cells.
Glomus tympanicum is a paraganglioma that arises from 
glomus bodies along the course of Jacobson’s nerve (the 
tympanic branch of CN IX) along the lateral aspect of the 
cochlea in the middle ear cavity. Glomus tympanicum is the 
most common primary tumor of the middle ear in adults, and 
presents in middle age with a slight female predominance. 
The typical clinical presentation is pulsatile tinnitus. Patients 
may also have conductive hearing loss. On otoscopic exami-
nation a fleshy vascular mass behind the tympanic membrane 
in the middle ear cavity is most often identified.
The classic imaging appearance is a demarcated mass 
along the cochlear promontory (Fig. 15.5). These tumors are 
soft tissue in density on CT, and on MR imaging they are 
iso- to mildly hyperintense to CSF on T1-weighted imaging, 
mildly hyperintense on T2-weighted imaging, and enhance 
intensely following contrast administration [9]. While these 
tumors are very vascular, the typical “salt and pepper” 
appearance seen in other glomus tumors/paragangliomas is 
frequently not seen in glomus tympanicum tumors due to 
their relatively small size. Once establishing the presence of 
a glomus tympanicum it is important to determine the extent 
of disease. These tumors are classified based on their spread 
from the cochlear promontory to the middle ear cavity/ossi-
cles, inner ear structures, external auditory canal, carotid 
canal, and the mastoid air cells. The radiologist should spec-
ify if the tumor is confined to the middle ear cavity (glomus 
tumors tend to engulf rather than erode the ossicles), identify 
if there is fistulization to the inner ears structures due to bone 
erosion, and identify extension of tumor into adjacent 
structures.
When there is tumor in the jugular foramen it is important 
to establish if the middle ear tumor is a projection of a larger 
glomus tumor arising in the jugular fossa—a glomus 
jugulare- tympanicum. Glomus jugulare paragangliomas 
arise from glomus bodies in the jugular foramen, either in the 
adventitia of the jugular bulb, the superior ganglion of cra-
nial nerve CN X, or along Arnold or Jacobsen nerves (auric-
ular branch of CN X and tympanic branch of CN IX, 
respectively). They frequently grow directly into the jugular 
vein (Fig. 15.6a, b).
15.6.4  Cholesterol Granuloma
Lucent, expansile lesions of the petrous apex (cholesterol 
granuloma, mucocele, epidermoid, meningocele) are com-
mon. They may be incidental lesions detected on CT of the 
head being performed for unrelated reasons, or they may be 
identified on a head CT or a temporal bone CT performed for 
related symptomatology. These lesions may cause symptoms 
due to mass effect on adjacent structures. The management 
of each petrous apex lesion is different and clinical history is 
often of limited use. Biopsy is often difficult to perform, and 
in certain instances are contraindicated (meningocele) and 
potentially harmful to the patient. Fortunately, a specific 
diagnosis can usually be made using a combination of CT 
and MR imaging together [10, 11]. On CT the pattern of 
bone expansion, remodeling, and/or erosion are important. 
On MR imaging the signal intensity on T1, T2, flair, DWI 
and enhanced T1 weighting are often diagnostic (e.g., cho-
lesterol granulomas are typically hyperintense on unen-
hanced T1-weighted imaging, epidermoids classically have 
restricted diffusion) [10, 11]. The size, location of the lesion, 
and its relationship to adjacent critical structures including 
the petrous internal carotid artery and the internal auditory 
canal are important to the referring physician.
Cholesterol granulomas typically arise in a pneumatized 
space, most often the petrous apex of the temporal bone. 
These develop due to recurrent micro-hemorrhages at the 
capillary level. This may be due to negative pressures in 
petrous air cells. The blood incites a mucosal reaction, 
giant cells, and cholesterol crystal deposition leading to 
recurrent hemorrhage. The cycle results in petrous apex 
Fig. 15.5 Glomus tympanicum. Axial multidetector CT image of the 
left temporal bone shows a soft tissue mass (GT) at the cochlear prom-
ontory (asterisk)
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expansion. This can result in a clinical presentation with 
cranial nerve symptoms (CNs V and VIII) and tinnitus. 
Cholesterol granulomas are expansile, lytic, circumscribed 
masses centered in the petrous apex and they are often uni-
locular (Fig. 15.7a). On MR imaging, cholesterol granulo-
mas while heterogeneous on all pulse sequences due to 
blood products of varying ages, they are characteristically 
hyperintense on T1-weighted images related to methemo-
globin (Fig. 15.7b).
15.7  Conclusion
The imaging workup for tinnitus and hearing loss in adults 
follows otoscopic exam and audiometry testing. Computed 
tomography and MR imaging have different and often com-
plementary roles in the evaluation of tinnitus and hearing 
loss depending on the clinical scenario and the suspected 
underlying cause. Imaging can often identify the cause, and 
evaluate the extent of disease for surgical planning.
a b
Fig. 15.6 (a, b). Glomus jugulare. Axial enhanced CT images show a vascular avidly enhancing mass in the jugular foramen (∗), with direct 
inferior growth into the internal jugular vein (V)
a b
Fig. 15.7 (a, b). Cholesterol granuloma. (a) Axial CT image in bone 
window shows a unilocular, expansile mass of the right petrous apex. 
(b) Axial unenhanced T1-weighted gradient image shows the character-
istic hyperintensity of these lesions related to blood products. The right 
mastoid air cells are opacified
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Take Home Messages
• The radiologist should be familiar with a few key 
temporal bone anatomical structures and levels on 
axial and coronal imaging.
• Imaging approach and differentials for hearing loss 
and tinnitus can be based on whether a mass is pres-
ent or absent.
• MR and CT are complementary modalities. The choice 
of imaging depends on the most likely clinical diagno-
sis following history and otoscopic examination.
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16.1  Introduction to Head and Neck Spaces
The neck is anatomically complex but can be organized into 
specific “spaces” or compartments based on fascial planes and 
individual space contents [1, 2]. Some authors argue that the use 
of the term “space” may be an oversimplification and lead to 
confusion. These authors propose naming fascial layers in func-
tional terms and using the term “compartment” which can be 
bound by bone, muscle, and/or fascia. For the purposes of clar-
ity and consistency with radiologic literature, this review will 
continue to use the term “space” but will point out potentially 
confusing terms and proposed newer terminology to promote 
interdisciplinary communication. The ability to place pathology 
within a neck space is the first step to generating a differential 
diagnosis; then specific imaging features and clinical context 
can be applied to narrow these different considerations.
The neck can be divided into suprahyoid and infrahyoid 
spaces by the hyoid bone. Some head and neck spaces trans-
gress both the suprahyoid and infrahyoid neck. Two layers 
of fascia, superficial and deep, are commonly used to define 
the spaces of the neck. The superficial cervical fascia (SCF) 
is a thin layer, investing loose connective and adipose tis-
sue, platysma, superficial lymph nodes, and muscles of facial 
expression. For clarification, some surgeons prefer to refer 
to SCF simply as “subcutaneous tissue” [3] to prevent con-
fusion with the superficial layer of the deep cervical fascia 
(SLDCF), which is described below.
The deep cervical fascia is subdivided into superficial, 
middle, and deep layers. The superficial layer of deep cervical 
fascia (SLDCF) lies between the SCF (or subcutaneous tissue) 
and the muscles of the neck, attaching anteriorly to the hyoid, 
superiorly to the mandible, mastoid process, and external 
occipital protuberance. The “rule of twos” may be helpful to 
remember that the SLDCF encloses two glands (submandibu-
lar and parotid) and two muscles (sternocleidomastoid and 
trapezius). Some surgeons prefer to refer to subdivisions of 
the SLDCF as the masticator fascia, submandibular fascia, and 
sternocleidomastoid/trapezius fascia. In other words, in some 
cases, it may be helpful to define fascia by function.
The middle layer of deep cervical fascia (MLDCF) extends 
from the skull base to the mediastinum, and is divided into 
a muscular layer investing the strap muscles, and visceral 
layer (also called buccopharyngeal in the suprahyoid neck) 
investing the larynx, pharynx, trachea, esophagus, and thy-
roid. The deep layer of deep cervical fascia (DLDCF) sur-
rounds the vertebral column and paravertebral muscles with 
two distinct components: the alar and prevertebral fascia. 
The alar layer forms the posterior and lateral walls of the 
retropharyngeal space and bridges the transverse processes 
of the vertebrae. The prevertebral layer encloses the para-
spinal muscles: the longus colli and longus capitis muscles; 
the anterior, middle, and posterior scalene muscles; and the 
levator scapulae. The carotid sheath is generally thought to 
be composed of all three layers of DCF; however, the thick-
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Learning Objectives
• To understand how the layers of the deep cervical 
fascia, along with muscles and bones, help to define 
compartments or “spaces” in the neck.
• To understand the normal anatomy and contents of 
each of these spaces in the suprahyoid and infrahy-
oid neck.
• To accurately localize neck pathology into a spe-
cific space in order to generate the best differential 
diagnosis.
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ness of the carotid sheath varies between individuals and at 
different levels in the neck.
The suprahyoid neck spaces comprise the area from the base 
of skull to the hyoid bone, excluding the orbits, paranasal sinuses, 
and oral cavity. The spaces of the suprahyoid neck include the 
pharyngeal mucosal space (PMS), the sublingual space (SLS), 
the submandibular space (SMS), the parapharyngeal space 
(PPS), the parotid space (PS), and masticator space (MS). The 
entire neck (suprahyoid plus infrahyoid) spaces include the 
carotid space (CS), retropharyngeal and danger space (RPS), 
and the perivertebral space (PVS). In addition to the entire neck 
spaces (above), infrahyoid neck contains the visceral space 
(VS), which comprises the thyroid and parathyroid glands and 
the larynx, hypopharynx, trachea, and cervical esophagus.
16.2  Suprahyoid Neck: Pharyngeal 
Mucosal Space (PMS)
Anatomy and Contents Contents of the pharyngeal muco-
sal space include the mucosa of the nasopharynx and oro-
pharynx, as well as submucosal structures such as Waldeyer’s 
ring, minor salivary glands (MSGs), the pharyngeal constric-
tor and levator veli palatine muscles, and the torus tubarius 
bordering the Eustachian tube orifice [4]. Waldeyer’s ring 
comprises the adenoids and the palatine and lingual tonsils; 
the ring-like configuration of lymphoid tissue can be thought 
of as a mechanism of protecting the body from inhaled and 
ingested antigens. Deep mucosa-lined tonsillar crypts result 
in a characteristic striped appearance on contrast-enhanced 
imaging and may hide small primary tumors.
Pathology Squamous cell carcinoma arising from the 
mucosa represents the most common malignant neoplasm in 
this space and is covered in a separate chapter. Tumors aris-
ing from Waldeyer’s ring lymphoid tissue and MSGs are 
considerably less common. Inflammatory disease of the oro-
pharynx represents a spectrum ranging from non-focal ton-
sillitis to tonsillar or peritonsillar abscess. (Fig.  16.1) 
Congenital lesions of the PMS include the central 
 nasopharyngeal Tornwaldt cyst and those related to the 
embryologic thyroglossal duct, including cysts and the lin-
gual thyroid. (Fig. 16.2).
Fig. 16.1 CECT shows characteristic striped appearance of the 
inflamed mucosa of Waldeyer’s ring in a patient with tonsillitis and 
adenoiditis
Fig. 16.2 Sagittal T2WI demonstrates a thyroglossal duct cyst at the 
base of tongue, part of the oropharynx. Adenoidal tissue lines the naso-
pharyngeal roof
Key Point
• While squamous cell carcinoma is the most common 
tumor of the PMS, the presence of Waldeyer’s ring 
lymphoid tissue and submucosal minor salivary 
glands may result in lymphoproliferative and sali-
vary neoplasms, respectively.
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16.3  Suprahyoid Neck: Parapharyngeal 
Space (PPS)
Anatomy and Contents The PPS represents a triangular fat-
containing space lateral to the PMS, bounded laterally by the 
masticator and parotid spaces, posteriorly by the retropharyngeal 
and carotid spaces, and superiorly by the skull base, with inferior 
extension into the submandibular space. The PPS contents are 
simple: fat, minor salivary glands, and, rarely, lymph nodes.
Pathology Pathology primary to the PPS is rare, with the 
majority of lesions salivary in origin and representing benign 
mixed tumors (BMTs) [5]. The PPS is primarily impacted by 
pathology of neighboring spaces, and the pattern of devia-
tion or deformity of the PPS fat may be helpful in identifying 
the space of origin. For example, while a well-defined mark-
edly T2-hyperintense mass bounded entirely by fat is likely a 
primary PPS BMT, a similar lesion contiguous with the deep 
lobe of the parotid and displacing the PPS fat anteromedially 
more likely originates in the parotid space (Fig.  16.3). 
Similarly, masticator space lesions displace the PPS fat pos-
teromedially, PMS lesions laterally, and carotid space lesions 
anteriorly.
16.4  Suprahyoid Neck: Masticator  
Space (MS)
Anatomy and Contents The MS is located lateral to the 
PPS, and contains the muscles of mastication (masseter, tem-
poralis, medial and lateral pterygoids), posterior body and 
ramus of the mandible and the mandibular nerve, a branch of 
the trigeminal nerve.
Pathology As with the PPS, most pathology of the MS arises 
in the neighboring spaces, with the most common being odon-
togenic infection arising from molar teeth within the neighbor-
ing oral cavity [6]. Dental abscesses may extend to the medial 
pterygoid or masseter muscles and may also result in osteomy-
elitis of the posterior mandibular body and condyle (Fig. 16.4). 
Another common non-neoplastic lesion affecting the MS is the 
venous malformation (VM), which has a predilection for the 
muscles of mastication and is a frequent incidental finding on 
a b
Fig. 16.3 (a) Primary BMT of the left PPS is surrounded entirely by fat on axial T1-weighted image. (b) Axial T1-weighted image shows a pri-
mary BMT of the left parotid space inseparable from the deep lobe and displacing PPS fat medially
Fig. 16.4 Axial CECT image shows a fluid collection within the 
enlarged left masseter muscle, representing an odontogenic abscess 
arising from the left mandibular third molar tooth
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imaging studies performed for unrelated indications (Fig. 16.5) 
The presence of phleboliths within a heterogeneously enhanc-
ing and markedly T2-hyperintense mass is virtually pathogno-
monic for VM. Cranial nerve V3 may be involved secondarily 
by perineural spread of tumor, or, much less commonly, by 
primary nerve sheath tumors such as schwannomas. Primary 
neoplasms of the muscles of mastication, such as sarcomas and 
lymphoproliferative malignancies, are exceedingly rare. More 
often, malignant MS disease results from spread of tumors aris-
ing in the pharynx, oral cavity, or parotid space.
16.5  Suprahyoid Neck: Parotid Space (PS)
Anatomy and Contents The PS contains the parotid gland, 
facial nerve, retromandibular vein, and branches of the exter-
nal carotid artery. The plane of the facial nerve bisects the 
gland into superficial and deep lobes; localization of lesions 
into these lobes is important in the prevention of inadvertent 
facial nerve injury during resection. This plane may be 
approximated on cross-sectional imaging by identifying the 
stylomandibular tunnel, between the styloid process and the 
posterior cortex of the mandibular condyle, as well as by the 
position of the retromandibular vein.
Pathology The parotid gland is the only salivary gland to 
contain lymph nodes, with the important consequence that the 
differential diagnosis for lymphadenopathy, including neo-
plastic and inflammatory etiologies, must be considered for 
any PS mass [7]. The parotid lymph nodes also represent first 
echelon drainage for cancers of the external auditory canal as 
well skin cancers of portions of the scalp and facial skin. 
Fortunately, most primary salivary epithelial neoplasms repre-
sent the benign mixed tumor (pleomorphic adenoma), which 
demonstrates very high signal on T2-weighted and ADC scans 
(Fig. 16.6). This is one of the few parotid neoplasms that dem-
Fig. 16.5 Axial T2-weighted image shows a markedly hyperintense 
mass in the anterior left masseter muscle with internal round areas of 
signal void. These represent phleboliths and are virtually pathogno-
monic for a venous malformation
a b
Fig. 16.6 (a) Axial STIR image demonstrates marked T2 prolongation 
of a well-defined mass in the right parotid superficial lobe found to 
represent a benign mixed tumor. (b) Corresponding ADC image dem-
onstrates high signal reflecting the gelatinous nature of these tumors 
with relative free diffusivity of water
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onstrate characteristic imaging features; in general, given the 
very diverse neoplastic histology of this region, a specific 
diagnosis cannot be reliably predicted based on CT or MR 
imaging. Acute parotitis may occur secondary to obstruction 
by calculi, retrograde migration of oral flora secondary to poor 
salivary flow, or hematogenic viral infection. Chronic parotitis 
is typically bilateral and reflects underlying systemic disease 
such as Sjogren syndrome or sarcoidosis.
16.6  Suprahyoid Neck: Sublingual (SLS) 
and Submandibular Space (SMS)
Anatomy and Contents The oral cavity is an anatomically 
complex area with an extensive convoluted mucosal surface 
covering its constituent structures, including the tongue, 
floor of mouth, hard palate, cheeks, and gingiva. The SLS is 
the portion of the floor of mouth below the tongue and above 
the mylohyoid muscle, a sling-like structure that separates 
the OC above from the SMS below (Fig. 16.7) [8]. The SLS 
contains the sublingual glands (SLGs), the deep lobes of the 
submandibular glands (SMGs) and submandibular ducts, the 
“neurovascular bundles” (lingual nerves, arteries, and veins), 
and cranial nerves 9 and 12. The SMS is relatively simple in 
composition, containing only the SMG superficial lobes, fat, 
lymph nodes, and the facial artery and vein.
Pathology The teeth and salivary glands are important 
sources of inflammatory disease in both the SLS and SMS, 
with the vast majority of neoplasms in this region represent-
ing squamous cell carcinoma originating from the OC 
mucosa. Salivary epithelial tumors may arise from the major 
salivary glands (SLG, SMG) or from minor salivary glands 
(MSGs) lying within the SLS submucosal space. Obstruction 
of the SLG or a submucosal MSG duct may result in forma-
tion of a ranula, an epithelial-lined cyst within the SLS. When 
these rupture, they may form pseudocysts that may “dive” or 
“plunge” behind the posterior free edge of the mylohyoid 
muscle into the SMS (Fig. 16.8).
16.7  Infrahyoid Neck: Visceral Space (VS)
Anatomy and Contents The VS is a central tubular space 
extending from the hyoid to the mediastinum, enclosed by 
the middle layer of deep cervical fascia. It is the only space 
found entirely in the infrahyoid neck. It contains the thyroid 
and parathyroid glands, the recurrent laryngeal nerve, the 
larynx, hypopharynx, trachea, and cervical esophagus. The 
thyroid gland is located anterior to the prevertebral muscula-
ture and posterior to the infrahyoid strap musculature, in 
close proximity to other structures of the visceral space 
including the larynx, trachea, and esophagus. The tracheo-
esophageal groove lies posteromedial to the thyroid lobe, 
and contains several important structures including the recur-
rent laryngeal nerve, paratracheal nodes, and parathyroid 
glands.
Fig. 16.7 Coronal T2 weighted image shows the sling-like mylohyoid 
muscle that separates the oral cavity above from the SMS below
Fig. 16.8 Axial CECT depicts a “diving” or “plunging” ranula extend-
ing from the SLS to the SMS behind the posterior free edge of the 
mylohyoid muscle
Key Point
• The parotid gland is the only salivary gland to contain 
lymph nodes; the differential diagnosis for lymphade-
nopathy must be considered for any PS mass.
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Thyroid and Parathyroid Pathology Abnormalities of the 
thyroid gland are a major indication for imaging the visceral 
space. In general, ultrasound is the workhorse imaging 
modality for inflammatory (Hashimoto’s) or infectious thy-
roiditis and for evaluation of the intrathyroidal nodule. 
Intrathyroidal nodules may represent colloid cysts, adeno-
mas, differentiated thyroid cancer, or even the rare metasta-
ses. Many ultrasound classification systems exist to risk 
stratify these nodules and decide on biopsy, including ones 
by the American Thyroid association (ATA) and Society of 
Radiologists in Ultrasound (SRU), and also new systems 
such as European (EU-TIRADS) and American College of 
Radiology Thyroid Imaging and Reporting Data System 
(ACR TIRADS) are gaining acceptance for its point based 
approach [9, 10].
Thyroid cancer is a heterogeneous group of malignan-
cies, including differentiated thyroid carcinomas (papillary 
and follicular), medullary and anaplastic carcinomas, and 
non- Hodgkin lymphoma. Cross-sectional imaging is more 
appropriate when there is a concern for extrathyroidal exten-
sion of tumor [11, 12] (Fig. 16.9) into surrounding structures 
such as the trachea or esophagus. For rapidly enlarging thy-
roid masses, anaplastic carcinoma and lymphoma should be 
considered. For multinodular goiters (MNG), ultrasound is 
used for surveillance of individual nodules, but non-contrast 
CT (NCCT) is often the choice for presurgical evaluation if 
airway compression necessitates removal. NCCT is help-
ful to evaluate the extent of airway compression, substernal 
extension for surgical planning and to exclude overt signs of 
malignancy.
Congenital lesions in the visceral space include infrahyoid 
thyroglossal duct cysts or ectopic thyroid tissue along the 
course of the thyroglossal duct. (Fig.  16.10) Thyroglossal 
duct cysts are the most common congenital neck masses; 
most present before age ten as a painless, movable mass that 
may fluctuate in size after upper respiratory tract infection. 
When suprahyoid, they are characteristically midline and 
when infrahyoid, they are often para-midline.
Nodules in the tracheoesophageal groove may represent 
parathyroid adenomas or carcinomas, lymph nodes or rarely 
schwannomas of the recurrent laryngeal nerve. Parathyroid 
adenomas are characteristically hypervascular, demonstrating 
rapid washin on early arterial phase and relatively rapid wash-
out on venous phase multiphase contrast enhanced CT [13].
Larynx, Hypopharynx, Trachea, and Esophagus 
Pathology The larynx and hypopharynx are most com-
monly imaged for staging squamous cell carcinoma (a pri-
mary mucosal space abnormality), covered in a separate 
Fig. 16.9 Axial CECT shows a papillary thyroid cancer with extrathy-
roidal extension and invasion of the trachea (arrow) and esophagus
Fig. 16.10 Axial CECT shows an infrahyoid off-midline cystic lesion 
(arrow), embedded in the strap musculature, compatible with a thyro-
glossal duct cyst
Key Point
• US is the primary imaging modality for both inflam-
matory disease and work-up of thyroid nodules, with 
cross- sectional imaging used when there is concern 
for extrathyroidal extension of tumor, or to evaluate 
potential airway compression or substernal extension.
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chapter. More rare submucosal tumors are usually well cir-
cumscribed on imaging and will not have an overlying muco-
sal abnormality on endoscopy. The ddx for submucosal 
masses includes minor salivary gland tumors, sarcomas, and 
lymphoma. Laryngeal chondrosarcomas most often arise in 
the cricoid cartilage with cartilage destruction, ring-like cal-
cification, and bright T2 signal on MRI (Fig. 16.11). Benign 
lesions of the larynx, including papillomas and hemangio-
mas, are also more rare.
Epiglottitis should be suspected in a child with difficulty 
breathing and swallowing and may initially be evaluated with 
plain film. When there is a classic “thumb” sign reflecting 
the swollen epiglottis, treatment may be initiated and CECT 
may not even be required. Adults may have supraglottis with 
CECT showing thickened epiglottis and aryepiglottic folds.
16.8  Entire Neck: Carotid Space
Anatomy and Contents The carotid space spans the supra-
hyoid and infrahyoid neck, extending from the skull base to 
the aortic arch, with all three layers of the deep cervical fascia 
contributing to the carotid sheath [14]. It is located posterior to 
the styloid process (and is referred to as the post-styloid PPS 
by some authors), anterior to the prevertebral muscles, and lat-
eral to the retropharyngeal space. The space can be subdivided 
into nasopharyngeal, oropharyngeal, cervical and mediastinal 
components. The suprahyoid CS contains the carotid artery, 
internal jugular vein (IJV), cranial nerves, IX, X, XI, XII, and 
the sympathetic chain. The infrahyoid CS differs in that all 
cranial nerves have exited except the vagus nerve. Lymph 
nodes are closely associated with the carotid space, along its 
lateral border. The carotid artery is located medially, IJV later-
ally, vagus nerve posteriorly along the vessels, and the sympa-
thetic chain posteriorly within the sheath.
Pathology Masses in the suprahyoid carotid space classi-
cally displace the parapharyngeal fat anteriorly and splay the 
carotid and jugular vein, often displacing the ICA anteriorly 
and IJV posterolaterally. Vascular pathology, primarily dis-
section or pseudoaneurysm of the carotid artery or thrombo-
sis/thrombophlebitis of the IJV, may easily be overlooked on 
routine neck CT or MRI. Specific attention should be paid to 
the carotid space to exclude dissection in any patient present-
ing with Horner’s syndrome (Fig. 16.12). An IJV thrombo-
phlebitis caused by an extension of oropharyngeal or 
odontogenic infection is referred to as Lemierre syndrome. 
CT and MR angiography or venography are studies of choice 
if there is high clinical suspicion for a vascular lesion.
The most common masses in the high nasopharyngeal 
carotid space, including glomus jugular paraganglioma, 
schwannoma and meningioma, often dumbbell inferiorly 
from the jugular foramen. Close attention to the skull base 
is important in any patient presenting with hoarseness/
vocal cord palsy or other cranial neuropathy involving CNs 
IX-XII. Bony changes on CT are an important clue to the 
correct diagnosis of a jugular foramen/carotid space mass at 
the skull base. Permeative destruction favors paraganglioma, 
smooth remodeling schwannoma, and hyperostosis menin-
gioma. On MRI, paragangliomas are intensely enhancing 
and can have the classic “salt and pepper” appearance with 
the “salt” representing microhemorrhages on T1-weighted 
(T1W) images and the pepper representing flow voids on 
T2-weighted (T2W) images. Glomus vagale and carotid 
body paragangliomas are also found in the carotid space. 
The rare vagale tumors arise along the high extracranial por-
tion of the vagus nerve in the high nasopharyngeal carotid 
apace and can extend intracranially. Carotid body tumors are 
located at the carotid bifurcation in the infrahyoid neck and 
splay the internal and external carotid arteries.
Carotid space nerve sheath tumors include schwannomas 
and neurofibromas. CS schwannomas are benign tumors of 
Schwann cells that invest CNs 9–12, most commonly CN 10 
(vagus). Neurofibromas are benign spindle cell neoplasms 
arising from the vagus nerve, hypoglossal nerve, or sympa-
thetic chain and are associated with neurofibromatosis type 
1. Schwannomas are typically fusiform enhancing tumors, 
Fig. 16.11 Axial CECT shows an expansile mass replacing the right 
cricoid cartilage with popcorn or ring-like calcification (arrow). On 
endoscopy, the surgeons saw a submucosal mass. Findings are compat-
ible with a chondrosarcoma
Key Point
• The CS spans the suprahyoid and infrahyoid neck, 
with all three layers of the DCF contributing to the 
carotid sheath.
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sometimes with cystic change, whereas neurofibromas are 
classically hypodense and hypoenhancing on CT and have a 
characteristic target sign on MRI. Nasopharyngeal CS schwan-
nomas displace the PPS fat anteriorly, the styloid anterolat-
erally, the ICA anteromedially, and the IJV posterolaterally 
(Fig. 16.13). This is in contradistinction to sympathetic chain 
schwannomas which displace the carotid artery and jugular 
vein together anteriorly. Oropharyngeal CS tumors also dis-
place the PPS fat anteriorly but also displace the posterior 
belly of the digastric muscle laterally. Infrahyoid neck CS 
nerve sheath tumors displace the carotid anteromedially.
16.9  Entire Neck: Retropharyngeal, 
Prevertebral and Danger Spaces (RPS)
Anatomy and Contents As mentioned in the introduction, 
the DLDCF has two components, the alar and prevertebral 
fascia, and this results in the formation of three posterior 
neck spaces: (1) retropharyngeal space (RPS), between the 
visceral and alar fascia, (2) danger space, between the alar 
and prevertebral fascia, and (3) prevertebral space, between 
the prevertebral fascia and the vertebral periosteum (part of 
the perivertebral space, discussed below). The importance of 
recognizing the division into these spaces primarily relates to 
their inferior extent. While the RPS terminates at the level of 
the T3 vertebra, the danger space extends more inferiorly to 
a point just above the diaphragm, and the prevertebral space 
continues to the coccyx. Though we typically cannot distin-
guish these spaces on imaging, we must remember to follow 
a posterior neck space collection to its inferior extent, recog-
nizing that this may lie within the chest or below. Contents of 
the RPS are simple, consisting of fat and lymph nodes.
Pathology Disease processes in the RPS can be categorized 
as related to nodal pathology and/or the presence of fluid. 
Fluid within the RPS may be encapsulated and represent an 
abscess (Fig. 16.14) or, much less commonly, a pseudomenin-
gocele representing a complication of spinal surgery. More 
frequent is edema or effusion of the RPS and this may occur as 
a reaction to a wide variety of disease processes, including 
pharyngitis, lymphatic or venous obstruction, angioedema, 
and radiation therapy [15]. Nodal enlargement may occur in 
the setting of inflammatory or neoplastic processes. When 
a b
Fig. 16.12 (a) Axial flair sequence shows crescentic shaped mural 
hyperintensity along the medial right ICA wall (arrow), expanding the 
caliber of the ICA, but only minimally narrowing the lumen. (b) The 
source image from a 3D time of flight also shows this crescentic high 
T1 signal (arrow) because of intrinsic T1 shortening, but on the MIP 
images from the post gadolinium MRA, a caliber change in the lumen 
could barely be perceived
Key Point
• Retropharyngeal collections that have entered the 
danger or prevertebral spaces can descend to the 
mediastinum and as far inferiorly as the coccyx.
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there is pharyngitis, lymphadenopathy may be reactive and 
homogenous, or, particularly in children, there may be the 
development of an intranodal abscess that may rupture into the 
RPS.  RPS lymph nodes may be involved in hematologic 
malignancy such as lymphoma, or may represent sites of met-
astatic disease from local malignancies, particularly those of 
the pharynx, paranasal sinuses, and thyroid gland (Fig. 16.15).
16.10  Entire Neck: Perivertebral Space
Anatomy and Contents The perivertebral space (PVS) is a 
cylindrical space around the vertebral column, invested in the 
DL-DCF from the skull base to the mediastinum. The PVS can 
be subdivided into the prevertebral space and the paraspinal 
space [16]. The contents of the PVS include the vertebral bod-
ies, disc spaces, musculature, and the vertebral arteries in the 
foramen transversarium. The retropharyngeal space lies directly 
anterior to the PVS and the paired carotid spaces lie anterolat-
eral. The prevertebral muscles are invested in the anterior 
DL-DCF, known as the “carpet” by surgeons. It is tenacious and 
serves as a barrier to infection and neoplasm. Lesions in the 
PVS tend to lift or displace the prevertebral muscles anteriorly, 
whereas RPS lesions displace these muscles posteriorly.
a b
Fig. 16.13 (a) Axial T1-weighted image shows a T1 isointense mass 
which displaces the PPS fat anteriorly. This suggests that the mass orig-
inates in the carotid space. (b) Axial postgadolinium, fat saturated 
T1-weighted image shows a fusiform, enhancing mass with central cys-
tic change. The ICA flow void is displaced anteromedially (arrowhead) 
and the IJV is compressed, which further confirms the carotid space 
origin. Note that retropharyngeal masses will displace the carotid 
laterally
Fig. 16.14 Axial CECT image shows suppurative retropharyngeal 
lymphadenopathy in a child with streptococcal pharyngitis. Note that 
the intranodal abscess has ruptured medially and is spilling into the 
RPS, where it may form a retropharyngeal abscess
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Pathology The vast majority of pathologic lesions in the 
perivertebral space involve the vertebral bodies and disc 
spaces, and the minority of lesions are centered in the 
paraspinal musculature. Therefore, pyogenic discitis/
osteomyelitis and bone metastasis are the most common 
pathologies found in this space (Fig.  16.16). Atypical 
infections such as tuberculosis are less common, but have 
characteristic imaging features such as sparing of the disc 
spaces. Primary bone tumors are also uncommon, but have 
characteristic locations and appearance. For example, 
chordomas can be suggested when a lesion is found in the 
upper cervical spine with characteristic bright T2 signal 
and enhancement.
16.11  Concluding Remarks
The neck is anatomically complex, but can be organized 
into compartments or “spaces” in order to organize the 
approach to neck masses. A thorough understanding of fas-
cial planes, the various spaces and their normal contents 
will help the radiologist generate the best differential diag-
noses to appropriately guide management. The parapharyn-
geal space (PPS) fat is especially important in the analysis 
of most suprahyoid neck masses, as the mass effect on this 
triangular fat pad often helps to localize the space of origin. 
Pathology will displace the PPS in a predictable pattern. For 
example, masses arising in the deep lobe of the parotid tend 
to displace the PPS anteromedially, carotid space masses 
displace the PPS anteriorly, masticator space masses push 
the PPS posteriorly, and pharyngeal mucosal space masses 
often push the PPS laterally. Each compartment has com-
mon and uncommon pathology, often based on the normal 
contents. Therefore, once a lesion is localized to the cor-
rect space, the radiologist can utilize imaging features and 
clinical information to provide a tailored list of differen-
tial considerations, or in some cases, a specific most likely 
diagnosis.
Fig. 16.15 Axial T1-weighted image without contrast shows an 
enlarged lateral retropharyngeal lymph node in a patient with metastatic 
papillary thyroid carcinoma. T1 shortening reflects colloid content
a b
Fig. 16.16 (a) Axial CECT 
shows enlargement and 
heterogeneous enhancement 
in the prevertebral space 
involving the prevertebral 
muscles and abutting the T2 
vertebral body. (b) Sagittal 
T1-weighted post gadolinium 
shows abnormal enhancement 
of lower cervical and upper 
thoracic vertebral bodies and 
a large area of non- 
enhancement (arrows), 
compatible with multi-level 
osteomyelitis. There is also 
epidural extension of 
infection (arrowhead)
A. H. Aiken and D. R. Shatzkes
213
H&N space contents
Space Boundaries Major contents Common pathology
Pharyngeal 
mucosal (PMS)
Mucosa to pharyngeal constrictors 
of nasopharynx and oropharynx 
(some include hypopharynx and 
oral cavity)
Mucosa, Waldeyer’s ring, minor 
salivary glands, constrictor and levator 
palatine muscles, cartilaginous 
Eustachian tube
Malignant tumors (mucosal = SCC or 





Skull base to mandibular angle, 
borders PPS, CS, PS, MS
Fat, minor salivary glands Benign salivary tumors, rare branchial 
cleft cyst or vascular malformation
Masticator (MS) Skull base to mandibular angle, 
lateral to PPS
Muscles of mastication, posterior body 
and ramus of mandible, CNV3
Odontogenic infections, venous 
malformations, sarcomas
Parotid (PS) Enclosed within the parotid fascia, 
lateral to PPS, MS
Parotid gland, CN7, lymph nodes, 
retromandibular vein, external carotid 
artery branches
Pleomorphic adenoma
Low and high grade malignant salivary 
neoplasms
Acute or chronic parotitis
Visceral (VS) Hyoid to mediastinum, anterior to 
PVS, medial to CS








Carotid (CS) Carotid sheath, enclosed by all 3 
layers of DCF, skull base to aortic 
arch (SHN + IFN)
SHN: ICA, IJV, CN 9–12
IFN: CCA, IJV, CN 10 (vagus)
Vascular pathology related to carotid 
(aneurysm, dissection, arteritis) or jugular 





Skull base to T3, between visceral 
and alar fascia
Fat and lymph nodes Metastatic lymph nodes (NPC, thyroid, 
hypopharynx, lymphoma)




Skull base to T4, posterior to RPS Prevertebral muscles, vertebral bodies, 
scalene muscles, brachial plexus roots, 
phrenic nerve, vertebral artery and vein
Discitis/osteomyelitis
Longus colli tendinitis





SCC squamous cell carcinoma, NPC nasopharyngeal carcinoma, ABC aneurysmal bone cyst, SHN suprahyoid neck, IFH infrahyoid neck, ICA 
internal carotid artery, CCA common carotid artery, IJV internal jugular vein
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Take Home Messages
• The three layers of the deep cervical fascia define 
spaces, each with unique contents and pathology.
• These spaces can be grouped as suprahyoid or 
infrahyoid, with some spaces, like the carotid and 
retropharyngeal spaces, spanning both levels.
• Displacement of the parapharyngeal fat can help 
determine site of origin of a suprahyoid mass.
• The visceral space is the only space contained 
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tions of the aerodigestive tract below the 
oropharynx.
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17.1  Imaging Approaches for HN SCC
Across the USA and across the world there are different 
thoughts and perspectives as to the best imaging modality to 
use for staging and surveillance, but also as to the ideal tim-
ing for use of the modalities after treatment and for ongoing 
surveillance. The AJCC offers some guidance about the util-
ity of imaging modalities for the staging of specific entities 
but offers no surveillance plan [1]. In the USA the National 
Comprehensive Cancer Network [NCCN] guidelines for HN 
cancer treatment sets out broad strokes but these surveil-
lance protocols are variably used and were developed with-
out radiologist input [2]. The NI-RADS reporting system for 
baseline and surveillance imaging after treatment was mod-
eled after the breast imaging BI-RADS system, and aims to 
standardize an imaging approach to HN cancer with man-
agement recommendations. Through ongoing studying of 
the results of this system, we seek to determine the accuracy 
of imaging and then further optimize surveillance algorithms 
in HN cancer [3–5].
When staging HN SCC some specific tumor sites are bet-
ter served by either CT or MR.  At different hospitals and 
imaging sites modalities may be favored because of cost, 
modality, availability, or patient tolerance for the imaging 
exam. Excellent quality whole neck imaging is more readily 
reproducible from patient to patient using CT than MR, and 
this is particularly true for the post-treatment patient who 
may have difficulty lying on a MR for an extended period 
while dealing with oral secretions. MR and PET are more 
expensive and may not be readily accessible in different loca-
tions in the USA because of insurance costs. Large field of 
view, non-optimized MR sequences and lack of familiarity 
with basic neck anatomy or MR artifacts will make detection 
of key findings difficult for the less experienced radiologist.
With these caveats in mind, MR offers specific utility in 
certain areas. For example, it is the preferred staging tool 
for nasopharyngeal carcinoma because the detection of skull 
base infiltration (T3) or intracranial extension of disease (T4) 
is extremely important for staging and treatment planning. 
Likewise, MR offers significantly better soft tissue contrast 
for detecting small primary tonsillar tumors and evaluating 
the deep extent of an infiltrative lesion when planning surgi-
cal resection or intensity modulated radiation therapy (IMRT). 
For this reason it is often used in the oral cavity and orophar-
ynx. In the larynx, MR is so affected by motion artifact that it 
is largely reserved for determination of cartilage penetration 
(T4a) when CT is equivocal. Finally, nodal disease at any site 
is almost equally well evaluated with either CT or MR.
Given the complexity of neck anatomy and intimately 
located structures, FDG-PET in the HN is best performed 
as a combined PET/CT examination. It is important to be 
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Learning Objectives
• To understand the development of HN SCC arising 
from different areas in the HN and particularly the 
contributions of viruses and environmental expo-
sure factors in its pathogenesis.
• To recognize the important features of the AJCC/
UICC staging system and how radiologists can use 
this system to provide more detailed, valuable reports.
• To develop a systematic method for evaluating all 
post- treatment scans from baseline through surveil-
lance in order to detect residual, recurrent, and new 
HN malignancies.
216
aware of the many tissues with variable degrees of normal 
FDG uptake, particularly muscles, brown fat, salivary and 
lymphoid tissue, and recent biopsy sites. These all serve as 
potential false-positive pitfalls in PET imaging. A potential 
false-negative finding is the absence of uptake in a predomi-
nantly cystic node. Correlation with neck CT imaging will 
allow correct identification of cystic nodal metastases.
Ultrasound (US) has a limited but important role in HN 
SCC.  At many practices in the USA it is largely reserved 
for interrogation of nodes that are equivocal on other imag-
ing modalities, and particularly when a positive finding, such 
as a contralateral node, might significantly alter staging and 
management. US can also serve as imaging guidance for fine 
needle aspiration (FNA).
17.2  Imaging Anatomy for HN SCC
It is from the squamous lining of the pharynx, larynx, and 
sinonasal cavity that mucosal SCC arises. The pharynx is 
really a muscular tube, extending from the skull base where 
it is attached by the pharyngobasilar fascia, to the larynx and 
cervical esophagus. Staging of SCC is individualized to each 
site, and, in the case of laryngeal SCC, to each of its three 
subsites [1, 6].
The nasopharynx is so-named as it is located posterior 
to the nasal cavity, extending from the most cranial aspect 
of the pharynx at the skull base to the level of the soft pal-
ate. Most nasopharyngeal carcinomas arise from the lateral 
pharyngeal recess, also known as the fossa of Rosenmüller, 
which is adjacent to the opening of the Eustachian tube, 
and thus nasopharyngeal tumors often result in middle ear 
effusion at the time of presentation. In the midline of the 
nasopharynx, immediately caudal to the clivus is the naso-
pharyngeal tonsillar tissue [“adenoids”] from which naso-
pharyngeal lymphoma may arise. Adenoidal hypertrophy 
most often occurs in response to viral pathogens including 
HIV infection, and can mimic nasopharyngeal neoplasms 
although there should be symmetry, distinction of this tis-
sue from prevertebral muscles and parapharyngeal fat, and 
on T2-weighted MR imaging there should preservation of a 
mucosal stripe [7].
Inferiorly the nasopharynx is contiguous with the oro-
pharynx, which extends caudally to the hyoid bone. The pos-
terior wall of the nasopharynx becomes the posterior wall of 
the oropharynx. The anterior tonsillar pillars and the circum-
vallate papillae of the tongue define the anterior limit of the 
oropharynx. The posterior one third of the tongue is called 
the tongue base and is the site of the lingual tonsillar tissue. 
This is part of the oropharynx and tumors arising here are 
staged using one of two oropharyngeal tumor staging sys-
tems depending on their pathologic p16 or high-risk HPV 
status [1, 6]. The anterior two thirds of the tongue is known 
as the oral tongue and lies in the oral cavity. Tumors arising 
from the inner mucosal surface of the lips, the gingiva of the 
maxilla and mandible, the hard palate, and the cheek lining 
[buccal mucosa] are all classified as oral cavity tumors and 
staged using the oral cavity staging forms.
Below the hyoid bone, the pharynx divides into the more 
anterior larynx airway, and the posterior hypopharynx for 
digestion. The posterior wall of the oropharynx continues as 
the posterior wall of the hypopharynx while the anterior wall 
of the hypopharynx is the post-cricoid region, the mucosa 
overlying the posterior surface of the cricoid cartilage of the 
larynx. The lateral recesses or “pockets” of the hypophar-
ynx are the pyriform sinuses, from which nearly two thirds 
of hypopharyngeal SCC arise. The aryepiglottic (AE) folds 
separate the hypopharynx from the supraglottic larynx and 
tumors arising from these folds are staged as supraglot-
tic tumors. The inferior aspect of the hypopharynx is at the 
inferior aspect of the cricopharyngeus muscle, which marks 
the beginning of the cervical esophagus. On cross-sectional 
imaging this can be determined by the inferior aspect of the 
cricoid cartilage, and on axial sections the semilunar shape 
of the collapsed hypopharynx abruptly transitions to the 
rounded contour of the muscular esophagus [8].
The larynx connects the oropharynx airway to the tracheal 
airway and is more anterior in the neck. Embryologically, 
and for tumor staging, it is divided into three subsites, each 
of which has a separate staging table. The glottis is the true 
vocal cords; muscular structures which give rise to voice and 
which extend from the arytenoid cartilages to the midline 
thyroid cartilage anteriorly. More than half of all laryngeal 
SCC arise from the mucosal surface of the glottis. The supra-
glottic larynx is comprised of the structures superior to this 
including the epiglottis, AE folds, and the false cords. The 
epiglottis has both laryngeal and lingual surfaces and its 
most superior aspect extends above the level of the hyoid 
bone although all tumors arising from the mucosal aspect 
of the epiglottis are considered supraglottic. The subglottis 
is the mucosal lining internal to the cricoid cartilage ring 
below the glottis. The subglottis is contiguous with the cer-
vical trachea and tumors of this area are the least common of 
all laryngeal SCC.
When talking about HN SCC the nasal cavity and para-
nasal sinuses are not often included in the discussion; how-
ever, they comprise up to 5% of all HN cancers and up to 
70% of these are mucosal SCC [9]. The nasal cavity is ante-
rior to the nasopharynx and from this branch the paired left 
and right paranasal sinuses: frontal, maxillary, sphenoid, 
and the anterior and posterior ethmoid air cells. Sinonasal 
SCC are not associated with tobacco, but have been associ-
ated with industrial exposure such as wood, nickel dust, or 
 formaldehyde [10, 11]. More recently it has been determined 
that approximately 25% of all sinonasal SCC are associated 
with high-risk HPV [9].
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17.3  Staging HN SCC
In 2018 the eighth edition AJCC/UICC tumor classification 
system was released after several years of collaborative work 
between the two committees and from evaluation of inter-
val research that better understood the molecular underpin-
nings and the prognosis of HN SCC [1, 6]. While there have 
been many changes to staging in HN SCC it is not neces-
sary to remember all the intricacies of staging tables. It is 
more important that the radiologist is aware that such tables 
exist and that when reporting imaging studies, reference to 
the specific criteria that determine the tumor (T), nodal (N), 
and metastasis (M) designation greatly enhances an imaging 
report by providing critical tumor information [12, 13]. It is 
ideal to have on hand a copy of the staging tables to ensure 
that information is included in the report, keeping in mind 
that it is not the radiologist’s role to provide a TNM stage, 
but rather to provide all information so that this can be done 
by the managing physician.
When evaluating the primary tumor (T) the specific crite-
ria in the tables may require distinction by size of the tumor 
or by specific invasion patterns. When measuring tumor 
size the longest diameter is used. It is important to refer to 
T criteria for specific areas of invasion in order to include 
such relevant positive or negative information in the radiol-
ogy report. Some criteria will not be known to the radiolo-
gist such as impairment of vocal cord mobility in laryngeal 
tumors, and depth of invasion (DOI) for oral cavity tumors, 
which is purely a pathological measurement. Minor changes 
have been made to the T criteria for nasopharyngeal carci-
noma and for oropharyngeal carcinoma and lip tumors have 
been removed from the oral cavity staging, and have their 
own T criterion under a new chapter of “cutaneous carci-
noma of the head and neck.”
The detection of perineural tumor (PNT) may sig-
nificantly alter the extent of surgical resection and/or the 
radiation treatment field even if it does not change the T des-
ignation and so should be sought on all examinations. Both 
mucosal and skin SCC exhibit neurotropism as do other skin 
malignancies, salivary gland tumors, and lymphomas. PNT 
is usually more readily evident on MR but may be found 
on CT with careful evaluation of known routes of spread. 
Evidence of perineural tumor may significantly alter the pri-
mary surgical plan and/or the radiation field [14].
The most significant change to the AJCC/UICC stag-
ing is the bifurcation of oropharyngeal tumor staging into 
those tumors which are shown to be p16 positive by immu-
nohistochemistry or shown to be high-risk HPV DNA posi-
tive, from those which are not. The former group of p16+/
HPV- associated oropharyngeal SCC have a markedly better 
prognosis despite their tendency to have early and extensive 
nodal metastasis [15, 16]. The nodal table and the overall 
prognostic table for these tumors have been markedly modi-
fied to reflect this, with up to 80% of these tumors now being 
classified as stage 1 with a 90% 5-year survival. This is in 
 contrast to p16−/non-HPV oropharyngeal SCC where most 
tumors are stage III or stage IV at presentation (Fig. 17.1).
The second major change to the eighth edition of the 
AJCC/UICC is alteration of the nodal staging table for all non-
HPV and non-EBV related SCC and development of separate 
a
b
Fig. 17.1 A 51-year-old man with a 30-pack year smoking history 
presents with a left neck mass. The primary is a large infiltrating tumor 
at the left tongue base extending into the floor of mouth (a, b). There are 
multiple ipsilateral heterogeneous level 2 and 3 nodal masses with ill-
defined margins (b). As a p16+ SCC this was T4N1M0, stage III. If this 
had been p16− it would be classified as T4aN3bM0 and stage IVB
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pathologic tables for these tumors when neck dissections are 
performed. This has the potential for significant confusion for 
radiologists, particularly when the p16/HPV status is unknown 
for oropharyngeal tumors. In this situation, it is critical to care-
fully evaluate the entire neck ipsilateral and contralateral to 
the primary site for any enlarged, heterogeneous, or frankly 
necrotic nodes and describe those that appear distinctly posi-
tive for tumor or which are highly suspicious. Extranodal 
extension of tumor (ENE) that is evident on clinical examina-
tion by the physician is now an important finding that upstages 
nodal disease to N3 for p16−/non-HPV and non-EBV lymph 
node SCC (Fig. 17.2). It has long been recognized that ENE 
is associated with a poorer prognosis and higher rate of tumor 
recurrence but it is only in this eighth edition that it has been 
included in the clinical and pathologic staging tables.
Evaluation for M1 disease (the presence of any metastasis) 
is best done with PET imaging although patients are always 
assumed to be M0 if no distant staging imaging/evaluation is 
performed. At the time of any staging neck scan, the lung api-
ces and the bones should always be evaluated for metastases. 
Additionally, as many SCC are tobacco and alcohol- related, 
these patients carry an increased risk of a second primary neo-
plasm. Second primary tumors are most frequently found with 
hypopharyngeal SCC and 1/3 are synchronous with the initial 
SCC. Second primary tumors are most commonly another HN 
SCC or esophageal or pulmonary primary tumors.
17.4  Unknown Primary Tumors
When a patient presents with a neck mass that is found to be 
nodal SCC, an initial clinical examination is performed in 
the ENT surgeon’s office. If a primary site is not evident, this 
is considered to be an “unknown primary tumor” and imag-
ing has an important role in trying to determine the origin so 
that biopsy can be directed. Radiation can also be targeted to 
the area of concern, thus reducing treatment morbidity. More 
than 90% of unknown primary SCC detected from FNA of 
a nodal mass in the absence of a clinically evident primary 
source, are due to p16+/HPV-associated oropharyngeal SCC 
[17]. It is thus critical to carefully evaluate the palatine and 
lingual tonsils which may harbor tumor in the depths of the 
tonsillar crypts where it may not be evident on clinical exam-
b
a
Fig. 17.2 Axial and coronal CECT in a 74-year-old woman presenting 
with a fixed left neck mass, representing clinical extranodal extension 
[cENE]. There is a large left tonsillar primary tumor and a nodal con-
glomerate at the left 2A nodal group (∗). The nodal mass has ill-defined 
margins with infiltration of the adjacent sternocleidomastoid muscle 
and posterior triangle fat planes. Extranodal extension denotes N3b dis-
ease for all HN SCC except NPC and p16+/HPV-associated OPSCC 
where it is not part of the nodal criteria
Key Points
• When staging a new tumor start by locating the pri-
mary site and then reference the appropriate table in 
AJCC/UICC for critical points to include in the report.
• Tumors should always be measured by their longest 
diameter and then describe the deep extent and 
evaluate for perineural tumor.
• Evaluate the regional drainage nodes and always 
look for contralateral nodal metastases.




ination. Thus subtle asymmetry of density/signal intensity or 
of size of the tonsil ipsilateral to a nodal mass suggests the 
most likely primary site and directs the surgeon to the pre-
ferred site for biopsy or tonsillectomy.
It is also important to be aware that nodal metastasis from 
a cutaneous SCC primary or from a pulmonary SCC can 
also be p16+ and this must also be considered in the dif-
ferential when a nodal FNA reveals p16+ SCC. In situations 
such as these when there is no primary oropharyngeal tumor 
evident, the node should also be tested for high-risk HPV 
prior to assuming an occult oropharyngeal source. PET/CT 
has proven to be extremely useful for determination of the 
primary tumor site in the presence of an unknown primary 
nodal metastasis and is frequently the first-line imaging study 
when a patient presents without a clinical source evident.
If the nodal SCC is p16−, then other sites of origin should 
be considered including the nasopharynx and hence EBV 
testing should be performed. If this is still negative and no 
primary site is evident on cross-sectional CT, MR, or PET/
CT, then no primary T designation is assigned.
In contrast to the situation where a new imaging study is 
ordered after FNA has proven that SCC is present, when a scan 
is ordered for a neck mass, any cystic or solid new mass in an 
adult should be assumed to be neoplastic until proven otherwise.
17.5  Baseline and Surveillance Imaging 
of HN SCC
Following surgery, radiation, and/or chemotherapy, a post- 
treatment baseline imaging study should be obtained and 
should be evaluated with knowledge of the primary site and 
AJCC/UICC tumor stage, and the entire treatment plan. 
Baseline scans, particularly following reconstruction flaps or 
radiation can be extremely difficult to evaluate, but under-
standing the expected findings following such treatment is 
paramount to anticipate the sites and appearances of treat-
ment change and therefore distinguish residual tumor and 
early recurrence. The baseline scan should show no evi-
dence of residual primary mass or abnormal lymph nodes 
(Fig. 17.3). It is particularly important to carefully evaluate 
both the primary site and neck nodal levels when there has 
been an unexpectedly prolonged delay from treatment to 
baseline scanning due to complications from surgery or other 
treatment, or loss of the patient to follow-up.
There is no consensus on the timing of the baseline scan 
but in the USA it is typically obtained at 8–10 weeks fol-
lowing chemoradiation, while postsurgical scans are often 
obtained around 10–12 weeks. PET/CT should be delayed 
to around 12 weeks to minimize false-positive FDG uptake 
from post-treatment inflammatory changes. The base-
line cross-sectional scan also serves as a “road map” of a 
deformed neck to increase sensitivity for early recurrent dis-
ease on the subsequent surveillance imaging. For this reason, 
it is ideal that the same cross-sectional modality chosen for 
baseline imaging, either CT or MR, is subsequently used for 
surveillance.
Radiation therapy has changed enormously over the 
last two decades with the increasing use of intensity mod-
ulated radiotherapy (IMRT) for head and neck cancers. 
IMRT maximizes dose to the tumor and minimizes radia-
tion to unaffected tissues but requires accurate delineation 
of tumor margins. This is often best done with MR although 
some practices use PET/CT or CECT alone, and may also 
a b c
Fig. 17.3 A 66-year-old man with a large left palatine tonsillar mass 
staged as p16+ SCC cT4N0M0 stage III (a). The patient completed 
chemoradiation with baseline CT 8 weeks later (b) showing marked 
decrease in enhancement and decrease in bulk. This is not completely 
resolved as is hoped for on the baseline scan. Short interval follow-up 
PET/CT was obtained 4 weeks later (c) showing no significant uptake. 
The patient has remained disease free
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require greater input from radiologists to ensure accurate 
treatment volumes [18]. Radiation with or without chemo-
therapy results in significant changes in the appearance of 
neck soft tissues [19]. Radiation results in acute inflamma-
tion of all tissues in the radiation field with extensive edema. 
Over time this converts to fibrosis with atrophy and altered 
signal intensity and texture on MR. Both acute and chronic 
expected radiation changes can be confusing on CT or MR, 
requiring careful evaluation and comparison with prior stud-
ies to detect early recurrences.
Surgical resection of a primary tumor and/or nodal 
drainage regions also results in variable changes to normal 
neck contours. Familiarity with the types of nodal neck dis-
sections and common flap reconstructions is necessary to 
evaluate for both complications and recurrence [20, 21]. It 
is extremely helpful to have knowledge of what surgical 
procedure was performed prior to evaluating such scans. 
Relatively simple resections, such as selective neck dissec-
tions, can be surprisingly subtle on imaging. Conversely, 
large resections with flap reconstructions can be quite 
complex, and imaging is hampered by metallic hardware. 
MR is less affected by hardware artifact and more sensi-
tive for recurrent tumor, however, the muscular component 
of a flap reconstruction will undergo denervation change 
resulting in variable MR signal intensity and enhancement 
[22, 23]. It is important on the baseline scan following neck 
reconstruction to ensure there is no residual or progressive 
tumor, and having knowledge of the pathology report and 
of positive tumor margins at the time of reconstruction can 
be very helpful in this regard.
Recurrent SCC most often occurs during the first 2 years 
following treatment. The frequency of surveillance imag-
ing during this time is variable and may be performed in 
3–6 month intervals, depending on the initial tumor staging 
and histologic prognostic features and the ongoing clini-
cal course and physical findings. At any follow-up imaging 
examination, the possibility of a second primary tumor must 
again be considered. Remember on every follow-up study to 
look for residual, recurrent, and new tumors.
With NI-RADS, the timing for imaging after surgery or 
chemotherapy for HN cancer is a baseline CT or MRI at 
8–12 weeks with concurrent PET.  If this is negative, neck 
imaging and chest CT is performed at 6 months, then further 
neck imaging at 6 months, and if this remains negative then 
neck and chest imaging at 8–12 months [24]. Any concern-
ing but not definitive findings at any point in the series of 
follow-up imaging steps is classified as NIR-RADS 2 and 
leads to either shorter interval imaging (3  months), PET, 
or direct inspection. Such examples of NI-RADS 2 find-
ings are focal superficial mucosal enhancement or focal 
mucosal FDG uptake, or discordance between the CT and 
PET (Fig.  17.4). The neck nodes also receive a NI-RADS 
score, with NI-RADS 2 most often leading to recommenda-
tion for PET imaging. Biopsy of the primary site or lymph 
nodes is recommended if there is strong concern for residual/
recurrent disease [NI-RADS 3] such as a new or enlarging, 
discrete nodule with robust enhancement or intense focal 
FDG uptake on PET. NI-RADS 4 is evidence of an already 
pathologically proven recurrence or definitive radiologic or 
clinical progression/recurrence that does not require biopsy. 
Using NI-RADS in your clinical practice not only allows 
ready communication with clinicians as to the degree of con-
cern of an imaging finding for malignancy, but also generates 
data-mineable report. These will allow future optimization 
a b c
Fig. 17.4 A 59-year-old man diagnosed with p16+ base of tongue 
SCC T4N2M0 (a) after presenting with bilateral adenopathy and a 
poorly enhancing but infiltrating mass. The patient was treated with 
chemoradiation although did not receive all cycles of chemotherapy. 
Baseline imaging after completion of treatment (b, c) shows residual 
enhancing soft tissue mass in the floor of mouth but resolution of the 
adenopathy. This mass in the floor of the mouth is highly concerning for 
residual disease and should be biopsied. It is therefore a NI-RADS 3. 
The resolved neck nodes are NI-RADS 1
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of imaging surveillance algorithms but also enable the user 
to determine their imaging accuracy and for practices to 
determine interobserver variability of reports.
17.6  Concluding Remarks
The radiologist has a valuable role in the management of HN 
SCC patients from initial staging or evaluation of a new neck 
mass, to post-treatment baseline imaging and surveillance. 
Post-treatment scans are often the most-complex exami-
nations to interpret and so having a systematic process of 
performing the scans and reviewing the scans is important. 
It is essential for all post-treatment scans to have a history 
of the initial tumor type, the treatment performed, and the 
time interval of such. Further clarity can also be added to a 
report when there is additional knowledge of prior pathol-
ogy reports, including surgical margins, and any clinical 
concerns for recurrent disease. The availability of much of 
this information via electronic medical records can greatly 
enhance the radiologist’s sensitivity for subtle findings and 
confidence with approaching such cases.
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Take Home Messages
• When reporting staging scans use the AJCC/UICC 
tables in order that the report includes critical criteria 
to enable the clinician to correctly stage the patient.
• HN post-treatment scans can be very difficult to 
read, but starting with a good history of the original 
tumor and the treatment plan set the stage for the 
best evaluation.
• Working with your clinicians to set a routine baseline 
and surveillance imaging plan and consistent imag-
ing protocols is a good practice to standardize patient 
care and make radiologists most familiar with the 
expected appearance of treatment changes over time.
• Incorporating NI-RADS to the report can help your 
team gauge their accuracy and refine their reports.
• A new cystic or solid neck mass in an adult patient 
is cancer until proven otherwise.
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LBP is one of the most widespread and common diseases, some 
statistics report that about two-thirds of adults suffer from LBP 
at some point in their life, being second only to upper respiratory 
tract [1]. It is the greatest contributor to years lived in disability 
throughout much of the world and the first cause of everyday 
life activity limitation as well as absence from work [2]. The 
2010 Global Burden of Disease Study considers LBP one of the 
ten diseases occurring worldwide [3], the prevalence of LBP 
is considered among 60–70% in European and US countries, 
with a recent increase even in younger population and a peak at 
35–55 years of age [4–7]. The incidence of LBP has been docu-
mented in 50% of people having light physical activity and in 
more than 70% of those performing heavy activities and is the 
most frequent cause of cessation of activity in patients younger 
than 45 years old [8]. Moreover, this condition has deep rela-
tionship with other pathologies such as depression, anxiety, and 
sleep disturbances [9].
Only 7–8% of patients with LBP have symptoms persist-
ing over 2 weeks and just 1% need a real treatment: among 
them, symptoms usually improve rapidly in 1 month [8], 1/3 
of them having—on the contrary—a persistent moderate to 
severe LBP after 1 year [10]. The etiology of chronic low 
back pain remains generally unknown or nonspecific (up to 
85%): there are several known causes of LBP syndrome (i.e., 
different from LBP) as age, psychosocial aspects (depres-
sion, stress, stop working), education (increasing LBP in 
low-educational status) [11], stress overload (heavy working 
or sport activities), smoking (the nicotine being a vascular 
degeneration agent reducing physiological disc nutrition), 
even genetic cause (74% heritability in twins), and obesity 
(body mass index of more than 30 kg/m2) [12]. Obesity in 
early adult age definitely increases the risk of nonspecific 
LBP as well as degenerative changes in lumbar spine [13].
Pure LBP conversely is generally related to pathologic 
degeneration of several structures involved in the spinal unit, 
as lumbar intervertebral disc, facet joints, muscular fascia, 
sacroiliac joints, ligaments, nerve root, and muscles directly 
[14]. Mechanical, traumatic, nutritional, and genetic factors 
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Learning Objectives
• To understand the very variable causes of low back 
pain.
• To appreciate the mostly benign clinical course of 
low back pain.
• To critically assess the critical relevance of imaging 
findings.
Key Points
• Section 18.1: Discogenic Low Back Pain (DLBP): 
The relationship between disc abnormalities and 
clinical symptoms is still debated.
• Section 18.2: Instability: Microinstability pres-
ents with a sensation of instability felt by the 
patient and objectively observed impaired muscle 
control.
• Section 18.3: Radicular Pain: Disc fragments may 
migrate behind the vertebral body and be over-
looked in limited imaging protocols.
• Section 18.4: Sacroiliac Joint Disease: Chronic sac-
roiliac joint arthritis frequently is the cause of low 
back pain, particularly in women.
• Section 18.5: Failed Back Surgery Syndrome: 
Epidural fibrosis is one of the most common causes 
of low back pain after surgery.
• Section 18.6: Vertebrogenic Low Back Pain: Not 
even Modic 1 abnormalities represent an indepen-
dent predictor of low back pain. They may be pres-
ent in asymptomatic individuals.
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The role of imaging is to provide accurate morphologic 
information and influence therapeutic decision making. A 
necessary component, which connects these two purposes, 
is accurate natural history data. This is critical as, according 
to Rego et al. [15], up to 40% of patients exhibited no indi-
cations to imaging. Up to about 59% of lumbar spine MRI 
examinations requested among different social and economic 
settings have been deemed as inappropriate, depending on 
the evaluation method [16–19]. Of all lumbar and thoracic 
spine CT examinations in young patients, up to 77% were 
judged as inappropriate; therefore, such examinations are 
responsible for an unjustified cost for individuals or health 
systems and unnecessary radiation exposure [20].
Any study looking at the natural history of degenerative 
disc disease, prognostic value of imaging, or its effect on 
therapeutic decision making will be confounded by the high 
prevalence of morphologic change in the asymptomatic popu-
lation [21–23]. Twenty to twenty-eight percent of asymptom-
atic patients demonstrate disc herniation and the majority 
have evidence of additional degenerative disc disease [21–23]. 
These findings are not only non-predictive in the moment, but 
prospectively as well. In a 7-year follow-up of a patient group 
with back pain [24], the original MR findings were not predic-
tive of the development or duration of low back pain.
18.1  Discogenic Low Back Pain (DLBP)
Studies that demonstrate innervation to the intervertebral 
disc provide evidence that may account for instances of dis-
cogenic low back pain [25]. It was revealed that innervation 
of the inner disc was observed only in painful discs, not in 
normal control discs [26, 27]. Moreover, stimulation of peri- 
discal nerve plexus widely contributes to disc pain generation. 
Though discography has been used in the past as gold standard 
in proving the existence of a discogenic pain, today a simple 
intra-discal injection of sterile solution is considered also [28].
MR imaging findings that correlate with painful discs on dis-
cography are those typical for disc degeneration, mainly signal 
loss of the disc on T2-WI, but also loss of disc height, the pres-
ence of a hyperintensity zone (HIZ), and Modic changes [29].
The hyperintensity zone (HIZ) is a localized region of 
high signal intensity on T2-WI within the annulus fibrosus. 
Histopathologically, these lesions represent replacement of 
the normal lamellar structure by a disorganized, vascular-
ized granulation tissue consisting of small round cells, fibro-
blasts, and newly formed blood vessels around tears that 
extend from the nucleus pulposus to the outer region of the 
annulus fibrosus [30]. Originally the presence of a HIZ was 
strongly correlated with a painful disc on discography [31]. 
This correlation has confirmed in multiple later studies, but 
was also questioned in a few other studies. In general, the 
association between an annular tear on MR images and low 
back pain is unclear.
18.2  Spinal Instability
Lumbar instability is one of the most common causes for 
chronic low back pain (LBP); in particular, it is the main 
cause of LBP in young patients, especially in athletes and 
overweight population, who are subjected to local extra stress.
The biomechanical alterations are related to the interver-
tebral disc degeneration that loses the physiological capacity 
to adsorb the applied load and to apply torsion resistance, 
with consequent change in the vector forces of the spinal 
unit, and dynamic overload of the posterior arches elements, 
especially of the zygapophyseal joints.
From a biomechanical point of view, the instability of a 
vertebral motion segment is defined as an abnormal reaction 
to applied loads with an increasing range of motion (ROM). 
The neutral zone (NZ), the displacement between the neu-
tral position and the initiation point of spinal resistance to 
physiological motion, is considered to be a better indicator 
of lumbar instability than the ROM [32, 33].
The concept of vertebral instability has evolved in the last 
years, and the new concept of “microinstability” was recently 
introduced: Microinstability can be defined as a pure motion/
biomechanical dysfunctional syndrome with no or minimal 
anatomical changes, in absence of spondylolisthesis.
Microinstability lumbar syndromes present with a 
subjective sensation of instability felt by the patient and 
an objectively observed impaired muscle control. In the 
absence of an adequate control by segmental muscles 
inserting directly on the spine, patients tend to stabilize the 
dysfunctional MS through muscles which provide a com-
pensatory global trunk stabilization for which high levels 
of intra-abdominal pressure are generated even during low-
load tasks [34].
In flexion microinstability, the most frequent type, signs 
suggestive of altered movement control within the neutral 
zone are a good range of spinal mobility, but with a “painful 
arc” and the inability to return to erect posture from forward 
bending without assistance. Patients are unable to maintain 
semi-flexed postures. A loss of lumbar lordosis during stand-
ing can be observed at the level of the unstable MS along 
with a greater flexion during forward bending [35].
Kirkaldy-Willis originally described the cascade of degen-
erative instability, consisting of three phases: an initial dys-
function, an instability time, and a final restabilization [36]. 
Instability begins with a dysfunctional time, marked by inter-
mittent nonspecific pain, associated with initial and slight 
morphological changes, followed by a stage of  so- called 
unstable dysfunction with pathological alterations affecting 
the constitutive elements of the motor spinal unit. At this 
stage pain becomes more persistent [36, 37] or chronic. This 
first phase of the degeneration cascade in absence of spon-
dylolisthesis in flexion-extension radiography can be consid-
ered as the equivalent of the clinical syndrome previously 
defined as microinstability.
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In the final phase of “restabilization,” the fibrosis of the 
joint capsules, the formation of osteophytes, the marked disc 
collapse, and the radial expansive remodeling of vertebral 
bodies lead to an overall increase in stiffness along with 
hypomobility. During this stage functional limitation and 
stiffness prevail; it can appear as neurological deficits, while 
spinal pain can eventually fade or subside [36].
Unfortunately, there are no validated clinical signs for 
diagnosing degenerative instability, with a large overlap of 
motion patterns between symptomatic and normal individu-
als, which renders difficult to state any cut-off to distinguish 
normality and instability [38].
Kotilainen and Valtonen described the three criteria for 
instability:
Failure to full return from the bent position because of a 
sudden attack of low back pain (i.e., instability catch); inabil-
ity to get a raised, straightened leg to move down and sud-
denly drops the leg due to a sharp pain in the low back (i.e., 
painful catch); and anxiety resulting from a sensation of col-
lapse of the low back because of a sudden attack of back pain 
during movement (i.e., apprehension) [39].
Moreover, no exam available allows to detect an active 
segmental hypermobility, in conditions where a microinsta-
bility is suspected.
Lower back pain which originates from the facet joints 
has not been shown by studies to relate to radiological or 
pathological changes [40, 41]. The value of plain radio-
graphs, computed tomography, and magnetic resonance 
imaging scans in diagnosing facet joint disease remains 
inconclusive [42]; furthermore, they are not able to predict 
the patients who would respond to controlled diagnostic 
blocks of the facet joint so imaging studies have their great-
est value in the exclusion of other pathological conditions.
Bone scintigraphy with single photon emission computed 
tomography (SPECT) is more sensitive in detecting facet 
joint lesions and allows more accurate anatomical localiza-
tion. A recent study suggested that SPECT could help to iden-
tify patients with low back pain who would benefit from facet 
joint injections [43].
Facet joint block (FJB) is an indispensable diagnostic 
instrument in order to distinguish painful from painless facet 
joints, and to plan the intervention strategy.
The procedure is safe, valid, and reliable; the risk of FJB 
is very low and complications are rare, although there are 
case reports on infections [44–46].
Saal describes as the gold standard of diagnostic FJB the 
highly controlled (CT, MRI) FJB at the median nerve branch 
(MBB) [47]. The CT or MRI guidance is responsible for the 
highest specificity of the test [47].
The specificity of the FJB is however not high, with false- 
positive rates ranging from 25% to 38% [48–50]. Standard 
blockade injections of the medial branches seem to anesthe-
tize the joint and also the muscles, ligaments, and periosteum 
they innervate [49].
18.3  Radicular Pain
Acute lumbar disc herniation is the most common cause of 
acute radicular leg pain. After excluding emergent causes, 
such as cauda equina syndrome, epidural abscess, fracture, 
or malignancy, a six-week trial of conservative management 
is indicated [51]. Patients should be advised to stay active. 
If symptoms persist after 6 weeks, or if there is worsening 
neurologic function, imaging and invasive procedures may 
be considered. Most patients with lumbar disc herniation 
improve over 6 weeks.
If a disc herniation is identified that correlates with physical 
findings, surgical discectomy may improve symptoms more 
quickly than continued conservative management. Epidural 
steroid injections can also provide short-term relief [51].
Herniated discs are more easily detected with MRI than 
with CT for many reasons. Firstly, MR imaging allows visual-
ization of the complete lumbar (or cervical or thoracic) spine 
in one examination. Secondly, sagittal images also depict the 
spinal canal in between intervertebral disc spaces. It is not 
unusual for a disc fragment to migrate (or extend) into the 
area behind the vertebral body. Some of these migrated discs 
can be missed on CT if axial slices are limited to the inter-
vertebral disc spaces examined. Finally, the intrinsic tissue 
contrast is usually better on MR. Especially the lumbosacral 
region can be hard to assess on CT due to beam hardening, 
especially in larger patients.
Chronic radicular pain can be caused by a disc herniation, 
but also vertebral osteophytic spurs, degenerative facet spurs 
and facet hypertrophy, and degenerative foraminal stenosis 
are an important cause of nerve root irritation. Foraminal 
nerve root entrapment is best visualized on T1-weighted 
MRI where the high contrast between fat tissue and the 
nerve root sheath is of great help. Usually a combination 
of hypertrophic degenerative facets with osteophytic spurs 
posteriorly, and vertebral osteophytes and/or disc hernia-
tion anteriorly diminishes the anteroposterior diameter of 
the foramen. Foraminal height is lessened by degenerative 
disc disease and subsequent disc height loss. Whenever the 
normal rounded (oval) appearance of the nerve root sheath 
is lost in combination with loss of the surrounding fat tissue, 
nerve root compression should be considered.
18.4  Sacroiliac Joint Disease
One frequent (5–25% of all LBP causes) [52–55] and fre-
quently misunderstood cause of LBP in adult males, par-
ticularly females, is the chronic sacroiliac joint arthritis 
secondary to acquired focal instability. The sacroiliac joint 
(SIJ) is the strongest and richest joint in human body as for 
ligaments (anterior sacroiliac, interosseous, sacrospinous, and 
sacrotuberous) and muscles (gluteus maximus, piriformis, and 
biceps femoris), concurring to stabilize the joint [56]. Despite 
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the great stability of this joint, there are several conditions that 
can reduce the stability of SIJ, generating chronic pain in a 
patient. SIJ ligaments are weaker in female patients as they are 
estrogen dependent, preparing the sacrum to the delivery nuta-
tion: as a consequence, postpartum chronic pain at the level of 
the sacrum can occur even after months after the delivery [57]. 
Another frequent cause of SI chronic pain is biomechanical 
changes in lumbar spinal unit mobility, secondary to surgical 
procedures like posterior interbody fixation (PIF)—generally 
performed in case of lumbar instability but conversely gen-
erating sacral instability too: it has been calculated that 75% 
of patients underwent PIF treatment suffer from painful SIJ 
instability in 5 years [58, 59]. Clinical symptoms related to SIJ 
disease are numerous, and no specific clinical sign supports 
the diagnosis. This uncommon uselessness of clinical symp-
toms analysis is related to the complexity of SIJ innervation, 
as the posterior surface of the joint receives collaterals from 
L3 to S4 dorsal rami [60], while anterior articulation is sup-
plied by L2 to S2 nerves [61, 62]. Consequently, SIJ syndrome 
is responsible for pain referred in several different areas of the 
body, as the lower limbs, pelvis, coxo-femoral area, buttock, 
and abdomen, overlaying other common causes of radicular 
pain. Even if several physical maneuvers are suggested to evo-
cate the pain and propose a SIJ disease, diagnosis and neuro-
radiological examinations (MRI, bone scanning, SPECT-CT) 
can show focal SIJ abnormalities proposing a SIJ syndrome, 
only diagnostic block of the SIJ injecting intra-articular anes-
thetics (lidocaine) is considered the gold standard method to 
confirm the disease [63].
18.5  Failed Back Surgery Syndrome
Failed back surgery syndrome (FBSS) is one of the most 
frequent causes of back pain in patient underwent surgical 
treatment, the etiology being controversial and complex. 
Epidural fibrosis is generally considered one of the most 
common causes of LBP after surgery, with patients hav-
ing extensive epidural scars having more frequent LBP and 
radicular pain that those with mild epidural fibrosis [64]. 
Moreover, epidural scars are responsible for neurological 
impairment demonstrated by electrophysiology and nerve 
root tethering as well as nerve inflammation induced by 
high local cytokines, and other inflammatory agent level has 
been described [65, 66]. In FBSS, the pain moves from a 
mechanic/inflammatory origin through a neuropathic pain: 
patients affected by it suffer from an increased sensitivity 
and responsiveness of receptors that generate an amplified 
reaction to mild algogenous stimuli (“hyperalgesia”) and/
or misinterpretation of stimuli coming from non-nocicep-
tive receptors (“allodynia”), generally related to abnormal 
activation of non- neuronal cells as microglia, together with 
changes in local pain neurotransmitter molecules, increas-
ing pain feeling [67].
18.6  Vertebrogenic Low Back Pain
Vertebral body endplates are a significant source of nonspe-
cific chronic low back pain.
Ample histologic, anatomic, and immunohistochemical 
evidence supports nociceptive role of the basivertebral nerve 
(BVN) in the pathogenesis of LBP in patients with endplates 
damage and Modic changes [68, 69].
As described by Antonacci the BVN enters the posterior ver-
tebral body via the basivertebral foramen and arborizes near the 
center of the vertebral body, sending branches to innervate the 
superior and inferior endplates. These nerve endings have been 
shown to proliferate in damaged and degenerated endplates and 
can be classified as pain fibers: they are PGP 9.5-positive and 
express Substance P and Trk-A receptors [70].
Many previous studies suggest that Modic type 1, that 
indicates edema and inflammation, is associated with LBP 
and has a stronger association with pain in comparison to 
Modic type 2, since pain decreases as Modic type 1 changes 
turns into Modic type 2. It is important to consider that 
Modic 1 is not an independent predictor of LBP, ad like other 
several degenerative changes have been shown to exist even 
in asymptomatic individuals [71–73].
Recent introduction of bone HDP SPECT/CT allows to 
distinguish incidental from clinically relevant findings, it is 
a hybrid imaging that allows the assessment of both mor-
phology and bone physiology in a single study. It is pos-
sible to demonstrate the increased metabolic activity of the 
suspected MRI findings with high sensitivity: abnormalities 
become apparent early and sensitivity is higher than with 
computed tomography (CT) or standard radiography, allow-
ing to treat patients suffering from Vertebrogenic pain with 
selective intraosseous BV ablation [74].
18.7  Concluding Remarks
In conclusion, low back pain remains an enigma with a poorly 
understood and variable pathogenesis, very often with a favor-
able outcome. Imaging findings quite often do not correlate 
with clinical symptoms, although there have been advances 
in understanding them better. Radiologists need to critically 
evaluate any findings in order to avoid overtreatment.
Take Home Message
• A small proportion of patients with acute low back 
pain have symptoms persisting over 2  weeks and 
just 1% required active treatment, and the etiology 
of chronic low back pain remains generally 
unknown or nonspecific. Therefore, to critically 
discuss imaging findings in relation to clinical rele-
vance is crucial.
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19.1  Imaging Modalities for Spinal Trauma
In the emergency setting the appropriate selection of imaging 
for spinal trauma depends upon several factors such as, modal-
ity availability, the patient’s clinical and neurological status, 
type of trauma (blunt, single, or multi-trauma), and other asso-
ciated co-morbidities. Clinical factors to consider also include 
the quality and severity of pain, limitations in motion, or the 
presence of permanent or transient neurological deficits. MRI is 
reserved for those patients with post- traumatic myelopathy (spi-
nal cord dysfunction) or in the instance whereupon a patient’s 
symptoms that cannot be explained by findings on radiographs 
or CT, or when a reliable neurologic exam cannot be obtained.
19.1.1  Plain Film Radiography
In the rare circumstance where MDCT is not available, the ini-
tial imaging modality is radiography. A minimum of a lateral 
and anteroposterior view must be obtained for the spinal axis 
with the addition of an open-mouth odontoid view for the cervi-
cal spine. Often additional views such as oblique views and/or 
the swimmer’s view are performed in an attempt to clear the cer-
vicothoracic junction. With the exception of pediatric trauma, in 
most settings, radiography has been supplanted by MDCT.
19.1.2  Computed Tomography (CT)
Thin section multi-detector computed tomography (MDCT) 
is the preferred method when evaluating the cervical spine for 
bony injury after blunt trauma. The entire spinal axis can be reli-
ably and expeditiously evaluated with automatic reformatting of 
the axial dataset into multiple planes allows for better and more 
exact diagnosis of bone- and soft tissue abnormalities [7–13]. 
Moreover in the instance of polytrauma, spine images can be 
reconstructed directly from chest, abdomen, and pelvis datasets 
with sensitivity that is equivalent to a dedicated spine CT study. 
This has the added benefit of minimizing radiation dose.
With the introduction of these new MDCT imaging tech-
niques most trauma centers have set up dedicated acute (multi-) 
trauma protocol(s) which include CT of the brain, cervical 
spine, thorax, abdomen, and pelvis, with subsequent reformat-
ting of images of the thoracic and lumbar spine. This both expe-
dites the data acquisition for medically unstable patients and 
serves to minimize radiation dose since the body imaging data 
can be reconstructed offline into targeted spine reconstructions. 
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• To understand the prevalence and clinical conse-
quences of spinal trauma.
• To appreciate the utility of radiography, computed 
tomography, and magnetic resonance imaging in the 
evaluation of spinal trauma and spinal cord injury.
• To comprehend the grading systems used in spinal 
trauma.
• To appreciate the soft tissue components of spinal 
trauma and how they differ in the pediatric population.
• To understand the imaging features of spinal cord 
injury and traumatic vascular injury.
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CT has a higher sensitivity to fractures (especially involving 
the posterior elements) than radiography. This rapid cross-sec-
tional imaging assessment of the spinal axis has been shown 
to be more efficient and safer by virtually eliminating the need 
for repeat radiographs and unnecessary patient transfers in the 
setting of an unstable spine. Moreover, the diagnostic quality 
of radiography varies considerably, is more time-consuming to 
acquire, and may be difficult to perform in a medically unstable 
patient. While MDCT excels at delineating bony injury, it also 
can detect many soft tissue abnormalities such as disc hernia-
tion, paravertebral soft tissue- and epidural hematoma. A high- 
resolution CT imaging protocol begins with submillimeter 
overlapping partitions to create an isotropic dataset that yields 
identical spatial resolution in any reconstructed plane. Axial 
data can be reformatted into thicker sections for diagnostic 
display; with reformatted 1.25–2 mm thin slices in the C1–C2 
region, 2–3 mm thin slices in the rest of the cervical spine, and 
3–4 mm thin slices in the thoracic and lumbar spine are typi-
cally chosen for axial presentation. Reformatted sagittal and 
coronal images of the entire spine are produced from contigu-
ous submillimeter (0.3–0.75  mm) axial images. Multiplanar 
reformatted (MPR) sagittal and coronal images of the entire 
spine are typically produced automatically from the scanning 
console or from a nearby workstation. Reconstructions are per-
formed with both bone and soft tissue algorithms.
19.1.3  Magnetic Resonance Imaging (MRI)
The greatest impact that MRI has made in the evaluation of spi-
nal trauma has been in assessment of the soft tissue component 
of injury. MRI is today considered the method of choice for 
assessing the spectrum of soft tissue injuries associated with 
spinal trauma. This includes damage to the intervertebral discs, 
ligaments, vascular structures, and spinal cord [14–16]. No 
other imaging modality has been able to faithfully reproduce 
the internal architecture of the spinal cord and it is this particu-
lar feature that is unique to MRI. Any patient who has a per-
sistent neurologic deficit after spinal trauma should undergo an 
MRI in the acute period to exclude direct damage/compression 
to the spinal cord. MRI provides unequivocal evidence of not 
only spinal cord injury, but will also reliably demonstrate disc 
injuries/herniations, paraspinal soft tissue edema (ligament 
strain/failure), epidural hematomas, and vascular injury. In 
addition, MRI provides the most reliable assessment of chronic 
spinal cord injury and the imaging analogs of post-traumatic 
progressive myelopathy (PTPM) which is often manifested 
with imaging as syrinx formation, myelomalacia, and cord 
atrophy. The extent with which MRI is able to determine spinal 
instability is overstated as MRI is unable to provide a reliable 
assessment of ligamentous integrity in most cases. In fact, MRI 
falsely overestimates the soft tissue component of injury [17].
An acute spinal trauma MR imaging protocol of the cervi-
cal spine shall include 3 mm thick sagittal T1 (T1-weighted) 
and T2-weighted (T2W) and short tau inversion recovery 
(STIR) sequences and 3 mm thick axial T2∗-weighted gradi-
ent echo (GRE) images without contrast. In the thoracic and 
lumbar spine, 4 mm thick sagittal T1-weighted, T2-weighted, 
and STIR sequences and axial 4  mm thick T1-weighted, 
T2-weighted, and T2∗GRE images without contrast is rec-
ommended. 3D volumetric axial GRE or T2-weighted parti-
tions at 1–2 mm thickness are useful in the cervical region. 
Fat-saturated T2-weighted images are valuable to evaluate 
for ligamentous and soft tissue injuries, and T2∗ GRE to 
evaluate for small hemorrhage or blood products in the spi-
nal cord.
19.2  Different Grading Systems to Evaluate 
Spinal Injuries
There are different classic grading scales for determining spinal 
instability of thoracolumbar injuries based upon the McAfee 
(two-column) and Denis three column concept [18, 19]. The 
Magerl classification relies exclusively on CT findings [20]. In 
recent years a new grading scale that is based on CT and mag-
netic resonance (MR) imaging findings, like the thoracolum-
bar injury classification and severity score (TLICS) has been 
developed by the Spine Trauma Group [21] to overcome some 
of the perceived difficulties regarding the use of other thora-
columbar spinal fracture classification systems for determining 
treatment. Also for the grading of the cervical spine a new grad-
ing scale and score system—the cervical spine Subaxial Injury 
Classification and Scoring (SLIC) system [22]—has been 
developed and is gaining acceptance among spine surgeons. 
The AO Spine classification system provides a comprehensive 
classification schema for upper cervical, subaxial cervical, tho-
racolumbar, and sacral injuries [23].
19.2.1  Injuries to the Vertebral Column
Classically, injuries to the spinal column are categorized 
by mechanism of injury and/or by instability. Instability is 
defined by White and Punjabi as abnormal translation between 
adjacent vertebral segments with normal physiologic motion. 
Unrecognized instability after trauma is a potential cause of 
delayed spinal cord injury. This is why early stabilization of 
the initial injury is an imperative to appropriate clinical man-
agement. The simplest method to test for instability in a con-
trolled environment is by performing flexion and extension 
Key Point
• Radiography has largely been supplanted by MDCT 
except in the pediatric population for evaluation of 
bony injury.
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lateral radiography to produce a visible subluxation at a sus-
pected level but this is rarely performed in practice.
From biomechanical point of view, the thoracolumbar 
spine can be divided into three osteo-ligamentous columns: 
anterior-, middle-, and posterior column [18]. The anterior 
column includes the anterior longitudinal ligament and ante-
rior two-thirds of the vertebral body and disc including annu-
lus fibrosus. The middle column is composed of the posterior 
third of the vertebral body and disc including annulus fibro-
sus, and posterior longitudinal ligament. Finally, the posterior 
column is composed of the pedicles, articular processes, facet 
capsules, laminae, ligamentum flavum, spinous processes, 
and the interspinous ligaments. The mechanism of injury will 
result in several different types of traumatic injuries to the cer-
vical, thoracic, and lumbar vertebral column and spinal cord, 
which may result in stable or unstable spine injuries. Although 
this biomechanical model is often inferred for cervical inju-
ries, there is no similar established model in the cervical spine.
Because of the distinct anatomic differences and the 
resultant injury patterns, injuries to the cervical spine 
are divided into subaxial injuries (cranial base to axis) 
and lower cervical injuries (C3–C7). The mechanism of 
injury to the cervical column can be divided into four 
major groups: hyperflexion, hyperextension, rotation, and 
vertical compression with frequent variations that include 
components of the major groups (e.g., flexion and rota-
tion). Hyperflexion injuries include anterior subluxation, 
bilateral interfacetal dislocation, simple wedge fracture, 
fracture of the spinous process, teardrop fracture, and 
odontoid (dens) fracture. Of these the simple wedge frac-
tures and isolated spinous process fractures are considered 
initially stable, while the other fractures are considered 
unstable such as the bilateral interfacetal dislocation and 
the teardrop fracture. The odontoid fracture can be consid-
ered stable or unstable depending on the type of fracture 
type. Hyperextension mechanism is less frequent than the 
hyperflexion and result in the following types of injuries: 
dislocation, avulsion fracture or fracture of the posterior 
arch of C1, teardrop fracture of C2, laminar fracture, and 
traumatic spondylolisthesis of C2 (Hangman’s fracture). 
Most of these injuries with the exception of Hangman’s 
fracture are defined as stable fractures; however, this does 
not imply that these injuries should go untreated. The 
hyperextension injuries are often associated with central 
cord syndrome especially in patients with pre-existing cer-
vical spondylosis and usually produce diffuse pre-verte-
bral soft tissue swelling. Vertical compression results in 
the Jefferson fracture which involves atlas and is consid-
ered unstable or burst fractures. A common site for injuries 
is the craniocervical junction (CCJ) and the atlantoaxial 
joint, which is the most mobile portion of the spine as it 
predominantly relies on a complex ligamentous frame-
work for stability. The imaging findings of important CCJ 
injuries, such as atlanto-occipital dissociation, occipital 
condyle fractures, atlas fractures with transverse ligament 
rupture, atlantoaxial distraction, and traumatic rotatory 
subluxation, are important to recognize in the acute setting 
as for the patient management.
Fractures in the lower thoracic and lumbar spine differ 
from those in the cervical spine. The thoracic and lumbar 
fractures are often complex and due to a combination of 
mechanisms. The thoracic cage confers substantial biome-
chanical protection to the thoracic spine. Therefore, statis-
tically, most injuries occur at the most mobile portion or 
the thoracolumbar junction where the thoracic cage ends. 
When injuries occur in the upper or middle thoracic spine 
it is usually a result of major trauma, e.g., high velocity 
trauma such as motor vehicular accidents. The most com-
mon fracture, at the thoracolumbar junction, is the simple 
compression- or wedge fracture (50% of all fractures) 
which is considered stable. The remaining types of frac-
tures among those the so- called seat belt injury, which can 
be divided into three subtypes: type I (Chance fracture) 
involves the posterior bony elements, type II (Smith frac-
ture) involves the posterior ligaments, and, in type III the 
annulus fibrosus is ruptured allowing for subluxation are 
considered unstable fractures [24]. With the advent of the 
three-point restraint system in motor vehicles, these severe 
hyperflexion-distraction injuries have become uncommon. 
The most common of all thoracolumbar fractures—the 
burst fractures account for 64–81% of all thoracolumbar 
fractures. The burst fracture, which can be divided into five 
subtypes, is associated with high incidence of injuries to 
the spinal cord, conus medullaris, cauda equina, and nerve 
roots [25]. It is important to remember that a burst fracture 
involving anterior and middle column can be misdiagnosed 
as mere compression fracture on plain films and, therefore 
may be misinterpreted as a simple compression or mild 
wedge fracture that involves only anterior column. CT has 
improved characterization of these injuries.
19.3  Soft Tissue Injuries
19.3.1  Traumatic Disc Herniation 
and Ligamentous Injury
Traumatic disc injuries are caused by distraction and shear-
ing with failure of the intervertebral disc. A direct injury to 
the disc is more common than post-traumatic disc extrusion. 
Key Point
• Different classification schemas are utilized to 
describe injury patterns based upon mechanism, 
anatomic and biomechanical differences in unique 
areas of the spine.
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Traumatic disc herniation should be considered when the disc 
exhibits high signal on T2-weighted images especially when 
traumatic vertebral body fractures and/or ligamentous injury 
is present at the same level [13]. Extruded disc material may 
extend into the epidural or pre-vertebral space. When there 
is a gap between parts of the vertebrae or by increased sig-
nal in the ligament or adjacent structures on fat suppressed 
T2-weighted or STIR images, a ligamentous injury is sus-
pected. Up to 25% of all cervical injuries will demonstrate 
signal changes in the posterior ligamentous complex. This 
finding does not equate with instability.
Ligamentous injury without underlying fracture in the cer-
vical spine is rare [26]. Disruption of the anterior longitudinal 
ligament is associated with hyperextension mechanisms with 
associated injury to the pre-vertebral muscles and intervertebral 
discs and can be identified as interruption of the normal linear 
band of hypointense signal of the ligament on T1-weighted 
images. Hyperflexion and distraction forces may cause disrup-
tion of the posterior ligament complex which is manifested by 
increased distance between spinous processes on lateral radi-
ography and increased signal in the interspinous region on MR 
sagittal STIR sequences. Abnormal angulation, distraction, and 
subluxation are often recognized on initial CT study.
19.3.2  Whiplash-Associated Disorders
Whiplash injuries represent a separate, relatively common 
entity (1–4/1000), resulting from an acceleration–deceleration 
mechanism of injury to the neck, typically from rear-end vehi-
cle collisions. Whiplash injury is among the leading automotive 
related injuries with respect to burden on patients, the healthcare 
system and insurance organizations [27]. The pathogenesis of 
whiplash complaints is still poorly understood. Injury to longi-
tudinal ligaments, facet joints, intervertebral discs, spinal cord, 
and muscles has been described as possible sources of (chronic) 
pain. More recently, with the development of more detailed MR 
imaging techniques, morphologic changes of the ligaments and 
membranes of the craniovertebral junction, especially the alar 
and transverse ligaments have been described [28].
Whiplash-associated disorders (WAD) is a clinical diag-
nosis and describes a variety of clinical manifestations, such 
as neck pain immediately or 24 h after trauma, neck stiffness, 
headache, dizziness, vertigo, auditory and visual distur-
bances, concentration, and psychological problems. Imaging 
findings include osseous injuries such as bone contusions 
and occult fractures, ligamentous injuries (most common 
finding), and tears. Disc lesions and post-traumatic hernia-
tion also can occur [29]. MRI signal changes of the alar and 
transverse ligaments may be observed. Whether these signal 
abnormalities are responsible for complaints of patients hav-
ing WAD remains controversial, as these signal abnormali-
ties have also been observed in asymptomatic individuals 
and were not significantly associated with clinical testing and 
prognosis of acute whiplash injury. A recent meta- analysis 
could not show any association between MRI signal changes 
in alar and transverse ligaments and WAD [28].
19.4  Injuries to the Spinal Cord
A majority (80%) of patients with spinal cord injury (SCI) 
harbor multisystem injuries [30], typically associated injuries 
include other bone fractures (29.3%) and brain injury (11.5%) 
[31]. Nearly all SCI damage both upper and lower motor neu-
rons because they involve both the gray matter and descending 
white matter tracts at the level of injury. The American Spinal 
Injury Association (ASIA) has suggested a comprehensive set 
of standardized clinical measurements which are based upon 
a detailed sensory and motor examination of all dermatomes 
and myotomes [32]. The neurologic deficit that results from 
injury to the spinal cord depends primarily upon the extent of 
damage at the injury site and the cranial-caudal location of the 
damage (i.e., the neurologic level of injury or NLI); anatomi-
cally higher injuries produce a greater neurologic deficit (e.g., 
cervical injury = quadriparesis, thoracic injury = paraparesis). 
These comprehensive set of standardized clinical measure-
ments have been adopted worldwide. Functional transection of 
the spinal cord is a more frequent manifestation of SCI com-
pared to true mechanical transection which is relatively rare 
and confined mostly to penetrating type injuries or extensive 
fracture- dislocations/translocations. SCI is further categorized 
clinically into anterior cord syndrome, Brown-Sequard syn-
drome, central cord syndrome, conus medullaris syndrome, 
and cauda equina syndrome depending upon the site of injury 
and the neurologic pattern of injury. Spontaneous neurologic 
recovery after spinal cord injury overall is relatively poor and 
largely depends upon the severity of neurologic deficit iden-
tified at the time of injury. Of the different spinal cord syn-
dromes the anterior cord syndrome has the worst prognosis of 
all cord syndromes, especially, if no recovery is noticed during 
the first 72 h after injury.
19.4.1  Spinal Cord Hemorrhage
Post-traumatic spinal cord hemorrhage or hemorrhagic con-
tusion is defined as the presence of a discrete area of hem-
Key Point
• MRI has unparalleled sensitivity to the gamut of soft 
tissue injuries associated with spinal trauma; however, 
signal changes on T2-weighted or STIR MR in the 
soft tissues due not equate with spinal instability.
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orrhage within the spinal cord after an injury. The most 
common location for hemorrhage to accumulate is within 
the central gray matter of the spinal cord, and centered at 
the point of mechanical impact [33–35]. Experimental and 
autopsy pathologic studies have shown that the underlying 
lesion most often will be hemorrhagic necrosis of the spinal 
cord while true hematomyelia will rarely be found [36]. There 
are significant clinical implications if there is identification 
of frank hemorrhage in the cervical spinal cord following 
trauma on an MRI examination. Originally it was thought 
that detection of intramedullary hemorrhage was predictive 
of a complete injury. However, the increased sensitivity and 
spatial resolution of current MRI techniques has shown that 
even small amounts of hemorrhage are identifiable in incom-
plete lesions. Therefore, the basic construct has been altered 
such that the detection of a sizable focus of blood (>4 mm in 
length on sagittal images) in the cervical spinal cord is often 
indicative of a complete neurological injury [37]. The ana-
tomic location of the hemorrhage closely corresponds to the 
neurological level of injury and the presence of frank hem-
orrhage implies a poor potential for neurological recovery 
(Fig. 19.1) [33–35, 38–42].
a b
Fig. 19.1 Acute hemorrhagic spinal cord injury. (a) Sagittal STIR 
sequence shows that there is a flexion type injury of C5 with acute ven-
tral angulation. The spinal cord is markedly swollen with edema span-
ning the entire length of the spinal cord. There is a central hemorrhagic 
focus which is of low signal intensity that spans from C4 to C6. Note 
the disruption of the posterior spinal soft tissues. (b) Axial GRE image 
at the C4 level shows that the hypointense hemorrhage is confined to the 
central gray matter
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19.4.2  Spinal Cord Edema
Spinal cord edema is defined as a focus of abnormal high 
signal intensity seen on MRI T2-weighted images [35]. 
Presumably, this signal abnormality reflects a focal accumula-
tion of intracellular and interstitial fluid in response to injury 
[34, 35, 43, 44]. Edema is usually well defined on the mid-sag-
ittal T2-weighted image while the axial T2-weighted images 
offer additional information in regard to involvement of struc-
tures in cross-section. Spinal cord edema involves a variable 
length of spinal cord above and below the level of injury, with 
discrete boundaries adjacent to uninvolved parenchyma and is 
invariably associated with some degree of spinal cord swell-
ing. The length of spinal cord affected by edema is directly 
proportional to the degree of initial neurologic deficit [33, 42]. 
Notable is that spinal cord edema can occur without MRI evi-
dence of intramedullary hemorrhage. Cord edema alone con-
notes a more favorable prognosis than cord hemorrhage [38].
19.5  Blunt Cerebrovascular Injury
Blunt cerebrovascular injury (BCVI) to the carotid arteries 
(CAs) and/or vertebral arteries (VAs) is a relatively rare but 
potentially devastating finding in patients with a high-impact 
trauma to the cervical spine and/or head. Most complica-
tions of BCVI occur hours to days after the initial trauma 
so early identification and prompt anticoagulation is impor-
tant to reduce the incidence of post-injury ischemic stroke 
(Fig. 19.2).
Cervical spine fractures have the strongest association 
with BCVI, and specific cervical spine fractures are highly 
predictive of BCVI.  These include fractures located at the 
upper cervical spine (C1–C3), subluxation, or involvement 
of the transverse foramina [45]. In the context of a carotid 
artery injury, it is thought that cervical hyperextension and 
contralateral rotation lead to stretching of the internal carotid 
artery (ICA) over the C1–C3 transverse processes, precipi-
tating a vessel wall injury [46]. Nearly all VAIs are associ-
ated with cervical spine subluxations and fractures involving 
the transverse foramen [47]. Other mechanisms of BCVI 
include hyperflexion, a direct blow, and strangulation.
According to the Denver criteria and Western Trauma 
Association (WTA) guidelines, radiologic risk factors 
associated with BCVI include high-energy injury mecha-
nisms with Le Fort II or III fracture patterns; basilar skull 
fracture with carotid canal involvement; cervical vertebral 
body or transverse foramen fracture, subluxation, or liga-
mentous injury; any fracture at C1–C3; closed head injuries 
with diffuse axonal injury and a Glasgow Coma Score of 
<6; clothesline- type injuries with associated swelling and/
or pain; or near-hanging with anoxia. Urgent screening for 
BCVI should be performed in these patients that may be still 
neurologically asymptomatic at this time [46].
With the widespread use of multi-detector CT scanners, 
CT angiography (CTA) has emerged as the first-line screen-
ing modality for BCVI.  CTA is a cost-effective screening 
tool in high-risk populations, ultimately preventing the most 
strokes at a reasonable cost [46].
Several grading systems exist, based on imaging find-
ings. The Denver grading scale (aka the Biffl scale) is a 
widely accepted and commonly used system. In grade I 
injury,  subtle vessel wall irregularities, a dissection/intra-
mural hematoma with <25% luminal stenosis is observed. 
In grade II injury, an intraluminal thrombus or raised intimal 
flap is visualized, or a dissection/intramural hematoma with 
>25% luminal narrowing. Grade III injury corresponds to 
traumatic pseudoaneurysms, observed as a variable-sized 
outpouching of the vessel wall. Grade IV injury represents 
a complete vessel occlusion, usually tapering in the CA and 
quite abrupt in the VA. Vessel transection represents a grade 
V injury, observed as free contrast extravasation into the 
surrounding tissues, or into the adjacent vein in the form of 
an arteriovenous fistula (AVF) [46, 47].
19.6  Injuries to the Pediatric Spine 
and Spinal Cord
Spinal injuries are generally less common in the pediatric 
population compared to adults with cervical spine injuries 
being most frequent spine injury of all spine injuries occur-
ring in up to 40–60% of all injuries in children. The etiology 
varies depending on the age of the child. The most common 
cause of pediatric cervical spine injury is a motor vehicle 
accident, but also obstetric complication, fall, and child 
abuse are known causes. In the adolescent, sports and diving 
accidents are other well-known causes. The specific biome-
chanics of the pediatric cervical spine leads to a different 
distribution of injuries and distinct radiological features and 
represent a distinct clinical entity compared to those seen 
in adults. Young children have a propensity for injuries to 
the CCJ, upper cervical injuries (i.e., cranial base to C2) 
whereas older children are prone to lower cervical injuries 
Key Point
• The combination of intramedullary hemorrhage and/
or edema correlates with neurologic function and 
capacity to recover after spinal cord injury (SCI).
Key Point
• Occult vertebral artery injury (dissection or occlusion) 
can occur in association with spinal trauma even with-
out the presence of spinal cord injury or fracture.
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similar to those seen in adults. The spinal cervical injuries 
in children <8  years of age demonstrate a high incidence 
of subluxation without fractures. The biomechanical differ-
ences are explained by the relative ratio of the size of the 
cranium to the body in the young child, lack of ligamentous 
stability, poor muscle strength, and increased forces relative 
to the older child and adult. Children are also more prone 
to spinal cord injury with otherwise normal radiographs so 
called SCIWORA (spinal cord injury without radiographic 
abnormality) compared to adults. This is especially evident 
in children younger than 9  years of age where there is a 
high incidence of reported complete cord injuries associated 
with SCIWORA. Suggested mechanisms of the SCIWORA 
include hyperextension or flexion injuries to the imma-
ture and the inherently elastic spine, which is vulnerable 
to external forces and allows for significant intersegmental 
movement and transient soft disc protrusion, resulting in dis-
traction injuries, and/or ischemic injury of the spinal cord 
[48]. The elasticity of the spine allows it to stretch up to 5 cm 
before rupture, whereas the spinal cord, which is anchored to 
the brachial plexus superiorly and the cauda equina inferi-
orly, ruptures after 4–6 mm of traction [49]. As MRI is read-
ily capable of detecting the soft tissue injury component, the 
concept of SCIWORA is less relevant.
a b
Fig. 19.2 Traumatic thrombosis/dissection of the bilateral vertebral 
arteries. (a) Sagittal T2-weighted image in a 32 y/o male after a skate- 
boarding accident. Traumatic subluxation of C2–3 with circumferential 
disruption of the disco-ligamentous complex and spinal cord compres-
sion/edema. (b) Axial T2-weighted image at the C2–3 level show high 
signal in both foramen transversarium from clot/slow flow in both ver-
tebral arteries
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The imaging algorithm for pediatric spinal trauma is 
somewhat different than that for adults. MDCT is used more 
judiciously due to radiation exposure considerations and at 
many places lower dose radiography is often utilized ini-
tially. MRI is always used if there is a consideration of a 
pure soft tissue injury or neurologic deficit.
19.7  Neurologic Recovery after Spinal 
Cord Injury
Although there are no pharmacologic “cures” for spinal cord 
injury, spontaneous neurologic recovery after injury can 
occur and it largely depends upon the severity of the initial 
neurologic deficit, the neurologic level of injury, patient age, 
and co-morbidities. Very few patients with a neurologically 
complete (i.e., no motor or sensory function below the injury 
level) actually regain any useful function below the injury 
level although most patients will spontaneously improve 
by one neurologic level (e.g., a C5 level spontaneously 
descends to a C6 level). Even these small improvements can 
have a substantial impact on a patients’ capacity to function 
independently.
The role of MRI to predict capacity for spontaneous neuro-
logic recovery after cervical SCI has been evaluated. Although 
there is considerable overlap in results some general charac-
terizations about the MRI appearance of SCI and neurologic 
recovery are evident. Intramedullary hemorrhage four milli-
meters or greater is equated with a severe neurologic deficit 
and a poor prognosis. Cord edema alone is indicative of a mild 
to moderate initial neurological deficit and a better capacity 
for spontaneous neurological improvement. The length of the 
cord lesion may also correlate with the initial deficit and in the 
neurological outcome. Newer MRI techniques such as diffu-
sion tensor imaging (DTI) (Fig. 19.3) have shown great prom-
ise not only in stratification of neurologic injury but has also 
been shown to have benefits in predicting recovery [50–52]. 
As novel pharmacologic therapies for SCI are developed and 
tested, MRI will likely play a more essential role in character-
izing the injury and helping to select patients for clinical trials.
Fig. 19.3 Disruption of the 
lateral cortical spinal tracts on 
tractography. Diffusion 
tractography performed on a 
lesioned rat spinal cord at 
9.4T shows disruption of the 
fiber tracts in the lateral 
column following a lesion in 
the lateral funiculus. (Image 
courtesy of Eric D. Schwartz 
MD)
Key Point
• Patterns of injury in the pediatric population are tre-
mendously different than adults; the imaging algo-
rithm is unique.
Key Point
• MRI findings of SCI have shown promise as a surro-
gate for the neurologic examination; better prognostic 
information is attained when MR imaging patterns are 
used in combination with the clinical examination.
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19.8  Concluding Remarks
The demographic of adult spinal trauma and spinal cord 
injury has changed over the last several decades noting a 
considerable increase in prevalence in the elderly. Safety 
measures in sports and motor vehicles have drastically 
reduced the incidence of spinal cord injury in the young 
adult and middle age population. Imaging algorithms for 
spinal trauma have also changed in the past few decades 
with greater reliance on MDCT over radiography in adults 
and greater emphasis towards minimizing radiation dose 
in the injured pediatric population. While there have been 
tremendous improvements in orthopedic stabilization 
methods through novel instrumentation/fusion techniques, 
there are still no known cures for paralysis. While spinal 
cord injury was previously considered to be a fatal dis-
ease with patient succumbing to injury at the scene or from 
long term complications, most SCI patients now survive 
and many return to meaningful lives while living with 
their disability. This is principally attributed to revolution-
ary improvements in rehabilitation and chronic care for the 
SCI patient.
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Take Home Messages
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• Spinal trauma is now more common in the elderly 
due to falls.
• MDCT has supplemented radiography.
• MRI reveals the soft tissue components of injury 
including damage to the spinal cord.
• MR signal changes with whiplash-associated disor-
ders are inconsistently present.
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20.1  Introduction
The diagnostic work-up of peripheral neuropathies relies on 
the patient’s clinical history, physical examination, and elec-
trophysiological studies, which usually provide enough infor-
mation about the location, severity, and the etiology of the 
underlying nerve injury in the majority of patients. However, 
electrodiagnostic studies, such as electromyography (EMG), do 
not display the anatomic detail needed for precise localization 
and treatment planning because of the deep location of nerves 
and the variable innervation of regional muscles. EMG sensi-
tivity for lumbosacral radiculopathy ranges from 49 to 86%. 
Therefore, imaging particularly with magnetic resonance imag-
ing (MRI)/magnetic resonance neurography (MRN) and ultra-
sound (US) has an increasing role in the evaluation of peripheral 
neuropathies [1]. Although US is more operator-dependent than 
MRI and less effective in cases of deep nerves of the pelvis and 
lumbosacral plexus, it is very effective for dynamic assessment 
of superficial peripheral nerves abnormalities, such as changes 
in nerve caliber, continuity, and echogenicity [2].
20.2  Anatomy of Peripheral Nerves
Peripheral nerves range from 1 to 20 mm in size, the largest 
being the sciatic nerve. Peripheral nerves are formed by multi-
ple axons, grouped into fascicles, the number of which depends 
on the size and length of the nerve. Endoneurium invests the 
Schwann cell–axon complex, with the inner border represented 
by the Schwann cell basement membrane and its outer border 
by the perineurium. The epineurium, the outermost connective 
tissue sheath, envelops the nerve and provides mechanical sup-
port for the axons. Endoneurial fluid within each fascicle is iso-
lated from the general extracellular space by tightly adherent 
epithelial-like cells of the perineurium and from the circulat-
ing blood by the tight junctions between the endothelial cells of 
the endoneurial capillaries. The endoneurium and perineurium 
form a functional, relatively impermeable barrier known as the 
blood–nerve interface that protects the peripheral nervous sys-
tem against toxic and infectious agents.
20.3  Brachial Plexus (BP)
The ventral rami of the C5 through T1 nerves give rise to 
the BP. The BP structures travel through the supraclavicu-
lar fossa paralleling the subclavian artery. Individual ven-
tral rami or roots are best seen on axial and coronal images. 
The sagittal plane is helpful for following the BP structures 
from the spine to the axilla as they lie perpendicular to the 
plane. The upper (C5-C6), middle (C7), and lower (C8-T1) 
trunks travel between anterior and middle scalene muscles, 
forming the lateral border of the scalene triangle [3]. In the 
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Learning Objectives
• Review the anatomy of the peripheral nerves and 
brachial and lumbosacral plexi.
• Understand the utility of different magnetic reso-
nance imaging (MRI) sequences and magnetic reso-
nance neurography (MRN) for identifying peripheral 
nerve diseases.
• Describe the imaging characteristics of different 
peripheral nerve diseases to help narrow the differ-
ential diagnosis.
• Discuss the role of advanced imaging techniques.
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supraclavicular triangle, the trunks divide into anterior and 
posterior divisions just before passing posterior to the clav-
icle and going from the lateral aspect of the anterior scalene 
muscle to the lateral border of the first rib [3]. The cords 
(lateral, medial, and posterior) course from the mid-clavicle 
to the inferomedial coracoid process and are named accord-
ing to location relative to the axillary artery. At the pectora-
lis minor muscle, just medial to the coracoid, axillary vein, 
and axillary artery, the cords change into the five terminal 
branches (radial, axillary, musculocutaneous, median, and 
ulnar nerves).
20.4  Lumbosacral Plexus (LSP)
The ventral rami of the L1-L4 spinal nerve roots and a small 
contribution from the 12th thoracic nerve coalesce within or 
posterior to the psoas major muscle to form the lumbar plexus 
[2]. The lumbar plexus gives rise to the iliohypogastric (L1), 
ilioinguinal (L1), genitofemoral (L1-L2), femoral (L2-L4), 
and lateral femoral cutaneous (L2-L3) nerves, which emerge 
lateral to the psoas major muscle. The obturator nerve and 
lumbosacral trunk come forward from the medial border of 
the psoas muscle. A minor (peroneal) branch of L4 combines 
with the ventral ramus of L5 to form the lumbosacral trunk. 
The latter descends over the sacral ala and joins the S1 to S3 
ventral rami on the anterior aspect of the piriformis muscle to 
form the sacral plexus [4]. The sacral plexus gives rise to the 
sciatic (L4-S3), pudendal (S2- S4), superior gluteal (L4-S1), 
and inferior gluteal (L5-S2) nerves.
20.5  Magnetic Resonance Neurography 
(MRN)
Although conventional MRI can provide structural informa-
tion, it is limited in its ability to visualize peripheral nerves 
due to low contrast resolution between the small nerves, mus-
cles, and vessels, signal intensity variability, and pulsatility 
artifacts. These disadvantages have largely been overcome 
with MRN.  The MRN technique relies on high magnetic 
field strength, T2-weighted sequences with fat suppression, 
dedicated surface coils, and small field of view (FOV). MRN 
can identify specific characteristics of nerve morphology, 
such as internal fascicular pattern, longitudinal variations in 
signal intensity and caliber, and connections and relations 
to other nerves or plexuses [5]. The most efficient fat sup-
pression is obtained with T2-weighted short time inversion 
recovery (STIR) sequences, which selectively eliminate 
the fat signal using an inversion recovery pulse of 150 ms. 
These sequences, however, are characterized by poor signal-
to-noise ratio and pulsatility artifacts caused by vessels. 
Alternative methods for fat suppression are T2 spectral adia-
batic inversion recovery imaging (SPAIR) or DIXON-type 
fat suppression, which both have improved signal-to-noise 
ratio, at the expense of lower contrast resolution. In order to 
obtain the best compromise between spatial resolution, FOV, 
and acquisition time, MRN sequences should be adapted to 
the anatomical region and the best echo time should be care-
fully selected in order to obtain a satisfactory differentiation 
between nerves and muscles, as the signal intensity of the 
nerve is very sensitive to small changes (Fig. 20.1).
Three-dimensional (3D) MRN is a refinement of conven-
tional MRN.  It is typically acquired with isotropic voxels, 
with the advantage of generating oblique and curved-planar 
reformations of nerve roots, peripheral nerves, and plexuses. 
This feature is particularly useful for imaging brachial and 
lumbosacral plexi, which cannot be fully displayed by 2D 
imaging (Fig.  20.2). On MRN axial images, normal nerves 
are rounded or ovoid structures, typically isointense to slightly 
hyperintense on T2, depending on the size of the nerve, on the 
amount of endoneurial fluid, and the degree of fat suppression. 
On T1 images, nerves are isointense to the adjacent muscles. 
The epineurium appears as a thin hypointense rim, and the 
transverse and longitudinal fascicular pattern may be identi-
fied in larger nerves such as the sciatic nerve. Diseased nerves 
become T2 hyperintense to muscle and are focally or globally 
enlarged [6]. The signal intensity change is due to increased 
water content in the epineurial space caused by blood–nerve 
barrier damage, axoplasmic flow blockade, inflammation, dis-
tal Wallerian degeneration and is relatively independent from 
Fig. 20.1 MRN (3  T), axial T2-STIR section at mid-thigh. Normal 
subject. The right sciatic nerve (arrow) is moderately hyperintense 
compared to the adjacent muscles and its transverse fascicular pattern is 
clearly identifiable
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the etiology of the neuropathy. Neuropathies with different 
etiologies cannot be distinguished only on the basis of signal 
intensity changes as there are no reliable quantitative methods 
to differentiate between the signal intensities of normal versus 
abnormal nerves. MRN has the advantage of a simultaneous 
exploration of nerves and muscles. Importantly, muscle dener-
vation represents a useful MR sign of peripheral nerve disease. 
In the acute phase of muscle denervation, increased signal 
intensity can be observed in T2 sequences as early as 24 h 
after nerve injury and lasting for more than 2 months [7]. In 
the subacute phase, a gradual decrease of T2 signal intensity 
is associated with fatty replacement, which progresses to fatty 
atrophy of the affected muscles, best displayed by T1 images. 
The MR changes precede the earliest EMG findings of dener-
vation, which are not detectable until the second week.
A comprehensive MRI protocol for the investigation of 
peripheral nerves should include MRN, which provide both 
structural and functional information on the nerves and mus-
cle denervation, T1 sequences which are helpful for a precise 
anatomical identification of nerves and for the identification 
of muscular atrophy, and contrast-enhanced T1sequences for 
the evaluation of the blood–nerve barrier integrity. MRN is 
effective in the diagnostic work-up of traumatic nerve injuries 
[8], nerve entrapment syndromes [9], and nerve tumors [10]. 
Lumbosacral MRN may demonstrate abnormal intraneural 
T2 signal in a substantial portion of patients with clinical 
symptoms of lower extremity radiculopathy and correlates 
with findings of active radiculopathy on EMG [11]. Recently 
MRN has been proposed for the evaluation of hereditary and 
immune-mediated disorders of peripheral nerves [12].
20.6  Diffusion Tensor Imaging
Diffusion tensor imaging (DTI) is a novel technique which 
has been recently applied to the investigation of peripheral 
nerve disorders. DTI provides “microstructural” information 
about nerve integrity. Nerves are characterized by greater 
water diffusion anisotropy compared to the surrounding tis-
sues, due to a barrier to water diffusion formed by axonal 
myelin sheaths. Diffusion imaging of the peripheral nerves 
is challenging because of their small size and course, par-
ticularly the BP because of the geometric distortion and arti-
facts along the course of the nerves between the neck and the 
shoulder. Additionally, DTI gives quantitative information 
about the degree and direction of water diffusion: fractional 
anisotropy (FA), apparent diffusion coefficient (ADC), mean 
diffusivity (MD), axial diffusivity (AD), and radial diffusiv-
ity (RD) [13]. Reconstructing the diffusion information to 
characterize the integrity of the white matter tracts (diffu-
sion tensor tractography, DTT) yields 3D representations of 
anisotropic nerve fibers. Successful tracking of the major 
peripheral nerves can be obtained using the same approach 
as deterministic tractography of the brain white matter bun-
dles. DTI has been extensively applied to the median nerve 
at the carpal tunnel and more recently to the BP and LSP, 
although its overall diagnostic value in clinical routine is still 
to be ascertained. Although DTI and tractography are not 
widely used clinically, good reproducibility of DTI quantita-
tive analysis with only small variations in calculated FA and 
ADC in the BP of normal volunteers has been shown [14].
20.7  Traumatic Injuries of Peripheral 
Nerves
Peripheral nerve injuries are classified into three types: neu-
ropraxia, axonotmesis, and neurotmesis, which are defined 
by the histopathology and specific anatomic structures of 
the nerve unit that are damaged (Table 20.1). Neuropraxia 
Fig. 20.2 3D MRN (3 T) of the brachial plexus. Oblique coronal refor-
mat. The supra and infraclavicular segments of the brachial plexus are 
simultaneously displayed in a single image. Upper trunk (UT), Middle 
trunk (MT), Lower trunk (LT), Lateral cord (LC), Posterior cord PC), 
Medial cord (MC)
Key Point
• MRN can characterize nerve morphology, longitu-
dinal variations in signal intensity and caliber, and 
connections and relations to other nerves or plex-
uses to help identify pathology in correlation with 
the patient’s clinical history, physical examination, 
and electrophysiological studies.
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is the mildest form of traumatic plexopathy, in which there 
is temporary loss of function, near complete recovery, and 
the absence of denervation atrophy of the muscle. The nerve 
is grossly intact but functionally impaired with slowed or 
absent conduction in the involved segment. More serious 
injury to the neural axons results in axonotmesis and neurot-
mesis. In axonotmesis, there is loss of axonal continuity and 
the endoneurium, with Wallerian degeneration distal to the 
site of injury. As such, recovery requires nerve regeneration 
to regain function. Depending on the severity of injury, MRN 
will demonstrate varying degrees of nerve enlargement, dis-
ruption, and effacement of nerve fascicles. In neurotmesis, 
disruption of the axons, myelin sheath, and surrounding 
perineurium and epineurial layers typically requires surgi-
cal intervention. MRN may reveal a neuroma in continuity 
or complete transection of the nerve with formation of an 
end- bulb neuroma [15]. EMG and nerve conduction studies 
provide functional information but are unable to differentiate 
axonotmesis from neurotmesis. MRI can be used to differen-
tiate neurapraxia from axonotmesis and neurotmesis through 
combined assessment of the characteristics of the injured 
nerve, typically represented by: (a) nerve enlargement with 
longitudinal variations in size, (b) increase in signal inten-
sity, (c) signal intensity anomalies of the corresponding mus-
cles, reflecting acute or subacute denervation.
20.8  Traumatic Injuries of the Brachial 
Plexus
MR imaging (including MR myelography and MRN) is 
primarily used to locate the injury level, i.e., the distinction 
between preganglionic lesions (avulsion of the cervical nerve 
roots from the spinal cord) and postganglionic lesions (distal 
to the dorsal root ganglion), which is important for prognosis 
and therapeutic management [16] (Table 20.2). Multiplanar 
and curved reformats from 3D MRN are helpful to identify 
postganglionic lesions. Of note, MRI within 1  month of 
injury can be challenging to evaluate because hemorrhage 
and edema can compromise visualization of the thecal sac 
and nerves. In adults, the majority of brachial plexopathies 
are due to traumatic injuries, usually resulting from high- 
velocity trauma, such as motorcycle accidents. In the pedi-
atric population, traumatic brachial plexopathy is often 
secondary to excessive severe traction force exerted on the 
brachial plexus during complicated deliveries. In pregangli-
onic injuries, MRI may reveal spinal cord edema in the acute 
phase (T2 hyperintensity) [17]. There may be susceptibility 
effects from hemosiderin, accentuated on T2∗ gradient sus-
ceptibility images. A helpful clue to preganglionic avulsion 
injury is the formation of a pseudomeningocele, which is seen 
in 80% of traumatic avulsions; notably, pseudomeningoceles 
take time to develop. This lesion is a sequela of traction on 
the cervical roots and meninges resulting in leakage of cere-
brospinal fluid in contiguous areas, anterior epidural space, 
neural foramina, perivertebral spaces, surrounded by a thin 
membrane. In complete avulsions, the ventral and dorsal 
roots are not identifiable, whereas partial avulsions are char-
acterized by rarefaction of the ventral or dorsal rootlets, with 
mild abnormalities of the dural sleeves (Fig. 20.3). Changes 
of muscular denervation, including alterations in signal inten-
sities and contrast enhancement, in the posterior cervical 
paraspinal muscles, particularly in the multifidus muscle, are 
an indirect imaging finding of a preganglionic injury.
In postganglionic injuries, the nerve may be stretched 
and remain in continuity. The acutely injured nerve is thick-
ened and typically T2 hyperintense. The secondary trunks 
are often characterized by marked tortuosity. Post-traumatic 
neuromas can be identified along the course of the roots or 
primary trunks as neuromas “in continuity,” characterized by 
fusiform swelling, or as “stump” neuromas (Fig. 20.4). DTT 
has been proposed as a diagnostic tool to assess traumatic BP 
lesions, due to high diagnostic accuracy in the identification 
of radicular avulsions, especially when extensive dural scar 
or CSF artifacts limit the usefulness of MRI [18] (Fig. 20.5).
For traumatic injuries of the upper limb, US is the 
examination of choice and can be performed imme-
Table 20.1 MR imaging in peripheral nerve injuries according to 
Seddon’s classification
Classification MR
Neurapraxia –  T2 hyperintensity of the nerve (within 24 h of 
trauma)
–  No muscle denervation
Axonotmesis –  T2 hyperintensity and enlargement of the nerve 
with fascicular hypertrophy, with or without 
neuroma in continuity
–  Muscle denervation
Neurotmesis –  Nerve disruption with stump neuroma
–  Muscle denervation
Table 20.2 MR imaging findings in different peripheral nerve injuries 
on MR Myelography
Brachial plexus injuries MR
Complete avulsion Traumatic pseudomeningoceles
Ventral and dorsal roots not identifiable
Denervation edema of the posterior 
paraspinal muscles
Partial avulsion Reduced number of rootlets on MIP 
projections
Ventral or dorsal root absent on axial 




Swelling and increased signal intensity of 
the roots, trunks and cords of the brachial 
plexus
Tortuosity and increased intensity of the 
infraclavicular brachial plexus
Post-traumatic neuromas along the course 
of the roots and/or primary trunks
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diately after trauma to demonstrate neurotmesis-type 
lesions to show nerve discontinuity. MRN can iden-
tify axonotmesis-type lesions, which appear as global 
nerve enlargement with mild fascicular hypertrophy that 
extends longitudinally and requires longer time for nerve 
regeneration.
DTI can be used to assess the nerve regeneration after 
surgery [19].
20.9  Traumatic Injuries of the Lumbosacral 
Plexus, Sciatic and Femoral Nerves
Indirect injury to the LSP may occur as a part of lumbar spine 
injuries, pelvic fractures, and hip fractures or dislocations. 
Pelvic or hip injuries typically cause stretch- or traction- 
related partial plexopathy and, less commonly, nerve avul-
sions. The avulsions of lumbosacral nerve roots typically 
involve L4, L5, and S1. MRN can locate the level of the 
injury and provide information about the associated muscle 
denervation (Fig. 20.6). Fibular nerve can be injured in fibu-
lar fractures and knee dislocations as well as in habitual leg 
crossing or repetitive exercise in athletes.
Iatrogenic injury to the LSP may result from surgical gyne-
cologic or anesthetic procedures, compression, traction, and 
vascular insults [20]. Traumatic injuries of the sciatic nerve can 
also occur as a complication of prosthetic hip surgery, most 
frequently involving the fibular division. Injuries of the femoral 
nerve can be secondary to pelvic trauma or iatrogenic in nature 
with nerve compression from hematoma or pseudoaneurysm 
during femoral artery puncture, respectively. The intrapelvic 
femoral nerve may show increased T2 signal and size or devia-
tion by hematoma, with denervation of the iliopsoas muscle. 
Fig. 20.3 22-year-old male, motor cycle accident, with complete right brachial plexus palsy. 3D MR Myelography. Right C7 and C8 (partial) 
avulsions of the ventral nerve roots (arrows)
Fig. 20.4 MRN, traumatic injury of the left brachial plexus. Neurotmesis 
of the left C6 nerve root: stump neuroma (arrow)
Key Point
• A pseudomeningocele is a preganglionic injury that 
is seen in 80% of traumatic avulsions. It results from 
traction on the cervical roots and meninges with CSF 
leakage into contiguous areas.
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a b
Fig. 20.5 Traumatic injury of the right brachial plexus. (a) MRN: the right brachial plexus is barely identifiable (arrow). (b) Tractography: right 




Fig. 20.6 24-year-old male, road accident, with left femoral shaft frac-
ture, sciatic nerve injury. MRN (1.5 T), axial T2-STIR at pelvic floor 
(a), proximal and mid-thigh (b, c), sagittal oblique reformat (d). 
Enlargement and hyperintensity of the left sciatic nerve, which is char-
acterized by fascicular hypertrophy (arrows). Increased signal intensity 
of semimembranosus, semitendinosus, and long head of the biceps 
femuri, due to acute denervation
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Although nerve abnormalities in the thigh can be difficult to 
detect, denervation of the quadriceps femoris may be a clue to 
femoral nerve injury distal to the groin ligament.
20.10  Entrapment Neuropathies
Peripheral nerve compression or entrapment usually 
occurs at specific anatomic locations, often close to 
limb joints, such as sites where a nerve courses through 
fibro-osseous or fibromuscular tunnels or penetrates 
muscles (Table  20.3). US and MRN can provide direct 
anatomic visualization of the entrapped nerves. US has 
the advantage of providing dynamic evaluation of nerve 
entrapment. MRN demonstrates varying degrees of signal 
intensity within the nerve, proximal to the site of entrap-
ment, and the associated muscle denervation changes. 
Proximal nerve enlargement and fascicular hypertrophy 
and distal flattening can develop with increasing severity 
of neuropathy.
20.11  Carpal Tunnel Syndrome
Carpal tunnel syndrome (CTS) is the most common peripheral 
nerve entrapment syndrome and has various etiologies, includ-
ing repetitive trauma, metabolic and hormonal conditions, and 
ganglion cysts. While US has 77.6% sensitivity and 86.8% 
specificity for diagnosing CTS, sensitivity of MRN is above 
90%. On MRN, abnormal nerve signal length and cross-sec-
tional area at the distal radioulnar joint are the best predictors of 
the severity [21]. Correlation between median nerve DTI met-
rics in the carpal tunnel and electrophysiology has been recently 
reported [22]. MRN is particularly useful for the evaluation of 
atypical CTS, when assessing for space-occupying lesion, and 
in patients with persistent symptoms after carpal tunnel release.
20.12  Ulnar Neuropathy at the Elbow
Ulnar nerve entrapment at the cubital tunnel is the second most 
common entrapment neuropathy. The dynamic US evaluation 
during flexion/extension of the elbow is crucial for showing 
subluxation of the ulnar nerve. MRN can discriminate between 
symptomatic ulnar nerve entrapment at the elbow and asymp-
tomatic controls with high diagnostic accuracy. In patients 
with electrophysiologically and clinically evident ulnar nerve 
entrapment, DTI may show regional FA decrease at the cubital 
tunnel, correlating with symptom severity (Fig. 20.7).
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Fig. 20.7 48-year old male with acute onset of right forearm pain and 
paresthesia. Ulnar nerve entrapment at the cubital tunnel. (a) Axial T1 
image at the right elbow (a), MRN at distal arm (b), and forearm (c). 
Deformation of the right ulnar nerve (black arrow in a). Proximal to the 
entrapment site, the ulnar nerve is enlarged and hyperintense with fas-
cicular hypertrophy (arrow in b). Denervation edema of the flexor carpi 
ulnaris (arrow in c)
Key Point
• Although both US and MRN offer anatomic delin-
eation of entrapped nerves, US has the advantage of 
providing dynamic evaluation of nerve entrapment.
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20.13  Non-traumatic Brachial 
and Lumbosacral Plexopathies
Idiopathic brachial plexitis or idiopathic neuralgic amyotro-
phy [INA] (aka Parsonage Turner syndrome) is a self- limiting 
inflammatory disorder usually affecting the unilateral BP, 
more commonly in males. Acute symptoms include neck, 
shoulder, and scapula pain. Muscle weakness ensues days 
or weeks after the initial pain, and the symptoms may last 
several months up to 3  years. MRN will show diffuse T2 
hyperintensity and enlargement of affected neural structures, 
commonly C5 and C6 nerve roots and the upper trunk, and 
denervation edema in various muscles that does not follow a 
typical innervation pattern (e.g., isolated edema in the teres 
minor muscle).
Although an autoimmune/inflammatory etiology has been 
hypothesized, a recent alternative theory is fascicular torsion 
which more frequently occurs in the suprascapular and radial 
nerves. MRN will reveal the characteristic “bulls’ eye sign” 
of central hypointensity surrounded by a hyperintense rim 
[23] (Fig. 20.8). MRN is also helpful in distinguishing INA 
from cervical spondylotic radiculopathy by demonstrating 
enlargement and increased signal intensity of cervical nerve 
roots at the level of foraminal stenosis, which correlate with 
the distribution of radicular pain and muscle weakness.
Idiopathic lumbosacral plexopathy (ILSP) is a self- limiting 
condition that presents with (sub)acute, severe, asymmetri-
cal leg pain, followed by asymmetrical multifocal weakness 
and atrophy in the subsequent weeks or months. Though 
some studies have hypothesized an immune- mediated etiol-
ogy, biopsies of distal cutaneous nerve segments have shown 
features of an inflammatory microvasculitis causing isch-
emic damage of the nerves [24]. Diabetic LSP neuropathy 
has similar clinical and pathological findings, suggesting that 
inflammation may form part of the final common pathway in 
both conditions. MRN shows increased signal intensity and 
mild contrast enhancement asymmetrically involving mul-
tiple nerve roots and terminal branches of the LSP as well 
muscle denervation changes.
LSP may be involved in retroperitoneal disorders, such 
as psoas abscess, hematoma, retroperitoneal fibrosis, and 
malignant disease (soft tissue or osseous), either by extrin-
sic compression or infiltration. Inflammatory sacroiliac joint 
arthritis may also involve the sacral component of the LSP.
Radiation plexopathy may manifest from a few months to 
years after brachytherapy or intraoperative radiation therapy, 
usually with doses exceeding 6000 cGy. This type of plexop-
athy is often painless and progresses slowly, in contradistinc-
tion to severely painful tumor-related plexopathy. Expected 
radiation-induced changes on MRN are uniform, symmet-
ric thickening, T2 hyperintensity, and faint to no contrast 
enhancement of BP and LSP within the irradiated region. It 
may be difficult to separate the neural structures from each 
other. Recurrent tumor often shows a focal or diffuse het-
a b
Fig. 20.8 62-year-old male with acute idiopathic neuralgic amyotrophy. (a) Axial T2 STIR, (b) axial T1. Swelling and increased signal intensity 
of the left radial nerve at mid-arm, with the bull’s eye sign (arrow)
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erogeneously enhancing mass [25]. Follow-up imaging is 
helpful to differentiate radiation-induced inflammation from 
tumor recurrence as the former will show fibrotic changes 
over time.
20.14  Thoracic Outlet Syndrome (TOS)
TOS includes three disorders involving the neurovascular 
bundle in its course through the interscalene triangle and 
costoclavicular space: classic TOS (or neurogenic TOS), 
vascular TOS, and non-specific TOS.  Classic TOS is the 
most frequent form, affecting middle-aged adults, especially 
women. It is characterized by chronic neck pain radiat-
ing to the supraclavicular region and arm, exacerbated by 
arm elevation, sometimes associated with paresthesias and 
numbness in C8/T1 dermatomes. Electrophysiological and 
clinical provocative tests are non-specific; however, MRI can 
reveal static or dynamic compression of the BP by structural 
abnormalities such as cervical or anomalous first rib, long 
C7 transverse process, muscular anomalies, or narrowed cos-
toclavicular space [26].
20.15  Immune-Mediated Neuropathies 
(Table 20.4)
Immune-mediated neuropathies are diagnosed clinically 
according to the distribution of deficits and based on elec-
trophysiology examination findings, laboratory parameters, 
and clinical context.
Guillain–Barre syndrome (GBS) or acute inflammatory 
demyelinating polyneuropathy (AIDP) is an acute syn-
drome, typically involving many nerves in a distal-to-proxi-
mal ascending distribution pattern. GBS is most commonly 
seen in the post respiratory or gastrointestinal tract infection 
or post-vaccination setting. MRI studies are usually not nec-
essary for diagnosis but may be needed to exclude “mimic 
disorders.” Initially, breakdown of the blood–nerve barrier is 
seen as intrathecal nerve root enhancement on MRI, particu-
larly of the anterior spinal nerve roots [27]. Chronic inflam-
matory demyelinating polyneuropathy (CIDP) is an acquired 
chronic, immune-mediated, multifocal, demyelinating neu-
ropathy. It is characterized by symmetrical proximal and 
distal weakness, with sensory loss, impaired balance, and 
areflexia and affects primarily the spinal nerves, BP and LSP 
plexi, and proximal nerve trunks but can also involve the cra-
nial nerves. CIDP is characterized by a broad spectrum of 
clinical phenotypes (~20% atypical) [28]. The most frequent 
MR imaging features are bilateral, symmetric hypertrophy 
and hyperintensity of the BP and LSP nerve roots, with grad-
ual normalization toward the distal segments [29] (Fig. 20.9). 
Patients with nerve root hypertrophy usually have a relaps-
ing–remitting course and a longer disease duration, which 
may be related to demyelination and remyelination.
Hereditary neuropathies such as Charcot–Marie–Tooth 
disease can mimic the appearance of CIDP on MRI with 
findings of focal or diffuse peripheral nerve enlargement 
and fatty degeneration of the involved muscles. The cross- 
sectional measurement of the sciatic nerve area in mid-thigh 
can be a helpful distinguishing feature [30].
Multifocal acquired demyelinating sensory and motor 
neuropathy (MADSAM) is characterized by an asymmet-
ric multifocal pattern of motor and sensory loss, conduc-
tion block, and other features of demyelination in nerve 
 conduction studies. Nerve hypertrophy is usually asymmet-
ric and multifocal in the peripheral nerve trunks [31].
Multifocal motor neuropathy (MMN) is a chronic, slowly 
progressive immune-mediated neuropathy, characterized by 
progressive, predominantly distal, asymmetric limb weak-
ness, mostly affecting upper limbs with minimal or no sensory 
impairment. The clinical presentation of MMN may mimic 
motor neuron disease, particularly in patients with predomi-
nant lower motor neuron impairment. MRI can be valuable to 
differentiate MMN from other neuropathies. About 40–50% 
of the patients with MMN show asymmetric hypertrophy and 
signal intensity abnormalities or contrast enhancement on 
MRI, and the pattern of signal alterations closely correlates 
with the distribution of muscle weakness [32].
20.16  Peripheral Nerve Tumors
The most common neurogenic tumors of the BP and LSP 
are schwannomas and neurofibromas. On MRI, peripheral 
nerve sheath tumors are typically fusiform or round-shaped 
soft tissue lesions in continuity with the nerve and show clas-
sic findings such as the target, fascicular, and tail signs on 
T2 images, split fat sign on T images, and the bag of worms 
sign for plexiform neurofibromas [33]. Conventional MRI 
sequences cannot reliably differentiate solitary neurofibro-
mas from schwannomas, although certain imaging features 
such as the surrounding T2 hypointense epineurium may be 
more typical of schwannomas than neurofibromas.
Table 20.4 MRI findings in inflammatory neuropathies
MRI Distribution
AIDP Enhancement of spinal nerve roots Bilateral and 
symmetrical
CIDP Hypertrophy and T2 hyperintensity 
of BP and LSP nerve roots, with 




MADSAM Hypertrophy and T2 hyperintensity 
of peripheral nerve trunks
Multifocal and 
asymmetrical
MMN Hypertrophy and T2 hyperintensity
Contrast enhancement of BP
Asymmetrical
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A schwannoma arises from a single nerve fascicle, tends to be 
encapsulated, and grows eccentrically, compressing normal adja-
cent axons [34]. Multiplanar 3D MRN can accurately display 
this anatomical relationship of a schwannoma attached to the 
main trunk of a nerve. Schwannomas are iso- to hypointense on 
T1 images and hyperintense T2 images and demonstrate variable 
enhancement, though more homogeneous than neurofibromas 
(Fig. 20.10). Approximately 40% of schwannomas may dem-
onstrate internal cystic change and 10% may show hemorrhage.
a b
Fig. 20.10 (a) Coronal STIR and (b) axial contrast-enhanced T1 images of a schwannoma demonstrate the origin from a single nerve (arrow) and 
STIR hyperintensity. The heterogeneous enhancement may reflect internal cystic change
a b
Fig. 20.9 50-year-old male, CIDP: 3D MRN, MIP views bilateral hypertrophy of the brachial (a) and lumbosacral plexus (b)
Key Point
• When MRN shows diffuse T2 hyperintensity and 
enlargement of affected neural structures in a patient 
with acute onset including neck, shoulder, and scap-
ula pain, look for the characteristic “bulls’ eye sign” 
to suggest idiopathic brachial plexitis or idiopathic 
neuralgic amyotrophy.
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A neurofibroma is composed of all peripheral nerve cel-
lular elements (Schwann cells, fibroblasts, perineural cells, 
and axons), grows diffusely within and along nerves, and is 
not encapsulated. The nerves expand radially while entrap-
ping native neural elements within the substance of the 
tumor. Approximately one-third of neurofibromas occur in 
the setting of neurocutaneous syndromes. Plexiform neuro-
fibromas are pathognomonic for neurofibromatosis I (NF1). 
Neurofibromas are isointense on T1 images with high periph-
eral signal and low-to-intermediate signal on T2 images 
(“target sign”), reflecting the distribution of myxoid material 
and fibrous tissue (Fig. 20.11). They tend to show variable 
contrast enhancement. Multiplanar 3D MRN illustrates that 
neurofibromas are not separated from the normal nerve.
Malignant peripheral nerve sheath tumors (MPNST) have 
higher prevalence in patients with NF1 and can develop as a 
long-term side effect of radiation therapy. Malignant degen-
eration of plexiform neurofibromas can occur in 5–13% of 
cases. The imaging distinction between benign nerve sheath 
tumors and MPNST can be challenging. Imaging features, 
such as advanced local invasion, bone destruction, poorly 
defined margins, absence of the target sign on T2 images, and 
larger size (>5 cm) suggest malignancy [34]. The combination 
of MRI findings (e.g., rapid growing, peripheral enhancement, 
peritumoral edema, intralesional cysts) has been reported 
to provide 61% sensitivity and 90% specificity in detect-
ing MPNST [35]. 18Fluorodeoxyglucose positron emission 
tomography is a complementary diagnostic tool, particularly 
for identifying tumors with aggressive behavior [36].
Intraneural perineurioma is a rare benign and slowly 
growing nerve tumor arising from the perineurial cells sur-
rounding the peripheral nerve fibers, most commonly occur-
ring in teenagers and young adults without sex predilection 
and presenting with progressive muscle weakness.
Because of the insidious clinical presentation, the diag-
nosis is often delayed. Perineuriomas have typical MRI fea-
tures: enlargement of the involved nerve over a considerable 
length, fusiform shape, mild increase in T2 signal inten-
sity, T1 isointense signal, and moderate to marked contrast 
enhancement. Individual fascicles are uniformly enlarged, 
and their preserved fascicular architecture gives a “honey-
comb” appearance on enhanced T1-fat-sat sequences.
Non-neurogenic tumors can cause plexopathy due to 
extrinsic compression or infiltration. Desmoid tumors, the 
most common non-neurogenic primary BP tumors, are isoin-
tense to muscle on T1 sequences and heterogeneously hyper-
intense on T2 sequences with areas of low T2 signal because 
of increased collagen content. They have infiltrative margins 
and show avid enhancement. Lipomas are characteristically 
isointense to fat on all MRI sequences and may externally 
compress BP and LSP.  Lymphoma can encase the plexi 
due to enlarged lymph nodes and, when primarily involv-
ing the nerve roots and trunks, demonstrates increased sig-
nal and nerve enlargement. In neurolymphomatosis, there is 
neoplastic endoneurial invasion, most often associated with 
non- Hodgkin’s lymphoma [37]. Prominent asymmetry, pain, 
and nodular MRI appearance may help distinguish neuro-
lymphomatosis from paraneoplastic immune demyelinating 
radiculoneuropathy. MRN shows T2/STIR hyperintensity, 
focal and diffuse nerve enlargement with fascicular disorga-
nization, and enhancement [37]. Primary neoplasms in close 
vicinity to the BP, such as bronchogenic carcinoma/Pancoast 
tumors of the thoracic apex (Fig. 20.12); neurogenic tumors 
of the vagus nerve, phrenic nerve, and sympathetic trunk; 
metastatic lymph nodes, and bone tumors can cause nerve 
irritation/compression or direct invasion into the BP. A help-
ful clue to identify a Pancoast tumor is to look for intermedi-
ate signal effacing the normal T1 fat signal superior to the 
lung apex, medial to the scalene muscles, and lateral to the 
spine. Axial images are useful to demonstrate possible para-
spinal extension of tumor in patients with complex symp-
toms, such as brachial plexopathy and Horner syndrome 
(second order neuron).
Fig. 20.11 Coronal MRN of a patient with NF1: neurofibroma of the 
left sciatic nerve with the “target” sign (empty arrow), neurofibroma 
with intermediate signal intensity of the pelvic floor (arrow), plexiform 
neurofibroma of the right sciatic nerve (double arrow)
Key Point
• MRN can accurately display the anatomical relation-
ship of a schwannoma attached to the main trunk of 
a nerve while a neurofibroma, composed of all 
peripheral nerve cellular elements, expands radially 
entrapping native neural elements within the tumor. 
A plexiform neurofibroma involves multiple nerve 
roots and has a “bag of worms” appearance. A peri-
neurioma shows fusiform enlargement and mild T2 
hyperintensity of the involved nerve and preserved 
fascicular architecture giving the “honeycomb” 
appearance on enhanced images.
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Non-tumoral masses, such as aneurysms/pseudoaneurysms 
can cause a compressive plexopathy. DTT can provide relevant 
topographical information on non-neurogenic soft tissue tumors 
and adjacent nerves when conventional MRI is unable to depict 
the course of the involved nerves or distinguish possible nerve 
infiltration [38]. DTT and low FA provide insight into neural 
integrity, with low diffusivity values indicating malignancy 
[10]. As increasing ADC suggests benignity of lesions, this dif-
fusion metric can also be potentially followed as a biomarker to 
detect tumor response/necrosis if the lesions are being followed 
longitudinally or after adjuvant medical treatment.
20.17  Concluding Remarks
Understanding of the brachial plexus and lumbosacral plexus 
anatomy is important for the accurate interpretation. Using 
an anatomic landmark-based approach to interrogate each 
individual component of the brachial plexus and lumbosacral 
plexus in combination with the direct and indirect imaging 
findings enables the development of a relevant differential 
diagnosis. By incorporating the clinical history, ancillary test 
results, and physical examination with the imaging findings, 
one can arrive at the correct diagnosis.
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